amphetamine - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:	amphetamine	go back to main search page
Accession:	CHEBI:2679	browse the term
Definition:	A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
Synonyms:	related_synonym:	1-Phenylpropan-2-amin; 1-phenyl-2-aminopropane; Amfetamine; Amphetamin; Benzedrine; alpha-methylbenzeneethaneamine; alpha-methylphenylethylamine; amfetamina; amfetaminum; amphetaminium; anfetamina; beta-Phenylisopropylamin; beta-aminopropylbenzene; beta-phenylisopropylamine; desoxynorephedrine; rac-(2R)-1-phenylpropan-2-amine; rac-amphetamine
	alt_id:	CHEBI:51062
	xref:	CAS:300-62-9; DrugBank:DB00182; Gmelin:406210; HMDB:HMDB0014328
	xref_mesh:	MESH:D000661
	xref:	Reaxys:507867; kegg.compound:C07514; kegg.drug:D07445; pubmed:23889359; pubmed:24408209; wikipedia.en:Amphetamine
	chemrof_formula:	C9H13N

show annotations for term's descendants Sort by:
Rat (2238 ) Mouse (2178 ) Human (2186 ) Chinchilla (0 ) Bonobo (0 ) Dog (0 ) Squirrel (0 ) Pig (0 ) Green Monkey (0) Naked Mole-rat (0 ) All
Genes (2238)

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATP binding cassette subfamily A member 2

decreases expression

EXP

Amphetamine results in decreased expression of ABCA2 mRNA

NCBI chr 3:28,642,660...28,662,689
Ensembl chr 3:28,642,758...28,662,681

G

ATP binding cassette subfamily B member 1A

decreases expression

EXP

Amphetamine results in decreased expression of ABCB1A mRNA

NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135

G

ATP binding cassette subfamily B member 7

decreases expression

EXP

Amphetamine results in decreased expression of ABCB7 mRNA

NCBI chr X:73,361,296...73,502,464
Ensembl chr X:73,361,310...73,502,547

G

ATP binding cassette subfamily C member 1

decreases expression

EXP

Amphetamine results in decreased expression of ABCC1 mRNA

NCBI chr10:1,022,041...1,162,431
Ensembl chr10:1,038,947...1,162,404

G

ATP binding cassette subfamily D member 2

increases expression

EXP

Amphetamine results in increased expression of ABCD2 mRNA

NCBI chr 7:124,142,597...124,191,202
Ensembl chr 7:124,142,595...124,191,202

G

ATP binding cassette subfamily G member 2

increases expression

EXP

Amphetamine results in increased expression of ABCG2 mRNA

NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493

G

ABI family, member 3

decreases expression

EXP

Amphetamine results in decreased expression of ABI3 mRNA

NCBI chr10:81,266,571...81,277,561
Ensembl chr10:81,266,571...81,277,561

G

actin binding transcription modulator

decreases expression

EXP

Amphetamine results in decreased expression of ABITRAM mRNA

NCBI chr 5:76,301,054...76,308,140
Ensembl chr 5:76,301,054...76,308,140

G

actin-binding LIM protein 1

decreases expression

EXP

Amphetamine results in decreased expression of ABLIM1 mRNA

NCBI chr 1:266,088,868...266,377,169
Ensembl chr 1:266,088,870...266,377,098

G

acetyl-CoA carboxylase alpha

decreases expression

EXP

Amphetamine results in decreased expression of ACACA mRNA

NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,511,857...69,773,888

G

acyl-CoA dehydrogenase family, member 10

decreases expression

EXP

Amphetamine results in decreased expression of ACAD10 mRNA

NCBI chr12:40,561,900...40,604,378
Ensembl chr12:40,566,701...40,604,378

G

angiotensin converting enzyme 2

increases expression

EXP

Amphetamine results in increased expression of ACE2 mRNA

NCBI chr X:33,925,458...33,972,851
Ensembl chr X:33,925,458...33,971,596

G

atypical chemokine receptor 3

increases expression

EXP

Amphetamine results in increased expression of ACKR3 mRNA; Amphetamine results in increased expression of CXCR7 mRNA

NCBI chr 9:98,247,300...98,258,877
Ensembl chr 9:98,246,605...98,260,214

G

acyl-CoA thioesterase 3

decreases expression

EXP

Amphetamine results in decreased expression of ACOT3 mRNA

NCBI chr 6:109,413,617...109,419,840
Ensembl chr 6:109,413,534...109,421,427
Ensembl chr 6:109,413,534...109,421,427

G

acyl-CoA thioesterase 7

increases expression

EXP

Amphetamine results in increased expression of ACOT7 mRNA

NCBI chr 5:167,969,284...168,062,033
Ensembl chr 5:167,968,895...168,062,033

G

acyl-CoA oxidase 1

increases expression

EXP

Amphetamine results in increased expression of ACOX1 mRNA

NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,905,083...101,930,136

G

acyl-CoA synthetase long-chain family member 3

decreases expression

EXP

Amphetamine results in decreased expression of ACSL3 mRNA

NCBI chr 9:87,563,601...87,613,078
Ensembl chr 9:87,563,601...87,613,097

G

acyl-CoA synthetase long-chain family member 4

increases expression

EXP

Amphetamine results in increased expression of ACSL4 mRNA

NCBI chr X:110,739,633...110,803,416
Ensembl chr X:110,739,648...110,803,261

G

acyl-CoA synthetase short-chain family member 1

decreases expression

EXP

Amphetamine results in decreased expression of ACSS1 mRNA

NCBI chr 3:159,910,809...159,960,748
Ensembl chr 3:159,910,809...159,960,748

G

actin, alpha, cardiac muscle 1

increases expression

EXP

Amphetamine results in increased expression of ACTC1 mRNA

NCBI chr 3:121,266,291...121,271,827
Ensembl chr 3:121,266,291...121,271,827

G

actin, gamma 1

increases expression

EXP

Amphetamine results in increased expression of ACTG1 mRNA

NCBI chr10:106,118,106...106,120,951
Ensembl chr10:106,118,108...106,120,951

G

ADAM metallopeptidase domain 15

increases expression

EXP

Amphetamine results in increased expression of ADAM15 mRNA

NCBI chr 2:177,052,363...177,062,879
Ensembl chr 2:177,052,363...177,062,849

G

ADAM metallopeptidase domain 8

increases expression

EXP

Amphetamine results in increased expression of ADAM8 mRNA

NCBI chr 1:204,206,206...204,218,988
Ensembl chr 1:204,206,199...204,218,485

G

ADAM metallopeptidase domain 9

increases expression

EXP

Amphetamine results in increased expression of ADAM9 mRNA

NCBI chr16:73,725,186...73,804,284
Ensembl chr16:73,725,114...73,804,646

G

ADAM metallopeptidase with thrombospondin type 1 motif, 10

decreases expression

EXP

Amphetamine results in decreased expression of ADAMTS10 mRNA

NCBI chr 7:15,033,859...15,063,800
Ensembl chr 7:15,033,934...15,063,800

G

ADAM metallopeptidase with thrombospondin type 1 motif, 9

increases expression

EXP

Amphetamine results in increased expression of ADAMTS9 mRNA

NCBI chr 4:126,847,726...127,019,924
Ensembl chr 4:126,847,729...127,019,876

G

ADAMTS-like 4

decreases expression

EXP

Amphetamine results in decreased expression of ADAMTSL4 mRNA

NCBI chr 2:185,924,582...185,936,039
Ensembl chr 2:185,924,594...185,935,796

G

adenosine deaminase, tRNA-specific 1

decreases expression

EXP

Amphetamine results in decreased expression of ADAT1 mRNA

NCBI chr19:56,825,153...56,866,136
Ensembl chr19:56,826,849...56,866,117

G

aarF domain containing kinase 1

decreases expression

EXP

Amphetamine results in decreased expression of ADCK1 mRNA

NCBI chr 6:113,005,333...113,107,960
Ensembl chr 6:113,008,111...113,132,359

G

adenylate cyclase 10

increases expression

EXP

Amphetamine results in increased expression of ADCY10 mRNA

NCBI chr13:80,280,595...80,366,939
Ensembl chr13:80,284,295...80,366,926

G

adenylate cyclase 3

decreases expression

EXP

Amphetamine results in decreased expression of ADCY3 mRNA

NCBI chr 6:32,819,602...32,923,174
Ensembl chr 6:32,843,961...32,923,173

G

adenylate cyclase 4

increases expression

EXP

Amphetamine results in increased expression of ADCY4 mRNA

NCBI chr15:33,236,201...33,252,070
Ensembl chr15:33,236,208...33,252,026

G

adenylate cyclase 6

decreases expression

EXP

Amphetamine results in decreased expression of ADCY6 mRNA

NCBI chr 7:131,621,860...131,642,923
Ensembl chr 7:131,621,860...131,642,770

G

adhesion G protein-coupled receptor B2

increases expression

EXP

Amphetamine results in increased expression of ADGRB2 mRNA

NCBI chr 5:147,581,573...147,646,726
Ensembl chr 5:147,611,580...147,646,726

G

adhesion G protein-coupled receptor E1

decreases expression

EXP

Amphetamine results in decreased expression of ADGRE1 mRNA

NCBI chr 9:2,329,398...2,484,959
Ensembl chr 9:2,329,438...2,484,959

G

adhesion G protein-coupled receptor E4

decreases expression

EXP

Amphetamine results in decreased expression of EMR4 mRNA

NCBI chr 9:10,085,258...10,240,346
Ensembl chr 9:10,085,352...10,240,229

G

adhesion G protein-coupled receptor E5

increases expression

EXP

Amphetamine results in increased expression of ADGRE5 mRNA

NCBI chr19:41,302,687...41,332,183
Ensembl chr19:41,303,213...41,324,641

G

adhesion G protein-coupled receptor F1

decreases expression

EXP

Amphetamine results in decreased expression of ADGRF1 mRNA

NCBI chr 9:25,158,198...25,210,744
Ensembl chr 9:25,147,588...25,208,916

G

adhesion G protein-coupled receptor F5

increases expression

EXP

Amphetamine results in increased expression of ADGRF5 mRNA

NCBI chr 9:25,014,861...25,128,045
Ensembl chr 9:25,018,277...25,121,237

G

adhesion G protein-coupled receptor G2

increases expression

EXP

Amphetamine results in increased expression of ADGRG2 mRNA

NCBI chr X:38,106,067...38,231,286
Ensembl chr X:38,106,067...38,231,331

G

adhesion G protein-coupled receptor G5

increases expression

EXP

Amphetamine results in increased expression of ADGRG5 mRNA

NCBI chr19:10,080,800...10,104,659
Ensembl chr19:10,085,388...10,103,220

G

adhesion G protein-coupled receptor G6

increases expression

EXP

Amphetamine results in increased expression of ADGRG6 mRNA

NCBI chr 1:10,633,004...10,774,685
Ensembl chr 1:10,631,829...10,774,023

G

adhesion G protein-coupled receptor L1

decreases expression

EXP

Amphetamine results in decreased expression of ADGRL1 mRNA

NCBI chr19:41,107,162...41,148,752
Ensembl chr19:41,109,117...41,148,896

G

adhesion G protein-coupled receptor L4

increases expression

EXP

Amphetamine results in increased expression of ELTD1 mRNA

NCBI chr 2:243,014,927...243,117,226
Ensembl chr 2:243,014,796...243,117,222

G

adiponectin, C1Q and collagen domain containing

increases expression

EXP

Amphetamine results in increased expression of ADIPOQ mRNA

NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169

G

adenosine A2a receptor

multiple interactions
affects response to substance
increases response to substance

ISO

ADORA2A protein affects the reaction [Amphetamine results in increased expression of PDYN mRNA]
ADORA2A protein affects the susceptibility to Amphetamine
ADORA2A protein results in increased susceptibility to Amphetamine
ADORA2A gene polymorphism results in increased susceptibility to Amphetamine

PMID:12700712 PMID:16118787

NCBI chr20:13,315,270...13,332,802
Ensembl chr20:13,315,270...13,332,802

G

adrenoceptor alpha 1D

affects response to substance

ISO

ADRA1D protein affects the susceptibility to Amphetamine

NCBI chr 3:139,246,333...139,262,331
Ensembl chr 3:139,246,323...139,262,331

G

adrenoceptor alpha 2C

decreases response to substance

ISO

ADRA2C protein results in decreased susceptibility to Amphetamine

NCBI chr14:79,695,514...79,697,476
Ensembl chr14:79,694,995...79,706,656

G

ALF transcription elongation factor 3

decreases expression

EXP

Amphetamine results in decreased expression of AFF3 mRNA

NCBI chr 9:47,894,903...48,352,380
Ensembl chr 9:47,894,903...48,353,000

G

AGBL carboxypeptidase 5

decreases expression

EXP

Amphetamine results in decreased expression of AGBL5 mRNA

NCBI chr 6:31,192,281...31,213,494
Ensembl chr 6:31,191,635...31,210,676

G

agmatinase

increases expression

EXP

Amphetamine results in increased expression of AGMAT mRNA

NCBI chr 5:159,326,680...159,357,300
Ensembl chr 5:159,343,160...159,357,299

G

argonaute RISC component 1

decreases expression

EXP

Amphetamine results in decreased expression of AGO1 mRNA

NCBI chr 5:144,006,618...144,064,740
Ensembl chr 5:144,006,618...144,041,624

G

1-acylglycerol-3-phosphate O-acyltransferase 2

increases expression

EXP

Amphetamine results in increased expression of AGPAT2 mRNA

NCBI chr 3:29,814,924...29,826,569
Ensembl chr 3:29,814,924...29,826,581

G

1-acylglycerol-3-phosphate O-acyltransferase 3

decreases expression

EXP

Amphetamine results in decreased expression of AGPAT3 mRNA

NCBI chr20:10,330,650...10,415,026
Ensembl chr20:10,394,465...10,410,632

G

alkylglycerone phosphate synthase

decreases expression

EXP

Amphetamine results in decreased expression of AGPS mRNA

NCBI chr 3:81,154,599...81,253,099
Ensembl chr 3:81,154,604...81,258,277

G

agrin

increases expression

EXP

Amphetamine results in increased expression of AGRN mRNA

NCBI chr 5:172,031,528...172,064,429
Ensembl chr 5:172,031,528...172,064,539

G

AT hook, DNA binding motif, containing 1

decreases expression

EXP

Amphetamine results in decreased expression of AHDC1 mRNA

NCBI chr 5:150,512,182...150,578,804
Ensembl chr 5:150,512,037...150,583,144

G

activation-induced cytidine deaminase

decreases expression

EXP

Amphetamine results in decreased expression of APOBEC3B mRNA

NCBI chr 4:157,446,120...157,455,958
Ensembl chr 4:157,444,697...157,456,356

G

allograft inflammatory factor 1

increases expression

EXP

Amphetamine results in increased expression of AIF1 mRNA

NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,652,243...3,657,339

G

androgen-induced 1

increases expression

EXP

Amphetamine results in increased expression of AIG1 mRNA

NCBI chr 1:9,866,546...10,089,454
Ensembl chr 1:9,866,548...10,089,155

G

adenylate kinase 1

increases expression

EXP

Amphetamine results in increased expression of AK1 mRNA

NCBI chr 3:36,310,113...36,320,760
Ensembl chr 3:36,310,197...36,320,757

G

A-kinase anchoring protein 1

decreases expression

EXP

Amphetamine results in decreased expression of AKAP1 mRNA

NCBI chr10:74,118,232...74,151,366
Ensembl chr10:74,119,124...74,138,190

G

A-kinase anchoring protein 17A

decreases expression

EXP

Amphetamine results in decreased expression of AKAP17B mRNA

NCBI chr12:21,424,202...21,428,308
Ensembl chr12:21,424,202...21,428,247

G

aldo-keto reductase family 1 member B15

increases expression

EXP

Amphetamine results in increased expression of AKR1B8 mRNA

NCBI chr 4:63,964,421...63,976,995
Ensembl chr 4:63,960,880...63,978,349

G

aldo-keto reductase family 1 member C8

increases expression

EXP

Amphetamine results in increased expression of AKR1CL mRNA

NCBI chr17:71,091,398...71,117,985
Ensembl chr17:71,083,080...71,117,957

G

AKT serine/threonine kinase 1

affects response to substance

ISO

AKT1 protein affects the susceptibility to Amphetamine

NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610

G

aminolevulinate dehydratase

multiple interactions

ISO

Amphetamine promotes the reaction [MDK gene mutant form results in increased expression of ALAD protein]

NCBI chr 5:80,977,562...80,987,901
Ensembl chr 5:80,977,562...80,988,041

G

albumin

decreases expression

EXP

Amphetamine results in decreased expression of ALB mRNA

NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865

G

aldehyde dehydrogenase 1 family, member A1

multiple interactions
decreases expression

ISO

MDK gene mutant form promotes the reaction [Amphetamine results in decreased expression of ALDH1A1 protein]

NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500

G

alkB homolog 8, tRNA methyltransferase

decreases expression

EXP

Amphetamine results in decreased expression of ALKBH8 mRNA

NCBI chr 6:6,121,402...6,198,226
Ensembl chr 6:6,124,253...6,198,080

G

ALMS1, centrosome and basal body associated protein

decreases expression

EXP

Amphetamine results in decreased expression of ALMS1 mRNA

NCBI chr 4:119,683,085...119,783,471
Ensembl chr 4:119,683,076...119,783,471

G

arachidonate 12-lipoxygenase, epidermal

decreases expression

EXP

Amphetamine results in decreased expression of ALOX12E mRNA

NCBI chr10:55,533,044...55,540,509
Ensembl chr10:55,533,044...55,540,509

G

arachidonate 5-lipoxygenase activating protein

increases expression

EXP

Amphetamine results in increased expression of ALOX5AP mRNA

NCBI chr12:10,785,254...10,809,295
Ensembl chr12:10,785,257...10,817,038

G

alkaline phosphatase, placental

multiple interactions

ISO

Amphetamine promotes the reaction [Isoproterenol results in increased expression of ALPP mRNA]

NCBI chr 9:95,213,763...95,216,509
Ensembl chr 9:95,213,374...95,219,451

G

APC membrane recruitment protein 1

decreases expression

EXP

Amphetamine results in decreased expression of AMER1 mRNA

NCBI chr X:64,310,492...64,326,377
Ensembl chr X:64,300,953...64,326,332

G

anti-Mullerian hormone receptor type 2

increases expression

EXP

Amphetamine results in increased expression of AMHR2 mRNA

NCBI chr 7:135,454,517...135,470,183
Ensembl chr 7:135,457,922...135,471,104

G

adhesion molecule with Ig like domain 1

decreases expression

EXP

Amphetamine results in decreased expression of AMIGO1 mRNA

NCBI chr 2:198,511,285...198,516,744
Ensembl chr 2:198,511,039...198,521,146

G

antagonist of mitotic exit network 1 homolog

increases expression

EXP

Amphetamine results in increased expression of AMN1 mRNA

NCBI chr 4:183,886,469...183,913,411
Ensembl chr 4:183,886,474...183,913,411

G

angiomotin like 2

increases expression

EXP

Amphetamine results in increased expression of AMOTL2 mRNA

NCBI chr 8:112,182,060...112,198,032
Ensembl chr 8:112,181,863...112,198,030

G

adenosine monophosphate deaminase 3

increases expression

EXP

Amphetamine results in increased expression of AMPD3 mRNA

NCBI chr 1:174,319,526...174,364,605
Ensembl chr 1:174,294,867...174,364,608

G

anaphase promoting complex subunit 1

decreases expression

EXP

Amphetamine results in decreased expression of ANAPC1 mRNA

NCBI chr 3:136,303,350...136,383,464
Ensembl chr 3:136,303,413...136,383,464

G

angiopoietin-like 4

increases expression

EXP

Amphetamine results in increased expression of ANGPTL4 mRNA

NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:15,252,473...15,258,681

G

ANKH inorganic pyrophosphate transport regulator

decreases expression

EXP

Amphetamine results in decreased expression of ANKH mRNA

NCBI chr 2:79,883,350...80,011,222
Ensembl chr 2:79,883,544...80,011,699

G

ankyrin repeat domain 1

increases expression

EXP

Amphetamine results in increased expression of ANKRD1 mRNA

NCBI chr 1:243,228,460...243,237,014
Ensembl chr 1:243,228,448...243,263,751

G

ankyrin repeat domain 13D

decreases expression

EXP

Amphetamine results in decreased expression of ANKRD13D mRNA

NCBI chr 1:210,995,012...211,007,430
Ensembl chr 1:210,995,148...211,007,369

G

ankyrin repeat domain containing 26

decreases expression

EXP

Amphetamine results in decreased expression of ANKRD26 mRNA

NCBI chr 4:153,342,901...153,412,321
Ensembl chr 4:153,343,578...153,412,256

G

ankyrin repeat domain 37

increases expression

EXP

Amphetamine results in increased expression of ANKRD37 mRNA

NCBI chr16:53,001,487...53,004,545
Ensembl chr16:52,994,740...53,004,545

G

ankyrin repeat domain 42

increases expression

EXP

Amphetamine results in increased expression of ANKRD42 mRNA

NCBI chr 1:156,060,516...156,103,543
Ensembl chr 1:156,060,516...156,103,517

G

ankyrin repeat domain 45

decreases expression

EXP

Amphetamine results in decreased expression of ANKRD45 mRNA

NCBI chr13:75,957,047...75,984,868
Ensembl chr13:75,957,926...75,984,910

G

ankyrin repeat domain containing 50

decreases expression

EXP

Amphetamine results in decreased expression of ANKRD50 mRNA

NCBI chr 2:123,394,311...123,428,788
Ensembl chr 2:123,396,606...123,427,340

G

ankyrin repeat domain 52

decreases expression

EXP

Amphetamine results in decreased expression of ANKRD52 mRNA

NCBI chr 7:1,390,730...1,410,139
Ensembl chr 7:1,391,325...1,407,410

G

ankyrin repeat domain 9

increases expression

EXP

Amphetamine results in increased expression of ANKRD9 mRNA

NCBI chr 6:135,827,355...135,830,002
Ensembl chr 6:135,775,869...135,837,893

G

ankyrin repeat and sterile alpha motif domain containing 3

decreases expression

EXP

Amphetamine results in decreased expression of ANKS3 mRNA

NCBI chr10:11,121,504...11,142,261
Ensembl chr10:11,121,553...11,142,491

G

anoctamin 1

increases expression

EXP

Amphetamine results in increased expression of ANO1 mRNA

NCBI chr 1:209,180,755...209,329,413
Ensembl chr 1:209,180,755...209,329,550

G

anoctamin 10

increases expression

EXP

Amphetamine results in increased expression of ANO10 mRNA

NCBI chr 8:130,719,177...130,838,243
Ensembl chr 8:130,718,755...130,877,636

G

anoctamin 8

decreases expression

EXP

Amphetamine results in decreased expression of ANO8 mRNA

NCBI chr16:18,197,829...18,207,205
Ensembl chr16:18,197,001...18,207,234

G

anoctamin 9

decreases expression

EXP

Amphetamine results in decreased expression of ANO9 mRNA

NCBI chr 1:205,638,571...205,659,780
Ensembl chr 1:205,638,572...205,659,489

G

annexin A1

increases expression

EXP

Amphetamine results in increased expression of ANXA1 mRNA

NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:227,287,717...227,306,831

G

annexin A2

increases expression

EXP

Amphetamine results in increased expression of ANXA2 mRNA

NCBI chr 8:78,986,252...79,022,638
Ensembl chr 8:78,986,242...79,022,631

G

annexin A4

increases expression

EXP

Amphetamine results in increased expression of ANXA4 mRNA

NCBI chr 4:120,741,750...120,798,534
Ensembl chr 4:120,741,750...120,798,513

G

annexin A7

multiple interactions

ISO

[PTN gene mutant form results in increased susceptibility to Amphetamine] which results in decreased expression of ANXA7 protein

NCBI chr15:3,869,180...3,897,827
Ensembl chr15:3,870,974...3,898,891

G

adaptor related protein complex 4 subunit mu 1

decreases expression

EXP

Amphetamine results in decreased expression of AP4M1 mRNA

NCBI chr12:22,163,474...22,171,734
Ensembl chr12:22,163,466...22,171,731

G

amyloid beta precursor protein binding family B member 1

decreases expression

EXP

Amphetamine results in decreased expression of APBB1 mRNA

NCBI chr 1:169,308,719...169,332,372
Ensembl chr 1:169,308,720...169,332,552

G

amyloid beta precursor protein binding family B member 2

decreases expression

EXP

Amphetamine results in decreased expression of APBB2 mRNA

NCBI chr14:41,849,638...42,232,930
Ensembl chr14:41,911,785...42,232,280

G

aph-1 homolog B, gamma secretase subunit

increases expression

EXP

Amphetamine results in increased expression of APH1B mRNA

NCBI chr 8:76,310,380...76,334,146
Ensembl chr 8:76,310,380...76,331,428

G

apolipoprotein B mRNA editing enzyme catalytic subunit 1

increases expression

EXP

Amphetamine results in increased expression of APOBEC1 mRNA

NCBI chr 4:157,472,879...157,500,496
Ensembl chr 4:157,472,868...157,498,909

G

apolipoprotein B receptor

increases expression

EXP

Amphetamine results in increased expression of APOBR mRNA

NCBI chr 1:190,599,595...190,603,782
Ensembl chr 1:190,597,638...190,616,809

G

aquaporin 12A

increases expression

EXP

Amphetamine results in increased expression of AQP12A mRNA

NCBI chr 9:101,001,939...101,007,425
Ensembl chr 9:101,001,939...101,007,425

G

aquaporin 7

increases expression

EXP

Amphetamine results in increased expression of AQP7 mRNA

NCBI chr 5:60,968,495...60,982,618
Ensembl chr 5:60,967,558...60,982,618

G

aquaporin 9

increases expression

EXP

Amphetamine results in increased expression of AQP9 mRNA

NCBI chr 8:80,678,027...80,718,273
Ensembl chr 8:80,678,030...80,717,240

G

ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3

increases expression

EXP

Amphetamine results in increased expression of ARAP3 mRNA

NCBI chr18:30,058,739...30,085,415
Ensembl chr18:30,058,275...30,084,865

G

activity-regulated cytoskeleton-associated protein

decreases expression
increases expression
increases expression

EXP
ISO

Amphetamine results in decreased expression of ARC mRNA
Amphetamine results in increased expression of ARC mRNA; Amphetamine results in increased expression of ARC protein
Amphetamine increases expression of Arc mRNA in brain

CTD
RGD

PMID:11879792 PMID:12638131 PMID:14596895 PMID:15183010 PMID:20223277 More...

NCBI chr 7:108,444,959...108,448,413
Ensembl chr 7:108,444,692...108,451,220

G

ADP-ribosylation factor 2

increases expression

EXP

Amphetamine results in increased expression of ARF2 mRNA

NCBI chr10:89,367,843...89,389,644
Ensembl chr10:89,368,044...89,389,651

G

ARF GTPase activating protein 3

increases expression

EXP

Amphetamine results in increased expression of ARFGAP3 mRNA

NCBI chr 7:116,312,996...116,359,300
Ensembl chr 7:116,313,001...116,359,592

G

Rho GTPase activating protein 18

increases expression

EXP

Amphetamine results in increased expression of ARHGAP18 mRNA

NCBI chr 1:20,222,948...20,456,827
Ensembl chr 1:20,222,954...20,456,670

G

Rho GTPase activating protein 27

decreases expression

EXP

Amphetamine results in decreased expression of ARHGAP27 mRNA

NCBI chr10:88,780,527...88,813,275
Ensembl chr10:88,780,527...88,814,616

G

Rho GTPase activating protein 35

decreases expression

EXP

Amphetamine results in decreased expression of ARHGAP35 mRNA

NCBI chr 1:86,330,566...86,447,414
Ensembl chr 1:86,330,566...86,447,414

G

Rho/Rac guanine nucleotide exchange factor 18

decreases expression

EXP

Amphetamine results in decreased expression of ARHGEF18 mRNA

NCBI chr12:6,192,958...6,300,997
Ensembl chr12:6,128,661...6,300,997

G

Rac/Cdc42 guanine nucleotide exchange factor 6

decreases expression

EXP

Amphetamine results in decreased expression of ARHGEF6 mRNA

NCBI chr X:140,182,734...140,302,812
Ensembl chr X:140,182,734...140,344,458

G

AT-rich interaction domain 2

decreases expression

EXP

Amphetamine results in decreased expression of ARID2 mRNA

NCBI chr 7:129,326,371...129,443,813
Ensembl chr 7:129,324,137...129,443,187

G

ARF like GTPase 5C

decreases expression

EXP

Amphetamine results in decreased expression of ARL5C mRNA

NCBI chr10:83,481,540...83,492,915
Ensembl chr10:83,481,540...83,488,406

G

armadillo repeat containing, X-linked 3

increases expression

EXP

Amphetamine results in increased expression of ARMCX3 mRNA

NCBI chr X:102,230,464...102,234,017
Ensembl chr X:102,219,848...102,263,297

G

actin related protein 2/3 complex, subunit 3

increases expression

EXP

Amphetamine results in increased expression of ARPC3 mRNA

NCBI chr12:39,833,569...39,847,436
Ensembl chr12:39,833,569...39,847,436

G

cAMP regulated phosphoprotein 21

decreases expression

EXP

Amphetamine results in decreased expression of ARPP21 mRNA

NCBI chr 8:120,912,964...121,077,586
Ensembl chr 8:120,912,970...121,031,357

G

arrestin, beta 1

decreases expression

EXP

Amphetamine results in decreased expression of ARRB1 mRNA

NCBI chr 1:163,249,654...163,321,711
Ensembl chr 1:163,250,157...163,340,859

G

arrestin domain containing 3

increases expression

EXP

Amphetamine results in increased expression of ARRDC3 mRNA

NCBI chr 2:12,873,202...12,885,716
Ensembl chr 2:12,873,202...12,885,875

G

ADP-ribosyltransferase 3

increases expression

EXP

Amphetamine results in increased expression of ART3 mRNA

NCBI chr14:15,921,540...16,003,764
Ensembl chr14:15,921,395...15,949,806

G

ARVCF, delta catenin family member

decreases expression

EXP

Amphetamine results in decreased expression of ARVCF mRNA

NCBI chr11:96,092,451...96,150,144
Ensembl chr11:96,092,451...96,150,163

G

ankyrin repeat and SOCS box-containing 13

decreases expression

EXP

Amphetamine results in decreased expression of ASB13 mRNA

NCBI chr17:71,474,531...71,493,238
Ensembl chr17:71,474,531...71,505,633

G

acid sensing ion channel subunit 1

increases expression

EXP

Amphetamine results in increased expression of ASIC1 protein

NCBI chr 7:132,677,158...132,707,379
Ensembl chr 7:132,698,723...132,707,832

G

acid sensing ion channel subunit 2

affects localization

EXP

Amphetamine affects the localization of ASIC2 protein

NCBI chr10:66,368,308...67,438,237
Ensembl chr10:66,368,310...66,636,245

G

argininosuccinate lyase

increases expression

EXP

Amphetamine results in increased expression of ASL mRNA

NCBI chr12:32,295,779...32,313,257
Ensembl chr12:32,295,633...32,317,261

G

acetylserotonin O-methyltransferase-like

increases expression

EXP

Amphetamine results in increased expression of ASMTL mRNA

NCBI chr12:21,429,119...21,431,847
Ensembl chr12:21,429,171...21,431,847

G

asparagine synthetase (glutamine-hydrolyzing)

increases expression

EXP

Amphetamine results in increased expression of ASNS mRNA

NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050

G

asparaginase and isoaspartyl peptidase 1

increases expression

EXP

Amphetamine results in increased expression of ASRGL1 mRNA

NCBI chr 1:215,436,180...215,456,188
Ensembl chr 1:215,435,218...215,456,198

G

argininosuccinate synthase 1

increases expression

EXP

Amphetamine results in increased expression of ASS1 mRNA

NCBI chr 3:35,144,765...35,194,632
Ensembl chr 3:35,144,999...35,194,627

G

ATPase family, AAA domain containing 5

decreases expression

EXP

Amphetamine results in decreased expression of ATAD5 mRNA

NCBI chr10:65,568,569...65,616,379
Ensembl chr10:65,568,591...65,616,376

G

ATCAY kinesin light chain interacting caytaxin

decreases expression

EXP

Amphetamine results in decreased expression of ATCAY mRNA

NCBI chr 7:9,138,485...9,162,249
Ensembl chr 7:9,138,587...9,163,370

G

activating transcription factor 3

increases expression

EXP

Amphetamine results in increased expression of ATF3 mRNA

NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750

G

activating transcription factor 4

increases expression

EXP

Amphetamine results in increased expression of ATF4 mRNA

NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739

G

activating transcription factor 7

decreases expression

EXP

Amphetamine results in decreased expression of ATF7 mRNA

NCBI chr 7:135,537,351...135,649,188
Ensembl chr 7:135,542,111...135,599,899

G

ATM serine/threonine kinase

decreases expression

EXP

Amphetamine results in decreased expression of ATM mRNA

NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:62,727,291...62,828,629

G

ATPase 13A3

decreases expression

EXP

Amphetamine results in decreased expression of ATP13A3 mRNA

NCBI chr11:83,860,725...83,946,899
Ensembl chr11:83,870,218...83,944,662

G

ATPase plasma membrane Ca2+ transporting 4

decreases expression

EXP

Amphetamine results in decreased expression of ATP2B4 mRNA

NCBI chr13:47,708,157...47,807,389
Ensembl chr13:47,711,121...47,758,876

G

ATP synthase F1 subunit alpha

multiple interactions
decreases expression

ISO

Amphetamine promotes the reaction [MDK gene mutant form results in decreased expression of ATP5F1A protein]; Amphetamine promotes the reaction [PTN gene mutant form results in decreased expression of ATP5F1A protein]
Amphetamine results in decreased expression of ATP5F1A protein

NCBI chr18:73,567,537...73,575,473
Ensembl chr18:73,567,526...73,575,922

G

ATP synthase F1 subunit delta

multiple interactions
decreases expression

ISO

Amphetamine inhibits the reaction [MDK gene mutant form results in decreased expression of ATP5F1D protein]; PTN gene mutant form inhibits the reaction [Amphetamine results in decreased expression of ATP5F1D protein]

NCBI chr 7:10,211,260...10,218,989
Ensembl chr 7:10,211,262...10,216,583

G

ATPase H+ transporting accessory protein 2

increases expression

EXP

Amphetamine results in increased expression of ATP6AP2 mRNA

NCBI chr X:12,856,708...12,883,670
Ensembl chr X:12,855,859...12,905,875

G

ATPase H+ transporting V0 subunit a2

decreases expression

EXP

Amphetamine results in decreased expression of ATP6V0A2 mRNA

NCBI chr12:37,608,211...37,640,860
Ensembl chr12:37,472,813...37,640,860

G

ATPase H+ transporting V0 subunit B

increases expression

EXP

Amphetamine results in increased expression of ATP6V0B mRNA

NCBI chr 5:136,708,823...136,710,339
Ensembl chr 5:136,708,823...136,716,828

G

ATPase H+ transporting V0 subunit C

increases expression

EXP

Amphetamine results in increased expression of ATP6V0C mRNA

NCBI chr10:13,700,764...13,707,147
Ensembl chr10:13,700,764...13,706,245

G

ATPase H+ transporting V1 subunit B2

increases expression

EXP

Amphetamine results in increased expression of ATP6V1B2 mRNA

NCBI chr16:25,384,254...25,408,388
Ensembl chr16:25,384,257...25,408,839

G

ATPase H+ transporting V1 subunit C1

increases expression

EXP

Amphetamine results in increased expression of ATP6V1C1 mRNA

NCBI chr 7:71,719,326...71,757,191
Ensembl chr 7:71,719,404...71,757,184

G

ATPase H+ transporting V1 subunit G1

increases expression

EXP

Amphetamine results in increased expression of ATP6V1G1 mRNA

NCBI chr 5:81,976,959...81,983,139
Ensembl chr 5:81,977,015...81,985,930

G

ATPase H+ transporting V1 subunit G3

decreases expression

EXP

Amphetamine results in decreased expression of ATP6V1G3 mRNA

NCBI chr13:52,351,787...52,376,784
Ensembl chr13:52,351,801...52,375,594

G

ATPase phospholipid transporting 8B2

decreases expression

EXP

Amphetamine results in decreased expression of ATP8B2 mRNA

NCBI chr 2:177,676,205...177,699,575
Ensembl chr 2:177,676,208...177,699,575

G

ATPase phospholipid transporting 8B4 (putative)

increases expression

EXP

Amphetamine results in increased expression of ATP8B4 mRNA

NCBI chr 3:134,008,367...134,212,394
Ensembl chr 3:134,009,580...134,210,260

G

ATR serine/threonine kinase

decreases expression

EXP

Amphetamine results in decreased expression of ATR mRNA

NCBI chr 8:105,306,299...105,403,742
Ensembl chr 8:105,306,305...105,403,718

G

ataxin 7

decreases expression

EXP

Amphetamine results in decreased expression of ATXN7 mRNA

NCBI chr15:13,547,859...13,693,311
Ensembl chr15:13,547,862...13,693,526

G

arginine vasopressin-induced 1

increases expression

EXP

Amphetamine results in increased expression of AVPI1 mRNA

NCBI chr 1:250,879,530...250,885,448
Ensembl chr 1:250,879,530...250,885,704

G

axin 2

decreases expression

EXP

Amphetamine results in decreased expression of AXIN2 mRNA

NCBI chr10:94,393,379...94,426,579
Ensembl chr10:94,395,909...94,426,575

G

Beta-1,3-galactosyltransferase 5

decreases expression

EXP

Amphetamine results in decreased expression of B3GALT5 mRNA

NCBI chr11:49,053,959...49,100,398
Ensembl chr11:49,006,560...49,101,283

G

beta-1,4-galactosyltransferase 3

increases expression

EXP

Amphetamine results in increased expression of B4GALT3 mRNA

NCBI chr13:86,223,827...86,229,886
Ensembl chr13:86,223,899...86,229,888

G

beta-1,4-galactosyltransferase 5

increases expression

EXP

Amphetamine results in increased expression of B4GALT5 mRNA

NCBI chr 3:176,437,073...176,453,001
Ensembl chr 3:176,437,073...176,488,978

G

B9 domain containing 2

increases expression

EXP

Amphetamine results in increased expression of B9D2 mRNA

NCBI chr 1:90,315,472...90,323,143
Ensembl chr 1:90,317,200...90,323,175

G

BTB domain and CNC homolog 2

decreases expression

EXP

Amphetamine results in decreased expression of BACH2 mRNA

NCBI chr 5:51,428,802...51,779,030
Ensembl chr 5:51,434,870...51,774,234

G

BCL2-associated agonist of cell death

increases expression

EXP

Amphetamine results in increased expression of BAD mRNA

NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034

G

BAI1-associated protein 3

decreases expression

EXP

Amphetamine results in decreased expression of BAIAP3 mRNA

NCBI chr10:14,764,768...14,777,516
Ensembl chr10:14,756,693...14,777,516

G

BMP and activin membrane-bound inhibitor

increases expression

EXP

Amphetamine results in increased expression of BAMBI mRNA

NCBI chr17:58,816,438...58,821,003
Ensembl chr17:58,816,442...58,821,247

G

B-cell scaffold protein with ankyrin repeats 1

decreases expression

EXP

Amphetamine results in decreased expression of BANK1 mRNA

NCBI chr 2:227,203,998...227,474,008
Ensembl chr 2:227,203,998...227,474,037

G

basic leucine zipper ATF-like transcription factor 3

increases expression

EXP

Amphetamine results in increased expression of BATF3 mRNA

NCBI chr13:105,220,782...105,232,365
Ensembl chr13:105,220,390...105,232,369

G

BCL2 associated X, apoptosis regulator

increases expression
increases response to substance

ISO

Amphetamine results in increased expression of BAX mRNA; Amphetamine results in increased expression of BAX protein
BAX protein results in increased susceptibility to Amphetamine

NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429

G

bromodomain adjacent to zinc finger domain, 1A

increases expression

EXP

Amphetamine results in increased expression of BAZ1A mRNA

NCBI chr 6:78,124,872...78,247,672
Ensembl chr 6:78,124,872...78,247,648

G

bromodomain adjacent to zinc finger domain, 2A

decreases expression

EXP

Amphetamine results in decreased expression of BAZ2A mRNA

NCBI chr 7:1,107,377...1,145,507
Ensembl chr 7:1,107,796...1,145,507

G

bromodomain adjacent to zinc finger domain, 2B

increases expression

EXP

Amphetamine results in increased expression of BAZ2B mRNA

NCBI chr 3:64,792,984...65,034,547
Ensembl chr 3:64,794,001...65,001,781

G

BBSome interacting protein 1

increases expression

EXP

Amphetamine results in increased expression of BBIP1 mRNA

NCBI chr 1:262,950,459...262,964,410
Ensembl chr 1:262,950,462...262,964,394

G

BCAR3 adaptor protein, NSP family member

decreases expression

EXP

Amphetamine results in decreased expression of BCAR3 mRNA

NCBI chr 2:213,209,907...213,323,305
Ensembl chr 2:213,209,893...213,323,302

G

branched chain keto acid dehydrogenase E1 subunit beta

decreases expression

EXP

Amphetamine results in decreased expression of BCKDHB mRNA

NCBI chr 8:93,725,277...93,907,799
Ensembl chr 8:93,725,275...93,907,798

G

BCL11 transcription factor A

decreases expression

EXP

Amphetamine results in decreased expression of BCL11A mRNA

NCBI chr14:102,230,147...102,325,289
Ensembl chr14:102,231,113...102,325,623

G

BCL11 transcription factor B

decreases expression

EXP

Amphetamine results in decreased expression of BCL11B mRNA

NCBI chr 6:132,598,968...132,692,123
Ensembl chr 6:132,598,968...132,691,301

G

BCL2, apoptosis regulator

decreases expression

EXP
ISO

Amphetamine results in decreased expression of BCL2 mRNA
Amphetamine results in decreased expression of BCL2 protein

PMID:15731293 PMID:30779732

NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900

G

Bcl2-like 15

increases expression

EXP

Amphetamine results in increased expression of BCL2L15 mRNA

NCBI chr 2:194,019,158...194,032,516
Ensembl chr 2:194,027,397...194,032,516

G

BCL6, transcription repressor

increases expression

EXP

Amphetamine results in increased expression of BCL6 mRNA

NCBI chr11:90,358,753...90,382,049
Ensembl chr11:90,358,753...90,382,047

G

BAF chromatin remodeling complex subunit BCL7A

decreases expression

EXP

Amphetamine results in decreased expression of BCL7A mRNA

NCBI chr12:38,872,851...38,904,770
Ensembl chr12:38,872,851...38,904,770

G

BCL9, transcription coactivator

decreases expression

EXP

Amphetamine results in decreased expression of BCL9 mRNA

NCBI chr 2:187,449,425...187,475,241
Ensembl chr 2:187,449,425...187,475,241

G

BCL9 like

decreases expression

EXP

Amphetamine results in decreased expression of BCL9L mRNA

NCBI chr 8:53,708,770...53,738,880
Ensembl chr 8:53,708,770...53,737,395

G

beta-carotene oxygenase 1

increases expression

EXP

Amphetamine results in increased expression of BCO1 mRNA

NCBI chr19:62,058,061...62,094,923
Ensembl chr19:62,058,089...62,094,917

G

beta-carotene oxygenase 2

increases expression

EXP

Amphetamine results in increased expression of BCO2 mRNA

NCBI chr 8:59,778,571...59,803,597
Ensembl chr 8:59,778,575...59,799,168

G

brain-derived neurotrophic factor

affects response to substance

ISO

BDNF gene mutant form affects the susceptibility to Amphetamine

NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657

G

BEN domain containing 3

decreases expression

EXP

Amphetamine results in decreased expression of BEND3 mRNA

NCBI chr20:48,562,383...48,599,194
Ensembl chr20:48,576,311...48,596,808

G

BEN domain containing 5

decreases expression

EXP

Amphetamine results in decreased expression of BEND5 mRNA

NCBI chr 5:131,519,214...131,565,228
Ensembl chr 5:131,519,214...131,762,906

G

Bet1 golgi vesicular membrane trafficking protein-like

increases expression

EXP

Amphetamine results in increased expression of BET1L mRNA

NCBI chr 1:205,361,041...205,365,036
Ensembl chr 1:205,361,041...205,364,706

G

beaded filament structural protein 2

increases expression

EXP

Amphetamine results in increased expression of BFSP2 mRNA

NCBI chr 8:112,885,087...112,942,246
Ensembl chr 8:112,885,087...112,942,246

G

bone gamma-carboxyglutamate protein

increases expression

EXP

Amphetamine results in increased expression of BGLAP mRNA

NCBI chr 2:176,136,341...176,137,318
Ensembl chr 2:176,136,341...176,137,318

G

basic helix-loop-helix family, member e22

decreases expression

EXP

Amphetamine results in decreased expression of BHLHE22 mRNA

NCBI chr 2:102,402,622...102,405,732
Ensembl chr 2:102,400,164...102,420,508

G

BICD family like cargo adaptor 1

decreases expression

EXP

Amphetamine results in decreased expression of BICDL1 mRNA

NCBI chr12:46,537,525...46,626,876
Ensembl chr12:46,538,396...46,628,866

G

BICD family like cargo adaptor 2

increases expression

EXP

Amphetamine results in increased expression of BICDL2 mRNA

NCBI chr10:13,196,205...13,204,642
Ensembl chr10:13,195,913...13,204,642

G

BCL2-interacting killer

increases expression

EXP

Amphetamine results in increased expression of BIK mRNA

NCBI chr 7:116,552,303...116,571,317
Ensembl chr 7:116,552,303...116,571,317

G

bridging integrator 1

decreases expression

EXP

Amphetamine results in decreased expression of BIN1 mRNA

NCBI chr18:24,282,840...24,341,461
Ensembl chr18:24,283,801...24,341,458

G

baculoviral IAP repeat-containing 2

increases expression

EXP

Amphetamine results in increased expression of BIRC2 mRNA

NCBI chr 8:13,253,697...13,273,672
Ensembl chr 8:13,253,706...13,271,911

G

baculoviral IAP repeat-containing 6

decreases expression

EXP

Amphetamine results in decreased expression of BIRC6 mRNA

NCBI chr 6:26,474,843...26,668,275
Ensembl chr 6:26,474,843...26,668,507

G

biogenesis of lysosomal organelles complex-1, subunit 3

increases expression

EXP

Amphetamine results in increased expression of BLOC1S3 mRNA

NCBI chr 1:88,283,864...88,286,244
Ensembl chr 1:88,280,115...88,294,060

G

Bcl2 modifying factor

decreases expression

EXP

Amphetamine results in decreased expression of BMF mRNA

NCBI chr 3:125,953,466...125,974,087
Ensembl chr 3:125,953,466...125,974,258

G

BMI1 proto-oncogene, polycomb ring finger

decreases expression

EXP

Amphetamine results in decreased expression of BMI1 mRNA

NCBI chr17:86,240,683...86,250,044
Ensembl chr17:86,243,491...86,250,024

G

BCL2 family apoptosis regulator BOK

increases expression

EXP

Amphetamine results in increased expression of BOK mRNA

NCBI chr 9:101,670,729...101,681,834
Ensembl chr 9:101,670,625...101,681,833

G

bromodomain containing 2

decreases expression

EXP

Amphetamine results in decreased expression of BRD2 mRNA

NCBI chr20:4,728,282...4,737,286
Ensembl chr20:4,728,951...4,737,290

G

bassoon (presynaptic cytomatrix protein)

increases expression

EXP

Amphetamine results in increased expression of BSN mRNA

NCBI chr 8:117,663,447...117,754,412
Ensembl chr 8:117,670,334...117,754,412

G

bone marrow stromal cell antigen 1

increases expression

EXP

Amphetamine results in increased expression of BST1 mRNA

NCBI chr14:71,466,179...71,482,671
Ensembl chr14:71,466,180...71,482,647

G

BTB domain containing 2

decreases expression

EXP

Amphetamine results in decreased expression of BTBD2 mRNA

NCBI chr 7:9,710,392...9,726,032
Ensembl chr 7:9,712,269...9,726,032

G

B and T lymphocyte associated

decreases expression

EXP

Amphetamine results in decreased expression of BTLA mRNA

NCBI chr11:69,069,734...69,099,331
Ensembl chr11:69,052,644...69,093,224

G

butyrophilin, subfamily 2, member A2

decreases expression

EXP

Amphetamine results in decreased expression of BTN2A2 mRNA

NCBI chr17:42,048,842...42,060,650
Ensembl chr17:42,048,842...42,060,650

G

butyrophilin-like 9

decreases expression

EXP

Amphetamine results in decreased expression of BTNL9 mRNA

NCBI chr10:33,967,098...33,990,304
Ensembl chr10:33,970,675...33,990,354

G

BUB1 mitotic checkpoint serine/threonine kinase B

decreases expression

EXP

Amphetamine results in decreased expression of BUB1B mRNA

NCBI chr 3:126,017,019...126,069,470
Ensembl chr 3:126,017,045...126,069,796

G

C1q and TNF related 12

increases expression

EXP

Amphetamine results in increased expression of C1QTNF12 mRNA

NCBI chr 5:171,833,854...171,838,229
Ensembl chr 5:171,833,854...171,838,800

G

C2 calcium-dependent domain containing 2

decreases expression

EXP

Amphetamine results in decreased expression of C2CD2 mRNA

NCBI chr11:50,694,680...50,759,096
Ensembl chr11:50,694,563...50,759,016

G

complement C3a receptor 1

decreases expression

EXP

Amphetamine results in decreased expression of C3AR1 mRNA

NCBI chr 4:157,747,419...157,756,609
Ensembl chr 4:157,746,089...157,776,323

G

complement C5a receptor 1

increases expression

EXP

Amphetamine results in increased expression of C5AR1 mRNA

NCBI chr 1:86,077,309...86,088,001

G

complement C7

increases expression

EXP

Amphetamine results in increased expression of C7 mRNA

NCBI chr 2:55,815,687...55,892,605
Ensembl chr 2:55,816,807...55,892,672

G

calcium voltage-gated channel subunit alpha1 C

increases expression

EXP

Amphetamine results in increased expression of CACNA1C mRNA; Amphetamine results in increased expression of CACNA1C protein

NCBI chr 4:153,431,169...154,051,932
Ensembl chr 4:153,436,427...154,051,762

G

calcium voltage-gated channel subunit alpha1 D

multiple interactions
affects response to substance

ISO

CACNA1D protein affects the reaction [Amphetamine results in increased expression of DRD2 mRNA alternative form]
CACNA1D protein affects the susceptibility to Amphetamine

NCBI chr16:5,233,682...5,527,549
Ensembl chr16:5,233,690...5,674,692

G

calcium voltage-gated channel auxiliary subunit beta 4

decreases expression

EXP

Amphetamine results in decreased expression of CACNB4 mRNA

NCBI chr 3:57,315,900...57,578,271
Ensembl chr 3:57,315,900...57,578,220

G

carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase

decreases expression

EXP

Amphetamine results in decreased expression of CAD mRNA

NCBI chr 6:31,012,091...31,035,098
Ensembl chr 6:31,012,091...31,035,297

G

calbindin 2

increases expression

ISO

Amphetamine results in increased expression of CALB2 protein

NCBI chr19:55,023,849...55,050,858
Ensembl chr19:55,023,838...55,057,952

G

calcitonin receptor

increases expression

EXP

Amphetamine results in increased expression of CALCR mRNA

NCBI chr 4:32,615,955...32,691,075
Ensembl chr 4:32,615,958...32,691,075

G

calcium homeostasis modulator family member 2

decreases expression

EXP

Amphetamine results in decreased expression of CALHM2 mRNA

NCBI chr 1:255,963,661...255,969,387
Ensembl chr 1:255,963,663...255,969,387

G

calmodulin 1

affects expression

EXP

Amphetamine affects the expression of CALM1 mRNA

NCBI chr 6:125,217,191...125,227,855
Ensembl chr 6:125,217,246...125,225,381

G

calmodulin 2

affects expression
increases expression

EXP

Amphetamine affects the expression of CALM2 mRNA
Amphetamine results in increased expression of CALM2 mRNA

PMID:10854758 PMID:30779732

NCBI chr 6:12,845,170...12,857,830
Ensembl chr15:64,519,554...64,520,657
Ensembl chr 6:64,519,554...64,520,657

G

calmodulin 3

affects expression

EXP

Amphetamine affects the expression of CALM3 mRNA

NCBI chr 1:86,718,761...86,725,869
Ensembl chr 1:86,717,321...86,725,960

G

calmodulin-like 3

increases expression

EXP

Amphetamine results in increased expression of CALML3 mRNA

NCBI chr17:71,329,438...71,333,068
Ensembl chr17:71,319,943...71,335,682

G

calcium/calmodulin-dependent protein kinase I

increases expression

EXP

Amphetamine results in increased expression of CAMK1 mRNA

NCBI chr 4:148,036,843...148,047,675
Ensembl chr 4:148,036,824...148,047,245

G

calcium/calmodulin-dependent protein kinase II delta

decreases expression

EXP

Amphetamine results in decreased expression of CAMK2D mRNA

NCBI chr 2:217,698,324...217,961,898
Ensembl chr 2:217,698,551...217,960,276

G

calcium/calmodulin-dependent protein kinase IV

decreases expression

EXP

Amphetamine results in decreased expression of CAMK4 mRNA

NCBI chr18:24,857,152...25,076,054
Ensembl chr18:24,857,146...25,077,193

G

calmodulin binding transcription activator 1

decreases expression

EXP

Amphetamine results in decreased expression of CAMTA1 mRNA

NCBI chr 5:166,791,639...167,639,502
Ensembl chr 5:166,793,101...167,639,733

G

capping actin protein, gelsolin like

increases expression

EXP

Amphetamine results in increased expression of CAPG mRNA

NCBI chr 4:106,152,912...106,170,010
Ensembl chr 4:106,152,890...106,170,672

G

calpain 15

decreases expression

EXP

Amphetamine results in decreased expression of CAPN15 mRNA

NCBI chr10:15,477,311...15,503,913
Ensembl chr10:15,477,313...15,503,913

G

calpain 3

decreases expression

EXP

Amphetamine results in decreased expression of CAPN3 mRNA

NCBI chr 3:127,860,002...127,913,677
Ensembl chr 3:127,861,589...127,911,638

G

calpain 5

decreases expression

EXP

Amphetamine results in decreased expression of CAPN5 mRNA

NCBI chr 1:161,827,474...161,884,142
Ensembl chr 1:161,827,474...161,884,142

G

calcium responsive transcription factor

decreases expression

EXP

Amphetamine results in decreased expression of CARF mRNA

NCBI chr 9:68,996,419...69,046,480
Ensembl chr 9:68,996,250...69,046,479

G

CART prepropeptide

increases expression
multiple interactions

EXP

Amphetamine results in increased expression of CARTPT mRNA; Amphetamine results in increased expression of CARTPT protein
NPY mutant form promotes the reaction [Amphetamine results in increased expression of CARTPT mRNA]; S-ethyl glutathione inhibits the reaction [Amphetamine results in decreased expression of CARTPT protein]; S-ethyl glutathione inhibits the reaction [Amphetamine results in increased expression of CARTPT mRNA]

PMID:16896163 PMID:25825358

NCBI chr 2:32,989,215...32,991,794
Ensembl chr 2:32,989,215...32,999,712

G

caspase 2

increases activity

EXP

Amphetamine results in increased activity of CASP2 protein

NCBI chr 4:72,116,265...72,134,023
Ensembl chr 4:72,116,246...72,134,022

G

caspase 3

multiple interactions
increases activity

ISO
EXP

Amphetamine results in increased cleavage of and results in increased activity of CASP3 protein
Amphetamine results in increased activity of CASP3 protein

PMID:15731293 PMID:16638611

NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732

G

caspase 7

decreases expression

EXP

Amphetamine results in decreased expression of CASP7 mRNA

NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512

G

caspase 9

increases activity

EXP

Amphetamine results in increased activity of CASP9 protein

Ensembl chr 5:159,391,188...159,409,648

G

calsequestrin 2

increases expression

EXP

Amphetamine results in increased expression of CASQ2 mRNA

NCBI chr 2:192,214,556...192,270,821
Ensembl chr 2:192,214,537...192,270,820

G

Cas scaffold protein family member 4

increases expression

EXP

Amphetamine results in increased expression of CASS4 mRNA

NCBI chr 3:181,580,954...181,620,945
Ensembl chr 3:181,581,902...181,620,945

G

cytosolic arginine sensor for mTORC1 subunit 2

decreases expression

EXP

Amphetamine results in decreased expression of CASTOR2 mRNA

NCBI chr12:28,213,927...28,256,593
Ensembl chr12:28,213,935...28,256,593

G

catalase

decreases activity

ISO

Amphetamine results in decreased activity of CAT protein

NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526

G

caveolin 1

increases expression

EXP

Amphetamine results in increased expression of CAV1 mRNA

NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:46,600,738...46,639,740

G

caveolae associated protein 2

increases expression

EXP

Amphetamine results in increased expression of CAVIN2 mRNA

NCBI chr 9:57,794,007...57,806,024
Ensembl chr 9:57,794,019...57,806,024

G

CBFA2/RUNX1 partner transcriptional co-repressor 3

decreases expression

EXP

Amphetamine results in decreased expression of CBFA2T3 mRNA

NCBI chr19:67,584,319...67,658,533
Ensembl chr19:67,589,258...67,658,136

G

Cbl proto-oncogene

decreases expression

EXP

Amphetamine results in decreased expression of CBL mRNA

NCBI chr 8:53,384,656...53,468,067
Ensembl chr 8:53,384,656...53,468,067

G

chromobox 2

decreases expression

EXP

Amphetamine results in decreased expression of CBX2 mRNA

NCBI chr10:104,777,054...104,785,922
Ensembl chr10:104,777,056...104,785,926

G

chromobox 4

decreases expression

EXP

Amphetamine results in decreased expression of CBX4 mRNA

NCBI chr10:104,835,685...104,841,727
Ensembl chr10:104,835,685...104,841,727

G

chromobox 6

decreases expression

EXP

Amphetamine results in decreased expression of CBX6 mRNA

NCBI chr 7:113,253,364...113,263,413
Ensembl chr 7:113,253,364...113,263,413

G

chromobox 7

decreases expression

EXP

Amphetamine results in decreased expression of CBX7 mRNA

NCBI chr 7:113,341,030...113,358,716
Ensembl chr 7:113,341,030...113,358,346

G

coiled-coil domain containing 102A

increases expression

EXP

Amphetamine results in increased expression of CCDC102A mRNA

NCBI chr19:10,108,553...10,124,652
Ensembl chr19:10,109,364...10,124,652

G

coiled-coil domain containing 120

decreases expression

EXP

Amphetamine results in decreased expression of CCDC120 mRNA

NCBI chr X:17,437,219...17,443,716
Ensembl chr X:17,425,624...17,444,717

G

coiled-coil domain containing 14

decreases expression

EXP

Amphetamine results in decreased expression of CCDC14 mRNA

NCBI chr11:79,557,267...79,593,128
Ensembl chr11:79,557,274...79,593,285

G

coiled-coil domain containing 142

decreases expression

EXP

Amphetamine results in decreased expression of CCDC142 mRNA

NCBI chr 4:117,164,055...117,172,286
Ensembl chr 4:117,166,135...117,173,935

G

coiled-coil domain containing 15

decreases expression

EXP

Amphetamine results in decreased expression of CCDC15 mRNA

NCBI chr 8:45,165,297...45,257,641
Ensembl chr 8:45,134,596...45,277,989

G

coiled-coil domain containing 50

decreases expression

EXP

Amphetamine results in decreased expression of CCDC50 mRNA

NCBI chr11:86,837,624...86,900,164
Ensembl chr11:86,837,624...86,899,980

G

coiled-coil domain containing 6

decreases expression

EXP

Amphetamine results in decreased expression of CCDC6 mRNA

NCBI chr20:18,431,243...18,527,227
Ensembl chr20:18,431,243...18,527,227

G

coiled-coil domain containing 61

increases expression

EXP

Amphetamine results in increased expression of CCDC61 mRNA

NCBI chr 1:87,665,541...87,685,732
Ensembl chr 1:87,665,541...87,685,732

G

coiled-coil domain containing 66

decreases expression

EXP

Amphetamine results in decreased expression of CCDC66 mRNA

NCBI chr16:2,668,810...2,700,717
Ensembl chr16:2,658,131...2,701,012

G

coiled-coil domain containing 80

increases expression

EXP

Amphetamine results in increased expression of CCDC80 mRNA

NCBI chr11:69,191,188...69,224,844
Ensembl chr11:69,191,189...69,224,844

G

coiled-coil domain containing 88C

decreases expression

EXP

Amphetamine results in decreased expression of CCDC88C mRNA

NCBI chr 6:125,899,337...126,019,162
Ensembl chr 6:125,899,526...126,018,865

G

coiled-coil domain containing 90B

increases expression

EXP

Amphetamine results in increased expression of CCDC90B mRNA

NCBI chr 1:156,045,192...156,058,750
Ensembl chr 1:156,045,138...156,061,403

G

cholecystokinin B receptor

affects response to substance

ISO

CCKBR protein affects the susceptibility to Amphetamine

PMID:11403953 PMID:11702094 PMID:16916582

NCBI chr 1:169,183,578...169,193,583
Ensembl chr 1:169,183,194...169,193,745

G

C-C motif chemokine ligand 9

increases expression

EXP

Amphetamine results in increased expression of CCL6 mRNA

NCBI chr10:68,863,994...68,868,928
Ensembl chr10:68,863,995...68,868,877

G

cellular communication network factor 6

decreases expression

EXP

Amphetamine results in decreased expression of CCN6 mRNA

NCBI chr20:44,123,932...44,139,745
Ensembl chr20:44,123,932...44,139,793

G

cyclin Y

increases expression

EXP

Amphetamine results in increased expression of CCNY mRNA

NCBI chr17:62,079,925...62,207,780
Ensembl chr17:62,079,925...62,207,979

G

chemokine (C-C motif) receptor 1-like 1

increases expression

EXP

Amphetamine results in increased expression of CCR1L1 mRNA

NCBI chr 8:132,467,425...132,478,489
Ensembl chr 8:132,468,452...132,469,522

G

C-C motif chemokine receptor 2

increases expression

EXP

Amphetamine results in increased expression of CCR2 mRNA

NCBI chr 8:132,611,883...132,619,106
Ensembl chr 8:132,611,410...132,620,059

G

C-C motif chemokine receptor 5

increases expression

EXP

Amphetamine results in increased expression of CCR5 mRNA

NCBI chr 8:132,629,097...132,660,980
Ensembl chr 8:132,629,683...132,637,594

G

C-C motif chemokine receptor 7

decreases expression

EXP

Amphetamine results in decreased expression of CCR7 mRNA

NCBI chr10:84,594,399...84,604,514
Ensembl chr10:84,593,594...84,604,501

G

centriole, cilia and spindle-associated protein

decreases expression

EXP

Amphetamine results in decreased expression of CCSAP mRNA

NCBI chr19:68,722,417...68,740,908

G

chaperonin containing TCP1 subunit 2

multiple interactions

ISO

[MDK gene mutant form results in decreased susceptibility to Amphetamine] which results in increased expression of CCT2 protein

NCBI chr 7:54,578,654...54,591,428
Ensembl chr 7:54,578,663...54,592,977

G

CD14 molecule

increases expression

EXP

Amphetamine results in increased expression of CD14 mRNA

NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292

G

CD180 molecule

decreases expression

EXP

Amphetamine results in decreased expression of CD180 mRNA

NCBI chr 2:35,589,889...35,602,837
Ensembl chr 2:35,589,451...35,603,982

G

CD19 molecule

decreases expression

EXP

Amphetamine results in decreased expression of CD19 mRNA

NCBI chr 1:190,417,853...190,424,494
Ensembl chr 1:190,417,853...190,424,355

G

Cd200 molecule

decreases expression
increases expression

EXP

Amphetamine results in decreased expression of CD200 mRNA
Amphetamine results in increased expression of CD200 mRNA

PMID:20223277 PMID:30779732

NCBI chr11:68,916,200...68,943,570
Ensembl chr11:68,916,224...68,943,569

G

CD22 molecule

decreases expression

EXP

Amphetamine results in decreased expression of CD22 mRNA

NCBI chr 1:95,243,785...95,270,430
Ensembl chr 1:95,244,868...95,259,730

G

Cd247 molecule

decreases expression

EXP

Amphetamine results in decreased expression of CD247 mRNA

NCBI chr13:80,576,264...80,651,422
Ensembl chr13:80,576,202...80,655,248

G

CD27 molecule

decreases expression

EXP

Amphetamine results in decreased expression of CD27 mRNA

NCBI chr 4:159,716,932...159,721,823
Ensembl chr 4:159,716,935...159,721,823

G

Cd28 molecule

decreases expression

EXP

Amphetamine results in decreased expression of CD28 mRNA

NCBI chr 9:69,660,316...69,689,192
Ensembl chr 9:69,545,326...69,689,192

G

CD2-associated protein

decreases expression

EXP

Amphetamine results in decreased expression of CD2AP mRNA

NCBI chr 9:25,580,071...25,679,968
Ensembl chr 9:25,583,975...25,679,968

G

Cd300a molecule

increases expression

EXP

Amphetamine results in increased expression of CD300A mRNA

NCBI chr10:100,428,826...100,441,693
Ensembl chr10:100,428,826...100,442,958

G

Cd300e molecule

increases expression

EXP

Amphetamine results in increased expression of CD300E mRNA

NCBI chr10:100,784,452...100,808,988
Ensembl chr10:100,790,431...100,808,297

G

Cd300 molecule-like family member E

increases expression

EXP

Amphetamine results in increased expression of CD300LE mRNA

NCBI chr10:100,770,070...100,779,293
Ensembl chr10:100,770,030...100,779,293

G

CD33 molecule

increases expression

EXP

Amphetamine results in increased expression of CD33 mRNA

NCBI chr 1:103,071,985...103,086,687
Ensembl chr 1:103,072,375...103,086,291

G

CD3 delta subunit of T-cell receptor complex

decreases expression

EXP

Amphetamine results in decreased expression of CD3D mRNA

NCBI chr 8:54,184,573...54,190,112
Ensembl chr 8:54,175,155...54,196,722

G

CD3 epsilon subunit of T-cell receptor complex

decreases expression

EXP

Amphetamine results in decreased expression of CD3E mRNA

NCBI chr 8:54,200,617...54,211,770
Ensembl chr 8:54,200,617...54,211,876

G

CD3 gamma subunit of T-cell receptor complex

decreases expression

EXP

Amphetamine results in decreased expression of CD3G mRNA

NCBI chr 8:54,177,572...54,184,087
Ensembl chr 8:54,177,977...54,183,918

G

Cd4 molecule

decreases expression

EXP

Amphetamine results in decreased expression of CD4 mRNA

NCBI chr 4:159,355,147...159,381,636
Ensembl chr 4:159,356,337...159,381,461

G

CD40 ligand

decreases expression

EXP

Amphetamine results in decreased expression of CD40LG mRNA

NCBI chr X:140,164,341...140,176,057
Ensembl chr X:140,164,302...140,176,475

G

CD44 molecule

increases expression

EXP

Amphetamine results in increased expression of CD44 mRNA

NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424

G

Cd5 molecule

decreases expression

EXP

Amphetamine results in decreased expression of CD5 mRNA

NCBI chr 1:216,790,245...216,811,209
Ensembl chr 1:216,790,245...216,811,209

G

Cd53 molecule

increases expression

EXP

Amphetamine results in increased expression of CD53 mRNA

NCBI chr 2:197,040,369...197,087,925
Ensembl chr 2:197,040,369...197,218,593

G

CD55 molecule (Cromer blood group)

increases expression

EXP

Amphetamine results in increased expression of CD55 mRNA

NCBI chr13:44,409,574...44,438,913
Ensembl chr13:44,409,587...44,438,107

G

Cd6 molecule

decreases expression

EXP

Amphetamine results in decreased expression of CD6 mRNA

NCBI chr 1:216,867,767...216,906,642
Ensembl chr 1:216,867,771...216,879,432

G

Cd63 molecule

increases expression

EXP

Amphetamine results in increased expression of CD63 mRNA

NCBI chr 7:1,909,538...1,924,937
Ensembl chr 7:1,922,169...1,924,938

G

CD9 molecule

increases expression

EXP

Amphetamine results in increased expression of CD9 mRNA

NCBI chr 4:159,942,553...159,975,463
Ensembl chr 4:159,942,560...159,975,444

G

codanin 1

decreases expression

EXP

Amphetamine results in decreased expression of CDAN1 mRNA

NCBI chr 3:128,129,664...128,143,520
Ensembl chr 3:128,129,301...128,143,549

G

cell division cycle 23

decreases expression

EXP

Amphetamine results in decreased expression of CDC23 mRNA

NCBI chr18:26,511,019...26,534,872
Ensembl chr18:26,510,355...26,532,646

G

CDC42 binding protein kinase beta

increases expression

EXP

Amphetamine results in increased expression of CDC42BPB mRNA

NCBI chr 6:136,154,905...136,241,259
Ensembl chr 6:136,154,905...136,237,570

G

CDC42 binding protein kinase gamma

decreases expression

EXP

Amphetamine results in decreased expression of CDC42BPG mRNA

NCBI chr 1:213,037,603...213,057,764
Ensembl chr 1:213,037,836...213,057,765

G

cadherin 24

decreases expression

EXP

Amphetamine results in decreased expression of CDH24 mRNA

NCBI chr15:32,061,588...32,071,323
Ensembl chr15:32,061,588...32,071,283

G

cyclin-dependent kinase 6

decreases expression

EXP

Amphetamine results in decreased expression of CDK6 mRNA

NCBI chr 4:31,592,384...31,784,732
Ensembl chr 4:31,601,192...31,781,701

G

cyclin-dependent kinase inhibitor 1A

increases expression

EXP

Amphetamine results in increased expression of CDKN1A mRNA

NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969

G

cell adhesion associated, oncogene regulated

decreases expression

EXP

Amphetamine results in decreased expression of CDON mRNA

NCBI chr 8:42,032,921...42,119,451
Ensembl chr 8:42,033,042...42,119,345

G

CCAAT/enhancer binding protein beta

increases expression

EXP

Amphetamine results in increased expression of CEBPB mRNA

NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072

G

CCAAT/enhancer binding protein delta

increases expression

EXP

Amphetamine results in increased expression of CEBPD mRNA

NCBI chr11:98,268,856...98,269,994
Ensembl chr11:98,265,651...98,280,824

G

CECR2, histone acetyl-lysine reader

decreases expression

EXP

Amphetamine results in decreased expression of CECR2 mRNA

NCBI chr 4:155,562,576...155,670,253
Ensembl chr 4:155,562,727...155,666,741

G

chymotrypsin like elastase 1

increases expression

EXP

Amphetamine results in increased expression of CELA1 mRNA

NCBI chr 7:133,651,939...133,665,136
Ensembl chr 7:133,651,941...133,665,061

G

cadherin, EGF LAG seven-pass G-type receptor 2

decreases expression

EXP

Amphetamine results in decreased expression of CELSR2 mRNA

NCBI chr 2:198,717,333...198,741,689
Ensembl chr 2:198,717,896...198,741,581

G

centrosomal protein 120

increases expression

EXP

Amphetamine results in increased expression of CEP120 mRNA

NCBI chr18:49,326,266...49,388,380
Ensembl chr18:49,326,266...49,388,243

G

centrosomal protein 152

decreases expression

EXP

Amphetamine results in decreased expression of CEP152 mRNA

NCBI chr 3:133,243,979...133,332,271
Ensembl chr 3:133,263,174...133,331,655
Ensembl chr 3:133,263,174...133,331,655

G

centrosomal protein 164

decreases expression

EXP

Amphetamine results in decreased expression of CEP164 mRNA

NCBI chr 8:54,967,621...55,031,264
Ensembl chr 8:54,967,621...55,031,206

G

centrosomal protein 250

decreases expression

EXP

Amphetamine results in decreased expression of CEP250 mRNA

NCBI chr 3:164,931,033...164,976,210
Ensembl chr 3:164,931,066...164,976,210

G

centrosomal protein 41

decreases expression

EXP

Amphetamine results in decreased expression of CEP41 mRNA

NCBI chr 4:60,238,602...60,279,670
Ensembl chr 4:60,239,539...60,254,419

G

centrosomal protein 68

decreases expression

EXP

Amphetamine results in decreased expression of CEP68 mRNA

NCBI chr14:98,649,993...98,671,892
Ensembl chr14:98,649,993...98,671,868

G

ceramide synthase 4

decreases expression

EXP

Amphetamine results in decreased expression of CERS4 mRNA

NCBI chr12:7,649,610...7,688,066
Ensembl chr12:7,649,610...7,688,070

G

cilia and flagella associated protein 119

increases expression

EXP

Amphetamine results in increased expression of CFAP119 mRNA

NCBI chr 1:191,627,662...191,647,429
Ensembl chr 1:191,623,673...191,632,829

G

cilia and flagella associated protein 144

increases expression

EXP

Amphetamine results in increased expression of CFAP144 mRNA

NCBI chr10:44,009,412...44,019,281
Ensembl chr10:44,009,412...44,019,281

G

cilia and flagella associated protein 184

increases expression

EXP

Amphetamine results in increased expression of CCDC96 mRNA

NCBI chr14:78,501,256...78,503,715
Ensembl chr14:78,486,414...78,507,808

G

cilia and flagella associated protein 44

decreases expression

EXP

Amphetamine results in decreased expression of CFAP44 mRNA

NCBI chr11:69,704,997...69,789,998
Ensembl chr11:69,705,719...69,789,905

G

cilia and flagella associated protein 45

increases expression

EXP

Amphetamine results in increased expression of CFAP45 mRNA

NCBI chr13:87,521,831...87,545,236
Ensembl chr13:87,521,518...87,545,234

G

complement factor D

increases expression

EXP

Amphetamine results in increased expression of CFD mRNA

NCBI chr 7:10,463,773...10,465,496
Ensembl chr 7:10,463,775...10,465,572

G

cell growth regulator with ring finger domain 1

increases expression

EXP

Amphetamine results in increased expression of CGRRF1 mRNA

NCBI chr15:22,560,902...22,588,815
Ensembl chr15:22,568,332...22,588,811

G

chromatin assembly factor 1 subunit A

decreases expression

EXP

Amphetamine results in decreased expression of CHAF1A mRNA

NCBI chr 9:961,225...987,825
Ensembl chr 9:961,084...987,868

G

chromodomain helicase DNA binding protein 3

decreases expression

EXP

Amphetamine results in decreased expression of CHD3 mRNA

NCBI chr10:54,562,437...54,588,842
Ensembl chr10:54,562,437...54,588,810

G

chromodomain helicase DNA binding protein 6

decreases expression

EXP

Amphetamine results in decreased expression of CHD6 mRNA

NCBI chr 3:170,016,204...170,177,480
Ensembl chr 3:170,016,204...170,177,558

G

chitinase 3 like 1

increases expression

EXP

Amphetamine results in increased expression of CHI3L1 mRNA

NCBI chr13:48,193,839...48,201,822
Ensembl chr13:48,193,800...48,201,825

G

cysteine-rich hydrophobic domain 1

decreases expression

EXP

Amphetamine results in decreased expression of CHIC1 mRNA

NCBI chr X:72,427,851...72,471,924
Ensembl chr X:72,427,851...72,471,924

G

chitinase domain containing 1

increases expression

EXP

Amphetamine results in increased expression of CHID1 mRNA

NCBI chr 1:206,024,059...206,059,259
Ensembl chr 1:205,998,801...206,059,227

G

CHM Rab escort protein

decreases expression

EXP

Amphetamine results in decreased expression of CHM mRNA

NCBI chr X:82,395,463...82,554,249
Ensembl chr X:82,396,816...82,568,642

G

charged multivesicular body protein 2A

increases expression

EXP

Amphetamine results in increased expression of CHMP2A mRNA

NCBI chr 1:82,731,212...82,735,088
Ensembl chr 1:82,732,231...82,738,613

G

charged multivesicular body protein 3

increases expression

EXP

Amphetamine results in increased expression of CHMP3 mRNA

NCBI chr 4:105,134,860...105,180,862
Ensembl chr 4:105,134,755...105,182,262

G

charged multivesicular body protein 5

increases expression

EXP

Amphetamine results in increased expression of CHMP5 mRNA

NCBI chr 5:60,877,369...60,894,512
Ensembl chr 5:60,877,341...60,894,511

G

cholinergic receptor, muscarinic 1

multiple interactions

EXP

[muscarinic toxin 7 binds to and results in decreased activity of CHRM1 protein] inhibits the reaction [Amphetamine results in increased abundance of Nitric Oxide]; [muscarinic toxin 7 binds to and results in decreased activity of CHRM1 protein] inhibits the reaction [Amphetamine results in increased oxidation of Lipids]

NCBI chr 1:214,996,180...215,012,136
Ensembl chr 1:214,995,872...215,020,602

G

cholinergic receptor, muscarinic 5

affects response to substance
decreases response to substance

ISO

CHRM5 protein affects the susceptibility to Amphetamine
CHRM5 gene results in decreased susceptibility to Amphetamine; CHRM5 protein mutant form results in decreased susceptibility to Amphetamine

PMID:15213703 PMID:19820917

NCBI chr 3:119,739,229...119,791,630
Ensembl chr 3:119,735,975...119,792,166

G

carbohydrate sulfotransferase 1

decreases expression

EXP

Amphetamine results in decreased expression of CHST1 mRNA

NCBI chr 3:99,003,987...99,030,214
Ensembl chr 3:99,009,958...99,031,262

G

carbohydrate sulfotransferase 10

decreases expression

EXP

Amphetamine results in decreased expression of CHST10 mRNA

NCBI chr 9:48,588,575...48,618,487
Ensembl chr 9:48,588,575...48,618,442

G

carbohydrate sulfotransferase 15

decreases expression

EXP

Amphetamine results in decreased expression of CHST15 mRNA

NCBI chr 1:196,458,978...196,540,088
Ensembl chr 1:196,460,425...196,491,444

G

carbohydrate sulfotransferase 3

decreases expression

EXP

Amphetamine results in decreased expression of CHST3 mRNA

NCBI chr20:28,657,308...28,694,976
Ensembl chr20:28,657,308...28,694,526

G

chromosome transmission fidelity factor 18

decreases expression

EXP

Amphetamine results in decreased expression of CHTF18 mRNA

NCBI chr10:15,247,525...15,255,573
Ensembl chr10:15,246,362...15,255,685

G

cell death-inducing DFFA-like effector c

increases expression

EXP

Amphetamine results in increased expression of CIDEC mRNA

NCBI chr 4:148,124,924...148,137,806
Ensembl chr 4:148,124,925...148,137,806

G

class II, major histocompatibility complex, transactivator

decreases expression

EXP

Amphetamine results in decreased expression of CIITA mRNA

NCBI chr10:5,646,854...5,694,393
Ensembl chr10:5,647,085...5,694,342

G

corepressor interacting with RBPJ, CIR1

increases expression

EXP

Amphetamine results in increased expression of CIR1 mRNA

NCBI chr 3:78,566,438...78,596,309
Ensembl chr 3:78,566,438...78,596,309

G

Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2

increases expression

EXP

Amphetamine results in increased expression of CITED2 mRNA

NCBI chr 1:14,132,303...14,134,746
Ensembl chr 1:14,103,457...14,134,782

G

creatine kinase B

decreases activity

EXP

Amphetamine results in decreased activity of CKB protein

NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:136,549,844...136,553,478

G

chemokine-like factor

increases expression

EXP

Amphetamine results in increased expression of CKLF mRNA

NCBI chr19:704,528...712,998
Ensembl chr19:697,451...712,998

G

creatine kinase, M-type

increases expression

EXP

Amphetamine results in increased expression of CKM mRNA

NCBI chr 1:88,189,382...88,199,717
Ensembl chr 1:88,189,485...88,199,719

G

creatine kinase, mitochondrial 1

decreases expression

ISO

Amphetamine results in decreased expression of CKMT1 protein

NCBI chr 3:128,783,408...128,789,485
Ensembl chr 3:128,783,597...128,789,483

G

creatine kinase, mitochondrial 2

increases expression

EXP

Amphetamine results in increased expression of CKMT2 mRNA

NCBI chr 2:24,815,008...24,845,511
Ensembl chr 2:24,815,008...24,845,511

G

chloride channel accessory 2

increases expression

EXP

Amphetamine results in increased expression of CLCA2 mRNA

NCBI chr 2:236,655,419...236,682,669
Ensembl chr 2:236,639,545...236,685,129

G

chloride voltage-gated channel 5

decreases expression

EXP

Amphetamine results in decreased expression of CLCN5 mRNA

NCBI chr X:17,857,260...18,011,844
Ensembl chr X:17,857,260...18,011,844

G

C-type lectin domain containing 10A

increases expression

EXP

Amphetamine results in increased expression of CLEC10A mRNA

NCBI chr10:55,374,914...55,379,110
Ensembl chr10:55,374,887...55,379,108

G

C-type lectin domain family 12, member A

increases expression

EXP

Amphetamine results in increased expression of CLEC12A mRNA

NCBI chr 4:164,484,162...164,502,793
Ensembl chr 4:164,484,162...164,510,233

G

C-type lectin domain family 1, member A

increases expression

EXP

Amphetamine results in increased expression of CLEC1A mRNA

NCBI chr 4:164,561,385...164,588,593
Ensembl chr 4:164,563,374...164,587,269

G

C-type lectin domain family 2, member G

increases expression

EXP

Amphetamine results in increased expression of CLEC2G mRNA

NCBI chr 4:164,303,865...164,313,737
Ensembl chr 4:164,300,076...164,314,591

G

C-type lectin domain family 4, member A2

increases expression

EXP

Amphetamine results in increased expression of CLEC4A2 mRNA

NCBI chr 4:157,934,342...157,993,595
Ensembl chr 4:157,934,357...157,993,588

G

C-type lectin domain family 4, member B2

increases expression

EXP

Amphetamine results in increased expression of CLEC4B2 mRNA

NCBI chr 4:158,148,434...158,171,933
Ensembl chr 4:158,148,314...158,172,249

G

C-type lectin domain family 4, member D

increases expression

EXP

Amphetamine results in increased expression of CLEC4D mRNA

NCBI chr 4:158,275,287...158,286,978
Ensembl chr 4:158,275,341...158,287,055

G

C-type lectin domain family 4, member E

increases expression

EXP

Amphetamine results in increased expression of CLEC4E mRNA

NCBI chr 4:158,292,624...158,298,607
Ensembl chr 4:158,293,311...158,298,467

G

C-type lectin domain family 4, member F

increases expression

EXP

Amphetamine results in increased expression of CLEC4F mRNA

NCBI chr 4:117,686,686...117,696,407
Ensembl chr 4:117,686,686...117,696,438

G

C-type lectin domain containing 7A

increases expression

EXP

Amphetamine results in increased expression of CLEC7A mRNA

NCBI chr 4:164,588,737...164,599,953
Ensembl chr 4:164,588,754...164,599,919

G

C-type lectin domain containing 9A

increases expression

EXP

Amphetamine results in increased expression of CLEC9A mRNA

NCBI chr 4:164,546,323...164,561,380
Ensembl chr 4:164,546,311...164,561,380

G

chloride intracellular channel 1

increases expression

EXP

Amphetamine results in increased expression of CLIC1 mRNA

NCBI chr20:3,769,522...3,778,367
Ensembl chr20:3,769,527...3,778,367

G

clock circadian regulator

decreases expression

EXP

Amphetamine results in decreased expression of CLOCK mRNA

NCBI chr14:32,262,747...32,346,872
Ensembl chr14:32,262,750...32,346,872

G

clathrin, light chain B

increases expression

EXP

Amphetamine results in increased expression of CLTB mRNA

NCBI chr17:10,006,416...10,024,278
Ensembl chr17:10,006,656...10,024,915

G

cytidine monophospho-N-acetylneuraminic acid hydroxylase

decreases expression

EXP

Amphetamine results in decreased expression of CMAH mRNA

NCBI chr17:40,985,129...41,070,317
Ensembl chr17:41,011,641...41,070,252

G

CKLF-like MARVEL transmembrane domain containing 6

increases expression

EXP

Amphetamine results in increased expression of CMTM6 mRNA

NCBI chr 8:123,301,131...123,319,230
Ensembl chr 8:123,300,918...123,319,230

G

CKLF-like MARVEL transmembrane domain containing 8

increases expression

EXP

Amphetamine results in increased expression of CMTM8 mRNA

NCBI chr 8:123,360,168...123,425,291
Ensembl chr 8:123,360,170...123,425,276

G

cap methyltransferase 2

decreases expression

EXP

Amphetamine results in decreased expression of CMTR2 mRNA

NCBI chr19:55,100,135...55,106,966
Ensembl chr19:55,099,843...55,124,234

G

cardiomyopathy associated 5

increases expression

EXP

Amphetamine results in increased expression of CMYA5 mRNA

NCBI chr 2:26,014,545...26,113,273
Ensembl chr 2:26,014,177...26,113,376

G

carnosine dipeptidase 2

increases expression

EXP

Amphetamine results in increased expression of CNDP2 mRNA

NCBI chr18:80,314,799...80,331,900
Ensembl chr18:80,314,801...80,331,900

G

calponin 3

decreases expression

EXP

Amphetamine results in decreased expression of CNN3 mRNA

NCBI chr 2:212,203,661...212,234,772
Ensembl chr 2:212,226,640...212,234,815

G

contactin associated protein 1

decreases expression

EXP

Amphetamine results in decreased expression of CNTNAP1 mRNA

NCBI chr10:86,610,140...86,625,896
Ensembl chr10:86,611,890...86,631,730

G

centrobin, centriole duplication and spindle assembly protein

decreases expression

EXP

Amphetamine results in decreased expression of CNTROB mRNA

NCBI chr10:54,521,338...54,546,569
Ensembl chr10:54,521,663...54,543,657

G

cordon-bleu WH2 repeat protein-like 1

decreases expression

EXP

Amphetamine results in decreased expression of COBLL1 mRNA

NCBI chr 3:70,161,369...70,324,844
Ensembl chr 3:70,161,372...70,323,460

G

coilin

decreases expression

EXP

Amphetamine results in decreased expression of COIL mRNA

NCBI chr10:74,286,279...74,307,597
Ensembl chr10:74,286,840...74,307,595

G

collagen type XI alpha 2 chain

decreases expression

EXP

Amphetamine results in decreased expression of COL11A2 mRNA

NCBI chr20:4,788,829...4,818,492
Ensembl chr20:4,788,829...4,817,648

G

collagen type XII alpha 1 chain

increases expression

EXP

Amphetamine results in increased expression of COL12A1 mRNA

NCBI chr 8:89,427,834...89,545,886
Ensembl chr 8:89,427,834...89,545,711

G

collagen type XVII alpha 1 chain

decreases expression

EXP

Amphetamine results in decreased expression of COL17A1 mRNA

NCBI chr 1:256,472,648...256,518,857
Ensembl chr 1:256,472,648...256,518,851

G

collagen type I alpha 1 chain

increases expression

EXP

Amphetamine results in increased expression of COL1A1 mRNA

NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460

G

collagen type I alpha 2 chain

increases expression

EXP

Amphetamine results in increased expression of COL1A2 mRNA

NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995

G

collagen type XXVII alpha 1 chain

decreases expression

EXP

Amphetamine results in decreased expression of COL27A1 mRNA

NCBI chr 5:81,662,822...81,781,502
Ensembl chr 5:81,661,685...81,781,502

G

collagen type IV alpha 1 chain

increases expression

EXP

Amphetamine results in increased expression of COL4A1 mRNA

NCBI chr16:84,885,597...84,996,482
Ensembl chr16:84,885,597...84,996,482

G

catechol-O-methyltransferase

increases expression
multiple interactions

ISO
EXP

Amphetamine results in increased expression of COMT mRNA
COMT protein affects the reaction [Amphetamine results in increased abundance of Dopamine]

PMID:14574438 PMID:16916582

NCBI chr11:96,072,371...96,091,956
Ensembl chr11:96,072,489...96,092,533

G

COP1, E3 ubiquitin ligase

increases expression

EXP

Amphetamine results in increased expression of RFWD2 mRNA

NCBI chr13:73,954,058...74,095,283
Ensembl chr13:73,963,145...74,095,269

G

COP9 signalosome subunit 5

increases expression

ISO

Amphetamine results in increased expression of COPS5 protein

NCBI chr 5:13,975,198...13,993,391
Ensembl chr 5:13,975,052...13,993,387

G

coenzyme Q10B

increases expression

EXP

Amphetamine results in increased expression of COQ10B mRNA

NCBI chr 9:64,048,168...64,068,082
Ensembl chr 9:64,048,103...64,068,322

G

coronin 2B

decreases expression

EXP

Amphetamine results in decreased expression of CORO2B mRNA

NCBI chr 8:71,802,329...71,912,739
Ensembl chr 8:71,802,329...71,912,739

G

coronin 7

decreases expression

EXP

Amphetamine results in decreased expression of CORO7 mRNA

NCBI chr10:11,386,683...11,447,422
Ensembl chr10:11,391,613...11,447,866

G

cytochrome c oxidase assembly factor heme A:farnesyltransferase COX10

decreases expression

EXP

Amphetamine results in decreased expression of COX10 mRNA

NCBI chr10:49,130,209...49,242,009
Ensembl chr10:49,130,209...49,242,009

G

cytochrome c oxidase assembly factor COX14

increases expression

EXP

Amphetamine results in increased expression of COX14 mRNA

NCBI chr 7:132,731,069...132,733,159
Ensembl chr 7:132,731,069...132,733,159

G

cytochrome c oxidase copper chaperone COX17

increases expression

EXP

Amphetamine results in increased expression of COX17 mRNA

NCBI chr11:75,906,245...75,912,036
Ensembl chr11:75,906,248...75,912,019

G

cytochrome c oxidase subunit 4i2

increases expression

EXP

Amphetamine results in increased expression of COX4I2 mRNA

NCBI chr 3:161,686,193...161,699,605
Ensembl chr 3:161,689,017...161,699,602

G

cytochrome c oxidase subunit 5A

increases expression

EXP

Amphetamine results in increased expression of COX5A mRNA

NCBI chr 8:66,818,284...66,829,691
Ensembl chr 8:66,818,196...66,830,279

G

cytochrome c oxidase subunit 6A2

increases expression

EXP

Amphetamine results in increased expression of COX6A2 mRNA

NCBI chr 1:192,218,970...192,221,188
Ensembl chr 1:192,218,970...192,219,716

G

cytochrome c oxidase, subunit VIIIb

increases expression

EXP

Amphetamine results in increased expression of COX8B mRNA

NCBI chr 1:205,406,813...205,408,273
Ensembl chr 1:205,406,813...205,408,311

G

centrosome assembly and centriole elongation protein

decreases expression

EXP

Amphetamine results in decreased expression of CPAP mRNA

NCBI chr15:34,742,838...34,806,020
Ensembl chr15:34,742,838...34,802,421

G

carboxypeptidase M

increases expression

EXP

Amphetamine results in increased expression of CPM mRNA

NCBI chr 7:55,111,599...55,172,114
Ensembl chr 7:55,111,599...55,172,114

G

copine 8

increases expression

EXP

Amphetamine results in increased expression of CPNE8 mRNA

NCBI chr 7:123,494,864...123,669,060
Ensembl chr 7:123,494,865...123,669,060

G

calcineurin-like phosphoesterase domain containing 1

increases expression

EXP

Amphetamine results in increased expression of CPPED1 mRNA

NCBI chr10:4,135,601...4,328,039
Ensembl chr10:4,208,463...4,231,065

G

carboxypeptidase Q

increases expression

EXP

Amphetamine results in increased expression of CPQ mRNA

NCBI chr 7:66,148,973...66,719,189
Ensembl chr 7:66,149,377...66,716,137

G

cleavage and polyadenylation specific factor 1

decreases expression

EXP

Amphetamine results in decreased expression of CPSF1 mRNA

NCBI chr 7:110,200,078...110,210,644
Ensembl chr 7:110,199,066...110,210,644

G

calcium release activated channel regulator 2A

decreases expression

EXP

Amphetamine results in decreased expression of CRACR2A mRNA

NCBI chr 4:162,094,247...162,207,926
Ensembl chr 4:162,110,929...162,221,529

G

calcium release activated channel regulator 2B

increases expression

EXP

Amphetamine results in increased expression of CRACR2B mRNA

NCBI chr 1:205,987,957...205,993,515
Ensembl chr 1:205,990,507...205,993,516

G

cAMP responsive element binding protein 1

multiple interactions
affects phosphorylation
decreases phosphorylation
affects activity
increases expression
affects response to substance

EXP
ISO

Amphetamine affects the reaction [Haloperidol results in increased activity of CREB1 protein modified form]; KN 62 inhibits the reaction [Amphetamine results in increased phosphorylation of CREB1 protein]
Baclofen inhibits the reaction [Amphetamine affects the phosphorylation of CREB1 protein]
Amphetamine results in decreased phosphorylation of CREB1 protein
Amphetamine affects the activity of CREB1 protein
Amphetamine results in increased expression of CREB1 mRNA; Amphetamine results in increased expression of CREB1 protein
CREB1 protein affects the susceptibility to Amphetamine

PMID:12125044 PMID:14622123 PMID:16896163 PMID:16983645 PMID:17878407 More...

NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339

G

cAMP responsive element binding protein 5

increases expression

EXP

Amphetamine results in increased expression of CREB5 mRNA

NCBI chr 4:83,723,587...84,124,786
Ensembl chr 4:83,723,194...84,120,793

G

cAMP responsive element modulator

increases response to substance
increases expression

ISO
EXP

CREM protein results in increased susceptibility to Amphetamine
Amphetamine results in increased expression of CREM mRNA

PMID:16899718 PMID:30779732

NCBI chr17:58,932,011...59,001,160
Ensembl chr17:58,934,147...59,001,160

G

corticotropin releasing hormone

affects expression

EXP

Amphetamine affects the expression of CRH protein

NCBI chr 2:104,059,184...104,061,048
Ensembl chr 2:104,058,770...104,061,386

G

corticotropin releasing hormone receptor 2

increases expression

EXP

Amphetamine results in increased expression of CRHR2 protein

NCBI chr 4:85,553,163...85,596,203
Ensembl chr 4:85,554,268...85,596,318

G

cysteine rich protein 1

increases expression

EXP

Amphetamine results in increased expression of CRIP1 mRNA

NCBI chr 6:138,047,801...138,055,672
Ensembl chr 6:138,047,801...138,055,672

G

cysteine-rich secretory protein LCCL domain containing 2

increases expression

EXP

Amphetamine results in increased expression of CRISPLD2 mRNA

NCBI chr19:64,961,764...65,020,099
Ensembl chr19:64,961,771...65,020,349

G

collapsin response mediator protein 1

decreases expression

EXP

Amphetamine results in decreased expression of CRMP1 mRNA

NCBI chr14:77,734,675...77,780,916
Ensembl chr14:77,734,675...77,780,916

G

ciliary rootlet coiled-coil, rootletin

decreases expression

EXP

Amphetamine results in decreased expression of CROCC mRNA

NCBI chr 5:158,603,979...158,646,728
Ensembl chr 5:158,603,556...158,640,238

G

C-reactive protein

decreases expression

EXP

Amphetamine results in decreased expression of CRP mRNA

NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514

G

CREB regulated transcription coactivator 1

decreases expression

EXP

Amphetamine results in decreased expression of CRTC1 mRNA

NCBI chr16:19,022,171...19,080,880
Ensembl chr16:19,022,005...19,080,880

G

cryptochrome circadian regulator 2

decreases expression

EXP

Amphetamine results in decreased expression of CRY2 mRNA

NCBI chr 3:98,830,479...98,860,437
Ensembl chr 3:98,830,483...98,860,447

G

crystallin, alpha B

increases expression

EXP

Amphetamine results in increased expression of CRYAB mRNA

NCBI chr 8:59,989,885...59,995,532
Ensembl chr 8:59,989,814...59,995,528

G

crystallin beta-gamma domain containing 3

increases expression

EXP

Amphetamine results in increased expression of CRYBG3 mRNA

NCBI chr11:54,218,399...54,330,962
Ensembl chr11:54,208,444...54,330,960

G

crystallin, mu

increases expression

EXP

Amphetamine results in increased expression of CRYM mRNA

NCBI chr 1:183,991,752...184,006,923
Ensembl chr 1:183,991,745...184,006,962

G

colony stimulating factor 1

increases expression

EXP

Amphetamine results in increased expression of CSF1 mRNA

NCBI chr 2:198,065,400...198,084,774
Ensembl chr 2:198,065,405...198,084,468

G

casein kinase 1, epsilon

affects response to substance
increases response to substance

ISO

CSNK1E gene polymorphism affects the susceptibility to Amphetamine
CSNK1E protein results in increased susceptibility to Amphetamine

NCBI chr 7:112,863,726...112,887,338
Ensembl chr 7:112,863,731...112,884,101

G

cysteine and glycine rich protein 3

increases expression

EXP

Amphetamine results in increased expression of CSRP3 mRNA

NCBI chr 1:107,664,338...107,682,916
Ensembl chr 1:107,664,338...107,682,916

G

cystatin B

increases expression

EXP

Amphetamine results in increased expression of CSTB mRNA

NCBI chr20:10,245,157...10,247,199
Ensembl chr20:10,245,158...10,247,199

G

cleavage stimulation factor subunit 2

decreases expression

EXP

Amphetamine results in decreased expression of CSTF2 mRNA

NCBI chr X:101,546,809...101,572,760
Ensembl chr X:101,546,819...101,572,764

G

CST telomere replication complex component 1

decreases expression

EXP

Amphetamine results in decreased expression of CTC1 mRNA

NCBI chr10:54,212,537...54,234,146
Ensembl chr10:54,207,083...54,234,147

G

cytotoxic T lymphocyte-associated protein 2 alpha

increases expression

EXP

Amphetamine results in increased expression of CTLA2A mRNA

NCBI chr17:3,809,052...3,828,872
Ensembl chr17:3,808,943...3,829,344

G

catenin beta 1

decreases expression

EXP

Amphetamine results in decreased expression of CTNNB1 protein

NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662

G

catenin, beta-interacting protein 1

increases expression

EXP

Amphetamine results in increased expression of CTNNBIP1 mRNA

NCBI chr 5:165,245,019...165,293,994
Ensembl chr 5:165,245,098...165,293,991

G

chymotrypsin C

increases expression

EXP

Amphetamine results in increased expression of CTRC mRNA

NCBI chr 5:159,430,333...159,439,557
Ensembl chr 5:159,430,335...159,439,545

G

cathepsin C

increases expression

EXP

Amphetamine results in increased expression of CTSC mRNA

NCBI chr 1:151,440,860...151,472,430
Ensembl chr 1:151,441,032...151,474,082

G

cathepsin F

increases expression

EXP

Amphetamine results in increased expression of CTSF mRNA

NCBI chr 1:211,582,169...211,587,917
Ensembl chr 1:211,582,098...211,587,916

G

cathepsin H

increases expression

EXP

Amphetamine results in increased expression of CTSH mRNA

NCBI chr 8:99,488,756...99,507,639
Ensembl chr 8:99,488,874...99,509,181

G

cathepsin K

increases expression

EXP

Amphetamine results in increased expression of CTSK mRNA

NCBI chr 2:185,747,548...185,758,512
Ensembl chr 2:185,747,165...185,765,582

G

cathepsin L

increases expression

EXP

Amphetamine results in increased expression of CTSL mRNA

NCBI chr17:770,104...776,266
Ensembl chr17:770,093...777,113

G

cathepsin S

increases expression

EXP

Amphetamine results in increased expression of CTSS mRNA

NCBI chr 2:185,775,316...185,803,440
Ensembl chr 2:185,775,296...185,803,440

G

cullin 9

decreases expression

EXP

Amphetamine results in decreased expression of CUL9 mRNA

NCBI chr 9:21,933,699...21,977,145
Ensembl chr 9:21,933,803...21,977,145

G

C-X3-C motif chemokine receptor 1

decreases expression

EXP

Amphetamine results in decreased expression of CX3CR1 mRNA

NCBI chr 8:128,661,294...128,679,048
Ensembl chr 8:128,654,833...128,685,983

G

C-X-C motif chemokine ligand 10

decreases expression

EXP

Amphetamine results in decreased expression of CXCL10 mRNA

NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261

G

C-X-C motif chemokine ligand 17

decreases expression

EXP

Amphetamine results in decreased expression of CXCL17 mRNA

NCBI chr 1:90,112,561...90,124,648
Ensembl chr 1:90,112,771...90,124,535

G

CXXC finger protein 5

decreases expression

EXP

Amphetamine results in decreased expression of CXXC5 mRNA

NCBI chr18:27,701,650...27,732,633
Ensembl chr18:27,701,188...27,732,635

G

cytochrome P450, family 19, subfamily a, polypeptide 1

decreases response to substance

ISO

CYP19A1 gene results in decreased susceptibility to Amphetamine

NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917

G

cytochrome P450, family 1, subfamily a, polypeptide 2

affects chemical synthesis
increases hydroxylation
decreases methylation

ISO

CYP1A2 protein affects the chemical synthesis of Amphetamine
CYP1A2 protein results in increased hydroxylation of Amphetamine analog
CYP1A2 protein results in decreased methylation of Amphetamine analog

PMID:15294457 PMID:29277574

NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149

G

cytochrome P450, family 2, subfamily b, polypeptide 3

affects chemical synthesis
decreases methylation
increases hydroxylation

ISO

CYP2B6 protein affects the chemical synthesis of Amphetamine
CYP2B6 protein results in decreased methylation of Amphetamine analog
CYP2B6 protein results in increased hydroxylation of Amphetamine analog

PMID:15294457 PMID:29277574

NCBI chr 1:90,780,468...90,859,852

G

cytochrome P450, family 2, subfamily C, polypeptide 6

decreases methylation
increases oxidation
increases hydroxylation

ISO

CYP2C19 protein results in decreased methylation of Amphetamine analog
CYP2C19 protein results in increased oxidation of Amphetamine analog
CYP2C19 protein results in increased hydroxylation of Amphetamine analog

NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798

G

cytochrome P450, family 2, subfamily d, polypeptide 4

affects chemical synthesis
decreases methylation
increases oxidation
increases hydroxylation

ISO

CYP2D6 protein affects the chemical synthesis of Amphetamine
CYP2D6 protein results in decreased methylation of Amphetamine analog
CYP2D6 protein results in increased oxidation of Amphetamine analog
CYP2D6 protein results in increased hydroxylation of Amphetamine analog

PMID:15294457 PMID:29277574

NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837

G

cytochrome P450, family 2, subfamily u, polypeptide 1

decreases expression

EXP

Amphetamine results in decreased expression of CYP2U1 mRNA

NCBI chr 2:222,523,516...222,541,055
Ensembl chr 2:222,523,518...222,541,124

G

cytochrome P450, family 3, subfamily a, polypeptide 2

multiple interactions
decreases alkylation
decreases methylation
affects chemical synthesis

ISO

Amphetamine promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]; N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [Amphetamine promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]]
CYP3A4 protein results in decreased alkylation of Amphetamine analog
CYP3A4 protein results in decreased methylation of Amphetamine analog
CYP3A4 protein affects the chemical synthesis of Amphetamine

PMID:15294457 PMID:21402137 PMID:29277574

NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857

G

cytochrome P450, family 4, subfamily f, polypeptide 17

decreases expression

EXP

Amphetamine results in decreased expression of CYP4F17 mRNA

NCBI chr 7:12,169,366...12,186,731
Ensembl chr 7:12,169,922...12,187,540

G

cytochrome P450, family 4, subfamily f, polypeptide 18

increases expression

EXP

Amphetamine results in increased expression of CYP4F18 mRNA

NCBI chr16:17,797,558...17,838,958
Ensembl chr16:17,740,001...17,838,958

G

cytochrome P450, family 4, subfamily f, polypeptide 5

decreases expression

EXP

Amphetamine results in decreased expression of CYP4F5 mRNA

NCBI chr 7:12,194,567...12,209,495
Ensembl chr 7:12,195,022...12,209,965

G

CYFIP related Rac1 interactor A

decreases expression

EXP

Amphetamine results in decreased expression of CYRIA mRNA

NCBI chr 6:40,774,165...40,883,005
Ensembl chr 6:40,774,171...40,881,860

G

cysteinyl leukotriene receptor 2

decreases expression

EXP

Amphetamine results in decreased expression of CYSLTR2 mRNA

NCBI chr15:54,599,043...54,638,314
Ensembl chr15:54,598,818...54,713,597

G

cysteine-rich transmembrane module containing 1

increases expression

EXP

Amphetamine results in increased expression of CYSTM1 mRNA

NCBI chr18:28,219,861...28,287,574
Ensembl chr18:28,220,004...28,287,574

G

cytokine like 1

increases expression

EXP

Amphetamine results in increased expression of CYTL1 mRNA

NCBI chr14:77,278,635...77,283,645
Ensembl chr14:77,278,636...77,283,645

G

DAB adaptor protein 2

increases expression

EXP

Amphetamine results in increased expression of DAB2 mRNA

NCBI chr 2:57,241,947...57,294,893
Ensembl chr 2:57,242,064...57,294,888

G

dachshund family transcription factor 2

decreases expression

EXP

Amphetamine results in decreased expression of DACH2 mRNA

NCBI chr X:82,644,374...83,210,181
Ensembl chr X:82,644,128...83,210,000

G

defender against cell death 1

increases expression

EXP

Amphetamine results in increased expression of DAD1 mRNA

NCBI chr15:31,647,326...31,667,159
Ensembl chr15:31,647,326...31,667,287

G

dystroglycan 1

decreases expression

EXP

Amphetamine results in decreased expression of DAG1 mRNA

NCBI chr 8:117,769,517...117,834,347
Ensembl chr 8:117,769,517...117,782,199

G

drebrin 1

affects response to substance

EXP

DBN1 protein affects the susceptibility to Amphetamine

NCBI chr17:9,155,729...9,170,121
Ensembl chr17:9,155,787...9,170,122

G

dihydrolipoamide branched chain transacylase E2

increases expression

EXP

Amphetamine results in increased expression of DBT mRNA

NCBI chr 2:207,166,660...207,195,528
Ensembl chr 2:207,166,652...207,195,525

G

dephospho-CoA kinase domain containing

decreases expression

EXP

Amphetamine results in decreased expression of DCAKD mRNA

NCBI chr10:88,457,829...88,489,011
Ensembl chr10:88,457,829...88,480,118

G

discoidin, CUB and LCCL domain containing 1

decreases expression

EXP

Amphetamine results in decreased expression of DCBLD1 mRNA

NCBI chr20:32,161,241...32,254,391
Ensembl chr20:32,161,254...32,281,176

G

deoxycytidine kinase

increases expression

EXP

Amphetamine results in increased expression of DCK mRNA

NCBI chr14:19,589,298...19,610,326
Ensembl chr14:19,589,298...19,610,326

G

doublecortin-like kinase 1

increases expression

EXP

Amphetamine results in increased expression of DCLK1 mRNA

NCBI chr 2:141,567,215...141,861,088
Ensembl chr 2:141,571,983...141,861,090

G

dCMP deaminase

decreases expression

EXP

Amphetamine results in decreased expression of DCTD mRNA

NCBI chr16:50,799,699...50,831,398
Ensembl chr16:50,787,875...50,831,186

G

DDAH family member 2, ADMA-independent

increases expression

EXP

Amphetamine results in increased expression of DDAH2 mRNA

NCBI chr20:3,766,115...3,769,161
Ensembl chr20:3,766,120...3,769,183

G

dopa decarboxylase

decreases expression

EXP

Amphetamine results in decreased expression of DDC mRNA

NCBI chr14:90,592,304...90,682,830
Ensembl chr14:90,592,304...90,682,806

G

DEAD/H-box helicase 11

decreases expression

EXP

Amphetamine results in decreased expression of DDX11 mRNA

NCBI chr 9:113,204,886...113,309,692
Ensembl chr 9:113,276,985...113,316,152

G

DExD-box helicase 21

decreases expression

EXP

Amphetamine results in decreased expression of DDX21 mRNA

NCBI chr20:31,077,044...31,097,238
Ensembl chr20:31,077,045...31,097,238

G

DEAD-box helicase 54

decreases expression

EXP

Amphetamine results in decreased expression of DDX54 mRNA

NCBI chr12:41,595,298...41,610,560
Ensembl chr12:41,595,555...41,611,053

G

DEAD-box helicase 56

decreases expression

EXP

Amphetamine results in decreased expression of DDX56 mRNA

NCBI chr14:85,325,942...85,336,262
Ensembl chr14:85,325,942...85,336,262

G

DEAF1 transcription factor

decreases expression

EXP

Amphetamine results in decreased expression of DEAF1 mRNA

NCBI chr 1:205,831,428...205,865,106
Ensembl chr 1:205,831,336...205,865,106

G

defensin alpha 5

increases expression

EXP

Amphetamine results in increased expression of DEFA5 mRNA

NCBI chr16:77,044,994...77,047,318
Ensembl chr16:77,044,994...77,047,318

G

defensin beta 24

increases expression

EXP

Amphetamine results in increased expression of DEFB24 mRNA

NCBI chr 3:161,506,850...161,512,983
Ensembl chr 3:161,506,851...161,512,983

G

delta(4)-desaturase, sphingolipid 2

increases expression

EXP

Amphetamine results in increased expression of DEGS2 mRNA

NCBI chr 6:133,360,449...133,377,677
Ensembl chr 6:133,360,457...133,364,422

G

DENN domain containing 1B

decreases expression

EXP

Amphetamine results in decreased expression of DENND1B mRNA

NCBI chr13:53,096,717...53,324,372
Ensembl chr13:53,092,261...53,324,369

G

DENN domain containing 1C

decreases expression

EXP

Amphetamine results in decreased expression of DENND1C mRNA

NCBI chr 9:1,991,035...2,003,330
Ensembl chr 9:1,991,039...2,003,151

G

DENN domain containing 4B

decreases expression

EXP

Amphetamine results in decreased expression of DENND4B mRNA

NCBI chr 2:178,018,095...178,034,054
Ensembl chr 2:178,018,358...178,034,054

G

DENN domain containing 4C

decreases expression

EXP

Amphetamine results in decreased expression of DENND4C mRNA

NCBI chr 5:106,316,942...106,421,484
Ensembl chr 5:106,318,281...106,415,489

G

DENN domain containing 5B

decreases expression

EXP

Amphetamine results in decreased expression of DENND5B mRNA

NCBI chr 4:183,688,039...183,821,012
Ensembl chr 4:183,692,227...183,820,508

G

DENN domain containing 6B

decreases expression

EXP

Amphetamine results in decreased expression of DENND6B mRNA

NCBI chr 7:122,139,159...122,154,720
Ensembl chr 7:122,141,317...122,153,131

G

diacylglycerol O-acyltransferase 1

increases expression

EXP

Amphetamine results in increased expression of DGAT1 mRNA

NCBI chr 7:110,104,514...110,119,091
Ensembl chr 7:110,098,906...110,115,016

G

DiGeorge syndrome critical region gene 6

increases expression

EXP

Amphetamine results in increased expression of DGCR6 mRNA

NCBI chr11:96,432,024...96,442,766
Ensembl chr11:96,432,024...96,437,255

G

diacylglycerol kinase, alpha

decreases expression

EXP

Amphetamine results in decreased expression of DGKA mRNA

NCBI chr 7:1,733,247...1,761,181
Ensembl chr 7:1,733,248...1,759,569

G

diacylglycerol kinase epsilon

decreases expression

EXP

Amphetamine results in decreased expression of DGKE mRNA

NCBI chr10:74,348,931...74,374,509
Ensembl chr10:74,350,246...74,374,478

G

diacylglycerol kinase, gamma

decreases expression

EXP

Amphetamine results in decreased expression of DGKG mRNA

NCBI chr11:91,888,957...92,083,715
Ensembl chr11:91,888,782...92,082,105

G

24-dehydrocholesterol reductase

decreases expression

EXP

Amphetamine results in decreased expression of DHCR24 mRNA

NCBI chr 5:126,573,366...126,599,940
Ensembl chr 5:126,573,338...126,599,936

G

7-dehydrocholesterol reductase

decreases expression

EXP

Amphetamine results in decreased expression of DHCR7 mRNA

NCBI chr 1:208,444,434...208,460,408
Ensembl chr 1:208,444,434...208,461,382

G

dihydrodiol dehydrogenase

decreases expression

EXP

Amphetamine results in decreased expression of DHDH mRNA

NCBI chr 1:105,088,108...105,102,560
Ensembl chr 1:105,090,309...105,101,567

G

DEAH-box helicase 33

decreases expression

EXP

Amphetamine results in decreased expression of DHX33 mRNA

NCBI chr10:56,206,680...56,223,189
Ensembl chr10:56,206,680...56,223,143

G

DEAH-box helicase 35

decreases expression

EXP

Amphetamine results in decreased expression of DHX35 mRNA

NCBI chr 3:167,869,971...167,927,300
Ensembl chr 3:167,870,055...167,927,300

G

DEAH-box helicase 37

decreases expression

EXP

Amphetamine results in decreased expression of DHX37 mRNA

NCBI chr12:36,856,119...36,876,245
Ensembl chr12:36,849,701...36,876,240

G

DExH-box helicase 57

decreases expression

EXP

Amphetamine results in decreased expression of DHX57 mRNA

NCBI chr 6:20,474,889...20,528,556
Ensembl chr 6:20,477,191...20,528,556

G

DEXH-box helicase 58

decreases expression

EXP

Amphetamine results in decreased expression of DHX58 mRNA

NCBI chr10:86,120,677...86,132,095
Ensembl chr10:86,120,677...86,131,844

G

dicer 1 ribonuclease III

decreases expression

EXP

Amphetamine results in decreased expression of DICER1 mRNA

NCBI chr 6:129,392,298...129,457,252
Ensembl chr 6:129,396,014...129,457,252

G

death inducer-obliterator 1

decreases expression

EXP

Amphetamine results in decreased expression of DIDO1 mRNA

NCBI chr 3:188,150,100...188,203,445
Ensembl chr 3:188,150,100...188,194,823

G

disco-interacting protein 2 homolog B

decreases expression

EXP

Amphetamine results in decreased expression of DIP2B mRNA

NCBI chr 7:133,053,393...133,231,430
Ensembl chr 7:133,053,401...133,228,874

G

dispatched RND transporter family member 1

decreases expression

EXP

Amphetamine results in decreased expression of DISP1 mRNA

NCBI chr13:97,252,574...97,398,329
Ensembl chr13:97,252,574...97,398,460

G

discs large MAGUK scaffold protein 3

decreases expression

EXP

Amphetamine results in decreased expression of DLG3 mRNA

NCBI chr X:69,899,694...69,951,928
Ensembl chr X:69,900,003...69,950,696

G

discs large MAGUK scaffold protein 4

decreases expression

EXP

Amphetamine results in decreased expression of DLG4 mRNA

NCBI chr10:55,239,397...55,267,780
Ensembl chr10:55,236,869...55,265,839

G

DM1 locus, WD repeat containing

decreases expression

EXP

Amphetamine results in decreased expression of DMWD mRNA

NCBI chr 1:87,850,475...87,857,263
Ensembl chr 1:87,850,604...87,857,624

G

Dmx-like 1

decreases expression

EXP

Amphetamine results in decreased expression of DMXL1 mRNA

NCBI chr18:45,179,505...45,349,999
Ensembl chr18:45,179,551...45,356,406

G

Dmx-like 2

increases expression

EXP

Amphetamine results in increased expression of DMXL2 mRNA

NCBI chr 8:63,637,314...63,803,911
Ensembl chr 8:63,637,314...63,781,116

G

DNA replication helicase/nuclease 2

increases expression

EXP

Amphetamine results in increased expression of DNA2 mRNA

NCBI chr20:25,660,339...25,689,285

G

dynein, axonemal, heavy chain 1

increases expression

EXP

Amphetamine results in increased expression of DNAH1 mRNA

NCBI chr16:6,462,419...6,523,545
Ensembl chr16:6,462,419...6,524,760

G

dynein axonemal intermediate chain 7

increases expression

EXP

Amphetamine results in increased expression of DNAI7 mRNA

NCBI chr 4:179,874,338...179,910,716
Ensembl chr 4:179,873,522...179,910,780

G

DnaJ heat shock protein family (Hsp40) member A1

increases expression

EXP

Amphetamine results in increased expression of DNAJA1 mRNA

NCBI chr 5:60,638,404...60,649,315
Ensembl chr 5:60,638,410...60,650,160

G

DnaJ heat shock protein family (Hsp40) member A3

decreases expression

EXP

Amphetamine results in decreased expression of DNAJA3 mRNA

NCBI chr10:11,361,168...11,386,599
Ensembl chr10:11,361,168...11,386,599

G

DnaJ heat shock protein family (Hsp40) member C27

decreases expression

EXP

Amphetamine results in decreased expression of DNAJC27 mRNA

NCBI chr 6:32,788,215...32,842,418
Ensembl chr 6:32,788,184...32,817,940

G

deoxyribonuclease 1L3

increases expression

EXP

Amphetamine results in increased expression of DNASE1L3 mRNA

NCBI chr15:19,351,683...19,378,536
Ensembl chr15:19,352,493...19,378,531

G

deoxyribonuclease 2 beta

decreases expression

EXP

Amphetamine results in decreased expression of DNASE2B mRNA

NCBI chr 2:238,131,182...238,168,041
Ensembl chr 2:238,131,185...238,146,558

G

delta/notch-like EGF repeat containing

increases expression

EXP

Amphetamine results in increased expression of DNER mRNA

NCBI chr 9:93,035,108...93,350,568
Ensembl chr 9:93,035,108...93,350,568

G

dynamin binding protein

decreases expression

EXP

Amphetamine results in decreased expression of DNMBP mRNA

NCBI chr 1:252,685,406...252,778,642
Ensembl chr 1:252,685,406...252,778,688

G

DNA methyltransferase 1

decreases expression

EXP

Amphetamine results in decreased expression of DNMT1 mRNA

NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:27,716,797...27,763,119

G

DNA methyltransferase 3 alpha

decreases expression

EXP

Amphetamine results in decreased expression of DNMT3A mRNA

NCBI chr 6:32,507,316...32,621,678
Ensembl chr 6:32,512,070...32,614,970

G

DNA methyltransferase 3 beta

decreases expression

EXP

Amphetamine results in decreased expression of DNMT3B mRNA

NCBI chr 3:162,590,777...162,629,313
Ensembl chr 3:162,604,037...162,629,313

G

dedicator of cytokinesis 7

decreases expression

EXP

Amphetamine results in decreased expression of DOCK7 mRNA

NCBI chr 5:118,714,863...118,898,362
Ensembl chr 5:118,714,863...118,898,335

G

DOT1 like histone lysine methyltransferase

decreases expression

EXP

Amphetamine results in decreased expression of DOT1L mRNA

NCBI chr 7:9,569,439...9,607,095
Ensembl chr 7:9,569,439...9,607,095

G

dolichyl-phosphate N-acetylglucosaminephosphotransferase 1

increases expression

EXP

Amphetamine results in increased expression of DPAGT1 mRNA

NCBI chr 8:53,560,869...53,567,625
Ensembl chr 8:53,555,239...53,567,898

G

dipeptidase 2

increases expression

EXP

Amphetamine results in increased expression of DPEP2 mRNA

NCBI chr19:50,795,322...50,806,320
Ensembl chr19:50,795,327...50,801,757
Ensembl chr19:50,795,327...50,801,757

G

diphthamide biosynthesis 1

decreases expression

EXP

Amphetamine results in decreased expression of DPH1 mRNA

NCBI chr10:60,526,417...60,538,102
Ensembl chr10:60,527,680...60,535,816

G

dipeptidylpeptidase 4

decreases expression

EXP

Amphetamine results in decreased expression of DPP4 mRNA

NCBI chr 3:67,370,794...67,452,422
Ensembl chr 3:67,370,804...67,452,422

G

dihydropyrimidinase-like 5

decreases expression

EXP

Amphetamine results in decreased expression of DPYSL5 mRNA

NCBI chr 6:31,295,035...31,379,348
Ensembl chr 6:31,295,035...31,379,348

G

dopamine receptor D1

multiple interactions
increases expression
decreases activity
decreases expression

EXP
ISO

[A 68930 binds to and results in increased activity of DRD1 protein] which affects the susceptibility to Amphetamine; [dihydrexidine binds to and results in increased activity of DRD1 protein] which affects the susceptibility to Amphetamine; [SCH 23390 binds to and results in decreased activity of DRD1 protein] which results in decreased susceptibility to Amphetamine
Amphetamine results in increased expression of DRD1 mRNA
Amphetamine results in decreased activity of DRD1 protein
Amphetamine results in decreased expression of DRD1 mRNA; Amphetamine results in decreased expression of DRD1 protein

PMID:14960337 PMID:16554467 PMID:16916582 PMID:19145071 PMID:19733155

NCBI chr17:10,545,488...10,550,029
Ensembl chr17:10,545,111...10,567,166

G

dopamine receptor D2

increases response to substance
affects response to substance
increases expression
increases activity
decreases expression
multiple interactions

ISO
EXP

DRD2 results in increased susceptibility to Amphetamine
DRD2 SNP affects the susceptibility to Amphetamine
Amphetamine results in increased expression of DRD2 mRNA; Amphetamine results in increased expression of DRD2 mRNA alternative form
Amphetamine results in increased activity of DRD2 protein
Amphetamine results in decreased expression of DRD2 mRNA; Amphetamine results in decreased expression of DRD2 protein
CACNA1D protein affects the reaction [Amphetamine results in increased expression of DRD2 mRNA alternative form]
Amphetamine inhibits the reaction [Spiperone binds to DRD2 protein]

PMID:2018630 PMID:7861147 PMID:11790512 PMID:15183010 PMID:16916582 More...

NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:58,605,403...58,669,339

G

dopamine receptor D3

increases response to substance
decreases expression

EXP

DRD3 protein results in increased susceptibility to Amphetamine
Amphetamine results in decreased expression of DRD3 mRNA; Amphetamine results in decreased expression of DRD3 protein

NCBI chr11:70,385,586...70,437,793
Ensembl chr11:70,385,586...70,446,760

G

dopamine receptor D5

multiple interactions

EXP

[A 68930 binds to and results in increased activity of DRD5 protein] which affects the susceptibility to Amphetamine; [dihydrexidine binds to and results in increased activity of DRD5 protein] which affects the susceptibility to Amphetamine

NCBI chr14:76,700,244...76,703,344
Ensembl chr14:76,700,241...76,703,466

G

drosha ribonuclease III

decreases expression

EXP

Amphetamine results in decreased expression of DROSHA mRNA

NCBI chr 2:63,591,885...63,703,688
Ensembl chr 2:63,591,968...63,703,687

G

DSN1 component of MIS12 kinetochore complex

decreases expression

EXP

Amphetamine results in decreased expression of DSN1 mRNA

NCBI chr 3:166,072,775...166,089,029
Ensembl chr 3:166,074,033...166,085,890

G

desmoplakin

increases expression

EXP

Amphetamine results in increased expression of DSP mRNA

NCBI chr17:26,829,153...26,877,419
Ensembl chr17:26,829,153...26,877,121

G

dystonin

decreases expression

EXP

Amphetamine results in decreased expression of DST mRNA

NCBI chr 9:43,631,716...44,025,535
Ensembl chr 9:43,631,517...44,025,533

G

dystrobrevin, beta

decreases expression

EXP

Amphetamine results in decreased expression of DTNB mRNA

NCBI chr 6:32,286,022...32,483,007
Ensembl chr 6:32,285,941...32,485,872

G

dihydrouridine synthase 4-like

decreases expression

EXP

Amphetamine results in decreased expression of DUS4L mRNA

NCBI chr 6:53,955,609...53,970,050
Ensembl chr 6:53,955,609...53,970,087

G

dual specificity phosphatase 1

increases expression

EXP

Amphetamine results in increased expression of DUSP1 mRNA; Amphetamine results in increased expression of DUSP1 protein

PMID:15329393 PMID:30779732

NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644

G

dual specificity phosphatase 18

increases expression

EXP

Amphetamine results in increased expression of DUSP18 mRNA

NCBI chr14:83,013,850...83,035,168
Ensembl chr14:83,011,014...83,056,929

G

dual specificity phosphatase 19

decreases expression

EXP

Amphetamine results in decreased expression of DUSP19 mRNA

NCBI chr 3:85,945,289...86,081,289

G

dual specificity phosphatase 3

increases expression

EXP

Amphetamine results in increased expression of DUSP3 mRNA

NCBI chr10:87,420,213...87,434,202
Ensembl chr10:87,419,494...87,434,063

G

dual specificity phosphatase 8

increases expression

EXP

Amphetamine results in increased expression of DUSP8 mRNA

NCBI chr 1:206,596,912...206,613,728
Ensembl chr 1:206,598,942...206,612,441

G

double homeobox 4

decreases expression

EXP

Amphetamine results in decreased expression of DUX4 mRNA

NCBI chr16:1,565,290...1,575,317
Ensembl chr16:1,567,553...1,575,468

G

dynein cytoplasmic 1 heavy chain 1

decreases expression

EXP

Amphetamine results in decreased expression of DYNC1H1 mRNA

NCBI chr 6:135,436,375...135,502,117
Ensembl chr 6:135,430,750...135,502,116

G

dynein cytoplasmic 2 heavy chain 1

decreases expression

EXP

Amphetamine results in decreased expression of DYNC2H1 mRNA

NCBI chr 8:12,473,955...12,697,075
Ensembl chr 8:12,473,955...12,697,058

G

dynein light chain Tctex-type 1

increases expression

EXP

Amphetamine results in increased expression of DYNLT1 mRNA

NCBI chr 1:49,292,093...49,299,051
Ensembl chr 1:49,282,243...49,298,951

G

dynein light chain Tctex-type 2B

increases expression

EXP

Amphetamine results in increased expression of DYNLT2B mRNA

NCBI chr11:81,864,195...81,872,555
Ensembl chr11:81,864,195...81,872,555

G

dual specificity tyrosine phosphorylation regulated kinase 2

decreases expression

EXP

Amphetamine results in decreased expression of DYRK2 mRNA

NCBI chr 7:56,235,276...56,265,741
Ensembl chr 7:56,235,276...56,265,942

G

DAZ interacting zinc finger protein 1

decreases expression

EXP

Amphetamine results in decreased expression of DZIP1 mRNA

NCBI chr15:102,363,392...102,417,085
Ensembl chr15:102,363,392...102,417,085

G

DAZ interacting zinc finger protein 3

decreases expression

EXP

Amphetamine results in decreased expression of DZIP3 mRNA

NCBI chr11:65,286,190...65,356,314
Ensembl chr11:65,286,190...65,356,314

G

E2F transcription factor 1

decreases expression

EXP

Amphetamine results in decreased expression of E2F1 mRNA

NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:163,524,739...163,535,563

G

ELL associated factor 1

increases expression

EXP

Amphetamine results in increased expression of EAF1 mRNA

NCBI chr16:6,704,727...6,719,476
Ensembl chr16:6,704,727...6,719,476

G

ecdysoneless cell cycle regulator

decreases expression

EXP

Amphetamine results in decreased expression of ECD mRNA

NCBI chr15:4,016,411...4,047,899
Ensembl chr15:4,016,403...4,047,897

G

endothelin converting enzyme 1

increases expression

EXP

Amphetamine results in increased expression of ECE1 mRNA

NCBI chr 5:155,361,031...155,462,723
Ensembl chr 5:155,360,639...155,462,719

G

enhancer of mRNA decapping 3

decreases expression

EXP

Amphetamine results in decreased expression of EDC3 mRNA

NCBI chr 8:67,002,032...67,047,563
Ensembl chr 8:67,002,014...67,047,559

G

EGF like repeats and discoidin domains 3

increases expression

EXP

Amphetamine results in increased expression of EDIL3 mRNA

NCBI chr 2:21,625,604...22,140,380
Ensembl chr 2:21,625,596...22,140,379

G

embryonic ectoderm development

increases expression

EXP

Amphetamine results in increased expression of EED mRNA

NCBI chr 1:153,280,419...153,307,537
Ensembl chr 1:153,280,422...153,307,500

G

eukaryotic translation elongation factor 1 alpha 2

increases expression

EXP

Amphetamine results in increased expression of EEF1A2 mRNA

NCBI chr 3:188,643,455...188,652,633
Ensembl chr 3:188,643,458...188,677,712

G

estrogen-induced osteoclastogenesis regulator 1

decreases expression

EXP

Amphetamine results in decreased expression of EEIG1 mRNA

NCBI chr 3:36,220,170...36,252,377
Ensembl chr 3:36,211,730...36,252,378

G

endonuclease/exonuclease/phosphatase family domain containing 1

increases expression

EXP

Amphetamine results in increased expression of EEPD1 mRNA

NCBI chr 8:32,233,834...32,340,148
Ensembl chr 8:32,233,070...32,340,147

G

EGF containing fibulin extracellular matrix protein 2

increases expression

EXP

Amphetamine results in increased expression of EFEMP2 mRNA

NCBI chr 1:212,211,057...212,218,739
Ensembl chr 1:212,210,972...212,218,739

G

EF hand domain family, member B

increases expression

EXP

Amphetamine results in increased expression of EFHB mRNA

NCBI chr 9:6,608,791...6,680,104
Ensembl chr 9:6,608,794...6,678,827

G

EF-hand domain containing 1

increases expression

EXP

Amphetamine results in increased expression of EFHC1 mRNA

NCBI chr 9:30,872,238...30,910,703
Ensembl chr 9:30,871,565...30,910,703

G

ephrin B2

decreases expression

EXP

Amphetamine results in decreased expression of EFNB2 mRNA

NCBI chr16:87,485,215...87,529,224
Ensembl chr16:87,485,198...87,529,208

G

embryonal Fyn-associated substrate

increases expression

EXP

Amphetamine results in increased expression of EFS mRNA

NCBI chr15:32,362,401...32,374,490
Ensembl chr15:32,361,843...32,371,743

G

egl-9 family hypoxia-inducible factor 3

increases expression

EXP

Amphetamine results in increased expression of EGLN3 mRNA

NCBI chr 6:77,385,549...77,411,015
Ensembl chr 6:77,385,549...77,411,015

G

early growth response 1

affects expression
decreases expression
increases expression
multiple interactions

EXP

Amphetamine affects the expression of EGR1 mRNA
Amphetamine results in decreased expression of EGR1 mRNA
Amphetamine results in increased expression of EGR1 mRNA
Methylphenidate promotes the reaction [Amphetamine results in increased expression of EGR1 mRNA]

PMID:10098858 PMID:10683413 PMID:12638131 PMID:15010207 PMID:15183010 More...

NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843

G

EH-domain containing 4

increases expression

EXP

Amphetamine results in increased expression of EHD4 mRNA

NCBI chr 3:127,511,973...127,575,856
Ensembl chr 3:127,511,954...127,576,072

G

euchromatic histone lysine methyltransferase 1

decreases expression

EXP

Amphetamine results in decreased expression of EHMT1 mRNA

NCBI chr 3:27,978,888...28,127,178
Ensembl chr 3:27,978,888...28,127,349

G

eukaryotic translation initiation factor 2 alpha kinase 4

decreases expression

EXP

Amphetamine results in decreased expression of EIF2AK4 mRNA

NCBI chr 3:125,810,207...125,895,574
Ensembl chr 3:125,810,060...125,895,574

G

eukaryotic translation initiation factor 4E binding protein 1

increases expression

EXP

Amphetamine results in increased expression of EIF4EBP1 mRNA

NCBI chr16:71,495,457...71,508,845
Ensembl chr16:71,487,930...71,508,874

G

eukaryotic translation initiation factor 4 gamma 1

decreases expression

EXP

Amphetamine results in decreased expression of EIF4G1 mRNA

NCBI chr11:93,726,322...93,746,387
Ensembl chr11:93,726,322...93,746,367

G

elaC ribonuclease Z 2

decreases expression

EXP

Amphetamine results in decreased expression of ELAC2 mRNA

NCBI chr10:50,131,449...50,154,755
Ensembl chr10:50,131,521...50,155,069

G

elastase, neutrophil expressed

increases expression

EXP

Amphetamine results in increased expression of ELANE mRNA

NCBI chr 7:10,467,877...10,469,725
Ensembl chr 7:10,467,877...10,469,725

G

E74 like ETS transcription factor 4

decreases expression

EXP

Amphetamine results in decreased expression of ELF4 mRNA

NCBI chr X:132,465,290...132,508,175
Ensembl chr X:132,468,539...132,478,689

G

ETS transcription factor ELK1

increases phosphorylation
multiple interactions

EXP

Amphetamine results in increased phosphorylation of ELK1 protein
KN 62 inhibits the reaction [Amphetamine results in increased phosphorylation of ELK1 protein]

NCBI chr X:3,692,367...3,709,252
Ensembl chr X:3,693,293...3,709,249

G

elastin

increases expression

EXP

Amphetamine results in increased expression of ELN mRNA

NCBI chr12:27,604,983...27,648,413
Ensembl chr12:27,604,680...27,648,413

G

elongator acetyltransferase complex subunit 1

decreases expression

EXP

Amphetamine results in decreased expression of ELP1 mRNA

NCBI chr 5:76,248,545...76,300,985
Ensembl chr 5:76,248,550...76,300,985

G

embigin

increases expression

EXP

Amphetamine results in increased expression of EMB mRNA

NCBI chr 2:50,803,468...50,858,001
Ensembl chr 2:50,801,973...50,862,920

G

ER membrane protein complex subunit 2

increases expression

EXP

Amphetamine results in increased expression of EMC2 mRNA

NCBI chr 7:76,471,899...76,508,866
Ensembl chr 7:76,471,899...76,510,178

G

endomucin

increases expression

EXP

Amphetamine results in increased expression of EMCN mRNA

NCBI chr 2:228,564,445...228,644,370
Ensembl chr 2:228,564,430...228,645,155

G

elastin microfibril interfacer 2

increases expression

EXP

Amphetamine results in increased expression of EMILIN2 mRNA

NCBI chr 9:118,607,312...118,667,087
Ensembl chr 9:118,606,891...118,666,957

G

epithelial membrane protein 1

increases expression

EXP

Amphetamine results in increased expression of EMP1 mRNA

NCBI chr 4:169,931,537...169,964,366
Ensembl chr 4:169,931,440...169,964,365

G

endoglin

increases expression

EXP

Amphetamine results in increased expression of ENG mRNA

NCBI chr 3:36,332,190...36,370,324
Ensembl chr 3:36,326,202...36,370,933

G

endo-beta-N-acetylglucosaminidase

decreases expression

EXP

Amphetamine results in decreased expression of ENGASE mRNA

NCBI chr10:104,205,753...104,218,416
Ensembl chr10:104,205,752...104,218,411

G

enkurin, TRPC channel interacting protein

increases expression

EXP

Amphetamine results in increased expression of ENKUR mRNA

NCBI chr17:88,599,057...88,622,668
Ensembl chr17:88,599,057...88,622,668

G

enolase 1

increases expression

EXP

Amphetamine results in increased expression of ENO1 mRNA

NCBI chr 5:166,002,867...166,014,252
Ensembl chr 3:77,946,261...77,986,003
Ensembl chr 5:77,946,261...77,986,003

G

enolase 2

multiple interactions

ISO

Amphetamine inhibits the reaction [MDK gene mutant form results in decreased expression of ENO2 protein]; Amphetamine inhibits the reaction [PTN gene mutant form results in decreased expression of ENO2 protein]

NCBI chr 4:159,258,371...159,267,220
Ensembl chr 4:159,258,371...159,267,220

G

enolase 3

decreases expression

EXP

Amphetamine results in decreased expression of ENO3 mRNA

NCBI chr10:55,868,880...55,876,099
Ensembl chr10:55,866,101...55,874,540

G

ectonucleoside triphosphate diphosphohydrolase 1

increases expression
multiple interactions

EXP
ISO

Amphetamine results in increased expression of ENTPD1 mRNA
[Amphetamine co-treated with coomassie Brilliant Blue] results in increased expression of ENTPD1 mRNA

PMID:30779732 PMID:31729632

NCBI chr 1:249,374,810...249,502,310
Ensembl chr 1:249,374,836...249,502,317

G

ectonucleoside triphosphate diphosphohydrolase 3

increases expression

ISO

Amphetamine results in increased expression of ENTPD3 mRNA

NCBI chr 8:129,124,540...129,155,528
Ensembl chr 8:129,124,709...129,156,252

G

ectonucleoside triphosphate diphosphohydrolase 6

decreases expression

EXP

Amphetamine results in decreased expression of ENTPD6 mRNA

NCBI chr 3:160,036,055...160,058,580
Ensembl chr 3:160,036,121...160,059,451

G

endosomal transmembrane epsin interactor 3

decreases expression

EXP

Amphetamine results in decreased expression of ENTREP3 mRNA

NCBI chr 2:176,886,903...176,893,047
Ensembl chr 2:176,887,135...176,893,047

G

E1A binding protein p300

decreases expression

EXP

Amphetamine results in decreased expression of EP300 mRNA

NCBI chr 7:114,987,857...115,058,652
Ensembl chr 7:114,946,982...115,058,574

G

erythrocyte membrane protein band 4.1 like 5

decreases expression

EXP

Amphetamine results in decreased expression of EPB41L5 mRNA

NCBI chr13:33,221,705...33,321,400
Ensembl chr13:33,223,589...33,321,133

G

Eph receptor A1

increases expression

EXP

Amphetamine results in increased expression of EPHA1 mRNA

NCBI chr 4:72,213,022...72,227,543
Ensembl chr 4:72,213,037...72,227,474

G

EPH receptor A10

decreases expression

EXP

Amphetamine results in decreased expression of EPHA10 mRNA

NCBI chr 5:142,424,260...142,460,305
Ensembl chr 5:142,424,296...142,460,305

G

Eph receptor A4

increases expression

EXP

Amphetamine results in increased expression of EPHA4 mRNA

NCBI chr 9:86,263,982...86,406,744
Ensembl chr 9:86,263,982...86,406,755

G

Eph receptor B6

decreases expression

EXP

Amphetamine results in decreased expression of EPHB6 mRNA

NCBI chr 4:71,458,632...71,473,889
Ensembl chr 4:71,458,971...71,476,659

G

EPM2A interacting protein 1

decreases expression

EXP

Amphetamine results in decreased expression of EPM2AIP1 mRNA

NCBI chr 8:120,112,265...120,119,613
Ensembl chr 8:120,112,084...120,121,458

G

erb-b2 receptor tyrosine kinase 3

decreases expression

EXP

Amphetamine results in decreased expression of ERBB3 mRNA

NCBI chr 7:1,579,079...1,600,379
Ensembl chr 7:1,579,816...1,601,120

G

ELKS/RAB6-interacting/CAST family member 1

decreases expression

EXP

Amphetamine results in decreased expression of ERC1 mRNA

NCBI chr 4:154,435,936...154,727,987
Ensembl chr 4:154,435,944...154,727,987

G

ERCC excision repair 6, chromatin remodeling factor

decreases expression

EXP

Amphetamine results in decreased expression of ERCC6 mRNA

NCBI chr16:7,771,311...7,841,895
Ensembl chr16:7,771,581...7,841,895

G

ERCC excision repair 6 like 2

decreases expression

EXP

Amphetamine results in decreased expression of ERCC6L2 mRNA

NCBI chr17:1,055,881...1,323,207
Ensembl chr17:1,222,139...1,316,056

G

Ets2 repressor factor

increases expression

EXP

Amphetamine results in increased expression of ERF mRNA

NCBI chr 1:89,957,760...89,966,213
Ensembl chr 1:89,957,760...89,966,213

G

endoplasmic reticulum oxidoreductase 1 alpha

increases expression

EXP

Amphetamine results in increased expression of ERO1A mRNA

NCBI chr15:20,974,771...21,010,170
Ensembl chr15:20,972,679...21,018,039

G

endoplasmic reticulum protein 29

multiple interactions

ISO

[MDK gene mutant form results in decreased susceptibility to Amphetamine] which results in increased expression of and results in increased phosphorylation of ERP29 protein; [PTN gene mutant form results in decreased susceptibility to Amphetamine] which results in increased expression of and results in increased phosphorylation of ERP29 protein

NCBI chr12:40,750,177...40,756,607
Ensembl chr12:40,750,314...40,757,010

G

endogenous retrovirus group V member 2, envelope

increases expression

EXP

Amphetamine results in increased expression of ERV3 mRNA

NCBI chr 3:139,582,024...139,587,909
Ensembl chr 3:139,582,024...139,587,909

G

epithelial splicing regulatory protein 1

increases expression

EXP

Amphetamine results in increased expression of ESRP1 mRNA

NCBI chr 5:29,224,831...29,279,381
Ensembl chr 5:29,225,360...29,279,278

G

electron transfer flavoprotein subunit beta lysine methyltransferase

increases expression

EXP

Amphetamine results in increased expression of ETFBKMT mRNA

NCBI chr 4:183,871,819...183,936,843
Ensembl chr 4:183,871,827...183,881,621

G

ETHE1, persulfide dioxygenase

increases expression

EXP

Amphetamine results in increased expression of ETHE1 mRNA

NCBI chr 1:89,311,948...89,327,000
Ensembl chr 1:89,311,934...89,326,998

G

ethanolamine kinase 1

decreases expression

EXP

Amphetamine results in decreased expression of ETNK1 mRNA

NCBI chr 4:177,857,001...177,901,278
Ensembl chr 4:177,856,960...177,924,721

G

ETS proto-oncogene 1, transcription factor

decreases expression

EXP

Amphetamine results in decreased expression of ETS1 mRNA

NCBI chr 8:39,303,936...39,426,022
Ensembl chr 8:39,303,925...39,426,021

G

ETS proto-oncogene 2, transcription factor

increases expression

EXP

Amphetamine results in increased expression of ETS2 mRNA

NCBI chr11:48,491,057...48,507,843
Ensembl chr11:48,491,394...48,507,842

G

ETS variant transcription factor 3

decreases expression

EXP

Amphetamine results in decreased expression of ETV3 mRNA

NCBI chr 2:175,263,389...175,278,217
Ensembl chr 2:175,263,459...175,278,208

G

Enah/Vasp-like

decreases expression

EXP

Amphetamine results in decreased expression of EVL mRNA

NCBI chr 6:133,238,547...133,358,730
Ensembl chr 6:133,238,547...133,358,729

G

exonuclease 5

increases expression

EXP

Amphetamine results in increased expression of EXO5 mRNA

NCBI chr 5:139,779,646...139,782,963
Ensembl chr 5:139,777,987...139,783,034

G

exocyst complex component 3-like 2

increases expression

EXP

Amphetamine results in increased expression of EXOC3L2 mRNA

NCBI chr 1:88,241,784...88,273,352
Ensembl chr 1:88,240,477...88,276,847

G

exocyst complex component 4

decreases expression

EXP

Amphetamine results in decreased expression of EXOC4 mRNA

NCBI chr 4:62,774,896...63,551,541
Ensembl chr 4:62,774,935...63,552,943

G

exostosin-like glycosyltransferase 3

decreases expression

EXP

Amphetamine results in decreased expression of EXTL3 mRNA

NCBI chr15:43,469,293...43,559,760
Ensembl chr15:43,471,366...43,495,356

G

coagulation factor XIII A1 chain

increases expression

EXP

Amphetamine results in increased expression of F13A1 mRNA

NCBI chr17:28,021,197...28,197,960
Ensembl chr17:28,020,845...28,197,948

G

coagulation factor II, thrombin

multiple interactions

ISO

Amphetamine promotes the reaction [F2 protein results in increased expression of F3 protein]

NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:98,051,960...98,065,246

G

coagulation factor III, tissue factor

increases expression
increases activity
multiple interactions

ISO
EXP

Amphetamine results in increased expression of F3 protein
Amphetamine results in increased activity of F3 protein
3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine inhibits the reaction [Amphetamine promotes the reaction [TNF protein results in increased expression of F3 protein]]; Amphetamine promotes the reaction [F2 protein results in increased expression of F3 protein]; Amphetamine promotes the reaction [TNF protein results in increased activity of F3 protein]; Amphetamine promotes the reaction [TNF protein results in increased expression of F3 mRNA]; Amphetamine promotes the reaction [TNF protein results in increased expression of F3 protein]; L 750667 inhibits the reaction [Amphetamine promotes the reaction [TNF protein results in increased expression of F3 protein]]
Amphetamine results in increased expression of F3 mRNA

PMID:20118172 PMID:30779732

NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369

G

fatty acid amide hydrolase

decreases expression
affects response to substance

EXP
ISO

Amphetamine results in decreased expression of FAAH mRNA
FAAH polymorphism affects the susceptibility to Amphetamine

PMID:19890266 PMID:30779732

NCBI chr 5:134,716,545...134,735,396
Ensembl chr 5:134,716,545...134,735,396

G

fatty acid binding protein 3

increases expression

EXP

Amphetamine results in increased expression of FABP3 mRNA

NCBI chr 5:147,936,027...147,942,870
Ensembl chr 5:147,936,119...147,942,881

G

fatty acid binding protein 4

increases expression

EXP

Amphetamine results in increased expression of FABP4 mRNA

NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972

G

fatty acid binding protein 5

increases expression

EXP

Amphetamine results in increased expression of FABP5 mRNA

NCBI chr 2:93,672,451...93,676,186
Ensembl chr 2:93,672,458...93,676,127

G

fumarylacetoacetate hydrolase

multiple interactions

ISO

Amphetamine inhibits the reaction [MDK gene mutant form results in decreased expression of FAH protein]

NCBI chr 1:147,957,931...147,980,708
Ensembl chr 1:147,957,935...147,981,046

G

family with sequence similarity 114, member A1

increases expression

EXP

Amphetamine results in increased expression of FAM114A1 mRNA

NCBI chr14:43,629,349...43,699,800
Ensembl chr14:43,629,375...43,699,800

G

family with sequence similarity 117, member B

decreases expression

EXP

Amphetamine results in decreased expression of FAM117B mRNA

NCBI chr 9:68,834,334...68,902,543
Ensembl chr 9:68,834,354...68,902,543

G

family with sequence similarity 135, member A

increases expression

EXP

Amphetamine results in increased expression of FAM135A mRNA

NCBI chr 9:33,916,449...33,997,140
Ensembl chr 9:33,916,449...33,997,051

G

family with sequence similarity 13, member A

increases expression

EXP

Amphetamine results in increased expression of FAM13A mRNA

NCBI chr 4:89,386,685...89,485,940
Ensembl chr 4:89,388,569...89,485,988

G

family with sequence similarity 169, member B

decreases expression

EXP

Amphetamine results in decreased expression of FAM169B mRNA

NCBI chr 1:131,288,780...131,378,548
Ensembl chr 1:131,288,799...131,370,145

G

family with sequence similarity 171, member A2

decreases expression

EXP

Amphetamine results in decreased expression of FAM171A2 mRNA

NCBI chr10:87,894,049...87,904,213
Ensembl chr10:87,893,543...87,904,247

G

family with sequence similarity 216, member A

increases expression

EXP

Amphetamine results in increased expression of FAM216A mRNA

NCBI chr12:39,859,307...39,868,450
Ensembl chr12:39,859,172...39,868,442

G

family with sequence similarity 227, member A

increases expression

EXP

Amphetamine results in increased expression of FAM227A mRNA

NCBI chr 7:113,054,751...113,096,898
Ensembl chr 7:113,054,751...113,096,868

G

family with sequence similarity 234, member A

increases expression

EXP

Amphetamine results in increased expression of FAM234A mRNA

NCBI chr10:15,736,741...15,768,043
Ensembl chr10:15,736,742...15,749,835

G

family with sequence similarity 50, member A

increases expression

EXP

Amphetamine results in increased expression of FAM50A mRNA

NCBI chr X:157,246,533...157,253,650
Ensembl chr X:157,246,533...157,253,650

G

family with sequence similarity 53, member A

decreases expression

EXP

Amphetamine results in decreased expression of FAM53A mRNA

NCBI chr14:81,308,127...81,348,930
Ensembl chr14:81,319,375...81,348,923

G

family with sequence similarity 78, member A

decreases expression

EXP

Amphetamine results in decreased expression of FAM78A mRNA

NCBI chr 3:35,753,712...35,771,600
Ensembl chr 3:35,753,712...35,770,448

G

FA complementation group G

decreases expression

EXP

Amphetamine results in decreased expression of FANCG mRNA

NCBI chr 5:62,027,494...62,037,202
Ensembl chr 5:62,027,500...62,035,787

G

FA complementation group I

decreases expression

EXP

Amphetamine results in decreased expression of FANCI mRNA

NCBI chr 1:142,736,636...142,792,999
Ensembl chr 1:142,736,653...142,792,999

G

Fas binding factor 1

decreases expression

EXP

Amphetamine results in decreased expression of FBF1 mRNA

NCBI chr10:101,874,661...101,900,497
Ensembl chr10:101,874,664...101,900,738

G

filamin binding LIM protein 1

increases expression

EXP

Amphetamine results in increased expression of FBLIM1 mRNA

NCBI chr 5:159,167,004...159,198,578
Ensembl chr 5:159,167,004...159,196,853

G

F-box and leucine-rich repeat protein 22

increases expression

EXP

Amphetamine results in increased expression of FBXL22 mRNA

NCBI chr 8:75,965,027...75,971,714
Ensembl chr 8:75,965,027...75,971,714

G

F-box and leucine-rich repeat protein 5

increases expression

EXP

Amphetamine results in increased expression of FBXL5 mRNA

NCBI chr14:71,517,452...71,559,850
Ensembl chr14:71,480,270...71,560,652

G

F-box protein 17

increases expression

EXP

Amphetamine results in increased expression of FBXO17 mRNA

NCBI chr 1:93,129,776...93,151,983
Ensembl chr 1:93,129,849...93,151,981

G

F-box protein 21

decreases expression

EXP

Amphetamine results in decreased expression of FBXO21 mRNA

NCBI chr12:44,231,918...44,266,035
Ensembl chr12:44,231,923...44,266,035

G

F-box protein 22

increases expression

EXP

Amphetamine results in increased expression of FBXO22 mRNA

NCBI chr 8:64,476,034...64,492,063
Ensembl chr 8:64,475,957...64,492,062

G

F-box protein 32

decreases expression

EXP

Amphetamine results in decreased expression of FBXO32 mRNA

NCBI chr 7:91,620,925...91,654,491
Ensembl chr 7:91,620,925...91,654,491

G

F-box protein 4

increases expression

EXP

Amphetamine results in increased expression of FBXO4 mRNA

NCBI chr 2:54,902,394...54,915,388
Ensembl chr 2:54,902,394...54,915,388

G

Fc alpha receptor

increases expression

EXP

Amphetamine results in increased expression of FCAR mRNA

NCBI chr 1:78,669,119...78,703,223

G

Fc epsilon receptor Ig

increases expression

EXP

Amphetamine results in increased expression of FCER1G mRNA

NCBI chr13:86,181,908...86,186,766
Ensembl chr13:86,181,908...86,186,859

G

Fc epsilon receptor II

decreases expression

EXP

Amphetamine results in decreased expression of FCER2 mRNA

NCBI chr12:6,540,697...6,552,364
Ensembl chr12:6,540,703...6,549,374

G

Fc gamma receptor 1A

increases expression

EXP

Amphetamine results in increased expression of FCGR1A mRNA

NCBI chr 2:186,539,941...186,548,941
Ensembl chr 2:186,539,942...186,548,858

G

Fc gamma receptor 2A

increases expression

EXP

Amphetamine results in increased expression of FCGR2A mRNA

NCBI chr13:85,813,516...85,830,269
Ensembl chr13:85,855,437...85,864,394
Ensembl chr13:85,855,437...85,864,394

G

Fc gamma receptor 2B

increases expression

EXP

Amphetamine results in increased expression of FCGR2B mRNA

NCBI chr13:85,725,897...85,740,517
Ensembl chr13:85,725,897...85,740,517

G

FCH and mu domain containing endocytic adaptor 1

decreases expression

EXP

Amphetamine results in decreased expression of FCHO1 mRNA

NCBI chr16:18,447,424...18,464,738
Ensembl chr16:18,447,424...18,464,698

G

FCH and mu domain containing endocytic adaptor 2

increases expression

EXP

Amphetamine results in increased expression of FCHO2 mRNA

NCBI chr 2:31,813,356...31,916,471
Ensembl chr 2:31,814,950...31,915,445

G

FCH and double SH3 domains 2

decreases expression

EXP

Amphetamine results in decreased expression of FCHSD2 mRNA

NCBI chr 1:164,775,916...165,097,391
Ensembl chr 1:164,775,926...165,097,391

G

Fc mu receptor

decreases expression

EXP

Amphetamine results in decreased expression of FCMR mRNA

NCBI chr13:44,889,628...44,903,926
Ensembl chr13:44,889,697...44,906,314

G

ficolin B

increases expression

EXP

Amphetamine results in increased expression of FCN1 mRNA; Amphetamine results in increased expression of FCNB mRNA

NCBI chr 3:31,791,750...31,800,188
Ensembl chr 3:31,791,750...31,800,188

G

Fc receptor-like 6

increases expression

EXP

Amphetamine results in increased expression of FCRL6 mRNA

NCBI chr13:87,595,058...87,604,657
Ensembl chr13:87,595,058...87,604,949

G

fucose kinase

decreases expression

EXP

Amphetamine results in decreased expression of FCSK mRNA

NCBI chr19:55,743,746...55,783,873
Ensembl chr19:55,739,842...55,800,496

G

FES proto-oncogene, tyrosine kinase

increases expression

EXP

Amphetamine results in increased expression of FES mRNA

NCBI chr 1:143,746,945...143,756,181
Ensembl chr 1:143,746,945...143,756,181

G

fibrinogen beta chain

increases expression

EXP

Amphetamine results in increased expression of FGB mRNA

NCBI chr 2:170,693,966...170,700,875
Ensembl chr 2:170,692,965...170,705,434

G

fibroblast growth factor 2

increases expression
affects expression

EXP

Amphetamine results in increased expression of FGF2 protein
Amphetamine affects the expression of FGF2 protein

PMID:10854759 PMID:16338078

NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493

G

FGGY carbohydrate kinase domain containing

increases expression

EXP

Amphetamine results in increased expression of FGGY mRNA

NCBI chr 5:115,514,573...115,901,713
Ensembl chr 5:115,472,211...115,901,714

G

fibrinogen-like 2

increases expression

EXP

Amphetamine results in increased expression of FGL2 mRNA

NCBI chr 4:14,602,762...14,608,405
Ensembl chr 4:14,602,771...14,608,405

G

FKBP prolyl isomerase 11

increases expression

EXP

Amphetamine results in increased expression of FKBP11 mRNA

NCBI chr 7:131,750,828...131,757,784
Ensembl chr 7:131,750,672...131,770,123

G

FKBP prolyl isomerase 2

increases expression

EXP

Amphetamine results in increased expression of FKBP2 mRNA

NCBI chr 1:213,596,931...213,599,606
Ensembl chr 1:213,596,931...213,600,790

G

FKBP prolyl isomerase 5

increases expression

EXP

Amphetamine results in increased expression of FKBP5 mRNA

NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,458,940...6,543,118

G

fukutin

decreases expression

EXP

Amphetamine results in decreased expression of FKTN mRNA

NCBI chr 5:73,134,746...73,191,772
Ensembl chr 5:73,135,361...73,189,181

G

Fms related receptor tyrosine kinase 3

increases expression

EXP

Amphetamine results in increased expression of FLT3 mRNA

NCBI chr12:12,660,035...12,735,584
Ensembl chr12:12,659,946...12,735,581

G

FLYWCH-type zinc finger 1

decreases expression

EXP

Amphetamine results in decreased expression of FLYWCH1 mRNA

NCBI chr10:13,279,232...13,298,955
Ensembl chr10:13,279,232...13,298,925

G

formin-like 3

decreases expression

EXP

Amphetamine results in decreased expression of FMNL3 mRNA

NCBI chr 7:132,333,130...132,384,483
Ensembl chr 7:132,333,130...132,384,483

G

flavin containing dimethylaniline monoxygenase 5

increases expression

EXP

Amphetamine results in increased expression of FMO5 mRNA

NCBI chr 2:187,885,741...187,938,468
Ensembl chr 2:187,910,964...187,938,464

G

fibronectin 1

increases expression

EXP

Amphetamine results in increased expression of FN1 mRNA

NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137

G

Fos proto-oncogene, AP-1 transcription factor subunit

multiple interactions
decreases expression
increases expression

ISO
EXP

HDAC1 gene mutant form promotes the reaction [Amphetamine results in increased expression of FOS mRNA]; SLC6A3 protein affects the reaction [Amphetamine results in increased expression of FOS protein]; SR 48692 inhibits the reaction [Amphetamine results in increased expression of FOS protein]
Amphetamine results in decreased expression of FOS mRNA
1-(quinoxalin-6-ylcarbonyl)piperidine promotes the reaction [Amphetamine results in increased expression of FOS mRNA]; 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Amphetamine results in increased expression of FOS mRNA]; Amphetamine promotes the reaction [FOSB protein alternative form binds to FOS promoter]; Amphetamine promotes the reaction [HDAC1 protein binds to FOS promoter]; Butyric Acid inhibits the reaction [Amphetamine results in decreased expression of FOS mRNA]; eticlopride inhibits the reaction [Amphetamine results in increased expression of FOS protein]; FOS protein promotes the reaction [Amphetamine results in decreased expression of NPY mRNA]; FOS protein promotes the reaction [Amphetamine results in increased expression of SOD1 mRNA]; FOSB protein alternative form inhibits the reaction [Amphetamine results in increased expression of FOS mRNA]; GDNF protein inhibits the reaction [Oxidopamine inhibits the reaction [Amphetamine results in increased expression of FOS protein]]; GRM5 protein promotes the reaction [Amphetamine results in increased expression of FOS mRNA]; lead acetate affects the reaction [Amphetamine results in increased expression of FOS protein]; Oxidopamine inhibits the reaction [Amphetamine results in increased expression of FOS protein]; Prazosin inhibits the reaction [Amphetamine results in increased expression of FOS protein]; Reserpine promotes the reaction [Amphetamine results in increased expression of FOS protein]; SCH 23390 inhibits the reaction [Amphetamine results in increased expression of FOS protein]; SL 327 inhibits the reaction [Amphetamine results in increased expression of FOS mRNA]
[Amphetamine co-treated with SLC6A3 protein] results in increased expression of FOS mRNA; [Amphetamine co-treated with SLC6A3 protein] results in increased expression of FOS protein
Amphetamine results in increased expression of FOS mRNA; Amphetamine results in increased expression of FOS protein

PMID:2118661 PMID:8298093 PMID:8864302 PMID:10098858 PMID:10904129 More...

NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598

G

FosB proto-oncogene, AP-1 transcription factor subunit

increases expression
multiple interactions
increases expression

ISO
EXP

Amphetamine results in increased expression of FOSB mRNA; Amphetamine results in increased expression of FOSB protein alternative form
SCH 23390 inhibits the reaction [Amphetamine results in increased expression of FOSB mRNA]
Amphetamine promotes the reaction [JUN protein binds to FOSB protein]; Amphetamine results in increased activity of [JUN protein binds to FOSB protein]
Amphetamine promotes the reaction [FOSB protein alternative form binds to FOS promoter]; FOSB protein alternative form inhibits the reaction [Amphetamine results in increased expression of FOS mRNA]
Amphetamine increases expression of Fosb protein in stress induced brain

CTD
RGD

PMID:12417638 PMID:15814102 PMID:15926929 PMID:17324382 PMID:18632938 More...

NCBI chr 1:88,082,324...88,089,506
Ensembl chr 1:88,082,127...88,089,477

G

FOS like 1, AP-1 transcription factor subunit

multiple interactions
increases expression

EXP
ISO

Amphetamine affects the reaction [Haloperidol results in increased expression of FOSL1 protein]
Amphetamine results in increased expression of FOSL1 protein

PMID:12125044 PMID:15814102

NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:212,183,833...212,192,391

G

FOS like 2, AP-1 transcription factor subunit

decreases expression
multiple interactions

ISO

Amphetamine results in decreased expression of FOSL2 protein
Amphetamine promotes the reaction [JUND protein binds to FOSL2 protein]; Amphetamine results in increased activity of [JUND protein binds to FOSL2 protein]

NCBI chr 6:30,017,952...30,039,269
Ensembl chr 6:30,021,916...30,039,406

G

forkhead box N3

decreases expression

EXP

Amphetamine results in decreased expression of FOXN3 mRNA

NCBI chr 6:124,191,695...124,572,070
Ensembl chr 6:124,195,701...124,572,040

G

forkhead box O1

decreases expression

EXP

Amphetamine results in decreased expression of FOXO1 mRNA

NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:138,462,697...138,541,419

G

forkhead box P1

decreases expression

EXP

Amphetamine results in decreased expression of FOXP1 mRNA

NCBI chr 4:133,117,346...133,808,647
Ensembl chr 4:133,122,055...133,500,272

G

forkhead box P3

decreases expression

EXP

Amphetamine results in decreased expression of FOXP3 mRNA

NCBI chr X:17,580,380...17,601,181
Ensembl chr X:17,580,380...17,595,894

G

forkhead box P4

decreases expression

EXP

Amphetamine results in decreased expression of FOXP4 mRNA

NCBI chr 9:20,556,270...20,612,967
Ensembl chr 9:20,556,270...20,612,967

G

FAD-dependent oxidoreductase domain containing 2

decreases expression

EXP

Amphetamine results in decreased expression of FOXRED2 mRNA

NCBI chr 7:111,402,322...111,419,056
Ensembl chr 7:111,402,322...111,417,988

G

formyl peptide receptor 2

increases expression

EXP

Amphetamine results in increased expression of FPR2 mRNA

NCBI chr 1:67,449,637...67,458,272
Ensembl chr 1:67,449,637...67,458,272

G

FRY like transcription coactivator

decreases expression

EXP

Amphetamine results in decreased expression of FRYL mRNA

NCBI chr14:35,307,225...35,545,199
Ensembl chr14:35,310,656...35,545,147

G

fascin actin-bundling protein 3

increases expression

EXP

Amphetamine results in increased expression of FSCN3 mRNA

NCBI chr 4:58,008,124...58,017,674
Ensembl chr 4:58,008,230...58,017,673

G

far upstream element binding protein 1

decreases expression

EXP

Amphetamine results in decreased expression of FUBP1 mRNA

NCBI chr 2:243,819,529...243,846,544
Ensembl chr 2:243,819,218...243,846,428

G

far upstream element binding protein 3

decreases expression

EXP

Amphetamine results in decreased expression of FUBP3 mRNA

NCBI chr 3:35,253,216...35,302,282
Ensembl chr 3:35,253,306...35,302,280

G

alpha-L-fucosidase 1

increases expression

EXP

Amphetamine results in increased expression of FUCA1 mRNA

NCBI chr 5:153,436,262...153,453,512
Ensembl chr 5:153,436,248...153,453,511

G

alpha-L-fucosidase 2

increases expression

EXP

Amphetamine results in increased expression of FUCA2 mRNA

NCBI chr 1:9,706,121...9,720,910
Ensembl chr 1:9,706,094...9,721,706

G

FXYD domain-containing ion transport regulator 1

increases expression

EXP

Amphetamine results in increased expression of FXYD1 mRNA

NCBI chr 1:95,414,556...95,418,645
Ensembl chr 1:95,414,557...95,418,591

G

FXYD domain-containing ion transport regulator 2

increases expression

EXP

Amphetamine results in increased expression of FXYD2 mRNA

NCBI chr 8:54,609,658...54,616,788
Ensembl chr 8:54,609,658...54,616,957

G

FYN proto-oncogene, Src family tyrosine kinase

decreases expression

EXP

Amphetamine results in decreased expression of FYN mRNA

NCBI chr20:44,322,635...44,514,498
Ensembl chr20:44,322,361...44,515,479

G

frizzled class receptor 7

increases expression

EXP

Amphetamine results in increased expression of FZD7 mRNA

NCBI chr 9:68,425,538...68,428,357
Ensembl chr 9:68,411,259...68,432,585

G

G0/G1switch 2

increases expression

EXP

Amphetamine results in increased expression of G0S2 mRNA

NCBI chr13:107,335,036...107,335,948
Ensembl chr13:107,335,036...107,336,293

G

GRB2-associated binding protein 1

increases expression

EXP

Amphetamine results in increased expression of GAB1 mRNA

NCBI chr19:44,035,693...44,143,617
Ensembl chr19:44,035,063...44,143,617

G

GRB2-associated binding protein 2

increases expression

EXP

Amphetamine results in increased expression of GAB2 mRNA

NCBI chr 1:160,841,066...161,036,940
Ensembl chr 1:160,841,066...161,036,940

G

gamma-aminobutyric acid type B receptor subunit 1

decreases expression

EXP

Amphetamine results in decreased expression of GABBR1 mRNA

NCBI chr20:1,469,779...1,499,352
Ensembl chr20:1,469,779...1,498,607

G

gamma-aminobutyric acid type B receptor subunit 2

multiple interactions

ISO

Amphetamine promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein co-treated with GABBR2 protein co-treated with GABRG2 protein]]

NCBI chr 5:65,743,073...66,083,695
Ensembl chr 5:65,743,073...66,083,695

G

GA binding protein transcription factor subunit beta 2

decreases expression

EXP

Amphetamine results in decreased expression of GABPB2 mRNA

NCBI chr 2:185,444,309...185,484,200
Ensembl chr 2:185,450,296...185,483,589

G

gamma-aminobutyric acid type A receptor subunit alpha 1

increases expression
multiple interactions

EXP
ISO

Amphetamine results in increased expression of GABRA1 mRNA
Amphetamine promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein co-treated with GABBR2 protein co-treated with GABRG2 protein]]

PMID:21729720 PMID:30779732

NCBI chr10:27,096,731...27,152,563
Ensembl chr10:27,096,740...27,152,442

G

gamma-aminobutyric acid type A receptor subunit gamma 2

multiple interactions

ISO

Amphetamine promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein co-treated with GABBR2 protein co-treated with GABRG2 protein]]

NCBI chr10:26,876,926...26,965,523
Ensembl chr10:26,876,926...26,965,523

G

glutamate decarboxylase 1

increases expression
affects expression
multiple interactions

ISO
EXP

Amphetamine results in increased expression of GAD1 mRNA
Amphetamine results in increased expression of GAD1 mRNA; Amphetamine results in increased expression of GAD1 protein
Amphetamine affects the expression of GAD1 protein
Amphetamine inhibits the reaction [3-acetylpyridine results in increased expression of GAD1 mRNA]; Propranolol inhibits the reaction [Amphetamine inhibits the reaction [3-acetylpyridine results in increased expression of GAD1 mRNA]]

PMID:8774452 PMID:14725721 PMID:18312583 PMID:19059431 PMID:23660488

NCBI chr 3:75,777,260...75,818,099
Ensembl chr 3:75,777,534...75,818,759

G

growth arrest and DNA-damage-inducible, alpha

increases expression

EXP

Amphetamine results in increased expression of GADD45A mRNA

NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807

G

polypeptide N-acetylgalactosaminyltransferase 12

decreases expression

EXP

Amphetamine results in decreased expression of GALNT12 mRNA

NCBI chr 5:66,180,171...66,208,931
Ensembl chr 5:66,180,164...66,208,938

G

polypeptide N-acetylgalactosaminyltransferase 6

decreases expression

EXP

Amphetamine results in decreased expression of GALNT6 mRNA

NCBI chr 7:133,668,612...133,715,909
Ensembl chr 7:133,668,615...133,698,439

G

polypeptide N-acetylgalactosaminyltransferase 7

decreases expression

EXP

Amphetamine results in decreased expression of GALNT7 mRNA

NCBI chr16:37,589,368...37,713,911
Ensembl chr16:37,589,425...37,713,909

G

glyceraldehyde-3-phosphate dehydrogenase

increases expression

EXP

Amphetamine results in increased expression of GAPDH mRNA

NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:159,648,592...159,653,377

G

GRB2 associated regulator of MAPK1 subtype 1

decreases expression

EXP

Amphetamine results in decreased expression of GAREM1 mRNA

NCBI chr18:12,695,082...12,860,219
Ensembl chr18:12,695,082...12,860,219

G

GTPase activating Rap/RanGAP domain-like 3

decreases expression

EXP

Amphetamine results in decreased expression of GARNL3 mRNA

NCBI chr 3:36,686,388...36,830,011
Ensembl chr 3:36,686,389...36,830,020

G

guanylate binding protein 5

decreases expression

EXP

Amphetamine results in decreased expression of GBP5 mRNA

NCBI chr 2:233,910,999...233,930,320
Ensembl chr 2:233,902,113...233,930,826

G

GTP cyclohydrolase I feedback regulator

increases expression

EXP

Amphetamine results in increased expression of GCHFR mRNA

NCBI chr 3:126,611,892...126,615,926
Ensembl chr 3:126,613,240...126,615,926

G

GCN1 activator of EIF2AK4

decreases expression

EXP

Amphetamine results in decreased expression of GCN1 mRNA

NCBI chr12:46,652,273...46,715,119
Ensembl chr12:46,652,273...46,713,488

G

glucosaminyl (N-acetyl) transferase 1

increases expression

EXP

Amphetamine results in increased expression of GCNT1 mRNA

NCBI chr 1:224,145,104...224,182,496
Ensembl chr 1:224,141,108...224,185,741

G

glucosaminyl (N-acetyl) transferase 2

decreases expression

EXP

Amphetamine results in decreased expression of GCNT2 mRNA

NCBI chr17:24,002,592...24,107,339
Ensembl chr17:24,002,597...24,106,989

G

glial cell derived neurotrophic factor

affects response to substance
multiple interactions

ISO
EXP

GDNF protein affects the susceptibility to Amphetamine
GDNF protein affects the susceptibility to [Oxidopamine co-treated with Amphetamine]; GDNF protein inhibits the reaction [Oxidopamine inhibits the reaction [Amphetamine results in increased expression of FOS protein]]

PMID:11031079 PMID:15269253 PMID:16943855

NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:58,621,327...58,647,240

G

glycerophosphodiester phosphodiesterase domain containing 5

increases expression

EXP

Amphetamine results in increased expression of GDPD5 mRNA

NCBI chr 1:163,091,844...163,173,559
Ensembl chr 1:163,091,833...163,173,559

G

gem (nuclear organelle) associated protein 4

decreases expression

EXP

Amphetamine results in decreased expression of GEMIN4 mRNA

NCBI chr10:61,560,172...61,571,765
Ensembl chr10:61,564,657...61,596,532

G

gem (nuclear organelle) associated protein 5

decreases expression

EXP

Amphetamine results in decreased expression of GEMIN5 mRNA

NCBI chr10:42,797,975...42,843,356
Ensembl chr10:42,797,982...42,843,356

G

glial fibrillary acidic protein

increases expression

ISO
EXP

Amphetamine results in increased expression of GFAP protein
Amphetamine results in increased expression of GFAP mRNA; Amphetamine results in increased expression of GFAP protein

PMID:15183010 PMID:15814102 PMID:20223277

NCBI chr10:88,352,987...88,361,661
Ensembl chr10:88,352,986...88,361,685

G

growth factor independent 1 transcriptional repressor

decreases expression

EXP

Amphetamine results in decreased expression of GFI1 mRNA

NCBI chr14:2,185,489...2,204,191
Ensembl chr14:2,187,286...2,196,730

G

GDNF family receptor alpha 3

decreases expression

EXP

Amphetamine results in decreased expression of GFRA3 mRNA

NCBI chr18:26,571,952...26,600,225
Ensembl chr18:26,571,921...26,600,225

G

gamma-glutamylamine cyclotransferase

decreases expression

EXP

Amphetamine results in decreased expression of GGACT mRNA

NCBI chr15:106,375,924...106,406,649
Ensembl chr15:106,366,120...106,404,004

G

gamma-glutamyl hydrolase

increases expression

EXP

Amphetamine results in increased expression of GGH mRNA

NCBI chr 5:38,326,747...38,349,655
Ensembl chr 5:38,326,594...38,349,647

G

gametogenetin

increases expression

EXP

Amphetamine results in increased expression of GGN mRNA

NCBI chr 1:93,598,076...93,601,598
Ensembl chr 1:93,597,538...93,608,471

G

GRB10 interacting GYF protein 1

decreases expression

EXP

Amphetamine results in decreased expression of GIGYF1 mRNA

NCBI chr12:24,800,996...24,819,719
Ensembl chr12:24,802,865...24,811,800

G

GTPase, IMAP family member 1

decreases expression

EXP

Amphetamine results in decreased expression of GIMAP1 mRNA

NCBI chr 4:79,018,473...79,022,360
Ensembl chr 4:79,018,202...79,022,525

G

GTPase, IMAP family member 6

decreases expression

EXP

Amphetamine results in decreased expression of GIMAP6 mRNA

NCBI chr 4:78,984,597...78,990,006
Ensembl chr 4:78,983,504...78,990,010

G

GTPase, IMAP family member 8

decreases expression

EXP

Amphetamine results in decreased expression of GIMAP8 mRNA

NCBI chr 4:78,931,003...78,942,491
Ensembl chr 4:78,931,029...78,942,488

G

glycosylated integral membrane protein 1

increases expression

EXP

Amphetamine results in increased expression of GINM1 mRNA

NCBI chr 1:4,066,766...4,082,640
Ensembl chr 1:4,066,766...4,082,617

G

gap junction protein, alpha 1

increases expression
multiple interactions

EXP

Amphetamine results in increased expression of GJA1 mRNA; Amphetamine results in increased expression of GJA1 protein
MAPK8 protein promotes the reaction [Amphetamine results in increased expression of GJA1 protein]; pyrazolanthrone inhibits the reaction [Amphetamine results in increased expression of GJA1 protein]

NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689

G

gap junction protein, gamma 2

increases expression

EXP

Amphetamine results in increased expression of GJC2 mRNA

NCBI chr10:44,462,203...44,470,924
Ensembl chr10:44,462,054...44,470,340

G

galactosidase, alpha

increases expression

EXP

Amphetamine results in increased expression of GLA mRNA

NCBI chr X:102,062,497...102,073,915
Ensembl chr X:102,056,718...102,073,915

G

glucuronic acid epimerase

decreases expression

EXP

Amphetamine results in decreased expression of GLCE mRNA

NCBI chr 8:71,441,607...71,507,639
Ensembl chr 8:71,441,616...71,507,587

G

GLI pathogenesis-related 1

increases expression

EXP

Amphetamine results in increased expression of GLIPR1 mRNA

NCBI chr 7:49,373,579...49,399,190
Ensembl chr 7:49,373,581...49,384,640

G

GLI pathogenesis-related 2

increases expression

EXP

Amphetamine results in increased expression of GLIPR2 mRNA

NCBI chr 5:62,966,163...62,998,016
Ensembl chr 5:62,966,195...62,998,716

G

glutaredoxin

increases expression

EXP

Amphetamine results in increased expression of GLRX mRNA

NCBI chr 2:7,073,737...7,083,548
Ensembl chr 2:7,073,759...7,083,543

G

glia maturation factor, gamma

increases expression

EXP

Amphetamine results in increased expression of GMFG mRNA

NCBI chr 1:92,856,154...92,866,722
Ensembl chr 1:92,854,995...92,866,723

G

G protein subunit alpha 15

increases expression

EXP

Amphetamine results in increased expression of GNA15 mRNA

NCBI chr 7:8,835,396...8,856,269
Ensembl chr 7:8,835,357...8,856,268

G

G protein subunit alpha i3

increases expression

EXP

Amphetamine results in increased expression of GNAI3 mRNA

NCBI chr 2:198,430,920...198,468,874

G

G protein subunit alpha z

decreases response to substance

ISO

GNAZ protein results in decreased susceptibility to Amphetamine

NCBI chr20:13,642,853...13,693,616
Ensembl chr20:13,644,020...13,669,287

G

glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase

decreases expression

EXP

Amphetamine results in decreased expression of GNE mRNA

NCBI chr 5:63,062,953...63,103,320
Ensembl chr 5:63,062,850...63,103,251

G

G protein subunit gamma 10

increases expression

EXP

Amphetamine results in increased expression of GNG10 mRNA

NCBI chr 5:78,651,167...78,658,060
Ensembl chr 5:78,651,167...78,658,059

G

G protein subunit gamma 8

increases expression

EXP

Amphetamine results in increased expression of GNG8 mRNA

NCBI chr 1:86,692,609...86,696,463
Ensembl chr 1:86,692,642...86,696,408

G

G protein nucleolar 3 like

decreases expression

EXP

Amphetamine results in decreased expression of GNL3L mRNA

NCBI chr X:23,404,324...23,437,501
Ensembl chr X:23,404,324...23,439,315

G

N-acetylglucosamine-1-phosphate transferase subunits alpha and beta

decreases expression

EXP

Amphetamine results in decreased expression of GNPTAB mRNA

NCBI chr 7:24,687,923...24,754,821
Ensembl chr 7:24,687,969...24,754,821

G

golgi membrane protein 1

decreases expression

EXP

Amphetamine results in decreased expression of GOLM1 mRNA

NCBI chr17:4,996,978...5,049,278
Ensembl chr17:4,996,223...5,047,414

G

glycerol-3-phosphate acyltransferase 3

increases expression

EXP

Amphetamine results in increased expression of AGPAT9 mRNA

NCBI chr14:9,018,762...9,072,552

G

G patch domain containing 1

decreases expression

EXP

Amphetamine results in decreased expression of GPATCH1 mRNA

NCBI chr 1:97,062,539...97,111,487
Ensembl chr 1:97,062,551...97,111,465

G

glypican 3

increases expression

EXP

Amphetamine results in increased expression of GPC3 mRNA

NCBI chr X:136,789,770...137,157,598
Ensembl chr X:136,789,770...137,157,639

G

glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1

increases expression

EXP

Amphetamine results in increased expression of GPIHBP1 mRNA

NCBI chr 7:109,166,334...109,169,448
Ensembl chr 7:109,163,160...109,169,448

G

glycoprotein nmb

increases expression

EXP

Amphetamine results in increased expression of GPNMB mRNA

NCBI chr 4:79,341,128...79,362,366
Ensembl chr 4:79,341,021...79,380,240

G

G protein-coupled receptor 137

increases expression

EXP

Amphetamine results in increased expression of GPR137 mRNA

NCBI chr 1:213,558,846...213,562,422
Ensembl chr 1:213,558,846...213,563,966

G

G protein-coupled receptor 155

decreases expression

EXP

Amphetamine results in decreased expression of GPR155 mRNA

NCBI chr 3:78,623,931...78,677,803
Ensembl chr 3:78,607,976...78,677,803

G

G protein-coupled receptor 176

decreases expression

EXP

Amphetamine results in decreased expression of GPR176 mRNA

NCBI chr 3:125,690,750...125,791,172
Ensembl chr 3:125,690,751...125,791,172

G

G protein-coupled receptor 25

increases expression

EXP

Amphetamine results in increased expression of GPR25 mRNA

NCBI chr13:50,264,516...50,266,422
Ensembl chr13:50,264,518...50,267,692

G

G protein-coupled receptor 33, pseudogene 1

increases expression

EXP

Amphetamine results in increased expression of GPR33 mRNA

NCBI chr 6:75,209,776...75,210,781
Ensembl chr 6:75,209,776...75,210,781

G

G protein-coupled receptor 68

decreases expression

EXP

Amphetamine results in decreased expression of GPR68 mRNA

NCBI chr 6:125,865,205...125,895,674
Ensembl chr 6:125,864,942...125,895,674

G

G protein-coupled receptor 83

increases expression

EXP

Amphetamine results in increased expression of GPR83 mRNA

NCBI chr 8:19,974,995...19,985,483
Ensembl chr 8:19,974,993...19,985,490

G

G protein-coupled receptor 84

decreases expression

EXP

Amphetamine results in decreased expression of GPR84 mRNA

NCBI chr 7:136,322,374...136,324,648
Ensembl chr 7:136,322,191...136,324,703

G

G protein-coupled receptor 85

increases expression

EXP

Amphetamine results in increased expression of GPR85 mRNA

NCBI chr 4:43,070,194...43,075,662
Ensembl chr 4:43,060,777...43,075,794

G

G protein-coupled receptor associated sorting protein 2

decreases expression

EXP

Amphetamine results in decreased expression of GPRASP2 mRNA

NCBI chr X:103,609,304...103,615,450
Ensembl chr X:103,501,226...103,641,988

G

G protein-coupled receptor, class C, group 5, member D

increases expression

EXP

Amphetamine results in increased expression of GPRC5D mRNA

NCBI chr 4:169,674,874...169,686,965
Ensembl chr 4:169,674,846...169,686,965

G

GPRIN family member 3

decreases expression

EXP

Amphetamine results in decreased expression of GPRIN3 mRNA

NCBI chr 4:89,902,198...89,987,496
Ensembl chr 4:89,892,867...89,987,565

G

glutathione peroxidase 1

increases expression

EXP

Amphetamine results in increased expression of GPX1 mRNA

NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581

G

GRAM domain containing 1A

decreases expression

EXP

Amphetamine results in decreased expression of GRAMD1A mRNA

NCBI chr 1:95,494,378...95,520,730
Ensembl chr 1:95,494,378...95,520,716

G

GRAM domain containing 2B

increases expression

EXP

Amphetamine results in increased expression of GRAMD2B mRNA

NCBI chr18:52,082,128...52,180,056
Ensembl chr18:52,082,029...52,180,054

G

GRAM domain containing 4

decreases expression

EXP

Amphetamine results in decreased expression of GRAMD4 mRNA

NCBI chr 7:119,030,225...119,103,875
Ensembl chr 7:119,030,225...119,103,875

G

GRB2-related adaptor protein

decreases expression

EXP

Amphetamine results in decreased expression of GRAP mRNA

NCBI chr10:46,798,423...46,851,524
Ensembl chr10:46,832,390...46,851,523

G

glutamate ionotropic receptor AMPA type subunit 2

affects expression

EXP

Amphetamine affects the expression of GRIA2 mRNA alternative form

NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:168,247,496...168,367,616

G

glutamate ionotropic receptor NMDA type subunit 1

increases phosphorylation

EXP

Amphetamine results in increased phosphorylation of GRIN1 protein

NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:28,501,836...28,528,754

G

glutamate ionotropic receptor NMDA type subunit 2B

decreases expression
multiple interactions
decreases response to substance
affects localization
increases expression

EXP

Amphetamine results in decreased expression of GRIN2B protein
rhyncophylline inhibits the reaction [Amphetamine results in increased expression of GRIN2B mRNA]; rhyncophylline inhibits the reaction [Amphetamine results in increased expression of GRIN2B protein]
GRIN2B protein results in decreased susceptibility to Amphetamine
Amphetamine affects the localization of GRIN2B protein
Amphetamine results in increased expression of GRIN2B mRNA; Amphetamine results in increased expression of GRIN2B protein

PMID:19349975 PMID:20422365

NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:170,322,617...170,773,570

G

glutamate metabotropic receptor 1

increases expression

EXP

Amphetamine results in increased expression of GRM1 mRNA

NCBI chr 1:6,878,542...7,273,447
Ensembl chr 1:6,878,545...7,273,443

G

glutamate metabotropic receptor 5

decreases expression
multiple interactions
increases expression

EXP

Amphetamine results in decreased expression of GRM5 mRNA
Amphetamine promotes the reaction [[2-chloro-5-hydroxyphenylglycine binds to and results in increased activity of GRM5 protein] which results in increased hydrolysis of Phosphatidylinositols]; GRM5 protein promotes the reaction [Amphetamine results in increased expression of FOS mRNA]
Amphetamine results in increased expression of GRM5 mRNA

PMID:11418936 PMID:14556238 PMID:15010207

NCBI chr 1:150,722,711...151,297,585
Ensembl chr 1:150,733,678...151,296,649

G

granulin precursor

increases expression

EXP

Amphetamine results in increased expression of GRN mRNA

NCBI chr10:87,887,834...87,893,938
Ensembl chr10:87,886,122...87,893,936

G

gasdermin C

increases expression

EXP

Amphetamine results in increased expression of GSDMC mRNA

NCBI chr 7:97,482,713...97,509,985
Ensembl chr 7:97,483,257...97,499,587

G

germ cell associated 1

increases expression

EXP

Amphetamine results in increased expression of GSG1 mRNA

NCBI chr 4:169,822,111...169,838,379
Ensembl chr 4:169,822,114...169,838,379

G

glycogen synthase kinase 3 alpha

decreases expression
increases response to substance

EXP
ISO

Amphetamine results in decreased expression of GSK3A protein
GSK3A gene mutant form results in increased susceptibility to Amphetamine

PMID:16144542 PMID:20357757

NCBI chr 1:89,943,669...89,953,514
Ensembl chr 1:89,943,669...89,953,593

G

glycogen synthase kinase 3 beta

increases response to substance
decreases expression

ISO
EXP

GSK3B gene mutant form results in increased susceptibility to Amphetamine
Amphetamine results in decreased expression of GSK3B protein

PMID:16144542 PMID:20357757

NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249

G

glutathione S-transferase, C-terminal domain containing

decreases expression

EXP

Amphetamine results in decreased expression of GSTCD mRNA

NCBI chr 2:224,173,764...224,268,743
Ensembl chr 2:224,173,473...224,265,680

G

glutathione S-transferase kappa 1

increases expression

EXP

Amphetamine results in increased expression of GSTK1 mRNA

NCBI chr 4:72,085,532...72,089,934
Ensembl chr 4:72,085,531...72,089,927

G

general transcription factor II I

decreases expression

EXP

Amphetamine results in decreased expression of GTF2I mRNA

NCBI chr12:28,037,344...28,112,677
Ensembl chr12:28,037,853...28,112,677

G

GTF2I repeat domain containing 1

decreases expression

EXP

Amphetamine results in decreased expression of GTF2IRD1 mRNA

NCBI chr12:27,890,594...27,997,506
Ensembl chr12:27,890,675...27,997,494

G

GTF2I repeat domain containing 2

decreases expression

EXP

Amphetamine results in decreased expression of GTF2IRD2 mRNA

NCBI chr12:28,134,199...28,179,089
Ensembl chr12:28,133,792...28,172,876

G

general transcription factor IIIC subunit 1

decreases expression

EXP

Amphetamine results in decreased expression of GTF3C1 mRNA

NCBI chr 1:189,634,645...189,700,848
Ensembl chr 1:189,634,645...189,700,995

G

guanylate cyclase 1 soluble subunit beta 1

increases expression

EXP

Amphetamine results in increased expression of GUCY1B1 mRNA

NCBI chr 2:169,646,897...169,697,060
Ensembl chr 2:169,646,898...169,696,987

G

guanylate cyclase 1 soluble subunit beta 2

increases expression

EXP

Amphetamine results in increased expression of GUCY1B2 mRNA

NCBI chr15:40,774,907...40,845,463
Ensembl chr15:40,774,906...40,845,463

G

glycogenin 1

increases expression

EXP

Amphetamine results in increased expression of GYG1 mRNA

NCBI chr 2:104,540,927...104,583,038
Ensembl chr 2:104,540,533...104,582,818

G

glycogen synthase 1

increases expression

EXP

Amphetamine results in increased expression of GYS1 mRNA

NCBI chr 1:105,051,916...105,071,763
Ensembl chr 1:105,051,961...105,072,419

G

Granzyme B-like 3

increases expression

EXP

Amphetamine results in increased expression of GZMBL3 mRNA

NCBI chr15:34,337,656...34,339,888
Ensembl chr15:34,337,656...34,340,883

G

H2A.Z variant histone 1

increases expression

EXP

Amphetamine results in increased expression of H2AZ1 mRNA

NCBI chr 2:229,026,464...229,031,411
Ensembl chr 2:229,028,843...229,031,411

G

H2B clustered histone 8

increases expression

EXP

Amphetamine results in increased expression of H2BC8 mRNA

NCBI chr17:47,404,405...47,405,155

G

H3.3 histone B

increases expression

EXP

Amphetamine results in increased expression of H3F3B mRNA

NCBI chr10:101,755,404...101,764,616
Ensembl chr10:101,755,404...101,757,636

G

3-hydroxyacyl-CoA dehydratase 1

increases expression

EXP

Amphetamine results in increased expression of HACD1 mRNA

NCBI chr17:81,992,284...82,014,676
Ensembl chr17:81,992,292...82,014,592

G

3-hydroxyacyl-CoA dehydratase 3

decreases expression

EXP

Amphetamine results in decreased expression of HACD3 mRNA

NCBI chr 8:74,396,441...74,433,700
Ensembl chr 8:74,396,442...74,433,700

G

hyaluronan synthase 1

increases expression

EXP

Amphetamine results in increased expression of HAS1 mRNA

NCBI chr 1:67,366,460...67,378,686
Ensembl chr 1:67,366,460...67,378,444

G

histone H3 associated protein kinase

decreases expression

EXP

Amphetamine results in decreased expression of HASPIN mRNA

NCBI chr10:58,246,244...58,249,031
Ensembl chr10:58,240,447...58,249,249

G

hepatitis A virus cellular receptor 2

increases expression

EXP

Amphetamine results in increased expression of HAVCR2 mRNA

NCBI chr10:31,383,801...31,415,334
Ensembl chr10:31,383,925...31,413,872

G

hemoglobin subunit beta

increases expression

EXP

Amphetamine results in increased expression of HBB mRNA

NCBI chr 1:167,662,310...167,663,721
Ensembl chr 1:167,630,245...167,663,873

G

heparin-binding EGF-like growth factor

decreases expression

EXP

Amphetamine results in decreased expression of HBEGF mRNA

NCBI chr18:28,380,337...28,390,220
Ensembl chr18:28,380,337...28,390,220

G

host cell factor C1

decreases expression

EXP

Amphetamine results in decreased expression of HCFC1 mRNA

NCBI chr X:156,839,100...156,864,132
Ensembl chr X:156,839,100...156,863,813

G

hypocretin receptor 1

multiple interactions

EXP

[1-(2-methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl urea binds to and results in decreased activity of HCRTR1 protein] inhibits the reaction [Amphetamine results in increased secretion of Dopamine]

NCBI chr 5:147,761,392...147,771,846
Ensembl chr 5:147,760,145...147,770,850

G

histone deacetylase 1

multiple interactions

ISO
EXP

HDAC1 gene mutant form promotes the reaction [Amphetamine results in increased expression of FOS mRNA]
Amphetamine promotes the reaction [HDAC1 protein binds to FOS promoter]

NCBI chr 5:147,138,328...147,165,387
Ensembl chr 5:147,138,156...147,165,387

G

histone deacetylase 10

decreases expression

EXP

Amphetamine results in decreased expression of HDAC10 mRNA

NCBI chr 7:122,078,768...122,084,457
Ensembl chr 7:122,078,768...122,083,870

G

histone deacetylase 6

increases expression

EXP

Amphetamine results in increased expression of HDAC6 mRNA

NCBI chr X:17,222,538...17,244,373
Ensembl chr X:17,222,856...17,244,370

G

histone deacetylase 7

decreases expression

EXP

Amphetamine results in decreased expression of HDAC7 mRNA

NCBI chr 7:130,803,013...130,841,181
Ensembl chr 7:130,803,013...130,841,017

G

histidine decarboxylase

decreases expression

EXP

Amphetamine results in decreased expression of HDC mRNA

NCBI chr 3:134,300,628...134,318,704
Ensembl chr 3:134,300,632...134,318,711

G

HDGF like 3

decreases expression

EXP

Amphetamine results in decreased expression of HDGFL3 mRNA

NCBI chr 1:145,233,996...145,287,115
Ensembl chr 1:145,236,758...145,286,001

G

HEAT repeat containing 1

decreases expression

EXP

Amphetamine results in decreased expression of HEATR1 mRNA

NCBI chr17:62,745,008...62,785,609
Ensembl chr17:62,745,008...62,785,186

G

HEAT repeat containing 3

decreases expression

EXP

Amphetamine results in decreased expression of HEATR3 mRNA

NCBI chr19:35,065,915...35,103,779
Ensembl chr19:35,067,060...35,103,978

G

HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2

increases expression

EXP

Amphetamine results in increased expression of HECW2 mRNA

NCBI chr 9:62,853,904...63,247,472
Ensembl chr 9:62,859,645...63,074,758

G

heart development protein with EGF-like domains 1

decreases expression

EXP

Amphetamine results in decreased expression of HEG1 mRNA

NCBI chr11:80,512,096...80,600,150
Ensembl chr11:80,512,096...80,600,092

G

DNA helicase B

decreases expression

EXP

Amphetamine results in decreased expression of HELB mRNA

NCBI chr 7:57,474,115...57,502,221
Ensembl chr 7:57,474,184...57,501,225

G

helicase, POLQ-like

decreases expression

EXP

Amphetamine results in decreased expression of HELQ mRNA

NCBI chr14:9,122,978...9,167,310
Ensembl chr14:9,122,978...9,167,310

G

helicase with zinc finger

decreases expression

EXP

Amphetamine results in decreased expression of HELZ mRNA

NCBI chr10:92,979,039...93,144,868
Ensembl chr10:92,999,733...93,138,075

G

HECT and RLD domain containing E3 ubiquitin protein ligase family member 1

decreases expression

EXP

Amphetamine results in decreased expression of HERC1 mRNA

NCBI chr 8:75,796,347...75,965,347
Ensembl chr 8:75,796,357...75,965,347

G

HECT and RLD domain containing E3 ubiquitin protein ligase 2

decreases expression

EXP

Amphetamine results in decreased expression of HERC2 mRNA

NCBI chr 1:116,009,681...116,243,888
Ensembl chr 1:116,040,736...116,243,884

G

HEXIM P-TEFb complex subunit 1

increases expression

EXP

Amphetamine results in increased expression of HEXIM1 mRNA

NCBI chr10:88,562,889...88,565,001
Ensembl chr10:88,560,519...88,580,000

G

hippocampus abundant gene transcript 1, pseudogene 1

increases expression

EXP

Amphetamine results in increased expression of HIAT1-PS1 mRNA

NCBI chr 1:75,789,216...75,792,142

G

HIG1 hypoxia inducible domain family, member 2A

increases expression

EXP

Amphetamine results in increased expression of HIGD2A mRNA

NCBI chr17:10,026,961...10,027,885
Ensembl chr17:10,026,961...10,027,874

G

histidine triad nucleotide binding protein 1

affects response to substance

ISO

HINT1 protein affects the susceptibility to Amphetamine

NCBI chr10:39,490,225...39,493,970
Ensembl chr 4:93,430,926...93,431,642
Ensembl chr10:93,430,926...93,431,642

G

histone cluster 1 H2B family member Q

increases expression

EXP

Amphetamine results in increased expression of HIST1H2BQ mRNA

NCBI chr17:41,859,955...41,869,889
Ensembl chr17:41,857,231...41,870,107
Ensembl chr17:41,857,231...41,870,107

G

HIVEP zinc finger 2

decreases expression

EXP

Amphetamine results in decreased expression of HIVEP2 mRNA

NCBI chr 1:10,176,880...10,376,089
Ensembl chr 1:10,179,402...10,376,089

G

HIVEP zinc finger 3

decreases expression

EXP

Amphetamine results in decreased expression of HIVEP3 mRNA

NCBI chr 5:138,610,592...139,013,058
Ensembl chr 5:138,943,312...139,010,430

G

holocarboxylase synthetase

decreases expression

EXP

Amphetamine results in decreased expression of HLCS mRNA

NCBI chr11:46,925,491...47,123,111
Ensembl chr11:46,925,491...47,105,082

G

homeobox containing 1

decreases expression

EXP

Amphetamine results in decreased expression of HMBOX1 mRNA

NCBI chr15:43,243,503...43,376,011
Ensembl chr15:43,222,470...43,376,011

G

high mobility group AT-hook 1

decreases expression

EXP

Amphetamine results in decreased expression of HMGA1 mRNA

NCBI chr20:5,612,902...5,620,596
Ensembl chr20:5,613,471...5,620,593

G

heme oxygenase 1

increases expression

EXP

Amphetamine results in increased expression of HMOX1 mRNA

NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818

G

HNF1 homeobox A

decreases expression

EXP

Amphetamine results in decreased expression of HNF1A mRNA

NCBI chr12:47,299,171...47,333,457
Ensembl chr12:47,306,245...47,332,755

G

HOP homeobox

increases expression

EXP

Amphetamine results in increased expression of HOPX mRNA

NCBI chr14:31,410,235...31,437,189
Ensembl chr14:31,410,221...31,437,188

G

homeo box C4

decreases expression

EXP

Amphetamine results in decreased expression of HOXC4 mRNA

NCBI chr 7:136,049,059...136,051,601
Ensembl chr 7:136,049,059...136,051,601

G

homeo box C6

decreases expression

EXP

Amphetamine results in decreased expression of HOXC6 mRNA

NCBI chr 7:136,013,679...136,051,601
Ensembl chr 7:136,024,961...136,027,365

G

hematopoietic prostaglandin D synthase

increases expression

EXP

Amphetamine results in increased expression of HPGDS mRNA

NCBI chr 4:95,698,265...95,727,733
Ensembl chr 4:95,702,392...95,938,501

G

hypoxanthine phosphoribosyltransferase 1

increases expression

EXP

Amphetamine results in increased expression of HPRT1 mRNA

NCBI chr X:137,655,744...137,687,718
Ensembl chr X:137,655,680...137,687,712

G

HPS1, biogenesis of lysosomal organelles complex 3 subunit 1

decreases expression

EXP

Amphetamine results in decreased expression of HPS1 mRNA

NCBI chr 1:251,500,427...251,526,529
Ensembl chr 1:251,500,427...251,526,739

G

HPS5, biogenesis of lysosomal organelles complex 2 subunit 2

increases expression

EXP

Amphetamine results in increased expression of HPS5 mRNA

NCBI chr 1:106,417,902...106,457,220
Ensembl chr 1:106,417,902...106,452,859

G

histidine rich calcium binding protein

increases expression

EXP

Amphetamine results in increased expression of HRC mRNA

NCBI chr 1:104,949,750...104,953,475
Ensembl chr 1:104,949,741...104,954,193

G

heparan sulfate 6-O-sulfotransferase 1

increases expression

EXP

Amphetamine results in increased expression of HS6ST1 mRNA

NCBI chr 9:45,779,402...45,818,583
Ensembl chr 9:45,779,019...45,818,582

G

heat shock factor binding protein 1

increases expression

EXP

Amphetamine results in increased expression of HSBP1 mRNA

NCBI chr19:64,309,703...64,314,035
Ensembl chr19:64,309,703...64,314,035

G

hydroxysteroid (17-beta) dehydrogenase 11

increases expression

EXP

Amphetamine results in increased expression of HSD17B11 mRNA

NCBI chr14:5,997,893...6,047,816
Ensembl chr14:5,997,906...6,047,811

G

heat shock protein family B (small) member 1

increases expression

EXP

Amphetamine results in increased expression of HSPB1 mRNA

NCBI chr12:26,430,640...26,432,301
Ensembl chr12:26,430,640...26,432,301

G

heat shock protein family B (small) member 8

increases expression

EXP

Amphetamine results in increased expression of HSPB8 mRNA

NCBI chr12:45,835,899...45,866,449
Ensembl chr12:45,837,066...45,851,937

G

5-hydroxytryptamine receptor 1B

increases response to substance
increases expression

EXP

HTR1B protein results in increased susceptibility to Amphetamine
Amphetamine results in increased expression of HTR1B mRNA

PMID:19817843 PMID:30779732

NCBI chr 8:91,395,405...91,414,815
Ensembl chr 8:91,052,432...91,418,583

G

5-hydroxytryptamine receptor 2A

increases expression

EXP

Amphetamine results in increased expression of HTR2A mRNA

NCBI chr15:56,360,647...56,428,703
Ensembl chr15:56,359,596...56,431,619

G

5-hydroxytryptamine receptor 7

increases expression

EXP

Amphetamine results in increased expression of HTR7 mRNA

NCBI chr 1:243,049,064...243,173,636
Ensembl chr 1:243,049,081...243,173,230

G

HtrA serine peptidase 4

increases expression

EXP

Amphetamine results in increased expression of HTRA4 mRNA

NCBI chr16:73,704,255...73,717,722
Ensembl chr16:73,704,184...73,717,722

G

hydrogen voltage-gated channel 1

decreases expression

EXP

Amphetamine results in decreased expression of HVCN1 mRNA

NCBI chr12:40,001,205...40,030,671
Ensembl chr12:40,001,498...40,042,020

G

hyccin PI4KA lipid kinase complex subunit 2

decreases expression

EXP

Amphetamine results in decreased expression of HYCC2 mRNA

NCBI chr 9:67,551,064...67,623,353
Ensembl chr 9:67,551,064...67,587,186

G

isoleucyl-tRNA synthetase 1

decreases expression

EXP

Amphetamine results in decreased expression of IARS1 mRNA

NCBI chr17:15,147,357...15,193,716
Ensembl chr17:15,147,357...15,193,652

G

isoleucyl-tRNA synthetase 2, mitochondrial

decreases expression

EXP

Amphetamine results in decreased expression of IARS2 mRNA

NCBI chr13:99,363,035...99,397,068
Ensembl chr13:99,362,696...99,397,068

G

interactor of little elongation complex ELL subunit 2

decreases expression

EXP

Amphetamine results in decreased expression of ICE2 mRNA

NCBI chr 8:78,921,962...78,965,983
Ensembl chr 8:78,924,421...78,966,200

G

inducible T-cell co-stimulator ligand

decreases expression

EXP

Amphetamine results in decreased expression of ICOSLG mRNA

NCBI chr20:10,600,078...10,610,385
Ensembl chr20:10,600,078...10,610,365

G

inhibitor of DNA binding 1

increases expression

EXP

Amphetamine results in increased expression of ID1 mRNA

NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:161,671,538...161,672,685

G

inhibitor of DNA binding 2

increases expression

EXP

Amphetamine results in increased expression of ID2 mRNA

NCBI chr 6:47,469,162...47,470,995
Ensembl chr 6:47,457,554...47,472,961

G

inhibitor of DNA binding 3

decreases expression

EXP

Amphetamine results in decreased expression of ID3 mRNA

NCBI chr 5:153,656,253...153,657,860
Ensembl chr 5:153,630,498...153,657,856

G

isocitrate dehydrogenase (NADP(+)) 1

increases expression

EXP

Amphetamine results in increased expression of IDH1 mRNA

NCBI chr 9:74,027,887...74,057,442
Ensembl chr 9:74,027,892...74,049,555

G

immediate early response 2

increases expression

EXP

Amphetamine results in increased expression of IER2 mRNA

NCBI chr19:40,399,373...40,400,897
Ensembl chr19:40,398,160...40,402,708

G

immediate early response 5-like

increases expression

EXP

Amphetamine results in increased expression of IER5L mRNA

NCBI chr 3:34,141,866...34,143,457
Ensembl chr 3:34,139,672...34,144,452

G

IFI30, lysosomal thiol reductase

increases expression

EXP

Amphetamine results in increased expression of IFI30 mRNA

NCBI chr16:18,709,570...18,713,635
Ensembl chr16:18,709,563...18,715,711

G

interferon-induced protein 44

decreases expression

EXP

Amphetamine results in decreased expression of IFI44 mRNA

NCBI chr 2:243,286,050...243,303,869
Ensembl chr 2:243,286,052...243,306,877

G

interferon-induced protein 44-like

decreases expression

EXP

Amphetamine results in decreased expression of IFI44L mRNA

NCBI chr 2:243,328,629...243,366,404
Ensembl chr 2:243,328,723...243,366,404

G

interferon-induced protein with tetratricopeptide repeats 3

increases expression

EXP

Amphetamine results in increased expression of IFIT3 mRNA

NCBI chr 1:241,527,326...241,532,469
Ensembl chr 1:241,526,880...241,532,521

G

interferon induced transmembrane protein 1

increases expression

EXP

Amphetamine results in increased expression of IFITM1 mRNA

NCBI chr 1:205,496,757...205,498,796
Ensembl chr 1:205,496,807...205,498,776

G

interferon induced transmembrane protein 2

increases expression

EXP

Amphetamine results in increased expression of IFITM2 mRNA

NCBI chr 1:205,481,168...205,482,348

G

interferon gamma receptor 1

increases expression

EXP

Amphetamine results in increased expression of IFNGR1 mRNA

NCBI chr 1:16,152,811...16,171,439
Ensembl chr 1:16,152,879...16,171,437

G

interferon-related developmental regulator 1

increases expression

EXP

Amphetamine results in increased expression of IFRD1 mRNA

NCBI chr 6:62,996,560...63,044,996
Ensembl chr 6:62,996,562...63,016,131

G

intraflagellar transport 122

increases expression

EXP

Amphetamine results in increased expression of IFT122 mRNA

NCBI chr 4:150,577,525...150,648,052
Ensembl chr 4:150,539,786...150,648,052

G

intraflagellar transport 43

increases expression

EXP

Amphetamine results in increased expression of IFT43 mRNA

NCBI chr 6:111,460,689...111,537,224
Ensembl chr 6:111,456,476...111,537,224

G

intraflagellar transport 57

increases expression

EXP

Amphetamine results in increased expression of IFT57 mRNA

NCBI chr11:64,528,349...64,593,545
Ensembl chr11:64,528,349...64,593,545

G

intraflagellar transport 88

decreases expression

EXP

Amphetamine results in decreased expression of IFT88 mRNA

NCBI chr15:35,685,678...35,786,875
Ensembl chr15:35,688,927...35,781,634

G

insulin-like growth factor binding protein 1

increases expression

EXP

Amphetamine results in increased expression of IGFBP1 mRNA

NCBI chr14:86,261,277...86,266,344
Ensembl chr14:86,261,277...86,266,344

G

insulin-like growth factor binding protein 5

increases expression

EXP

Amphetamine results in increased expression of IGFBP5 mRNA

NCBI chr 9:81,901,605...81,914,187
Ensembl chr 9:81,897,616...81,914,390

G

gamma-2a immunoglobulin heavy chain

decreases expression

EXP

Amphetamine results in decreased expression of IGHG3 mRNA

G

immunoglobulin mu DNA binding protein 2

decreases expression

EXP

Amphetamine results in decreased expression of IGHMBP2 mRNA

NCBI chr 1:209,935,922...209,958,570
Ensembl chr 1:209,934,969...209,958,766

G

immunoglobulin superfamily, member 7

increases expression

EXP

Amphetamine results in increased expression of IGSF7 mRNA

NCBI chr10:100,652,768...100,660,499
Ensembl chr10:100,655,705...100,682,549

G

IKAROS family zinc finger 1

decreases expression

EXP

Amphetamine results in decreased expression of IKZF1 mRNA

NCBI chr14:90,468,696...90,556,522
Ensembl chr14:90,469,172...90,557,574

G

IKAROS family zinc finger 2

decreases expression

EXP

Amphetamine results in decreased expression of IKZF2 mRNA

NCBI chr 9:78,495,670...78,640,896
Ensembl chr 9:78,492,275...78,640,463

G

IKAROS family zinc finger 3

decreases expression

EXP

Amphetamine results in decreased expression of IKZF3 mRNA

NCBI chr10:83,956,850...84,049,861
Ensembl chr10:83,962,030...84,049,861

G

interleukin 13 receptor subunit alpha 1

increases expression

EXP

Amphetamine results in increased expression of IL13RA1 mRNA

NCBI chr X:120,213,670...120,294,777
Ensembl chr X:120,214,075...120,274,461

G

interleukin 16

decreases expression

EXP

Amphetamine results in decreased expression of IL16 mRNA

NCBI chr 1:147,026,852...147,127,177
Ensembl chr 1:147,027,097...147,127,023

G

interleukin 1 beta

increases expression

EXP

Amphetamine results in increased expression of IL1B mRNA

NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601

G

interleukin 1 receptor type 2

increases expression

EXP

Amphetamine results in increased expression of IL1R2 mRNA

NCBI chr 9:49,879,928...49,920,374
Ensembl chr 9:49,877,266...49,920,374

G

interleukin 21 receptor

decreases expression

EXP

Amphetamine results in decreased expression of IL21R mRNA

NCBI chr 1:189,598,682...189,626,340
Ensembl chr 1:189,598,558...189,626,342

G

interleukin 22 receptor subunit alpha 2

increases expression

EXP

Amphetamine results in increased expression of IL22RA2 mRNA

NCBI chr 1:16,172,238...16,228,009
Ensembl chr 1:16,184,113...16,197,950

G

interleukin 27 receptor subunit alpha

decreases expression

EXP

Amphetamine results in decreased expression of IL27RA mRNA

NCBI chr19:41,014,730...41,026,740
Ensembl chr19:41,014,730...41,026,760

G

interleukin 2 receptor subunit alpha

decreases expression

EXP

Amphetamine results in decreased expression of IL2RA mRNA

NCBI chr17:71,759,802...71,808,475
Ensembl chr17:71,759,802...71,808,507

G

interleukin 2 receptor subunit gamma

decreases expression

EXP

Amphetamine results in decreased expression of IL2RG mRNA

NCBI chr X:70,435,340...70,439,052
Ensembl chr X:70,435,343...70,439,161

G

interleukin 3 receptor subunit alpha

increases expression

EXP

Amphetamine results in increased expression of IL3RA mRNA

NCBI chr12:21,431,848...21,437,336
Ensembl chr12:21,431,848...21,437,250

G

interleukin 4 induced 1

decreases expression

EXP

Amphetamine results in decreased expression of IL4I1 mRNA

NCBI chr 1:104,435,540...104,461,049
Ensembl chr 1:104,435,981...104,461,053

G

interleukin 6

increases expression

EXP

Amphetamine results in increased expression of IL6 mRNA

NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610

G

interleukin 9 receptor

decreases expression

EXP

Amphetamine results in decreased expression of IL9R mRNA

NCBI chr10:15,936,156...15,947,613
Ensembl chr10:15,936,156...15,947,613

G

inosine monophosphate dehydrogenase 1

decreases expression

EXP

Amphetamine results in decreased expression of IMPDH1 mRNA

NCBI chr 4:58,767,230...58,782,825
Ensembl chr 4:58,767,230...58,783,124

G

inhibin subunit alpha

increases expression

EXP

Amphetamine results in increased expression of INHA mRNA

NCBI chr 9:84,443,109...84,446,010
Ensembl chr 9:84,443,109...84,446,009

G

inhibin subunit beta B

increases expression

EXP

Amphetamine results in increased expression of INHBB mRNA

NCBI chr13:33,083,671...33,089,373
Ensembl chr13:33,083,671...33,089,609

G

INO80 complex ATPase subunit

decreases expression

EXP

Amphetamine results in decreased expression of INO80 mRNA

NCBI chr 3:126,822,280...126,919,532
Ensembl chr 3:126,822,280...126,919,532

G

INO80 complex subunit D

decreases expression

EXP

Amphetamine results in decreased expression of INO80D mRNA

NCBI chr 9:71,940,941...72,007,879
Ensembl chr 9:71,951,031...72,040,232

G

inositol polyphosphate-4-phosphatase type II B

decreases expression

EXP

Amphetamine results in decreased expression of INPP4B mRNA

NCBI chr19:42,824,710...43,575,039
Ensembl chr19:42,829,871...43,185,091

G

insulin-like 3

decreases expression

EXP

Amphetamine results in decreased expression of INSL3 mRNA

NCBI chr16:18,432,668...18,434,539

G

integrator complex subunit 2

decreases expression

EXP

Amphetamine results in decreased expression of INTS2 mRNA

NCBI chr10:71,529,021...71,576,529
Ensembl chr10:71,401,151...71,575,206

G

importin 11

decreases expression

EXP

Amphetamine results in decreased expression of IPO11 mRNA

NCBI chr 2:39,903,316...40,076,485
Ensembl chr 6:128,852,646...128,855,832

G

importin 4

decreases expression

EXP

Amphetamine results in decreased expression of IPO4 mRNA

NCBI chr15:33,087,321...33,097,241
Ensembl chr15:33,087,321...33,097,241

G

importin 8

decreases expression

EXP

Amphetamine results in decreased expression of IPO8 mRNA

NCBI chr 4:183,460,583...183,529,259
Ensembl chr 4:183,460,583...183,524,519

G

importin 9

decreases expression

EXP

Amphetamine results in decreased expression of IPO9 mRNA

NCBI chr13:49,362,244...49,414,477
Ensembl chr13:49,365,716...49,414,477

G

IQ motif and Sec7 domain ArfGEF 3

decreases expression

EXP

Amphetamine results in decreased expression of IQSEC3 mRNA

NCBI chr 4:156,283,040...156,379,396
Ensembl chr 4:156,283,043...156,379,396

G

interleukin-1 receptor-associated kinase 3

decreases expression

EXP

Amphetamine results in decreased expression of IRAK3 mRNA

NCBI chr 7:57,538,522...57,600,166
Ensembl chr 7:57,539,557...57,598,706

G

interferon regulatory factor 6

decreases expression

EXP

Amphetamine results in decreased expression of IRF6 mRNA

NCBI chr13:107,200,876...107,220,083
Ensembl chr13:107,200,731...107,220,049

G

interferon regulatory factor 8

decreases expression

EXP

Amphetamine results in decreased expression of IRF8 mRNA

NCBI chr19:65,699,284...65,721,066
Ensembl chr19:65,699,284...65,721,062

G

integrin subunit alpha 3

decreases expression

EXP

Amphetamine results in decreased expression of ITGA3 mRNA

NCBI chr10:80,486,998...80,522,548
Ensembl chr10:80,486,999...80,518,901

G

integrin subunit alpha 4

decreases expression

EXP

Amphetamine results in decreased expression of ITGA4 mRNA

NCBI chr 3:84,569,487...84,646,276
Ensembl chr 3:84,560,369...84,641,039

G

integrin subunit alpha 5

increases expression

EXP

Amphetamine results in increased expression of ITGA5 mRNA

NCBI chr 7:136,358,097...136,381,305
Ensembl chr 7:136,358,097...136,381,305

G

integrin subunit alpha D

decreases expression

EXP

Amphetamine results in decreased expression of ITGAD mRNA

NCBI chr 1:192,190,204...192,218,864
Ensembl chr 1:192,190,204...192,218,864

G

inter-alpha trypsin inhibitor, heavy chain 1

decreases expression

EXP

Amphetamine results in decreased expression of ITIH1 mRNA

NCBI chr16:6,128,696...6,142,813
Ensembl chr16:6,128,698...6,142,853

G

IL2-inducible T-cell kinase

decreases expression

EXP

Amphetamine results in decreased expression of ITK mRNA

NCBI chr10:31,254,667...31,316,004
Ensembl chr10:31,254,667...31,316,004

G

integral membrane protein 2C

increases expression

EXP

Amphetamine results in increased expression of ITM2C mRNA

NCBI chr 9:93,993,922...94,007,737
Ensembl chr 9:93,993,895...94,007,704

G

inositol 1,4,5-trisphosphate receptor, type 1

decreases expression

EXP

Amphetamine results in decreased expression of ITPR1 mRNA

NCBI chr 4:142,743,401...143,066,505
Ensembl chr 4:142,743,334...143,066,504

G

inositol 1,4,5-trisphosphate receptor, type 3

decreases expression

EXP

Amphetamine results in decreased expression of ITPR3 mRNA

NCBI chr20:5,138,553...5,204,189
Ensembl chr20:5,118,834...5,204,184

G

isovaleryl-CoA dehydrogenase

decreases expression

EXP

Amphetamine results in decreased expression of IVD mRNA

NCBI chr 3:126,305,584...126,326,016
Ensembl chr 3:126,305,364...126,328,160

G

influenza virus NS1A binding protein

increases expression

EXP

Amphetamine results in increased expression of IVNS1ABP mRNA

NCBI chr13:65,977,069...65,996,685
Ensembl chr13:65,977,045...65,997,547

G

jade family PHD finger 1

decreases expression

EXP

Amphetamine results in decreased expression of JADE1 mRNA

NCBI chr 2:126,471,124...126,524,252
Ensembl chr 2:126,471,124...126,524,252

G

jade family PHD finger 2

decreases expression

EXP

Amphetamine results in decreased expression of JADE2 mRNA

NCBI chr10:36,576,187...36,625,129
Ensembl chr10:36,576,187...36,623,532

G

jagged canonical Notch ligand 1

increases expression

EXP

Amphetamine results in increased expression of JAG1 mRNA

NCBI chr 3:144,859,453...144,894,883
Ensembl chr 3:144,859,453...144,894,872

G

Janus kinase 3

decreases expression

EXP

Amphetamine results in decreased expression of JAK3 mRNA

NCBI chr16:18,418,807...18,432,515
Ensembl chr16:18,420,415...18,433,222

G

janus kinase and microtubule interacting protein 1

decreases expression

EXP

Amphetamine results in decreased expression of JAKMIP1 mRNA

NCBI chr14:77,871,034...77,991,566
Ensembl chr14:77,871,034...77,991,525

G

junctional adhesion molecule 2

increases expression

EXP

Amphetamine results in increased expression of JAM2 mRNA

NCBI chr11:37,316,287...37,366,517
Ensembl chr11:37,317,511...37,367,510

G

Jun dimerization protein 2

increases expression

EXP

Amphetamine results in increased expression of JDP2 mRNA

NCBI chr 6:110,988,927...111,033,392
Ensembl chr 6:110,992,806...111,033,392

G

jumonji domain containing 1C

increases expression

EXP

Amphetamine results in increased expression of JMJD1C mRNA

NCBI chr20:21,330,990...21,508,580
Ensembl chr20:21,330,990...21,461,916

G

jumonji domain containing 7

decreases expression

EXP

Amphetamine results in decreased expression of JMJD7 mRNA

NCBI chr 3:127,452,238...127,458,326
Ensembl chr 3:127,452,255...127,458,325

G

junction mediating and regulatory protein, p53 cofactor

decreases expression

EXP

Amphetamine results in decreased expression of JMY mRNA

NCBI chr 2:26,401,047...26,465,959
Ensembl chr 2:26,409,969...26,465,649

G

Jrk helix-turn-helix protein

decreases expression

EXP

Amphetamine results in decreased expression of JRK mRNA

NCBI chr 7:108,479,646...108,484,329
Ensembl chr 7:108,453,398...108,495,813

G

Jun proto-oncogene, AP-1 transcription factor subunit

increases expression
decreases response to substance
multiple interactions
increases phosphorylation

ISO
EXP

Amphetamine results in increased expression of JUN protein
Amphetamine results in increased expression of JUN mRNA; Amphetamine results in increased expression of JUN protein
JUN protein results in decreased susceptibility to Amphetamine
Amphetamine promotes the reaction [JUN protein binds to FOSB protein]; Amphetamine results in increased activity of [JUN protein binds to FOSB protein]
JUN protein promotes the reaction [Amphetamine results in decreased expression of NPY mRNA]; JUN protein promotes the reaction [Amphetamine results in increased expression of SOD1 mRNA]; pyrazolanthrone inhibits the reaction [Amphetamine results in increased phosphorylation of JUN protein]

PMID:8298093 PMID:15194466 PMID:15814102 PMID:16084549

NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285

G

JunB proto-oncogene, AP-1 transcription factor subunit

decreases expression

ISO

Amphetamine results in decreased expression of JUNB protein

NCBI chr19:40,081,126...40,082,910
Ensembl chr19:40,073,541...40,085,218

G

JunD proto-oncogene, AP-1 transcription factor subunit

decreases expression
increases expression
multiple interactions

ISO
EXP

Amphetamine results in decreased expression of JUND protein
Amphetamine results in increased expression of JUND mRNA
Amphetamine promotes the reaction [JUND protein binds to FOSL2 protein]; Amphetamine results in increased activity of [JUND protein binds to FOSL2 protein]

PMID:15814102 PMID:30779732

NCBI chr16:18,768,093...18,769,771
Ensembl chr16:18,764,985...18,782,148

G

junction plakoglobin

decreases expression

EXP

Amphetamine results in decreased expression of JUP mRNA

NCBI chr10:85,800,812...85,827,881
Ensembl chr10:85,800,814...85,827,429

G

lysine acetyltransferase 14

decreases expression

EXP

Amphetamine results in decreased expression of KAT14 mRNA

NCBI chr 3:152,194,560...152,235,048
Ensembl chr 3:152,194,696...152,235,052

G

lysine acetyltransferase 2A

decreases expression

EXP

Amphetamine results in decreased expression of KAT2A mRNA

NCBI chr10:86,132,535...86,140,877
Ensembl chr10:86,132,535...86,140,485

G

kelch repeat and BTB domain containing 11

decreases expression

EXP

Amphetamine results in decreased expression of KBTBD11 mRNA

NCBI chr16:81,318,596...81,340,334
Ensembl chr16:81,313,093...81,340,390

G

potassium voltage-gated channel subfamily A member 1

increases response to substance
multiple interactions

ISO
EXP

KCNA1 protein results in increased susceptibility to Amphetamine
KCNA1 protein affects the reaction [Amphetamine results in increased secretion of Dopamine]

NCBI chr 4:161,150,378...161,160,051
Ensembl chr 4:161,147,418...161,160,044

G

potassium voltage-gated channel subfamily A regulatory beta subunit 2

decreases expression

EXP

Amphetamine results in decreased expression of KCNAB2 mRNA

NCBI chr 5:168,182,228...168,270,760
Ensembl chr 5:168,184,613...168,270,760

G

potassium voltage-gated channel subfamily A regulatory beta subunit 3

decreases expression

EXP

Amphetamine results in decreased expression of KCNAB3 mRNA

NCBI chr10:54,546,638...54,555,209
Ensembl chr10:54,546,618...54,553,357

G

potassium voltage-gated channel subfamily H member 2

decreases expression

EXP

Amphetamine results in decreased expression of KCNH2 mRNA

NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:11,692,980...11,751,421

G

potassium inwardly-rectifying channel, subfamily J, member 1

decreases expression

EXP

Amphetamine results in decreased expression of KCNJ1 mRNA

NCBI chr 8:39,014,822...39,066,716
Ensembl chr 8:39,037,992...39,066,715

G

potassium inwardly-rectifying channel, subfamily J, member 5

decreases expression

EXP

Amphetamine results in decreased expression of KCNJ5 mRNA

NCBI chr 8:38,981,598...39,011,197
Ensembl chr 8:38,983,034...39,011,101

G

potassium two pore domain channel subfamily K member 13

increases expression

EXP

Amphetamine results in increased expression of KCNK13 mRNA

NCBI chr 6:124,970,363...125,074,919
Ensembl chr 6:124,971,212...125,075,923

G

potassium two pore domain channel subfamily K member 5

decreases expression

EXP

Amphetamine results in decreased expression of KCNK5 mRNA

NCBI chr15:4,171,625...4,213,896
Ensembl chr15:4,171,610...4,213,897

G

potassium calcium-activated channel subfamily M regulatory beta subunit 1

decreases expression

EXP

Amphetamine results in decreased expression of KCNMB1 mRNA

NCBI chr10:19,062,014...19,119,005
Ensembl chr10:19,062,291...19,073,204

G

potassium channel tetramerization domain containing 11

increases expression

EXP

Amphetamine results in increased expression of KCTD11 mRNA

NCBI chr10:55,101,292...55,103,455
Ensembl chr10:55,100,801...55,103,583

G

KDEL endoplasmic reticulum protein retention receptor 3

increases expression

EXP

Amphetamine results in increased expression of KDELR3 mRNA

NCBI chr 7:112,959,632...112,969,858
Ensembl chr 7:112,959,718...112,969,858

G

KH-type splicing regulatory protein

decreases expression

EXP

Amphetamine results in decreased expression of KHSRP mRNA

NCBI chr 9:1,949,557...1,959,400
Ensembl chr 9:1,949,557...1,959,497

G

kinesin family member 18A

increases expression

EXP

Amphetamine results in increased expression of KIF18A mRNA

NCBI chr 3:116,219,007...116,279,378
Ensembl chr 3:116,219,007...116,279,227

G

kinesin family member 21B

decreases expression

EXP

Amphetamine results in decreased expression of KIF21B mRNA

NCBI chr13:50,127,842...50,177,822
Ensembl chr13:50,127,842...50,177,822

G

kinesin family member 3C

decreases expression

EXP

Amphetamine results in decreased expression of KIF3C mRNA

NCBI chr 6:32,086,879...32,125,812
Ensembl chr 6:32,086,124...32,126,066

G

kinesin family member C3

increases expression

EXP

Amphetamine results in increased expression of KIFC3 mRNA

NCBI chr19:9,831,159...9,926,405
Ensembl chr19:9,831,159...9,926,405

G

kinesin light chain 3

decreases expression

EXP

Amphetamine results in decreased expression of KLC3 mRNA

NCBI chr 1:88,173,842...88,183,806
Ensembl chr 1:88,173,404...88,184,253

G

KLF transcription factor 10

increases expression

EXP

Amphetamine results in increased expression of KLF10 mRNA

NCBI chr 7:71,352,612...71,358,680
Ensembl chr 7:71,350,573...71,358,948

G

KLF transcription factor 11

increases expression

EXP

Amphetamine results in increased expression of KLF11 mRNA

NCBI chr 6:47,014,312...47,026,152
Ensembl chr 6:47,014,326...47,037,044

G

KLF transcription factor 12

decreases expression

EXP

Amphetamine results in decreased expression of KLF12 mRNA

NCBI chr15:83,037,548...83,469,998
Ensembl chr15:83,045,463...83,670,640

G

kelch domain containing 1

decreases expression

EXP

Amphetamine results in decreased expression of KLHDC1 mRNA

NCBI chr 6:93,406,226...93,501,475
Ensembl chr 6:93,448,758...93,501,702

G

kelch domain containing 8B

decreases expression

EXP

Amphetamine results in decreased expression of KLHDC8B mRNA

NCBI chr 8:118,020,136...118,025,102
Ensembl chr 8:118,020,376...118,025,102

G

kelch-like family member 13

increases expression

EXP

Amphetamine results in increased expression of KLHL13 mRNA

NCBI chr X:118,747,298...118,912,279
Ensembl chr X:118,747,298...118,855,035

G

kelch-like family member 17

decreases expression

EXP

Amphetamine results in decreased expression of KLHL17 mRNA

NCBI chr 5:172,095,701...172,101,945
Ensembl chr 5:172,094,940...172,101,195

G

kelch-like family member 22

decreases expression

EXP

Amphetamine results in decreased expression of KLHL22 mRNA

NCBI chr11:96,695,168...96,736,079
Ensembl chr11:96,695,171...96,738,065

G

kelch-like family member 3

decreases expression

EXP

Amphetamine results in decreased expression of KLHL3 mRNA

NCBI chr17:6,528,114...6,651,338
Ensembl chr17:6,528,487...6,651,338

G

kelch-like family member 36

decreases expression

EXP

Amphetamine results in decreased expression of KLHL36 mRNA

NCBI chr19:64,830,218...64,851,251
Ensembl chr19:64,836,877...64,851,250

G

kelch-like family member 41

increases expression

EXP

Amphetamine results in increased expression of KLHL41 mRNA

NCBI chr 3:74,842,118...74,855,244

G

kelch-like family member 8

decreases expression

EXP

Amphetamine results in decreased expression of KLHL8 mRNA

NCBI chr14:6,112,472...6,158,001
Ensembl chr14:6,112,490...6,157,966

G

killer cell lectin-like receptor, subfamily A, member 1

increases expression

EXP

Amphetamine results in increased expression of KLRA1 mRNA

NCBI chr 4:166,291,838...166,313,615
Ensembl chr 4:166,291,841...166,313,615

G

killer cell lectin-like receptor subfamily B member 1B

increases expression

EXP

Amphetamine results in increased expression of KLRB1B mRNA

NCBI chr 4:163,634,357...163,647,629
Ensembl chr 4:163,634,941...163,647,767

G

killer cell lectin like receptor K1

decreases expression

EXP

Amphetamine results in decreased expression of KLRK1 mRNA

NCBI chr 4:164,767,377...164,778,453
Ensembl chr 4:164,767,946...164,778,382

G

lysine methyltransferase 2A

decreases expression

EXP

Amphetamine results in decreased expression of KMT2A mRNA

NCBI chr 8:54,013,547...54,089,219
Ensembl chr 8:54,013,547...54,089,317

G

lysine methyltransferase 2C

decreases expression

EXP

Amphetamine results in decreased expression of KMT2C mRNA

NCBI chr 4:10,353,698...10,755,965
Ensembl chr 4:10,353,735...10,568,620

G

lysine methyltransferase 2D

decreases expression

EXP

Amphetamine results in decreased expression of KMT2D mRNA

NCBI chr 7:131,859,696...131,901,032
Ensembl chr 7:131,859,696...131,900,072

G

KRAS proto-oncogene, GTPase

increases expression

EXP

Amphetamine results in increased expression of KRAS mRNA

NCBI chr 4:179,916,255...179,949,613
Ensembl chr 4:179,919,802...179,949,320

G

KRAB-A domain containing 1

decreases expression

EXP

Amphetamine results in decreased expression of KRBA1 mRNA

NCBI chr 4:78,672,384...78,693,984
Ensembl chr 4:78,672,400...78,693,987

G

keratin 14

increases expression

EXP

Amphetamine results in increased expression of KRT14 mRNA

NCBI chr10:85,638,182...85,642,450

G

keratin 17

increases expression

EXP

Amphetamine results in increased expression of KRT17 mRNA

NCBI chr10:85,679,068...85,683,792
Ensembl chr10:85,679,070...85,683,787

G

keratin 19

increases expression

EXP

Amphetamine results in increased expression of KRT19 mRNA

NCBI chr10:85,576,235...85,580,952
Ensembl chr10:85,576,235...85,580,952

G

keratin 71

increases expression

EXP

Amphetamine results in increased expression of KRT71 mRNA

NCBI chr 7:134,752,240...134,778,765
Ensembl chr 7:134,752,248...134,761,033

G

L1 cell adhesion molecule

decreases expression

EXP

Amphetamine results in decreased expression of L1CAM mRNA

NCBI chr X:156,748,597...156,775,116
Ensembl chr X:156,748,597...156,775,077

G

L3MBTL histone methyl-lysine binding protein 3

decreases expression

EXP

Amphetamine results in decreased expression of L3MBTL3 mRNA

NCBI chr 1:20,807,679...20,908,609
Ensembl chr 1:20,808,973...20,908,608

G

laccase domain containing 1

decreases expression

EXP

Amphetamine results in decreased expression of LACC1 mRNA

NCBI chr15:58,799,477...58,816,840
Ensembl chr15:58,786,637...58,816,840

G

lactamase, beta

increases expression

EXP

Amphetamine results in increased expression of LACTB mRNA

NCBI chr 8:76,452,679...76,469,986
Ensembl chr 8:76,452,349...76,468,716

G

laminin subunit alpha 2

decreases expression

EXP

Amphetamine results in decreased expression of LAMA2 mRNA

NCBI chr 1:19,492,126...20,140,056
Ensembl chr 1:19,244,599...20,140,056

G

laminin subunit alpha 3

decreases expression

EXP

Amphetamine results in decreased expression of LAMA3 mRNA

NCBI chr18:3,797,898...4,033,021
Ensembl chr18:3,797,939...4,026,449

G

laminin subunit beta 2

increases expression

EXP

Amphetamine results in increased expression of LAMB2 mRNA

NCBI chr 8:118,056,899...118,069,090
Ensembl chr 8:118,056,935...118,069,090

G

laminin subunit gamma 1

decreases expression

EXP

Amphetamine results in decreased expression of LAMC1 mRNA

NCBI chr13:67,924,872...68,051,986
Ensembl chr13:67,924,872...68,051,986

G

lysosomal-associated membrane protein 2

increases expression

EXP

Amphetamine results in increased expression of LAMP2 mRNA

NCBI chr X:122,038,734...122,087,745
Ensembl chr X:121,922,187...122,087,675

G

late endosomal/lysosomal adaptor, MAPK and MTOR activator 3

increases expression

EXP

Amphetamine results in increased expression of LAMTOR3 mRNA

NCBI chr 2:229,084,795...229,097,028
Ensembl chr 2:229,084,858...229,099,383

G

lysosomal protein transmembrane 4 alpha

increases expression

EXP

Amphetamine results in increased expression of LAPTM4A mRNA

NCBI chr 6:37,438,503...37,456,238
Ensembl chr 6:37,438,121...37,456,223

G

La ribonucleoprotein 1, translational regulator

decreases expression

EXP

Amphetamine results in decreased expression of LARP1 mRNA

NCBI chr10:42,691,833...42,746,816
Ensembl chr10:42,691,600...42,746,816

G

linker for activation of T cells

decreases expression

EXP

Amphetamine results in decreased expression of LAT mRNA

NCBI chr 1:190,367,111...190,372,515
Ensembl chr 1:190,367,109...190,372,153

G

LBH regulator of WNT signaling pathway

decreases expression

EXP

Amphetamine results in decreased expression of LBH mRNA

NCBI chr 6:28,321,040...28,344,855
Ensembl chr 6:28,321,040...28,370,238

G

LCK proto-oncogene, Src family tyrosine kinase

decreases expression

EXP

Amphetamine results in decreased expression of LCK mRNA

NCBI chr 5:147,172,642...147,201,267
Ensembl chr 5:147,172,642...147,201,267

G

lactate dehydrogenase A

increases expression

EXP

Amphetamine results in increased expression of LDHA mRNA

NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:106,502,182...106,517,521

G

low density lipoprotein receptor class A domain containing 3

decreases expression

EXP

Amphetamine results in decreased expression of LDLRAD3 mRNA

NCBI chr 3:108,694,528...108,936,330
Ensembl chr 3:108,694,528...108,936,368

G

low density lipoprotein receptor class A domain containing 4

decreases expression

EXP

Amphetamine results in decreased expression of LDLRAD4 mRNA

NCBI chr18:63,789,089...64,118,166
Ensembl chr18:63,790,440...64,113,064

G

low density lipoprotein receptor adaptor protein 1

decreases expression

EXP

Amphetamine results in decreased expression of LDLRAP1 mRNA

NCBI chr 5:152,239,296...152,262,290
Ensembl chr 5:152,229,505...152,262,290

G

lymphoid enhancer binding factor 1

decreases expression

EXP

Amphetamine results in decreased expression of LEF1 mRNA

NCBI chr 2:222,340,541...222,453,931
Ensembl chr 2:222,340,704...222,453,929

G

left right determination factor 1

increases expression

EXP

Amphetamine results in increased expression of LEFTY1 mRNA

NCBI chr13:95,188,091...95,191,488
Ensembl chr13:95,188,091...95,191,488

G

leptin receptor overlapping transcript-like 1

increases expression

EXP

Amphetamine results in increased expression of LEPROTL1 mRNA

NCBI chr16:64,744,148...64,756,776
Ensembl chr16:64,743,717...64,756,776

G

leucine zipper and EF-hand containing transmembrane protein 1

decreases expression

EXP

Amphetamine results in decreased expression of LETM1 mRNA

NCBI chr14:81,167,268...81,206,776
Ensembl chr14:81,162,309...81,209,459

G

galectin 3

increases expression

EXP

Amphetamine results in increased expression of LGALS3 mRNA

NCBI chr15:23,099,795...23,111,731
Ensembl chr15:23,086,841...23,111,737

G

galectin 5

increases expression

EXP

Amphetamine results in increased expression of LGALS5 mRNA

NCBI chr10:64,351,976...64,355,137
Ensembl chr10:64,351,964...64,355,180

G

LHFPL tetraspan subfamily member 2

increases expression

EXP

Amphetamine results in increased expression of LHFPL2 mRNA

NCBI chr 2:27,016,404...27,169,830
Ensembl chr 2:27,016,700...27,162,859

G

leukocyte immunoglobulin like receptor B4

increases expression

EXP

Amphetamine results in increased expression of LILRB4 mRNA

NCBI chr 1:78,847,685...78,853,294
Ensembl chr 1:78,847,685...78,853,326

G

LIM domain containing 1

decreases expression

EXP

Amphetamine results in decreased expression of LIMD1 mRNA

NCBI chr 8:131,998,262...132,045,924
Ensembl chr 8:131,999,770...132,045,922

G

Lck interacting transmembrane adaptor 1

decreases expression

EXP

Amphetamine results in decreased expression of LIME1 mRNA

NCBI chr 3:188,868,338...188,870,661
Ensembl chr 3:188,868,320...188,870,658

G

LIM domain kinase 1

decreases expression

EXP

Amphetamine results in decreased expression of LIMK1 mRNA

NCBI chr12:27,663,177...27,697,085
Ensembl chr12:27,663,018...27,697,209

G

LIM domain kinase 2

decreases expression

EXP

Amphetamine results in decreased expression of LIMK2 mRNA

NCBI chr14:82,384,256...82,509,755
Ensembl chr14:82,435,480...82,509,644

G

leucine rich repeat and Ig domain containing 3

increases expression

EXP

Amphetamine results in increased expression of LINGO3 mRNA

NCBI chr 7:9,519,252...9,530,675
Ensembl chr 7:9,513,743...9,531,155

G

lines homolog 1

increases expression

EXP

Amphetamine results in increased expression of LINS mRNA

NCBI chr 1:129,677,815...129,705,399
Ensembl chr 1:129,692,225...129,703,826

G

lipase G, endothelial type

decreases expression

EXP

Amphetamine results in decreased expression of LIPG mRNA

NCBI chr18:70,790,077...70,811,259
Ensembl chr18:70,790,077...70,812,260

G

lipopolysaccharide-induced TNF factor

increases expression

EXP

Amphetamine results in increased expression of LITAF mRNA

NCBI chr10:5,163,258...5,199,930
Ensembl chr10:5,163,242...5,199,930

G

LLGL scribble cell polarity complex component 1

decreases expression

EXP

Amphetamine results in decreased expression of LLGL1 mRNA

NCBI chr10:45,878,936...45,893,609
Ensembl chr10:45,879,012...45,893,603

G

lamin B2

decreases expression

EXP

Amphetamine results in decreased expression of LMNB2 mRNA

NCBI chr 7:9,443,308...9,459,468
Ensembl chr 7:9,440,128...9,459,342

G

LIM domain 7

decreases expression

EXP

Amphetamine results in decreased expression of LMO7 mRNA

NCBI chr15:84,981,689...85,184,554
Ensembl chr15:84,981,735...85,184,551

G

leucyl and cystinyl aminopeptidase

decreases expression

EXP

Amphetamine results in decreased expression of LNPEP mRNA

NCBI chr 1:66,931,712...67,027,610
Ensembl chr 1:66,931,712...67,027,610

G

LON peptidase N-terminal domain and ring finger 3

increases expression

EXP

Amphetamine results in increased expression of LONRF3 mRNA

NCBI chr X:120,430,975...120,469,648
Ensembl chr X:120,430,996...120,464,572

G

lipin 1

decreases expression

EXP

Amphetamine results in decreased expression of LPIN1 mRNA

NCBI chr 6:45,039,110...45,145,845
Ensembl chr 6:45,041,522...45,145,991

G

lipin 3

decreases expression

EXP

Amphetamine results in decreased expression of LPIN3 mRNA

NCBI chr 3:169,953,479...169,978,034
Ensembl chr 3:169,960,522...169,978,031

G

lipoprotein lipase

increases expression

EXP

Amphetamine results in increased expression of LPL mRNA

NCBI chr16:25,596,205...25,621,928
Ensembl chr16:25,596,211...25,622,107

G

LPS responsive beige-like anchor protein

decreases expression

EXP

Amphetamine results in decreased expression of LRBA mRNA

NCBI chr 2:173,919,330...174,500,536
Ensembl chr 2:173,921,747...174,500,527

G

leucine-rich alpha-2-glycoprotein 1

increases expression

EXP

Amphetamine results in increased expression of LRG1 mRNA

NCBI chr 9:1,034,691...1,036,937
Ensembl chr 9:1,034,679...1,037,337

G

leucine-rich repeats and immunoglobulin-like domains 1

decreases expression

EXP

Amphetamine results in decreased expression of LRIG1 mRNA

NCBI chr 4:128,687,723...128,788,219
Ensembl chr 4:128,687,723...128,788,219

G

LDL receptor related protein 11

decreases expression

EXP

Amphetamine results in decreased expression of LRP11 mRNA

NCBI chr 1:3,868,665...3,928,513
Ensembl chr 1:3,899,985...3,928,507

G

LDL receptor related protein 12

increases expression

EXP

Amphetamine results in increased expression of LRP12 mRNA

NCBI chr 7:72,825,979...72,897,308
Ensembl chr 7:72,825,979...72,897,171

G

LDL receptor related protein 6

decreases expression

EXP

Amphetamine results in decreased expression of LRP6 mRNA

NCBI chr 4:168,997,937...169,131,716
Ensembl chr 4:169,000,968...169,131,716

G

leucine rich repeat containing 20

decreases expression

EXP

Amphetamine results in decreased expression of LRRC20 mRNA

NCBI chr20:29,965,673...30,071,185
Ensembl chr20:29,972,001...30,071,184

G

leucine rich repeat containing 49

increases expression

EXP

Amphetamine results in increased expression of LRRC49 mRNA

NCBI chr 8:69,948,962...70,056,579
Ensembl chr 8:69,948,972...70,079,636

G

leucine rich repeat containing 75A

increases expression

EXP

Amphetamine results in increased expression of LRRC75A mRNA

NCBI chr10:47,798,028...47,842,577
Ensembl chr10:47,798,028...47,842,577

G

leucine rich repeat containing 8 VRAC subunit B

decreases expression

EXP

Amphetamine results in decreased expression of LRRC8B mRNA

NCBI chr14:4,655,273...4,721,648
Ensembl chr14:4,655,273...4,721,076

G

LRR binding FLII interacting protein 2

increases expression

EXP

Amphetamine results in increased expression of LRRFIP2 mRNA

NCBI chr 8:119,969,908...120,071,270
Ensembl chr 8:119,969,871...120,073,475

G

leucine-rich repeat kinase 2

increases expression

EXP

Amphetamine results in increased expression of LRRK2 mRNA

NCBI chr 7:124,706,246...124,867,234
Ensembl chr 7:124,706,080...124,867,239

G

leucine-rich repeats and WD repeat domain containing 1

decreases expression

EXP

Amphetamine results in decreased expression of LRWD1 mRNA

NCBI chr12:26,166,648...26,179,689
Ensembl chr12:26,166,648...26,185,200

G

LSM family member 14B

decreases expression

EXP

Amphetamine results in decreased expression of LSM14B mRNA

NCBI chr 3:187,503,251...187,514,041
Ensembl chr 3:187,503,045...187,512,473

G

lymphocyte-specific protein 1

increases expression

EXP

Amphetamine results in increased expression of LSP1 mRNA

NCBI chr 1:207,044,157...207,077,891
Ensembl chr 1:207,044,159...207,077,893

G

lanosterol synthase

decreases expression

EXP

Amphetamine results in decreased expression of LSS mRNA

NCBI chr20:12,090,641...12,118,230
Ensembl chr20:12,073,543...12,118,253

G

leukotriene A4 hydrolase

increases expression

EXP

Amphetamine results in increased expression of LTA4H mRNA

NCBI chr 7:29,856,846...29,888,642
Ensembl chr 7:29,856,802...29,888,641

G

leukotriene B4 receptor

increases expression

EXP

Amphetamine results in increased expression of LTB4R mRNA

NCBI chr15:33,233,120...33,235,636
Ensembl chr15:33,232,820...33,235,637

G

lymphotoxin beta receptor

increases expression

EXP

Amphetamine results in increased expression of LTBR mRNA

NCBI chr 4:159,795,115...159,801,571
Ensembl chr 4:159,795,115...159,807,296

G

lumican

increases expression

EXP

Amphetamine results in increased expression of LUM mRNA

NCBI chr 7:34,245,323...34,252,510
Ensembl chr 7:34,245,360...34,252,508

G

Ly49 inhibitory receptor 7

increases expression

EXP

Amphetamine results in increased expression of LY49I7 mRNA

NCBI chr 4:166,584,725...166,604,575
Ensembl chr 4:166,585,010...166,598,801

G

Ly49 stimulatory receptor 7

increases expression

EXP

Amphetamine results in increased expression of LY49S7 mRNA

NCBI chr 4:166,491,218...166,511,293
Ensembl chr 4:166,491,504...166,509,673

G

immunoreceptor Ly49si2

increases expression

EXP

Amphetamine results in increased expression of LY49SI2 mRNA

NCBI chr 4:165,358,092...165,410,591

G

lymphocyte antigen 6 family member A

increases expression

EXP

Amphetamine results in increased expression of LY6AL mRNA

NCBI chr 7:109,064,222...109,067,757

G

lymphocyte antigen 6 family member D

increases expression

EXP

Amphetamine results in increased expression of LY6D mRNA

NCBI chr 7:108,532,207...108,533,943
Ensembl chr 7:108,532,215...108,533,716

G

lymphocyte antigen 6 family member E

decreases expression

EXP

Amphetamine results in decreased expression of LY6E mRNA

NCBI chr 7:108,815,970...108,820,444
Ensembl chr 7:108,816,887...108,820,443

G

lymphocyte antigen 6 family member G6C

increases expression

EXP

Amphetamine results in increased expression of LY6G6C mRNA

NCBI chr20:3,758,290...3,760,987
Ensembl chr20:3,758,290...3,762,927

G

lymphocyte antigen 6 family member G6D

increases expression

EXP

Amphetamine results in increased expression of LY6G6D mRNA

NCBI chr20:3,746,630...3,757,036
Ensembl chr20:3,742,116...3,757,193

G

lymphocyte antigen 6 family member G6F

increases expression

EXP

Amphetamine results in increased expression of LY6G6F mRNA

NCBI chr20:3,742,116...3,746,984
Ensembl chr20:3,742,116...3,757,193

G

lymphocyte antigen 6 family member H

increases expression

EXP

Amphetamine results in increased expression of LY6H mRNA

NCBI chr 7:109,139,527...109,142,108
Ensembl chr 7:109,139,527...109,246,799

G

lymphocyte antigen 6 complex, locus I

increases expression

EXP

Amphetamine results in increased expression of LY6I mRNA

NCBI chr 7:108,943,081...108,948,499
Ensembl chr 7:108,943,081...108,945,889

G

lymphocyte antigen 9

decreases expression

EXP

Amphetamine results in decreased expression of LY9 mRNA

NCBI chr13:86,610,762...86,633,314
Ensembl chr13:86,611,784...86,657,293

G

lymphocyte antigen 96

increases expression

EXP

Amphetamine results in increased expression of LY96 mRNA

NCBI chr 5:7,365,536...7,397,864
Ensembl chr 5:7,365,557...7,395,816

G

lysozyme 2

increases expression

EXP

Amphetamine results in increased expression of LYZ2 mRNA

NCBI chr 7:54,792,715...54,798,060
Ensembl chr 7:54,792,716...54,798,011

G

microtubule-actin crosslinking factor 1

decreases expression

EXP

Amphetamine results in decreased expression of MACF1 mRNA

NCBI chr 5:140,908,829...141,234,127
Ensembl chr 5:140,908,837...141,233,890

G

mono-ADP ribosylhydrolase 1

increases expression

EXP

Amphetamine results in increased expression of MACROD1 mRNA

NCBI chr 1:213,675,413...213,831,571
Ensembl chr 1:213,675,406...213,816,348

G

MAP-kinase activating death domain

decreases expression

EXP

Amphetamine results in decreased expression of MADD mRNA

NCBI chr 3:97,570,141...97,613,688
Ensembl chr 3:97,570,787...97,613,509

G

MAF bZIP transcription factor F

increases expression

EXP

Amphetamine results in increased expression of MAFF mRNA

NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:112,791,416...112,804,147

G

MAF bZIP transcription factor K

increases expression

EXP

Amphetamine results in increased expression of MAFK mRNA

NCBI chr12:19,948,473...19,970,351
Ensembl chr12:19,948,476...19,959,192

G

MAGE family member D2

increases expression

EXP

Amphetamine results in increased expression of MAGED2 mRNA

NCBI chr X:23,160,928...23,364,994
Ensembl chr X:23,160,931...23,169,104

G

MAGI family member, X-linked

increases expression

EXP

Amphetamine results in increased expression of MAGIX mRNA

NCBI chr X:17,496,092...17,504,370
Ensembl chr X:17,496,225...17,504,369

G

male germ cell-associated kinase

increases expression

EXP

Amphetamine results in increased expression of MAK mRNA

NCBI chr17:23,889,417...23,936,857
Ensembl chr17:23,889,516...23,936,855

G

mitochondrial assembly of ribosomal large subunit 1

increases expression

EXP

Amphetamine results in increased expression of MALSU1 mRNA

NCBI chr 4:79,381,963...79,390,786
Ensembl chr 4:79,374,393...79,411,608

G

MALT1 paracaspase

decreases expression

EXP

Amphetamine results in decreased expression of MALT1 mRNA

NCBI chr18:61,212,290...61,266,272
Ensembl chr18:61,212,317...61,266,272

G

mastermind-like transcriptional coactivator 2

decreases expression

EXP

Amphetamine results in decreased expression of MAML2 mRNA

NCBI chr 8:18,552,480...18,869,923
Ensembl chr 8:18,552,281...18,869,900

G

mannosidase, alpha, class 1A, member 1

decreases expression

EXP

Amphetamine results in decreased expression of MAN1A1 mRNA

NCBI chr20:33,745,158...33,928,584
Ensembl chr20:33,745,165...33,928,584

G

monoamine oxidase A

increases expression

EXP

Amphetamine results in increased expression of MAOA mRNA

NCBI chr X:8,615,239...8,681,372
Ensembl chr X:8,615,239...8,682,631

G

monoamine oxidase B

decreases response to substance
multiple interactions

ISO

MAOB gene mutant form results in decreased susceptibility to Amphetamine
Baclofen affects the reaction [MAOB gene mutant form results in decreased susceptibility to Amphetamine]

NCBI chr X:8,490,405...8,594,065
Ensembl chr X:8,490,344...8,594,375

G

mitogen-activated protein kinase kinase 6

decreases expression

EXP

Amphetamine results in decreased expression of MAP2K6 mRNA

NCBI chr10:95,872,747...95,987,747
Ensembl chr10:95,872,546...95,987,721

G

mitogen activated protein kinase kinase kinase 12

decreases expression

EXP

Amphetamine results in decreased expression of MAP3K12 mRNA

NCBI chr 7:135,507,082...135,527,396
Ensembl chr 7:135,508,790...135,515,137

G

mitogen activated protein kinase kinase kinase 3

increases expression

EXP

Amphetamine results in increased expression of MAP3K3 mRNA

NCBI chr10:91,519,976...91,588,651
Ensembl chr10:91,519,888...91,588,651

G

mitogen activated protein kinase kinase kinase 4

decreases expression

EXP

Amphetamine results in decreased expression of MAP3K4 mRNA

NCBI chr 1:50,977,870...51,067,117
Ensembl chr 1:50,979,586...51,067,117

G

mitogen-activated protein kinase kinase kinase kinase 4

decreases expression

EXP

Amphetamine results in decreased expression of MAP4K4 mRNA

NCBI chr 9:49,696,573...49,822,353
Ensembl chr 9:49,696,700...49,822,353

G

mitogen activated protein kinase 1

increases phosphorylation
multiple interactions
decreases phosphorylation

EXP
ISO

Amphetamine results in increased phosphorylation of MAPK1 protein
Diltiazem affects the reaction [Amphetamine results in increased phosphorylation of MAPK1 protein]; KN 62 inhibits the reaction [Amphetamine results in increased phosphorylation of MAPK1 protein]
Amphetamine results in decreased phosphorylation of MAPK1 protein

PMID:12060798 PMID:15329393 PMID:20620199

NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825

G

mitogen activated protein kinase 3

multiple interactions
increases phosphorylation
decreases phosphorylation

EXP
ISO

Diltiazem affects the reaction [Amphetamine results in increased phosphorylation of MAPK3 protein]; KN 62 inhibits the reaction [Amphetamine results in increased phosphorylation of MAPK3 protein]
PTN protein inhibits the reaction [Amphetamine results in decreased phosphorylation of MAPK3 protein]

PMID:12060798 PMID:15329393 PMID:20620199

NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411

G

mitogen-activated protein kinase 8

multiple interactions

EXP

MAPK8 protein promotes the reaction [Amphetamine results in increased expression of GJA1 protein]

NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427

G

mitogen activated protein kinase binding protein 1

decreases expression

EXP

Amphetamine results in decreased expression of MAPKBP1 mRNA

NCBI chr 3:127,401,612...127,452,152
Ensembl chr 3:127,401,612...127,449,983

G

methionyl-tRNA synthetase 2, mitochondrial

decreases expression

EXP

Amphetamine results in decreased expression of MARS2 mRNA

NCBI chr 9:64,214,935...64,228,408
Ensembl chr 9:64,215,128...64,338,443

G

MARVEL domain containing 1

increases expression

EXP

Amphetamine results in increased expression of MARVELD1 mRNA

NCBI chr 1:250,903,342...250,907,393
Ensembl chr 1:250,903,342...250,907,393

G

MYC associated factor X

increases expression

EXP

Amphetamine results in increased expression of MAX mRNA

NCBI chr 6:101,369,989...101,395,333
Ensembl chr 6:101,369,988...101,395,549

G

myoglobin

increases expression

EXP

Amphetamine results in increased expression of MB mRNA

NCBI chr 7:110,640,511...110,647,742
Ensembl chr 7:110,640,512...110,647,958

G

metallo-beta-lactamase domain containing 2

decreases expression

EXP

Amphetamine results in decreased expression of MBLAC2 mRNA

NCBI chr 2:13,721,752...13,764,558
Ensembl chr 2:13,721,360...13,766,626

G

muscleblind-like splicing regulator 1

decreases expression

EXP

Amphetamine results in decreased expression of MBNL1 mRNA

NCBI chr 2:146,789,570...146,964,136
Ensembl chr 2:146,789,596...146,964,134

G

membrane bound O-acyltransferase domain containing 1

increases expression

EXP

Amphetamine results in increased expression of MBOAT1 mRNA

NCBI chr17:34,540,032...34,653,705
Ensembl chr17:34,540,041...34,653,698

G

membrane bound O-acyltransferase domain containing 2

increases expression

EXP

Amphetamine results in increased expression of MBOAT2 mRNA

NCBI chr 6:47,199,751...47,326,215
Ensembl chr 6:47,199,774...47,326,208

G

membrane bound O-acyltransferase domain containing 4

increases expression

EXP

Amphetamine results in increased expression of MBOAT4 mRNA

NCBI chr16:64,765,151...64,780,545
Ensembl chr16:64,767,350...64,776,370

G

membrane bound O-acyltransferase domain containing 7

increases expression

EXP

Amphetamine results in increased expression of MBOAT7 mRNA

NCBI chr 1:74,440,618...74,454,896
Ensembl chr 1:74,439,660...74,454,894

G

myelin basic protein

increases expression

EXP

Amphetamine results in increased expression of MBP mRNA

NCBI chr18:78,130,652...78,241,174
Ensembl chr18:78,130,325...78,241,174

G

malonyl-CoA-acyl carrier protein transacylase

increases expression

EXP

Amphetamine results in increased expression of MCAT mRNA

NCBI chr 7:116,573,632...116,585,767
Ensembl chr 7:116,573,368...116,584,562

G

MCC regulator of WNT signaling pathway

decreases expression

EXP

Amphetamine results in decreased expression of MCC mRNA

NCBI chr18:37,042,350...37,517,114
Ensembl chr18:37,049,253...37,517,076

G

minichromosome maintenance complex component 2

decreases expression

EXP

Amphetamine results in decreased expression of MCM2 mRNA

NCBI chr 4:122,903,679...122,918,205
Ensembl chr 4:122,903,682...122,918,094

G

minichromosome maintenance complex component 3

decreases expression

EXP

Amphetamine results in decreased expression of MCM3 mRNA

NCBI chr 9:30,715,602...30,733,746
Ensembl chr 9:30,715,602...30,733,746

G

minichromosome maintenance complex component 5

decreases expression

EXP

Amphetamine results in decreased expression of MCM5 mRNA

NCBI chr19:13,488,813...13,510,131
Ensembl chr19:13,488,813...13,517,758

G

minichromosome maintenance complex component 6

decreases expression

EXP

Amphetamine results in decreased expression of MCM6 mRNA

NCBI chr13:42,379,161...42,404,352
Ensembl chr13:42,379,162...42,465,467

G

minichromosome maintenance domain containing 2

decreases expression

EXP

Amphetamine results in decreased expression of MCMDC2 mRNA

NCBI chr 5:14,071,609...14,120,435
Ensembl chr 5:14,080,968...14,120,351

G

microcephalin 1

decreases expression

EXP

Amphetamine results in decreased expression of MCPH1 mRNA

NCBI chr16:77,724,251...77,926,773
Ensembl chr16:77,724,251...77,926,462

G

MAPK regulated co-repressor interacting protein 2

increases expression

EXP

Amphetamine results in increased expression of MCRIP2 mRNA

NCBI chr10:15,388,325...15,393,302
Ensembl chr10:15,388,325...15,398,730

G

multiple C2 and transmembrane domain containing 2

increases expression

EXP

Amphetamine results in increased expression of MCTP2 mRNA

NCBI chr 1:135,179,845...135,412,798
Ensembl chr 1:135,179,845...135,412,694

G

mitochondrial calcium uniporter dominant negative subunit beta

increases expression

EXP

Amphetamine results in increased expression of MCUB mRNA

NCBI chr 2:221,153,525...221,223,814
Ensembl chr 2:221,153,525...221,223,814

G

mediator of DNA damage checkpoint 1

decreases expression

EXP

Amphetamine results in decreased expression of MDC1 mRNA

NCBI chr20:2,898,496...2,914,960
Ensembl chr20:2,900,308...2,914,960

G

midkine

decreases response to substance
multiple interactions

ISO

MDK gene mutant form results in decreased susceptibility to Amphetamine
[MDK gene mutant form results in decreased susceptibility to Amphetamine] which results in increased expression of and results in increased phosphorylation of ERP29 protein; [MDK gene mutant form results in decreased susceptibility to Amphetamine] which results in increased expression of CCT2 protein; Amphetamine inhibits the reaction [MDK gene mutant form results in decreased expression of ATP5F1D protein]; Amphetamine inhibits the reaction [MDK gene mutant form results in decreased expression of ENO2 protein]; Amphetamine inhibits the reaction [MDK gene mutant form results in decreased expression of FAH protein]; Amphetamine promotes the reaction [MDK gene mutant form results in decreased expression of ATP5F1A protein]; Amphetamine promotes the reaction [MDK gene mutant form results in increased expression of ALAD protein]; MDK gene mutant form inhibits the reaction [Amphetamine results in increased expression of RAN protein]; MDK gene mutant form promotes the reaction [Amphetamine results in decreased expression of ALDH1A1 protein]

NCBI chr 3:98,356,789...98,358,960
Ensembl chr 3:98,356,789...98,358,743

G

Mdm1 nuclear protein

increases expression

EXP

Amphetamine results in increased expression of MDM1 mRNA

NCBI chr 7:55,615,459...55,651,889
Ensembl chr 7:55,615,608...55,651,888

G

MDM2 proto-oncogene

increases expression

EXP

Amphetamine results in increased expression of MDM2 mRNA

NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:55,176,560...55,200,791

G

midasin AAA ATPase 1

decreases expression

EXP

Amphetamine results in decreased expression of MDN1 mRNA

NCBI chr 5:51,851,785...51,982,688
Ensembl chr 5:51,851,809...51,982,688

G

mediator complex subunit 1

decreases expression

EXP

Amphetamine results in decreased expression of MED1 mRNA

NCBI chr10:83,641,851...83,685,560
Ensembl chr10:83,641,862...83,685,545

G

mediator complex subunit 12

decreases expression

EXP

Amphetamine results in decreased expression of MED12 mRNA

NCBI chr X:70,444,615...70,467,780
Ensembl chr X:70,444,705...70,467,708

G

mediator complex subunit 31

increases expression

EXP

Amphetamine results in increased expression of MED31 mRNA

NCBI chr10:57,335,507...57,338,889
Ensembl chr10:57,335,507...57,338,889

G

myocyte enhancer factor 2B

decreases expression

EXP

Amphetamine results in decreased expression of MEF2B mRNA

NCBI chr16:19,286,951...19,305,547
Ensembl chr16:19,286,953...19,302,910

G

myocyte enhancer factor 2C

decreases expression

EXP

Amphetamine results in decreased expression of MEF2C mRNA

NCBI chr 2:15,708,732...15,871,639
Ensembl chr 2:15,708,924...15,871,640

G

MEFV innate immunity regulator, pyrin

increases expression

EXP

Amphetamine results in increased expression of MEFV mRNA

NCBI chr10:12,288,514...12,303,337
Ensembl chr10:12,293,782...12,303,333

G

Meis homeobox 3

decreases expression

EXP

Amphetamine results in decreased expression of MEIS3 mRNA

NCBI chr 1:85,986,602...86,000,873
Ensembl chr 1:85,990,050...86,000,873

G

methionyl aminopeptidase type 1D (mitochondrial)

decreases expression

EXP

Amphetamine results in decreased expression of METAP1D mRNA

NCBI chr 3:76,687,149...76,759,681
Ensembl chr 3:76,687,171...76,759,655

G

methyltransferase 13, eEF1A N-terminus and K55

decreases expression

EXP

Amphetamine results in decreased expression of METTL13 mRNA

NCBI chr13:77,419,393...77,433,228
Ensembl chr13:77,419,397...77,433,104

G

methyltransferase like 17

decreases expression

EXP

Amphetamine results in decreased expression of METTL17 mRNA

NCBI chr15:27,055,851...27,062,530
Ensembl chr15:27,055,897...27,062,522

G

methyltransferase like 2

decreases expression

EXP

Amphetamine results in decreased expression of METTL2 mRNA

NCBI chr10:90,595,411...90,609,234
Ensembl chr10:90,595,411...90,610,228

G

methyltransferase 4, N6-adenosine

decreases expression

EXP

Amphetamine results in decreased expression of METTL4 mRNA

NCBI chr 9:118,887,740...118,967,433
Ensembl chr 9:118,887,528...118,911,364

G

mex-3 RNA binding family member B

decreases expression

EXP

Amphetamine results in decreased expression of MEX3B mRNA

NCBI chr 1:146,264,319...146,268,554
Ensembl chr 1:146,264,318...146,268,543

G

mex-3 RNA binding family member D

decreases expression

EXP

Amphetamine results in decreased expression of MEX3D mRNA

NCBI chr 7:9,976,253...9,983,383
Ensembl chr 7:9,976,253...9,983,383

G

milk fat globule EGF and factor V/VIII domain containing

decreases expression

EXP

Amphetamine results in decreased expression of MFGE8 mRNA

NCBI chr 1:142,474,027...142,489,431
Ensembl chr 1:142,474,028...142,489,431

G

multifunctional ROCO family signaling regulator 1

decreases expression

EXP

Amphetamine results in decreased expression of MFHAS1 mRNA

NCBI chr16:63,248,833...63,336,441
Ensembl chr16:63,250,455...63,336,602

G

mitofusin 2

decreases expression

EXP

Amphetamine results in decreased expression of MFN2 mRNA

NCBI chr 5:163,587,463...163,617,363
Ensembl chr 5:163,587,463...163,618,495

G

major facilitator superfamily domain containing 4A

decreases expression

EXP

Amphetamine results in decreased expression of MFSD4A mRNA

NCBI chr13:46,015,321...46,062,633
Ensembl chr13:46,021,659...46,062,633

G

MAX dimerization protein MGA

decreases expression

EXP

Amphetamine results in decreased expression of MGA mRNA

NCBI chr 3:127,300,558...127,396,694
Ensembl chr 3:127,328,264...127,394,826

G

alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A

decreases expression

EXP

Amphetamine results in decreased expression of MGAT4A mRNA

NCBI chr 9:47,169,229...47,282,577
Ensembl chr 9:47,169,232...47,282,574

G

alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase

decreases expression

EXP

Amphetamine results in decreased expression of MGAT5 mRNA

NCBI chr13:41,228,327...41,516,462
Ensembl chr13:41,228,360...41,516,461

G

matrix Gla protein

increases expression

EXP

Amphetamine results in increased expression of MGP mRNA

NCBI chr 4:171,497,472...171,500,888
Ensembl chr 4:171,497,471...171,500,859

G

microsomal glutathione S-transferase 2

increases expression

EXP

Amphetamine results in increased expression of MGST2 mRNA

NCBI chr 2:137,821,787...137,866,664
Ensembl chr 2:137,836,140...137,866,661

G

MICAL-like 1

decreases expression

EXP

Amphetamine results in decreased expression of MICALL1 mRNA

NCBI chr 7:112,557,192...112,587,618
Ensembl chr 7:112,557,192...112,587,618

G

midline 2

decreases expression

EXP

Amphetamine results in decreased expression of MID2 mRNA

NCBI chr X:109,143,057...109,245,257
Ensembl chr X:109,143,253...109,245,255

G

MIER family member 2

decreases expression

EXP

Amphetamine results in decreased expression of MIER2 mRNA

NCBI chr 7:10,804,238...10,819,979
Ensembl chr 7:10,804,268...10,819,979

G

mitoguardin 1

decreases expression

EXP

Amphetamine results in decreased expression of MIGA1 mRNA

NCBI chr 2:243,884,071...243,939,059
Ensembl chr 2:243,886,617...243,937,086

G

mitoguardin 2

decreases expression

EXP

Amphetamine results in decreased expression of MIGA2 mRNA

NCBI chr 3:34,034,018...34,056,703
Ensembl chr 3:34,034,044...34,056,703

G

MINDY lysine 48 deubiquitinase 1

increases expression

EXP

Amphetamine results in increased expression of MINDY1 mRNA

NCBI chr 2:185,550,026...185,561,987
Ensembl chr 2:185,548,993...185,561,986

G

microRNA 1

increases expression

EXP

Amphetamine results in increased expression of MIR1 mRNA

NCBI chr18:2,160,327...2,160,413

G

microRNA 125a

increases expression

EXP

Amphetamine results in increased expression of MIR125A mRNA

NCBI chr 1:67,350,675...67,350,759
Ensembl chr 1:67,350,675...67,350,759

G

microRNA 126a

increases expression

EXP

Amphetamine results in increased expression of MIR126A mRNA

NCBI chr 3:29,813,150...29,813,267

G

microRNA 133b

increases expression

EXP

Amphetamine results in increased expression of MIR133B mRNA

NCBI chr 9:30,594,582...30,594,665
Ensembl chr 9:30,594,582...30,594,665

G

microRNA 146b

increases expression

EXP

Amphetamine results in increased expression of MIR146B mRNA

NCBI chr 1:255,144,860...255,144,947
Ensembl chr 1:255,144,860...255,144,947

G

microRNA 152

increases expression

EXP

Amphetamine results in increased expression of MIR152 mRNA

NCBI chr10:82,329,383...82,329,467
Ensembl chr10:82,329,383...82,329,467

G

microRNA 191

increases expression

EXP

Amphetamine results in increased expression of MIR191 mRNA

NCBI chr 8:118,142,627...118,142,717

G

microRNA 192

increases expression

EXP

Amphetamine results in increased expression of MIR192 mRNA

NCBI chr 1:212,994,209...212,994,318
Ensembl chr 1:212,994,209...212,994,318

G

microRNA 203

increases expression

EXP

Amphetamine results in increased expression of MIR203 mRNA

NCBI chr 6:137,020,691...137,020,805

G

microRNA 204

increases expression

EXP

Amphetamine results in increased expression of MIR204 mRNA

NCBI chr 1:229,743,461...229,743,570
Ensembl chr 1:229,743,461...229,743,570

G

microRNA 205

increases expression

EXP

Amphetamine results in increased expression of MIR205 mRNA

NCBI chr13:107,564,535...107,564,642

G

microRNA 214

increases expression

EXP

Amphetamine results in increased expression of MIR214 mRNA

NCBI chr13:77,121,645...77,121,752
Ensembl chr13:77,121,643...77,121,752

G

microRNA 223

increases expression

EXP

Amphetamine results in increased expression of MIR223 mRNA

NCBI chr X:65,151,383...65,151,492
Ensembl chr X:65,151,383...65,151,492

G

microRNA 375

increases expression

EXP

Amphetamine results in increased expression of MIR375 mRNA

NCBI chr 9:83,906,582...83,906,656

G

microRNA 429

increases expression

EXP

Amphetamine results in increased expression of MIR429 mRNA

NCBI chr 5:171,929,682...171,929,766

G

MKS transition zone complex subunit 1

decreases expression

EXP

Amphetamine results in decreased expression of MKS1 mRNA

NCBI chr10:73,152,599...73,167,451
Ensembl chr10:73,153,186...73,163,886

G

malectin

decreases expression

EXP

Amphetamine results in decreased expression of MLEC mRNA

NCBI chr12:47,118,918...47,133,598
Ensembl chr12:47,118,855...47,130,064

G

MLLT6, PHD finger containing

decreases expression

EXP

Amphetamine results in decreased expression of MLLT6 mRNA

NCBI chr10:83,152,317...83,175,264
Ensembl chr10:83,153,698...83,175,250

G

metabolism of cobalamin associated B

decreases expression

EXP

Amphetamine results in decreased expression of MMAB mRNA

NCBI chr12:47,819,757...47,833,127
Ensembl chr12:47,819,724...47,833,118

G

metabolism of cobalamin associated C

decreases expression

EXP

Amphetamine results in decreased expression of MMACHC mRNA

NCBI chr 5:135,403,094...135,409,285
Ensembl chr 5:135,402,404...135,409,235

G

matrix metallopeptidase 19

increases expression

EXP

Amphetamine results in increased expression of MMP19 mRNA

NCBI chr 7:1,805,732...1,814,054
Ensembl chr 7:1,805,860...1,814,863

G

matrix metallopeptidase 24

increases expression

EXP

Amphetamine results in increased expression of MMP24 mRNA

NCBI chr 3:164,739,226...164,783,696
Ensembl chr 3:164,739,226...164,783,696

G

matrix metallopeptidase 25

increases expression

EXP

Amphetamine results in increased expression of MMP25 mRNA

NCBI chr10:13,164,974...13,180,503
Ensembl chr10:13,164,977...13,180,503

G

MN1 proto-oncogene, transcriptional regulator

decreases expression

EXP

Amphetamine results in decreased expression of MN1 mRNA

NCBI chr12:50,841,632...50,880,795
Ensembl chr12:50,841,632...50,880,795

G

myeloid cell nuclear differentiation antigen

increases expression

EXP

Amphetamine results in increased expression of IFI204 mRNA

NCBI chr13:88,550,224...88,567,892
Ensembl chr13:88,550,228...88,566,537

G

MOB kinase activator 3B

decreases expression

EXP

Amphetamine results in decreased expression of MOB3B mRNA

NCBI chr 5:54,342,509...54,534,164
Ensembl chr 5:54,338,056...54,454,678

G

molybdenum cofactor sulfurase

increases expression

EXP

Amphetamine results in increased expression of MOCOS mRNA

NCBI chr18:16,206,402...16,251,928
Ensembl chr18:16,206,402...16,251,928

G

MOK protein kinase

increases expression

EXP

Amphetamine results in increased expression of MOK mRNA

NCBI chr 6:135,645,018...135,675,894
Ensembl chr 6:135,645,018...135,676,174

G

mortality factor 4 like 2

increases expression

EXP

Amphetamine results in increased expression of MORF4L2 mRNA

NCBI chr X:104,874,850...104,885,946
Ensembl chr X:104,852,693...104,892,855

G

MORN repeat containing 3

increases expression

EXP

Amphetamine results in increased expression of MORN3 mRNA

NCBI chr12:39,166,463...39,190,737
Ensembl chr12:39,168,112...39,189,367

G

Mov10 RNA helicase

increases expression

EXP

Amphetamine results in increased expression of MOV10 mRNA

NCBI chr 2:194,982,014...195,003,513
Ensembl chr 2:194,982,014...195,003,442

G

myeloperoxidase

increases expression

EXP

Amphetamine results in increased expression of MPO mRNA

NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056

G

MAGUK p55 scaffold protein 3

increases expression

EXP

Amphetamine results in increased expression of MPP3 mRNA

NCBI chr10:87,445,905...87,475,461
Ensembl chr10:87,445,905...87,474,811

G

metallophosphoesterase 1

decreases expression

EXP

Amphetamine results in decreased expression of MPPE1 mRNA

NCBI chr18:63,033,329...63,051,461
Ensembl chr18:63,027,281...63,051,461

G

myelin protein zero-like 2

increases expression

EXP

Amphetamine results in increased expression of MPZL2 mRNA

NCBI chr 8:54,244,920...54,256,064
Ensembl chr 8:54,243,556...54,256,074

G

muscle RAS oncogene homolog

decreases expression

EXP

Amphetamine results in decreased expression of MRAS mRNA

NCBI chr 8:108,823,374...108,886,104
Ensembl chr 8:108,823,374...108,875,911

G

mannose receptor, C type 1

increases expression

EXP

Amphetamine results in increased expression of MRC1 mRNA

NCBI chr17:82,157,725...82,239,411
Ensembl chr17:82,157,705...82,239,410

G

mannose receptor, C type 2

decreases expression

EXP

Amphetamine results in decreased expression of MRC2 mRNA

NCBI chr10:90,761,751...90,823,055
Ensembl chr10:90,761,878...90,823,055

G

MRE11 homolog, double strand break repair nuclease

decreases expression

EXP

Amphetamine results in decreased expression of MRE11A mRNA

NCBI chr 8:19,900,211...19,961,906
Ensembl chr 8:19,913,772...19,961,904

G

MAS related GPR family member X3

increases expression

EXP

Amphetamine results in increased expression of MRGPRX3 mRNA

NCBI chr 1:106,857,685...106,883,199
Ensembl chr 1:106,857,687...106,883,145

G

mitochondrial rRNA methyltransferase 1

decreases expression

EXP

Amphetamine results in decreased expression of MRM1 mRNA

NCBI chr10:70,187,842...70,194,785
Ensembl chr10:70,188,748...70,194,131

G

mitochondrial ribosomal protein L33

increases expression

EXP

Amphetamine results in increased expression of MRPL33 mRNA

NCBI chr 6:30,545,794...30,553,987
Ensembl chr 6:30,545,794...30,553,987

G

mitochondrial ribosomal protein S6

increases expression

EXP

Amphetamine results in increased expression of MRPS6 mRNA

NCBI chr11:44,778,667...44,834,420
Ensembl chr11:44,781,554...44,834,962

G

myocardin related transcription factor A

decreases expression

EXP

Amphetamine results in decreased expression of MKL1 mRNA

NCBI chr 7:114,424,481...114,594,594
Ensembl chr 7:114,424,481...114,594,594

G

membrane spanning 4-domains A4C

decreases expression

EXP

Amphetamine results in decreased expression of MS4A4C mRNA

NCBI chr 1:217,549,861...217,571,106
Ensembl chr 1:217,558,979...217,572,308

G

membrane spanning 4-domains A6A

decreases expression

EXP

Amphetamine results in decreased expression of MS4A6C mRNA

NCBI chr 1:217,826,261...217,839,606
Ensembl chr 1:217,826,261...217,850,013

G

membrane-spanning 4-domains, subfamily A, member 6B

decreases expression

EXP

Amphetamine results in decreased expression of MS4A6B mRNA

NCBI chr 1:217,705,785...217,727,719
Ensembl chr 1:217,705,961...217,727,450

G

mutS homolog 2

decreases expression

EXP

Amphetamine results in decreased expression of MSH2 mRNA

NCBI chr 6:12,567,368...12,626,534
Ensembl chr 6:12,567,368...12,626,503

G

mutS homolog 5

increases expression

EXP

Amphetamine results in increased expression of MSH5 mRNA

NCBI chr20:3,779,180...3,797,996
Ensembl chr20:3,781,578...3,797,994

G

mutS homolog 6

decreases expression

EXP

Amphetamine results in decreased expression of MSH6 mRNA

NCBI chr 6:12,316,190...12,333,505
Ensembl chr 6:12,316,198...12,333,844

G

MSL complex subunit 1

increases expression

EXP

Amphetamine results in increased expression of MSL1 mRNA

NCBI chr10:84,251,362...84,263,384
Ensembl chr10:84,251,642...84,261,971

G

mesothelin-like

decreases expression

EXP

Amphetamine results in decreased expression of MSLNL mRNA

NCBI chr10:15,260,084...15,276,190
Ensembl chr10:15,263,955...15,276,490

G

macrophage stimulating 1 receptor

decreases expression

EXP

Amphetamine results in decreased expression of MST1R mRNA

NCBI chr 8:117,471,928...117,491,059
Ensembl chr 8:117,475,968...117,490,515

G

metallothionein 1A

increases expression

EXP

Amphetamine results in increased expression of MT1A mRNA

NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200
Ensembl chr X:79,695,809...79,696,200
Ensembl chr19:79,695,809...79,696,200

G

metallothionein 2

increases expression

EXP

Amphetamine results in increased expression of MT2A mRNA

NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709

G

metastasis associated 1

decreases expression

EXP

Amphetamine results in decreased expression of MTA1 mRNA

NCBI chr 6:137,999,845...138,038,696
Ensembl chr 6:137,999,915...138,038,696

G

metastasis associated 1 family, member 3

decreases expression

EXP

Amphetamine results in decreased expression of MTA3 mRNA

NCBI chr 6:16,619,575...16,739,732
Ensembl chr 6:16,621,998...16,739,485

G

methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1

decreases expression

EXP

Amphetamine results in decreased expression of MTHFD1 mRNA

NCBI chr 6:100,713,510...100,781,013
Ensembl chr 6:100,713,681...100,781,957

G

methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like

decreases expression

EXP

Amphetamine results in decreased expression of MTHFD1L mRNA

NCBI chr 1:42,849,424...43,038,313
Ensembl chr 1:42,849,374...43,038,309

G

methenyltetrahydrofolate synthetase domain containing

decreases expression

EXP

Amphetamine results in decreased expression of MTHFSD mRNA

NCBI chr19:66,072,952...66,086,917
Ensembl chr19:66,056,560...66,086,925

G

myotubularin related protein 10

increases expression

EXP

Amphetamine results in increased expression of MTMR10 mRNA

NCBI chr 1:127,271,139...127,322,621
Ensembl chr 1:127,270,870...127,322,621

G

myotubularin related protein 9

decreases expression

EXP

Amphetamine results in decreased expression of MTMR9 mRNA

NCBI chr15:41,945,102...41,967,136
Ensembl chr15:41,945,105...41,967,136

G

5-methyltetrahydrofolate-homocysteine methyltransferase

decreases expression

EXP

Amphetamine results in decreased expression of MTR mRNA

NCBI chr17:62,911,705...62,996,544
Ensembl chr17:62,911,771...62,996,541

G

metaxin 3

decreases expression

EXP

Amphetamine results in decreased expression of MTX3 mRNA

NCBI chr 2:25,800,530...25,814,755
Ensembl chr 2:25,801,411...25,814,754

G

mucin 20, cell surface associated

increases expression

EXP

Amphetamine results in increased expression of MUC20 mRNA

NCBI chr11:81,492,844...81,506,571
Ensembl chr11:81,492,891...81,506,571

G

mutY DNA glycosylase

decreases expression

EXP

Amphetamine results in decreased expression of MUTYH mRNA

NCBI chr 5:135,510,666...135,522,777
Ensembl chr 5:135,517,695...135,522,776

G

MX dynamin like GTPase 1

decreases expression

EXP

Amphetamine results in decreased expression of MX1 mRNA

NCBI chr11:50,269,056...50,294,699
Ensembl chr11:50,269,057...50,292,904

G

MX dynamin like GTPase 2

decreases expression

EXP

Amphetamine results in decreased expression of MX2 mRNA

NCBI chr11:50,375,101...50,399,373
Ensembl chr11:50,375,191...50,402,478

G

max dimerization protein 1

increases expression

EXP

Amphetamine results in increased expression of MXD1 mRNA

NCBI chr 4:120,654,731...120,678,972
Ensembl chr 4:120,654,731...120,675,129

G

myeloid-associated differentiation marker

increases expression

EXP

Amphetamine results in increased expression of MYADM mRNA

NCBI chr 1:74,779,616...74,796,752
Ensembl chr 1:74,775,698...74,789,710

G

MYB proto-oncogene, transcription factor

decreases expression

EXP

Amphetamine results in decreased expression of MYB mRNA

NCBI chr 1:17,759,309...17,793,306
Ensembl chr 1:17,759,309...17,792,547

G

MYB binding protein 1a

decreases expression

EXP

Amphetamine results in decreased expression of MYBBP1A mRNA

NCBI chr10:57,555,458...57,565,819
Ensembl chr10:57,555,452...57,566,041

G

MYB proto-oncogene like 1

decreases expression

EXP

Amphetamine results in decreased expression of MYBL1 mRNA

NCBI chr 5:14,365,768...14,401,012
Ensembl chr 5:14,365,768...14,399,588

G

myosin binding protein C3

increases expression

EXP

Amphetamine results in increased expression of MYBPC3 mRNA

NCBI chr 3:97,550,974...97,569,216
Ensembl chr 3:97,551,061...97,569,216

G

myc target 1

increases expression

EXP

Amphetamine results in increased expression of MYCT1 mRNA

NCBI chr 1:44,423,478...44,434,751
Ensembl chr 1:44,423,544...44,436,992

G

myosin heavy chain 11

decreases expression

EXP

Amphetamine results in decreased expression of MYH11 mRNA

NCBI chr10:1,250,554...1,345,681
Ensembl chr10:1,263,194...1,345,678

G

myosin heavy chain 3

decreases expression

EXP

Amphetamine results in decreased expression of MYH3 mRNA

NCBI chr10:52,269,185...52,293,000
Ensembl chr10:52,269,185...52,293,000

G

myosin heavy chain 6

increases expression

EXP

Amphetamine results in increased expression of MYH6 mRNA

NCBI chr15:32,388,102...32,413,663
Ensembl chr15:32,387,487...32,411,333

G

myosin light chain 2

increases expression

EXP

Amphetamine results in increased expression of MYL2 mRNA

NCBI chr12:40,114,964...40,126,236
Ensembl chr12:40,114,958...40,129,149

G

myosin light chain 3

increases expression

EXP

Amphetamine results in increased expression of MYL3 mRNA

NCBI chr 8:119,617,077...119,623,215
Ensembl chr 8:119,616,868...119,623,216

G

myosin light chain 6

increases expression

EXP

Amphetamine results in increased expression of MYL6 mRNA

NCBI chr 7:1,495,301...1,498,512
Ensembl chr 7:1,495,747...1,498,344

G

myosin light chain 6B

increases expression

EXP

Amphetamine results in increased expression of MYL6B mRNA

NCBI chr X:44,450,733...44,451,711

G

myosin light chain 7

increases expression

EXP

Amphetamine results in increased expression of MYL7 mRNA

NCBI chr14:84,994,644...84,997,173
Ensembl chr14:84,993,736...84,997,372

G

myosin X

decreases expression

EXP

Amphetamine results in decreased expression of MYO10 mRNA

NCBI chr 2:77,831,532...78,036,137
Ensembl chr 2:77,831,532...78,036,137

G

myosin XVIIIa

decreases expression

EXP

Amphetamine results in decreased expression of MYO18A mRNA

NCBI chr10:63,152,303...63,253,543
Ensembl chr10:63,152,103...63,253,543

G

myosin XIX

decreases expression

EXP

Amphetamine results in decreased expression of MYO19 mRNA

NCBI chr10:70,250,500...70,279,867
Ensembl chr10:70,250,022...70,279,858

G

myosin IE

decreases expression

EXP

Amphetamine results in decreased expression of MYO1E mRNA

NCBI chr 8:79,768,828...79,961,048
Ensembl chr 8:79,753,596...79,961,045

G

myosin IG

decreases expression

EXP

Amphetamine results in decreased expression of MYO1G mRNA

NCBI chr14:85,600,619...85,615,760
Ensembl chr14:85,600,619...85,615,760

G

myozenin 2

increases expression

EXP

Amphetamine results in increased expression of MYOZ2 mRNA

NCBI chr 2:213,826,052...213,852,778
Ensembl chr 2:213,826,052...213,852,914

G

myelin regulatory factor

increases expression

EXP

Amphetamine results in increased expression of MRF mRNA

NCBI chr 1:216,279,057...216,311,155
Ensembl chr 1:216,279,057...216,311,178

G

Nedd4 binding protein 1

decreases expression

EXP

Amphetamine results in decreased expression of N4BP1 mRNA

NCBI chr19:36,396,082...36,446,835
Ensembl chr19:36,396,324...36,446,835

G

N(alpha)-acetyltransferase 25, NatB auxiliary subunit

decreases expression

EXP

Amphetamine results in decreased expression of NAA25 mRNA

NCBI chr12:40,758,909...40,811,192
Ensembl chr12:40,758,728...40,811,291

G

nucleus accumbens associated 1

affects response to substance
decreases expression

ISO
EXP

NACC1 protein affects the susceptibility to Amphetamine
Amphetamine results in decreased expression of NACC1 mRNA

PMID:17945361 PMID:30779732

NCBI chr19:40,373,436...40,391,351
Ensembl chr19:40,373,449...40,391,347

G

nuclear assembly factor 1 ribonucleoprotein

decreases expression

EXP

Amphetamine results in decreased expression of NAF1 mRNA

NCBI chr16:27,604,228...27,634,963
Ensembl chr16:27,603,918...27,634,963

G

NLR family, apoptosis inhibitory protein 5

decreases expression

EXP

Amphetamine results in decreased expression of NAIP5 mRNA

NCBI chr 2:33,289,785...33,342,807
Ensembl chr 2:33,282,466...33,323,401

G

nucleosome assembly protein 1-like 4

decreases expression

EXP

Amphetamine results in decreased expression of NAP1L4 mRNA

NCBI chr 1:208,139,105...208,175,597
Ensembl chr 1:208,139,113...208,174,569

G

nicotinate phosphoribosyltransferase

increases expression

EXP

Amphetamine results in increased expression of NAPRT mRNA

NCBI chr 7:109,457,328...109,460,817
Ensembl chr 7:109,457,378...109,460,817

G

napsin A aspartic peptidase

increases expression

EXP

Amphetamine results in increased expression of NAPSA mRNA

NCBI chr 1:104,200,967...104,213,603
Ensembl chr 1:104,200,960...104,213,608

G

N-acetyltransferase 10

decreases expression

EXP

Amphetamine results in decreased expression of NAT10 mRNA

NCBI chr 3:110,566,582...110,604,829
Ensembl chr 3:110,566,582...110,604,836

G

N-acetyltransferase 8-like

increases expression

EXP

Amphetamine results in increased expression of NAT8L mRNA

NCBI chr14:80,980,629...80,987,264
Ensembl chr14:80,980,629...80,987,463

G

neuron navigator 1

decreases expression

EXP

Amphetamine results in decreased expression of NAV1 mRNA

NCBI chr13:49,418,755...49,671,117
Ensembl chr13:49,418,755...49,671,004

G

neuron navigator 2

decreases expression

EXP

Amphetamine results in decreased expression of NAV2 mRNA

NCBI chr 1:107,799,968...108,458,546
Ensembl chr 1:107,805,096...108,458,546

G

NBAS subunit of NRZ tethering complex

decreases expression

EXP

Amphetamine results in decreased expression of NBAS mRNA

NCBI chr 6:41,777,253...42,081,895
Ensembl chr 6:41,755,851...42,081,895

G

NBL1, DAN family BMP antagonist

increases expression

EXP

Amphetamine results in increased expression of NBL1 mRNA

NCBI chr 5:156,601,986...156,613,182
Ensembl chr 5:156,601,986...156,613,186

G

neurochondrin

decreases expression

EXP

Amphetamine results in decreased expression of NCDN mRNA

NCBI chr 5:144,322,287...144,332,117
Ensembl chr 5:144,322,287...144,332,047

G

neutrophil cytosolic factor 4

increases expression

EXP

Amphetamine results in increased expression of NCF4 mRNA

NCBI chr 7:111,705,926...111,723,893
Ensembl chr 7:111,706,520...111,723,898

G

NCK-associated protein 1

increases expression

EXP

Amphetamine results in increased expression of NCKAP1 mRNA

NCBI chr 3:85,824,333...85,898,748
Ensembl chr 3:85,824,336...85,898,797

G

NCK-associated protein 5-like

decreases expression

EXP

Amphetamine results in decreased expression of NCKAP5L mRNA

NCBI chr 7:132,433,569...132,470,638
Ensembl chr 7:132,433,574...132,470,836

G

nuclear receptor coactivator 2

decreases expression

EXP

Amphetamine results in decreased expression of NCOA2 mRNA

NCBI chr 5:10,618,712...10,852,776
Ensembl chr 5:10,618,722...10,852,776

G

nuclear receptor coactivator 3

decreases expression

EXP

Amphetamine results in decreased expression of NCOA3 mRNA

NCBI chr 3:175,157,824...175,237,831
Ensembl chr 3:175,157,821...175,240,631

G

nuclear receptor co-repressor 2

decreases expression

EXP

Amphetamine results in decreased expression of NCOR2 mRNA

NCBI chr12:37,127,736...37,289,612
Ensembl chr12:37,127,686...37,289,612

G

nudE neurodevelopment protein 1-like 1

increases expression

EXP

Amphetamine results in increased expression of NDEL1 mRNA

NCBI chr10:54,001,435...54,080,909
Ensembl chr10:54,016,149...54,062,375

G

N-myc downstream regulated 1

increases expression

EXP

Amphetamine results in increased expression of NDRG1 mRNA

NCBI chr 7:100,573,526...100,614,902
Ensembl chr 7:100,573,523...100,614,913

G

NADH:ubiquinone oxidoreductase subunit B7

increases expression

EXP

Amphetamine results in increased expression of NDUFB7 mRNA

NCBI chr19:41,472,953...41,477,291
Ensembl chr19:41,472,953...41,477,291

G

NADH:ubiquinone oxidoreductase subunit S4

increases expression

EXP

Amphetamine results in increased expression of NDUFS4 mRNA

NCBI chr 2:47,684,420...47,794,914
Ensembl chr 2:47,684,406...47,794,931

G

nebulette

decreases expression

EXP

Amphetamine results in decreased expression of NEBL mRNA

NCBI chr17:85,022,953...85,374,848
Ensembl chr17:85,022,963...85,374,172

G

NEDD4 E3 ubiquitin protein ligase

decreases expression

EXP

Amphetamine results in decreased expression of NEDD4 mRNA

NCBI chr 8:82,264,751...82,349,642
Ensembl chr 8:82,264,649...82,349,633

G

nei-like DNA glycosylase 1

decreases expression

EXP

Amphetamine results in decreased expression of NEIL1 mRNA

NCBI chr 8:66,446,106...66,452,844
Ensembl chr 8:66,445,953...66,452,378

G

NIMA-related kinase 10

increases expression

EXP

Amphetamine results in increased expression of NEK10 mRNA

NCBI chr15:12,808,981...13,013,679
Ensembl chr15:12,813,606...13,013,567

G

nuclear envelope integral membrane protein 2

decreases expression

EXP

Amphetamine results in decreased expression of NEMP2 mRNA

NCBI chr 9:56,353,233...56,372,586
Ensembl chr 9:56,353,233...56,372,493

G

neuraminidase 3

decreases expression

EXP

Amphetamine results in decreased expression of NEU3 mRNA

NCBI chr 1:163,549,834...163,560,997
Ensembl chr 1:163,549,738...163,561,049

G

nuclear factor of activated T-cells 2

decreases expression

EXP

Amphetamine results in decreased expression of NFATC2 mRNA

NCBI chr 3:177,615,189...177,747,493
Ensembl chr 3:177,618,314...177,747,380

G

nuclear factor of activated T-cells 3

decreases expression

EXP

Amphetamine results in decreased expression of NFATC3 mRNA

NCBI chr19:50,870,464...50,944,992
Ensembl chr19:50,870,489...50,944,992

G

NFE2 like bZIP transcription factor 2

increases expression

EXP

Amphetamine results in increased expression of NFE2L2 mRNA

NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090

G

nuclear factor I/C

decreases expression

EXP

Amphetamine results in decreased expression of NFIC mRNA

NCBI chr 7:8,928,423...8,963,455
Ensembl chr 7:8,904,117...8,963,409

G

nuclear factor, interleukin 3 regulated

increases expression

EXP

Amphetamine results in increased expression of NFIL3 mRNA

NCBI chr17:12,432,376...12,447,605
Ensembl chr17:12,432,198...12,450,826

G

nuclear factor I X

increases expression

EXP

Amphetamine results in increased expression of NFIX mRNA

NCBI chr19:40,259,873...40,356,966
Ensembl chr19:40,260,084...40,353,092

G

nuclear factor kappa B subunit 2

decreases expression

EXP

Amphetamine results in decreased expression of NFKB2 mRNA

NCBI chr 1:255,106,010...255,114,649
Ensembl chr 1:255,107,374...255,114,637

G

NFKB inhibitor alpha

increases expression

EXP

Amphetamine results in increased expression of NFKBIA mRNA

NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072

G

nerve growth factor receptor

decreases expression

EXP

Amphetamine results in decreased expression of NGFR mRNA

NCBI chr10:81,012,077...81,030,305
Ensembl chr10:81,012,089...81,030,305

G

niban apoptosis regulator 2

increases expression

EXP

Amphetamine results in increased expression of NIBAN2 mRNA

NCBI chr 3:36,572,356...36,621,968
Ensembl chr 3:36,572,377...36,621,967

G

ninjurin 2

increases expression

EXP

Amphetamine results in increased expression of NINJ2 mRNA

NCBI chr 4:154,978,660...155,080,860
Ensembl chr 4:155,073,295...155,080,860

G

NIPA magnesium transporter 2

increases expression

EXP

Amphetamine results in increased expression of NIPA2 mRNA

NCBI chr 1:115,935,759...115,960,034
Ensembl chr 1:115,936,063...115,959,913

G

NIPA-like domain containing 1

decreases expression

EXP

Amphetamine results in decreased expression of NIPAL1 mRNA

NCBI chr14:35,891,645...35,915,658
Ensembl chr14:35,891,647...35,915,658

G

NIPA-like domain containing 2

decreases expression

EXP

Amphetamine results in decreased expression of NIPAL2 mRNA

NCBI chr 7:67,659,628...67,771,105
Ensembl chr 7:67,659,628...67,769,959

G

nipsnap homolog 3B

increases expression

EXP

Amphetamine results in increased expression of NIPSNAP3B mRNA

NCBI chr 5:72,446,945...72,465,090
Ensembl chr 5:72,432,957...72,465,544

G

Sodium/potassium transporting ATPase interacting 1

decreases expression

EXP

Amphetamine results in decreased expression of NKAIN1 mRNA

NCBI chr 5:148,031,685...148,076,834
Ensembl chr 5:148,031,338...148,076,834

G

NFKB repressing factor

decreases expression

EXP

Amphetamine results in decreased expression of NKRF mRNA

NCBI chr X:120,992,038...121,010,251
Ensembl chr X:120,992,038...121,010,251

G

notchless homolog 1

decreases expression

EXP

Amphetamine results in decreased expression of NLE1 mRNA

NCBI chr10:68,331,609...68,342,562
Ensembl chr10:68,331,609...68,340,386

G

neuroligin 3

decreases expression

EXP

Amphetamine results in decreased expression of NLGN3 mRNA

NCBI chr X:70,469,251...70,497,380
Ensembl chr X:70,469,457...70,497,379

G

NLR family, CARD domain containing 3

decreases expression

EXP

Amphetamine results in decreased expression of NLRC3 mRNA

NCBI chr10:12,055,809...12,093,449
Ensembl chr10:12,057,738...12,091,393

G

NLR family, pyrin domain containing 10

decreases expression

EXP

Amphetamine results in decreased expression of NLRP10 mRNA

NCBI chr 1:172,357,648...172,365,205
Ensembl chr 1:172,357,648...172,365,205

G

NLR family, pyrin domain containing 12

increases expression

EXP

Amphetamine results in increased expression of NLRP12 mRNA

NCBI chr 1:74,848,020...74,885,945
Ensembl chr 1:74,848,063...74,876,341

G

NLR family, pyrin domain containing 3

increases expression

EXP

Amphetamine results in increased expression of NLRP3 mRNA

NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,828,014...44,853,394

G

nicotinamide nucleotide adenylyltransferase 3

increases expression

EXP

Amphetamine results in increased expression of NMNAT3 mRNA

NCBI chr 8:107,771,124...107,888,528
Ensembl chr 8:107,771,509...107,900,016

G

nitric oxide associated 1

decreases expression

EXP

Amphetamine results in decreased expression of NOA1 mRNA

NCBI chr14:31,189,570...31,205,600
Ensembl chr14:31,188,978...31,205,599

G

NOC2-like nucleolar associated transcriptional repressor

decreases expression

EXP

Amphetamine results in decreased expression of NOC2L mRNA

NCBI chr 5:172,102,369...172,114,168
Ensembl chr 5:172,101,223...172,114,162

G

nocturnin

increases expression

EXP

Amphetamine results in increased expression of NOCT mRNA

NCBI chr 2:137,422,074...137,442,282
Ensembl chr 2:137,422,074...137,442,282

G

nucleolar protein 6

decreases expression

EXP

Amphetamine results in decreased expression of NOL6 mRNA

NCBI chr 5:61,055,863...61,083,249
Ensembl chr 5:61,055,863...61,083,264

G

nucleolar protein 9

decreases expression

EXP

Amphetamine results in decreased expression of NOL9 mRNA

NCBI chr 5:167,829,249...167,849,364
Ensembl chr 5:167,829,264...167,849,366

G

NOP2 nucleolar protein

decreases expression

EXP

Amphetamine results in decreased expression of NOP2 mRNA

NCBI chr 4:159,618,894...159,630,697
Ensembl chr 4:159,618,966...159,630,697

G

nitric oxide synthase 2

multiple interactions
increases expression

EXP

Melatonin inhibits the reaction [Amphetamine results in increased expression of NOS2 mRNA]; S-methylisothiopseudouronium inhibits the reaction [Amphetamine results in increased expression of NOS2 mRNA]

NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880

G

NADPH oxidase 1

decreases expression

EXP

Amphetamine results in decreased expression of NOX1 mRNA

NCBI chr X:101,572,338...101,625,571
Ensembl chr X:101,572,340...101,595,520

G

defensin NP-4 precursor

increases expression

EXP

Amphetamine results in increased expression of NP4 mRNA

NCBI chr16:77,197,061...77,199,713
Ensembl chr16:77,121,639...77,122,502
Ensembl chr16:77,121,639...77,122,502

G

NPC intracellular cholesterol transporter 2

increases expression

EXP

Amphetamine results in increased expression of NPC2 mRNA

NCBI chr 6:110,128,325...110,149,245
Ensembl chr 6:110,128,325...110,150,004

G

aminopeptidase-like 1

decreases expression

EXP

Amphetamine results in decreased expression of NPEPL1 mRNA

NCBI chr 3:183,312,185...183,324,744
Ensembl chr 3:183,312,185...183,324,744

G

N-acetylneuraminate pyruvate lyase

increases expression

EXP

Amphetamine results in increased expression of NPL mRNA

NCBI chr13:68,205,602...68,247,940
Ensembl chr13:68,205,603...68,247,999

G

natriuretic peptide A

increases expression

EXP

Amphetamine results in increased expression of NPPA mRNA

NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:163,712,184...163,713,493

G

natriuretic peptide receptor 1

increases expression

EXP

Amphetamine results in increased expression of NPR1 mRNA

NCBI chr 2:178,231,766...178,247,591
Ensembl chr 2:178,231,766...178,247,088

G

natriuretic peptide receptor 2

decreases expression

EXP

Amphetamine results in decreased expression of NPR2 mRNA

NCBI chr 5:62,678,197...62,697,360
Ensembl chr 5:62,678,367...62,697,343

G

neuropeptide Y

increases response to substance
decreases response to substance
affects expression
increases expression
multiple interactions
affects response to substance
decreases expression

EXP
ISO

NPY protein results in increased susceptibility to Amphetamine
NPY protein results in decreased susceptibility to Amphetamine
Amphetamine affects the expression of NPY protein
Amphetamine results in increased expression of NPY mRNA
FOS protein promotes the reaction [Amphetamine results in decreased expression of NPY mRNA]; Haloperidol promotes the reaction [Amphetamine results in decreased expression of NPY protein]; JUN protein promotes the reaction [Amphetamine results in decreased expression of NPY mRNA]; NPY mutant form promotes the reaction [Amphetamine results in increased expression of CARTPT mRNA]; PRKCA protein promotes the reaction [Amphetamine results in decreased expression of NPY mRNA]; S-ethyl glutathione inhibits the reaction [Amphetamine results in decreased expression of NPY mRNA]; S-ethyl glutathione inhibits the reaction [Amphetamine results in decreased expression of NPY protein]
NPY protein affects the susceptibility to Amphetamine
Amphetamine results in decreased expression of NPY mRNA; Amphetamine results in decreased expression of NPY protein

PMID:12005258 PMID:12183048 PMID:15183010 PMID:15680483 PMID:15985714 More...

NCBI chr 4:80,212,111...80,219,310
Ensembl chr 4:80,212,111...80,219,310

G

NAD(P)H quinone dehydrogenase 1

increases expression

EXP

Amphetamine results in increased expression of NQO1 mRNA

NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260

G

nuclear receptor subfamily 1, group D, member 1

decreases expression

EXP

Amphetamine results in decreased expression of NR1D1 mRNA

NCBI chr10:84,224,599...84,231,812
Ensembl chr10:84,224,540...84,231,812

G

nuclear receptor subfamily 1, group D, member 2

decreases expression

EXP

Amphetamine results in decreased expression of NR1D2 mRNA

NCBI chr15:9,955,034...9,981,329
Ensembl chr15:9,954,906...9,981,330

G

nuclear receptor subfamily 1, group I, member 2

multiple interactions

ISO

Amphetamine promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]; N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [Amphetamine promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]]

NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380

G

nuclear receptor subfamily 2, group C, member 2

decreases expression

EXP

Amphetamine results in decreased expression of NR2C2 mRNA

NCBI chr 4:126,167,350...126,223,942
Ensembl chr 4:126,168,085...126,223,942

G

nuclear receptor subfamily 3, group C, member 1

decreases expression

EXP

Amphetamine results in decreased expression of NR3C1 mRNA

NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843

G

nuclear receptor subfamily 4, group A, member 1

multiple interactions
decreases expression
increases expression

EXP

Amphetamine promotes the reaction [Ibotenic Acid results in decreased expression of NR4A1 mRNA]
Amphetamine results in decreased expression of NR4A1 mRNA
Amphetamine results in increased expression of NR4A1 mRNA

PMID:12638131 PMID:14622910 PMID:15183010 PMID:30779732

NCBI chr 7:134,247,153...134,268,044
Ensembl chr 7:134,247,192...134,268,041

G

Notch-regulated ankyrin repeat protein

increases expression

EXP

Amphetamine results in increased expression of NRARP mRNA

NCBI chr 3:28,390,745...28,393,299
Ensembl chr 3:28,390,733...28,393,453

G

neuregulin 1

increases expression

EXP

Amphetamine results in increased expression of NRG1 mRNA

NCBI chr16:65,954,084...67,007,484
Ensembl chr16:65,953,865...66,999,849

G

neuregulin 4

increases expression

EXP

Amphetamine results in increased expression of NRG4 mRNA

NCBI chr 8:64,483,559...64,555,671
Ensembl chr 8:64,488,722...64,573,439

G

neuropilin 1

decreases expression

EXP

Amphetamine results in decreased expression of NRP1 mRNA

NCBI chr19:73,256,557...73,411,705
Ensembl chr19:73,256,557...73,411,702

G

neurexin 2

decreases expression

EXP

Amphetamine results in decreased expression of NRXN2 mRNA

NCBI chr 1:213,155,673...213,271,526
Ensembl chr 1:213,155,673...213,271,526

G

nuclear receptor binding SET domain protein 1

decreases expression

EXP

Amphetamine results in decreased expression of NSD1 mRNA

NCBI chr17:9,317,085...9,431,528
Ensembl chr17:9,317,085...9,452,250

G

neuronal vesicle trafficking associated 1

decreases expression

EXP

Amphetamine results in decreased expression of NSG1 mRNA

NCBI chr14:76,861,079...76,882,822
Ensembl chr14:76,860,746...76,883,390

G

NSL1 component of MIS12 kinetochore complex

decreases expression

EXP

Amphetamine results in decreased expression of NSL1 mRNA

NCBI chr13:105,176,163...105,205,179
Ensembl chr13:105,180,183...105,196,117

G

neurotrophin 3

multiple interactions
affects expression

EXP

Lithium inhibits the reaction [Amphetamine affects the expression of NTF3 protein]; Valproic Acid inhibits the reaction [Amphetamine affects the expression of NTF3 protein]

NCBI chr 4:160,601,161...160,670,623
Ensembl chr 4:160,600,770...160,676,349

G

netrin G2

decreases expression

EXP

Amphetamine results in decreased expression of NTNG2 mRNA

NCBI chr 3:32,889,856...32,949,032
Ensembl chr 3:32,890,575...32,943,821

G

neurotrophic receptor tyrosine kinase 1

increases expression

EXP

Amphetamine results in increased expression of NTRK1 mRNA

NCBI chr 2:175,534,844...175,551,664
Ensembl chr 2:175,534,844...175,551,787

G

neurotensin

increases expression

ISO

Amphetamine results in increased expression of NTS mRNA

NCBI chr 7:39,451,484...39,460,888
Ensembl chr 7:39,451,073...39,460,961

G

nucleobindin 2

increases expression

EXP

Amphetamine results in increased expression of NUCB2 mRNA

NCBI chr 1:180,185,121...180,221,644
Ensembl chr 1:180,199,551...180,230,116

G

nudix hydrolase 16

increases expression

EXP

Amphetamine results in increased expression of NUDT16 mRNA

NCBI chr 8:114,618,706...114,620,761
Ensembl chr 8:114,618,725...114,620,951

G

nudix hydrolase 9

increases expression

EXP

Amphetamine results in increased expression of NUDT9 mRNA

NCBI chr14:5,980,042...5,997,998
Ensembl chr14:5,980,043...6,005,783

G

nuclear mitotic apparatus protein 1

decreases expression

EXP

Amphetamine results in decreased expression of NUMA1 mRNA

NCBI chr 1:165,709,893...165,784,848
Ensembl chr 1:165,709,905...165,784,848

G

nucleoporin 160

decreases expression

EXP

Amphetamine results in decreased expression of NUP160 mRNA

NCBI chr 3:97,120,723...97,183,227
Ensembl chr 3:97,121,628...97,180,720

G

nucleoporin 188

decreases expression

EXP

Amphetamine results in decreased expression of NUP188 mRNA

NCBI chr 3:33,957,778...34,014,122
Ensembl chr 3:33,957,791...34,014,122

G

nucleoporin 210

decreases expression

EXP

Amphetamine results in decreased expression of NUP210 mRNA

NCBI chr 4:125,068,736...125,167,238
Ensembl chr 4:125,068,736...125,167,047

G

nucleoporin 210-like

decreases expression

EXP

Amphetamine results in decreased expression of NUP210L mRNA

NCBI chr 2:177,843,647...177,962,975
Ensembl chr 2:177,845,633...177,962,969

G

nucleoporin 62 C-terminal like

increases expression

EXP

Amphetamine results in increased expression of NUP62CL mRNA

NCBI chr X:108,457,043...108,513,525
Ensembl chr X:108,457,043...108,512,664

G

NYN domain and retroviral integrase containing

decreases expression

EXP

Amphetamine results in decreased expression of NYNRIN mRNA

NCBI chr15:33,302,778...33,325,120
Ensembl chr15:33,295,954...33,324,383

G

2 ' -5 ' oligoadenylate synthetase 1K

increases expression

EXP

Amphetamine results in increased expression of OAS1K mRNA

NCBI chr12:41,423,100...41,432,330
Ensembl chr12:41,422,937...41,432,330

G

ornithine aminotransferase

increases expression

EXP

Amphetamine results in increased expression of OAT mRNA

NCBI chr 1:196,777,973...196,797,754
Ensembl chr 1:196,777,975...196,797,754

G

osteoclast stimulatory transmembrane protein

decreases expression

EXP

Amphetamine results in decreased expression of OCSTAMP mRNA

NCBI chr 3:174,550,420...174,560,907
Ensembl chr 3:174,550,935...174,556,289

G

ornithine decarboxylase 1

increases expression

EXP

Amphetamine results in increased expression of ODC1 mRNA

NCBI chr 6:46,058,439...46,065,148
Ensembl chr 6:46,058,463...46,065,146

G

2-oxoglutarate and iron-dependent oxygenase domain containing 1

decreases expression

EXP

Amphetamine results in decreased expression of OGFOD1 mRNA

NCBI chr19:10,950,950...10,980,519
Ensembl chr19:10,950,060...10,980,519

G

2-oxoglutarate and iron-dependent oxygenase domain containing 2

increases expression

EXP

Amphetamine results in increased expression of OGFOD2 mRNA

NCBI chr12:38,143,329...38,146,630
Ensembl chr12:38,142,900...38,146,630

G

opioid growth factor receptor-like 1

increases expression

EXP

Amphetamine results in increased expression of OGFRL1 mRNA

NCBI chr 9:33,320,501...33,338,742
Ensembl chr 9:33,324,392...33,339,237

G

olfactory receptor 1585

increases expression

EXP

Amphetamine results in increased expression of OLR1585 mRNA

NCBI chr13:88,579,747...88,595,231

G

olfactory receptor 59

increases expression

EXP

Amphetamine results in increased expression of OLR59 mRNA

NCBI chr 1:166,604,972...166,639,634
Ensembl chr 1:166,604,141...166,623,265

G

oligophrenin 1

increases expression

EXP

Amphetamine results in increased expression of OPHN1 mRNA

NCBI chr X:67,639,956...68,018,217
Ensembl chr X:67,643,252...68,016,831

G

opticin

decreases expression

EXP

Amphetamine results in decreased expression of OPTC mRNA

NCBI chr13:47,906,145...47,920,334
Ensembl chr13:47,906,197...47,917,416

G

olfactory receptor family 13 subfamily A member 27B

decreases expression

EXP

Amphetamine results in decreased expression of OR13A27B mRNA

NCBI chr 1:204,823,127...204,824,059
Ensembl chr 1:204,823,121...204,824,059

G

ORAI calcium release-activated calcium modulator 1

increases expression

EXP

Amphetamine results in increased expression of ORAI1 mRNA

NCBI chr12:39,195,139...39,209,030
Ensembl chr12:39,195,163...39,209,408

G

ORAI calcium release-activated calcium modulator 2

decreases expression

EXP

Amphetamine results in decreased expression of ORAI2 mRNA

NCBI chr12:26,136,922...26,157,041
Ensembl chr12:26,132,193...26,157,041

G

orosomucoid 1

increases expression

EXP

Amphetamine results in increased expression of ORM1 mRNA

NCBI chr 5:81,788,509...81,791,661
Ensembl chr 5:81,788,395...81,791,667

G

oxysterol binding protein-like 3

decreases expression

EXP

Amphetamine results in decreased expression of OSBPL3 mRNA

NCBI chr 4:80,677,383...80,854,169
Ensembl chr 4:80,677,390...80,854,169

G

oxysterol binding protein-like 5

decreases expression

EXP

Amphetamine results in decreased expression of OSBPL5 mRNA

NCBI chr 1:208,291,441...208,362,086
Ensembl chr 1:208,291,441...208,362,169

G

oxysterol binding protein-like 7

decreases expression

EXP

Amphetamine results in decreased expression of OSBPL7 mRNA

NCBI chr10:82,532,335...82,549,999
Ensembl chr10:82,532,411...82,549,999

G

oxysterol binding protein-like 9

increases expression

EXP

Amphetamine results in increased expression of OSBPL9 mRNA

NCBI chr 5:129,047,776...129,190,838
Ensembl chr 5:129,047,781...129,190,836

G

osteoclast associated Ig-like receptor

increases expression

EXP

Amphetamine results in increased expression of OSCAR mRNA

NCBI chr 1:74,521,626...74,529,119
Ensembl chr 1:74,515,001...74,529,119

G

oncostatin M

increases expression

EXP

Amphetamine results in increased expression of OSM mRNA

NCBI chr14:83,327,202...83,332,073
Ensembl chr14:83,327,554...83,331,827

G

odd-skipped related transcription factor 2

increases expression

EXP

Amphetamine results in increased expression of OSR2 mRNA

NCBI chr 7:68,372,500...68,380,195
Ensembl chr 7:68,373,049...68,380,805

G

purinergic receptor P2X 4

increases expression

EXP

Amphetamine results in increased expression of P2RX4 mRNA

NCBI chr12:39,505,438...39,523,349
Ensembl chr12:39,505,438...39,523,094

G

purinergic receptor P2Y12

increases expression

EXP

Amphetamine results in increased expression of P2RY12 mRNA

NCBI chr 2:145,631,487...145,673,194
Ensembl chr 2:145,629,967...145,633,410

G

prolyl 3-hydroxylase 3

increases expression

EXP

Amphetamine results in increased expression of P3H3 mRNA

NCBI chr 4:159,332,514...159,348,428
Ensembl chr 4:159,332,434...159,348,004

G

prolyl 4-hydroxylase subunit alpha 1

increases expression

EXP

Amphetamine results in increased expression of P4HA1 mRNA

NCBI chr20:27,784,696...27,895,785
Ensembl chr20:27,845,141...27,895,404

G

prolyl 4-hydroxylase, transmembrane

decreases expression

EXP

Amphetamine results in decreased expression of P4HTM mRNA

NCBI chr 8:118,153,158...118,172,199
Ensembl chr 8:118,153,158...118,171,002

G

phosphofurin acidic cluster sorting protein 2

decreases expression

EXP

Amphetamine results in decreased expression of PACS2 mRNA

NCBI chr 6:137,918,040...137,977,767
Ensembl chr 6:137,918,051...137,977,767

G

protein kinase C and casein kinase substrate in neurons 1

decreases expression

EXP

Amphetamine results in decreased expression of PACSIN1 mRNA

NCBI chr20:5,719,929...5,769,492
Ensembl chr20:5,721,311...5,767,109

G

p21 (RAC1) activated kinase 6

decreases expression

EXP

Amphetamine results in decreased expression of PAK6 mRNA

NCBI chr 3:126,092,576...126,128,320
Ensembl chr 3:126,093,013...126,128,318

G

paralemmin A kinase anchor protein

decreases expression

EXP

Amphetamine results in decreased expression of PAKAP mRNA

NCBI chr 5:76,976,906...77,443,656
Ensembl chr 5:76,977,112...77,443,656

G

palmdelphin

increases expression

EXP

Amphetamine results in increased expression of PALMD mRNA

NCBI chr 2:207,574,413...207,626,239
Ensembl chr 2:207,574,249...207,626,239

G

pantothenate kinase 3

decreases expression

EXP

Amphetamine results in decreased expression of PANK3 mRNA

NCBI chr10:20,733,191...20,757,017
Ensembl chr10:20,733,127...20,757,015

G

pannexin 2

increases expression

EXP

Amphetamine results in increased expression of PANX2 mRNA

NCBI chr 7:122,018,937...122,032,009
Ensembl chr 7:122,018,937...122,032,004

G

progestin and adipoQ receptor family member 3

increases expression

EXP

Amphetamine results in increased expression of PAQR3 mRNA

NCBI chr14:12,766,539...12,796,461
Ensembl chr14:12,766,570...12,790,001

G

progestin and adipoQ receptor family member 5

decreases expression

EXP

Amphetamine results in decreased expression of PAQR5 mRNA

NCBI chr 8:71,327,397...71,409,201
Ensembl chr 8:71,327,397...71,409,201

G

par-6 family cell polarity regulator beta

decreases expression

EXP

Amphetamine results in decreased expression of PARD6B mRNA

NCBI chr 3:177,209,429...177,230,509
Ensembl chr 3:177,209,258...177,230,510

G

Parkinsonism associated deglycase

affects response to substance

ISO

PARK7 protein affects the susceptibility to Amphetamine

NCBI chr 5:166,636,551...166,659,825
Ensembl chr 5:166,636,552...166,659,825

G

poly (ADP-ribose) polymerase 1

decreases expression

EXP

Amphetamine results in decreased expression of PARP1 mRNA

NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567

G

prolyl-tRNA synthetase 2, mitochondrial

decreases expression

EXP

Amphetamine results in decreased expression of PARS2 mRNA

NCBI chr 5:126,662,882...126,667,981
Ensembl chr 5:126,657,700...126,676,455

G

PATJ, crumbs cell polarity complex component

decreases expression

EXP

Amphetamine results in decreased expression of PATJ mRNA

NCBI chr 5:118,177,557...118,480,301
Ensembl chr 5:118,177,565...118,480,301

G

paired box 5

decreases expression

EXP

Amphetamine results in decreased expression of PAX5 mRNA

NCBI chr 5:63,554,784...63,741,380
Ensembl chr 5:63,560,722...63,739,987

G

PBX homeobox interacting protein 1

increases expression

EXP

Amphetamine results in increased expression of PBXIP1 mRNA

NCBI chr 2:177,154,056...177,167,810
Ensembl chr 2:177,154,101...177,167,328

G

protocadherin gamma subfamily A, 1

decreases expression

EXP

Amphetamine results in decreased expression of PCDHGA1 mRNA

NCBI chr18:29,738,639...29,919,095

G

protocadherin gamma subfamily A, 2

decreases expression

EXP

Amphetamine results in decreased expression of PCDHGA2 mRNA

NCBI chr18:29,745,189...29,919,095

G

protocadherin gamma subfamily A, 8

decreases expression

EXP

Amphetamine results in decreased expression of PCDHGA8 mRNA

NCBI chr18:29,805,113...29,919,095

G

protocadherin gamma subfamily B, 8

decreases expression

EXP

Amphetamine results in decreased expression of PCDHGB8 mRNA

NCBI chr18:29,839,560...29,919,095

G

polycomb group ring finger 2

decreases expression

EXP

Amphetamine results in decreased expression of PCGF2 mRNA

NCBI chr10:83,178,926...83,191,610
Ensembl chr10:83,179,916...83,183,999

G

piccolo (presynaptic cytomatrix protein)

increases expression

EXP

Amphetamine results in increased expression of PCLO mRNA

NCBI chr 4:20,646,604...21,005,171
Ensembl chr 4:20,646,604...21,005,111

G

pericentrin

decreases expression

EXP

Amphetamine results in decreased expression of PCNT mRNA

NCBI chr20:12,189,767...12,278,179
Ensembl chr20:12,192,353...12,278,178

G

phosphate cytidylyltransferase 1B, choline

decreases expression

EXP

Amphetamine results in decreased expression of PCYT1B mRNA

NCBI chr X:62,371,934...62,465,460
Ensembl chr X:62,356,009...62,465,459

G

programmed cell death 10

increases expression

EXP

Amphetamine results in increased expression of PDCD10 mRNA

NCBI chr 2:162,602,516...162,644,690
Ensembl chr 2:162,602,516...162,644,612

G

programmed cell death 11

decreases expression

EXP

Amphetamine results in decreased expression of PDCD11 mRNA

NCBI chr 1:255,922,198...255,963,336
Ensembl chr 1:255,922,225...255,963,336

G

programmed cell death 6

increases expression

EXP

Amphetamine results in increased expression of PDCD6 mRNA

NCBI chr 1:30,795,105...30,810,771
Ensembl chr 1:30,795,040...30,810,773

G

phosphodiesterase 4D

decreases expression

EXP

Amphetamine results in decreased expression of PDE4D mRNA

NCBI chr 2:41,748,337...43,262,567
Ensembl chr 2:42,110,838...43,262,569

G

phosphodiesterase 4D interacting protein

decreases expression

EXP

Amphetamine results in decreased expression of PDE4DIP mRNA

NCBI chr 2:187,982,002...188,178,937
Ensembl chr 2:187,981,878...188,178,869

G

phosphodiesterase 7B

decreases expression

EXP

Amphetamine results in decreased expression of PDE7B mRNA

NCBI chr 1:16,994,072...17,312,828
Ensembl chr 1:17,002,286...17,312,456

G

protein disulfide isomerase family A, member 6

increases expression

EXP

Amphetamine results in increased expression of PDIA6 mRNA

NCBI chr 6:45,791,704...45,808,947
Ensembl chr 6:45,791,678...45,810,091

G

pyruvate dehydrogenase kinase 4

increases expression

EXP

Amphetamine results in increased expression of PDK4 mRNA

NCBI chr 4:34,558,327...34,568,329
Ensembl chr 4:34,556,330...34,568,381

G

podoplanin

increases expression

EXP

Amphetamine results in increased expression of PDPN mRNA

NCBI chr 5:160,884,995...160,919,112
Ensembl chr 5:160,884,993...160,925,637

G

pyruvate dehydrogenase phosphatase regulatory subunit

decreases expression

EXP

Amphetamine results in decreased expression of PDPR mRNA

NCBI chr19:55,974,611...56,019,045
Ensembl chr19:55,974,550...56,019,044

G

pyridoxal phosphatase

decreases expression

EXP

Amphetamine results in decreased expression of PDXP mRNA

NCBI chr 7:112,352,971...112,358,419
Ensembl chr 7:112,352,726...112,358,419

G

prodynorphin

increases expression
multiple interactions

EXP
ISO

Amphetamine results in increased expression of PDYN mRNA
ADORA2A protein affects the reaction [Amphetamine results in increased expression of PDYN mRNA]
Baclofen inhibits the reaction [Amphetamine results in increased expression of PDYN mRNA]; CTAP octapeptide inhibits the reaction [Amphetamine results in increased expression of PDYN mRNA]; tyrosyl-tetrahydroisoquinolinecarbonyl-psi(methylamino)phenylalanyl-phenylalanine inhibits the reaction [Amphetamine results in increased expression of PDYN mRNA]

PMID:12700712 PMID:14521997 PMID:15033416 PMID:15592348

NCBI chr 3:137,354,161...137,366,503
Ensembl chr 3:137,354,161...137,366,503

G

pellino E3 ubiquitin protein ligase family member 3

decreases expression

EXP

Amphetamine results in decreased expression of PELI3 mRNA

NCBI chr 1:211,659,416...211,672,280
Ensembl chr 1:211,661,610...211,672,239

G

proenkephalin

decreases expression
multiple interactions
increases expression

ISO
EXP

Amphetamine results in decreased expression of PENK mRNA
3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid inhibits the reaction [Amphetamine results in increased expression of PENK mRNA]; Baclofen inhibits the reaction [Amphetamine results in increased expression of PENK mRNA]; Dizocilpine Maleate inhibits the reaction [Amphetamine results in increased expression of PENK mRNA]; FG 9041 inhibits the reaction [Amphetamine results in increased expression of PENK mRNA]; tyrosyl-tetrahydroisoquinolinecarbonyl-psi(methylamino)phenylalanyl-phenylalanine inhibits the reaction [Amphetamine results in increased expression of PENK mRNA]

PMID:12850537 PMID:14521997 PMID:15033416 PMID:15592348 PMID:15814102

NCBI chr 5:21,981,381...21,987,074
Ensembl chr 5:21,981,382...21,986,705

G

period circadian regulator 1

increases expression

EXP

Amphetamine results in increased expression of PER1 mRNA

NCBI chr10:54,299,002...54,313,804
Ensembl chr10:54,302,641...54,314,211

G

period circadian regulator 2

increases expression

EXP

Amphetamine results in increased expression of PER2 mRNA

NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:99,454,830...99,496,993

G

period circadian regulator 3

decreases expression

EXP

Amphetamine results in decreased expression of PER3 mRNA

NCBI chr 5:166,740,914...166,778,243
Ensembl chr 5:166,743,050...166,777,999

G

p53 apoptosis effector related to PMP22

increases expression

EXP

Amphetamine results in increased expression of PERP mRNA

NCBI chr 1:15,361,784...15,374,230
Ensembl chr 1:15,361,778...15,374,687

G

phosphoribosylformylglycinamidine synthase

decreases expression

EXP

Amphetamine results in decreased expression of PFAS mRNA

NCBI chr10:54,189,157...54,210,685
Ensembl chr10:54,189,157...54,207,272

G

phosphofructokinase, muscle

decreases expression

EXP

Amphetamine results in decreased expression of PFKM mRNA

NCBI chr 7:131,100,684...131,138,250
Ensembl chr 7:131,100,753...131,138,248

G

phosphoglycerate mutase 1

increases expression

EXP

Amphetamine results in increased expression of PGAM1 mRNA

NCBI chr 1:250,673,152...250,680,762
Ensembl chr 1:250,673,049...250,690,203

G

protein geranylgeranyltransferase type I subunit beta

decreases expression

EXP

Amphetamine results in decreased expression of PGGT1B mRNA

NCBI chr18:41,138,536...41,182,145
Ensembl chr18:41,139,965...41,182,139

G

phosphoglycerate kinase 1

increases expression

EXP

Amphetamine results in increased expression of PGK1 mRNA

NCBI chr X:75,336,988...75,352,962
Ensembl chr X:75,336,687...75,352,959

G

phosphoglycolate phosphatase

increases expression

EXP

Amphetamine results in increased expression of PGP mRNA

NCBI chr10:13,999,782...14,002,408
Ensembl chr10:13,999,331...14,002,408

G

phosphatidylglycerophosphate synthase 1

increases expression

EXP

Amphetamine results in increased expression of PGS1 mRNA

NCBI chr10:103,713,306...103,748,924
Ensembl chr10:103,713,316...103,749,233

G

phosphatase and actin regulator 4

decreases expression

EXP

Amphetamine results in decreased expression of PHACTR4 mRNA

NCBI chr 5:149,828,716...149,904,955
Ensembl chr 5:149,833,367...149,905,187

G

peptidase inhibitor 16

increases expression

EXP

Amphetamine results in increased expression of PI16 mRNA

NCBI chr20:7,377,739...7,387,003
Ensembl chr20:7,377,729...7,387,691

G

phosphatidylinositol binding clathrin assembly protein

increases expression

EXP

Amphetamine results in increased expression of PICALM mRNA

NCBI chr 1:153,468,982...153,550,086
Ensembl chr 1:153,469,202...153,550,237

G

phosphatidylinositol glycan anchor biosynthesis, class B

decreases expression

EXP

Amphetamine results in decreased expression of PIGB mRNA

NCBI chr 8:82,622,484...82,656,323
Ensembl chr 8:82,632,445...82,656,323

G

phosphatidylinositol glycan anchor biosynthesis, class O

decreases expression

EXP

Amphetamine results in decreased expression of PIGO mRNA

NCBI chr 5:62,040,979...62,052,067
Ensembl chr 5:62,037,308...62,052,075

G

PIH1 domain containing 2

increases expression

EXP

Amphetamine results in increased expression of PIH1D2 mRNA

NCBI chr 8:59,863,271...59,871,465
Ensembl chr 8:59,862,899...59,887,927

G

phosphoinositide-3-kinase adaptor protein 1

decreases expression

EXP

Amphetamine results in decreased expression of PIK3AP1 mRNA

NCBI chr 1:250,040,250...250,194,364
Ensembl chr 1:250,040,250...250,154,226

G

phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta

decreases expression

EXP

Amphetamine results in decreased expression of PIK3C2B mRNA

NCBI chr13:47,046,866...47,107,733
Ensembl chr13:47,047,127...47,107,725

G

phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma

decreases expression

EXP

Amphetamine results in decreased expression of PIK3CG mRNA

NCBI chr 6:54,494,247...54,529,563
Ensembl chr 6:54,478,603...54,529,509

G

phosphoinositide-3-kinase interacting protein 1

decreases expression

EXP

Amphetamine results in decreased expression of PIK3IP1 mRNA

NCBI chr14:82,428,315...82,440,261
Ensembl chr14:82,428,248...82,440,260

G

phosphoinositide-3-kinase regulatory subunit 3

decreases expression

EXP

Amphetamine results in decreased expression of PIK3R3 mRNA

NCBI chr 5:134,936,790...135,009,303
Ensembl chr 5:134,934,857...135,007,762

G

phosphoinositide kinase, FYVE-type zinc finger containing

decreases expression

EXP

Amphetamine results in decreased expression of PIKFYVE mRNA

NCBI chr 9:74,057,488...74,151,610
Ensembl chr 9:74,057,514...74,151,610

G

Pim-2 proto-oncogene, serine/threonine kinase

decreases expression

EXP

Amphetamine results in decreased expression of PIM2 mRNA

NCBI chr X:17,289,509...17,294,778
Ensembl chr X:17,289,509...17,294,778

G

phosphatidylinositol-5-phosphate 4-kinase type 2 beta

decreases expression

EXP

Amphetamine results in decreased expression of PIP4K2B mRNA

NCBI chr10:83,202,379...83,231,292
Ensembl chr10:83,197,287...83,231,292

G

paired-Ig-like receptor A2

increases expression

EXP

Amphetamine results in increased expression of PIRA2 mRNA

NCBI chr 1:74,283,713...74,338,208

G

paired Ig-like receptor B

increases expression

EXP

Amphetamine results in increased expression of LILRB3 mRNA

NCBI chr 1:74,414,556...74,433,015
Ensembl chr 1:74,331,291...74,422,116

G

phosphatidylinositol transfer protein, membrane-associated 2

decreases expression

EXP

Amphetamine results in decreased expression of PITPNM2 mRNA

NCBI chr12:38,008,399...38,140,046
Ensembl chr12:38,066,006...38,140,046

G

piwi-like RNA-mediated gene silencing 4

increases expression

EXP

Amphetamine results in increased expression of PIWIL4 mRNA

NCBI chr 8:19,817,985...19,861,327
Ensembl chr 8:19,817,986...19,861,419

G

PBX/knotted 1 homeobox 2

decreases expression

EXP

Amphetamine results in decreased expression of PKNOX2 mRNA

NCBI chr 8:44,789,464...45,051,933
Ensembl chr 8:44,789,467...44,979,754

G

plakophilin 2

increases expression

EXP

Amphetamine results in increased expression of PKP2 mRNA

NCBI chr11:98,165,974...98,231,916
Ensembl chr11:98,165,974...98,231,916

G

phospholipase A2 group IIA

increases expression

EXP

Amphetamine results in increased expression of PLA2G2A mRNA

NCBI chr 5:156,359,725...156,362,302
Ensembl chr 5:156,359,725...156,362,297

G

phospholipase A2 group 4A

increases expression

EXP

Amphetamine results in increased expression of PLA2G4A mRNA

NCBI chr13:64,427,921...64,572,352
Ensembl chr13:64,427,916...64,589,641

G

phospholipase A2 group IVB

decreases expression

EXP

Amphetamine results in decreased expression of PLA2G4B mRNA

NCBI chr 3:127,458,022...127,467,637
Ensembl chr 3:127,459,273...127,467,637

G

phospholipase A2 group VII

increases expression

EXP

Amphetamine results in increased expression of PLA2G7 mRNA

NCBI chr 9:24,859,491...24,901,747
Ensembl chr 9:24,859,502...24,901,747

G

PLAG1 zinc finger

decreases expression

EXP

Amphetamine results in decreased expression of PLAG1 mRNA

NCBI chr 5:21,699,650...21,754,325
Ensembl chr 5:21,702,987...21,711,240

G

phospholipase C beta 1

increases expression

EXP

Amphetamine results in increased expression of PLCB1 mRNA

NCBI chr 3:142,512,765...143,224,042
Ensembl chr 3:142,513,033...143,225,646

G

phospholipase C, delta 1

increases expression

EXP

Amphetamine results in increased expression of PLCD1 mRNA

NCBI chr 8:127,672,955...127,695,939
Ensembl chr 8:127,672,980...127,695,939

G

phospholipase C, delta 3

increases expression

EXP

Amphetamine results in increased expression of PLCD3 mRNA

NCBI chr10:88,526,802...88,548,116
Ensembl chr10:88,526,802...88,548,069

G

phospholipase C, gamma 1

decreases expression

EXP

Amphetamine results in decreased expression of PLCG1 mRNA

NCBI chr 3:169,805,299...169,836,040
Ensembl chr 3:169,804,846...169,836,050

G

phospholipase C, gamma 2

decreases expression

EXP

Amphetamine results in decreased expression of PLCG2 mRNA

NCBI chr19:62,456,196...62,592,684
Ensembl chr19:62,453,259...62,592,684

G

phosphatidylinositol-specific phospholipase C, X domain containing 2

decreases expression

EXP

Amphetamine results in decreased expression of PLCXD2 mRNA

NCBI chr11:68,263,626...68,315,962
Ensembl chr11:68,263,566...68,316,327

G

phospholipase D1

increases expression

EXP

Amphetamine results in increased expression of PLD1 mRNA

NCBI chr 2:112,777,820...112,975,857
Ensembl chr 2:112,777,951...112,976,245

G

phospholipase D2

increases expression

EXP

Amphetamine results in increased expression of PLD2 mRNA

NCBI chr10:55,754,957...55,772,819
Ensembl chr10:55,754,988...55,771,435

G

pleckstrin

increases expression

EXP

Amphetamine results in increased expression of PLEK mRNA

NCBI chr14:95,598,650...95,631,326
Ensembl chr14:95,598,654...95,655,721

G

pleckstrin homology domain containing A8

decreases expression

EXP

Amphetamine results in decreased expression of PLEKHA8 mRNA

NCBI chr 4:85,053,765...85,104,376
Ensembl chr 4:85,053,854...85,104,376

G

pleckstrin homology domain containing B2

increases expression

EXP

Amphetamine results in increased expression of PLEKHB2 mRNA

NCBI chr 9:44,545,473...44,578,122
Ensembl chr 9:44,534,539...44,578,119

G

pleckstrin homology domain containing N1

decreases expression

EXP

Amphetamine results in decreased expression of PLEKHN1 mRNA

NCBI chr 5:172,087,524...172,095,566
Ensembl chr 5:172,087,055...172,095,374

G

perilipin 1

increases expression

EXP

Amphetamine results in increased expression of PLIN1 mRNA

NCBI chr 1:143,073,612...143,086,199
Ensembl chr 1:143,074,214...143,086,206

G

perilipin 2

increases expression

EXP

Amphetamine results in increased expression of PLIN2 mRNA

NCBI chr 5:106,202,634...106,258,748
Ensembl chr 5:106,202,634...106,258,878

G

perilipin 5

increases expression

EXP

Amphetamine results in increased expression of PLIN5 mRNA

NCBI chr 9:1,026,910...1,033,352
Ensembl chr 9:1,026,307...1,033,284

G

procollagen lysine, 2-oxoglutarate 5-dioxygenase 2

increases expression

EXP

Amphetamine results in increased expression of PLOD2 mRNA

NCBI chr 8:101,964,318...102,047,022
Ensembl chr 8:101,964,318...102,047,022

G

proteolipid protein 1

increases expression

EXP

Amphetamine results in increased expression of PLP1 mRNA

NCBI chr X:104,933,921...104,993,317
Ensembl chr X:104,975,780...104,993,314

G

proteolipid protein 2

increases expression

EXP

Amphetamine results in increased expression of PLP2 mRNA

NCBI chr X:17,506,153...17,509,552
Ensembl chr X:17,506,059...17,509,550

G

plastin 3

increases expression

EXP

Amphetamine results in increased expression of PLS3 mRNA

NCBI chr X:116,401,247...116,495,898
Ensembl chr X:116,401,293...116,495,893

G

phospholipid scramblase 3

decreases expression

EXP

Amphetamine results in decreased expression of PLSCR3 mRNA

NCBI chr10:55,064,349...55,070,120
Ensembl chr10:55,065,345...55,070,369

G

phorbol-12-myristate-13-acetate-induced protein 1

increases expression

EXP

Amphetamine results in increased expression of PMAIP1 mRNA

NCBI chr18:62,255,970...62,262,384
Ensembl chr18:62,255,598...62,262,382

G

prostate transmembrane protein, androgen induced 1

increases expression

EXP

Amphetamine results in increased expression of PMEPA1 mRNA

NCBI chr 3:182,430,193...182,478,649
Ensembl chr 3:182,430,193...182,478,649

G

PML nuclear body scaffold

decreases expression

EXP

Amphetamine results in decreased expression of PML mRNA

NCBI chr 8:67,523,164...67,557,801
Ensembl chr 8:67,523,164...67,576,083

G

purine nucleoside phosphorylase

increases expression

EXP

Amphetamine results in increased expression of PNP mRNA

NCBI chr15:26,644,147...26,651,808
Ensembl chr15:26,643,858...26,678,162

G

patatin-like phospholipase domain containing 2

increases expression

EXP

Amphetamine results in increased expression of PNPLA2 mRNA

NCBI chr 1:205,982,279...205,987,361
Ensembl chr 1:205,982,258...205,987,359

G

patatin-like phospholipase domain containing 7

increases expression

EXP

Amphetamine results in increased expression of PNPLA7 mRNA

NCBI chr 3:28,180,670...28,259,673
Ensembl chr 3:28,180,751...28,259,672

G

protein O-fucosyltransferase 1

decreases expression

EXP

Amphetamine results in decreased expression of POFUT1 mRNA

NCBI chr 3:162,168,855...162,195,798
Ensembl chr 3:162,168,606...162,195,018

G

DNA polymerase alpha 1, catalytic subunit

decreases expression

EXP

Amphetamine results in decreased expression of POLA1 mRNA

NCBI chr X:62,028,475...62,342,455
Ensembl chr X:62,028,476...62,342,355

G

DNA polymerase delta 1, catalytic subunit

decreases expression

EXP

Amphetamine results in decreased expression of POLD1 mRNA

NCBI chr 1:104,161,984...104,178,074
Ensembl chr 1:104,162,016...104,172,982

G

DNA polymerase epsilon, catalytic subunit

decreases expression

EXP

Amphetamine results in decreased expression of POLE mRNA

NCBI chr12:52,005,155...52,053,761
Ensembl chr12:52,005,155...52,053,662

G

DNA polymerase epsilon 2, accessory subunit

decreases expression

EXP

Amphetamine results in decreased expression of POLE2 mRNA

NCBI chr 6:93,410,713...93,448,782
Ensembl chr 6:93,410,758...93,435,361

G

DNA polymerase gamma, catalytic subunit

decreases expression

EXP

Amphetamine results in decreased expression of POLG mRNA

NCBI chr 1:142,792,119...142,808,933
Ensembl chr 1:142,792,119...142,808,838

G

DNA polymerase iota

decreases expression

EXP

Amphetamine results in decreased expression of POLI mRNA

NCBI chr18:66,389,214...66,409,734
Ensembl chr18:66,364,236...66,409,819

G

DNA polymerase mu

decreases expression

EXP

Amphetamine results in decreased expression of POLM mRNA

NCBI chr14:84,921,039...84,930,649
Ensembl chr14:84,921,045...84,930,622

G

RNA polymerase I subunit A

decreases expression

EXP

Amphetamine results in decreased expression of POLR1A mRNA

NCBI chr 4:105,508,305...105,572,272
Ensembl chr 4:105,508,248...105,574,036

G

RNA polymerase I subunit B

decreases expression

EXP

Amphetamine results in decreased expression of POLR1B mRNA

NCBI chr 3:136,787,130...136,811,608
Ensembl chr 3:136,787,107...136,811,607

G

RNA polymerase I and III subunit D

increases expression

EXP

Amphetamine results in increased expression of POLR1D mRNA

NCBI chr12:13,084,505...13,118,069
Ensembl chr12:13,084,512...13,095,627

G

RNA polymerase II subunit I

increases expression

EXP

Amphetamine results in increased expression of POLR2I mRNA

NCBI chr 1:94,610,976...94,612,413
Ensembl chr 1:94,610,942...94,613,000

G

RNA polymerase III subunit E

decreases expression

EXP

Amphetamine results in decreased expression of POLR3E mRNA

NCBI chr 1:184,897,383...184,925,547
Ensembl chr 1:184,897,426...184,926,534

G

RNA polymerase mitochondrial

decreases expression

EXP

Amphetamine results in decreased expression of POLRMT mRNA

NCBI chr 7:10,610,149...10,620,411
Ensembl chr 7:10,610,198...10,621,205

G

protein-O-mannose kinase

decreases expression

EXP

Amphetamine results in decreased expression of POMK mRNA

NCBI chr16:72,788,842...72,801,122
Ensembl chr16:72,794,831...72,801,103

G

proteasome maturation protein

increases expression

EXP

Amphetamine results in increased expression of POMP mRNA

NCBI chr12:12,198,262...12,212,132
Ensembl chr12:12,198,263...12,210,880

G

protein-O-mannosyltransferase 2

decreases expression

EXP

Amphetamine results in decreased expression of POMT2 mRNA

NCBI chr 6:112,486,416...112,525,799
Ensembl chr 6:112,486,416...112,525,799

G

POP1 homolog, ribonuclease P/MRP subunit

decreases expression

EXP

Amphetamine results in decreased expression of POP1 mRNA

NCBI chr 7:67,590,502...67,618,187
Ensembl chr 7:67,590,522...67,618,293

G

popeye domain cAMP effector 2

increases expression

EXP

Amphetamine results in increased expression of POPDC2 mRNA

NCBI chr11:75,850,068...75,897,094
Ensembl chr11:75,880,274...75,896,269

G

POU class 2 homeobox 2

decreases expression

EXP

Amphetamine results in decreased expression of POU2F2 mRNA

NCBI chr 1:89,810,153...89,897,560
Ensembl chr 1:89,812,093...89,897,564

G

peter pan homolog

decreases expression

EXP

Amphetamine results in decreased expression of PPAN mRNA

NCBI chr 8:27,700,147...27,704,127
Ensembl chr 8:27,700,152...27,704,128

G

pro-platelet basic protein

increases expression

EXP

Amphetamine results in increased expression of PPBP mRNA

NCBI chr14:17,586,495...17,587,299
Ensembl chr14:17,586,495...17,587,299

G

PPFIA binding protein 1

decreases expression

EXP

Amphetamine results in decreased expression of PPFIBP1 mRNA

NCBI chr 4:181,538,249...181,682,079
Ensembl chr 4:181,539,450...181,682,076

G

protein phosphatase, Mg2+/Mn2+ dependent, 1F

decreases expression

EXP

Amphetamine results in decreased expression of PPM1F mRNA

NCBI chr11:97,568,627...97,598,613
Ensembl chr11:97,568,625...97,598,545

G

protein phosphatase, Mg2+/Mn2+ dependent, 1J

increases expression

EXP

Amphetamine results in increased expression of PPM1J mRNA

NCBI chr 2:194,966,854...194,972,228
Ensembl chr 2:194,966,950...194,972,227

G

protein phosphatase 1, regulatory subunit 12B

decreases expression

EXP

Amphetamine results in decreased expression of PPP1R12B mRNA

NCBI chr13:48,751,256...48,948,933
Ensembl chr13:48,751,477...48,948,922

G

protein phosphatase 1, regulatory subunit 16B

decreases expression

EXP

Amphetamine results in decreased expression of PPP1R16B mRNA

NCBI chr 3:167,743,518...167,839,511
Ensembl chr 3:167,743,952...167,839,242

G

protein phosphatase 1, regulatory subunit 3C

increases expression

EXP

Amphetamine results in increased expression of PPP1R3C mRNA

NCBI chr 1:243,873,524...243,878,527
Ensembl chr 1:243,871,704...243,878,835

G

protein phosphatase 1, regulatory subunit 3G

decreases expression

EXP

Amphetamine results in decreased expression of PPP1R3G mRNA

NCBI chr17:29,080,407...29,083,739
Ensembl chr17:29,070,658...29,085,135

G

protein phosphatase 4, regulatory subunit 4

decreases expression

EXP

Amphetamine results in decreased expression of PPP4R4 mRNA

NCBI chr 6:128,427,884...128,518,776
Ensembl chr 6:128,427,893...128,528,039

G

PPARG related coactivator 1

decreases expression

EXP

Amphetamine results in decreased expression of PPRC1 mRNA

NCBI chr 1:254,851,136...254,867,570
Ensembl chr 1:254,851,164...254,867,570

G

protein regulator of cytokinesis 1

increases expression

EXP

Amphetamine results in increased expression of PRC1 mRNA

NCBI chr 1:143,659,312...143,681,019
Ensembl chr 1:143,659,481...143,681,012

G

PR/SET domain 11

decreases expression

EXP

Amphetamine results in decreased expression of PRDM11 mRNA

NCBI chr 3:99,381,093...99,460,805
Ensembl chr 3:99,387,518...99,460,962

G

PR/SET domain 15

decreases expression

EXP

Amphetamine results in decreased expression of PRDM15 mRNA

NCBI chr11:50,633,973...50,691,624
Ensembl chr11:50,633,973...50,691,823

G

PR/SET domain 9

increases expression

EXP

Amphetamine results in increased expression of PRDM9 mRNA

NCBI chr 1:65,178,666...65,198,851
Ensembl chr 1:65,178,666...65,198,737

G

peroxiredoxin 5

increases expression

EXP

Amphetamine results in increased expression of PRDX5 mRNA

NCBI chr 1:213,529,042...213,532,787
Ensembl chr 1:213,529,035...213,533,020

G

proteoglycan 4

increases expression

EXP

Amphetamine results in increased expression of PRG4 mRNA

NCBI chr13:65,037,363...65,054,764
Ensembl chr13:65,037,363...65,054,508

G

primase and DNA directed polymerase

decreases expression

EXP

Amphetamine results in decreased expression of PRIMPOL mRNA

NCBI chr16:52,413,894...52,450,975
Ensembl chr16:52,413,935...52,450,950

G

protein kinase cAMP-dependent type II regulatory subunit alpha

decreases expression
affects response to substance
increases expression

EXP

Amphetamine results in decreased expression of PRKAR2A mRNA
PRKAR2A protein affects the susceptibility to Amphetamine
Amphetamine results in increased expression of PRKAR2A mRNA; Amphetamine results in increased expression of PRKAR2A protein

PMID:16896163 PMID:30779732

NCBI chr 8:118,271,608...118,337,332
Ensembl chr 8:118,274,167...118,337,330

G

protein kinase C, alpha

increases expression
increases response to substance
decreases expression
multiple interactions

EXP

Amphetamine results in increased expression of PRKCA mRNA
PRKCA protein results in increased susceptibility to Amphetamine
Amphetamine results in decreased expression of PRKCA mRNA
PRKCA protein promotes the reaction [Amphetamine results in decreased expression of NPY mRNA]

PMID:16101753 PMID:30779732

NCBI chr10:93,388,991...93,787,617
Ensembl chr10:93,388,991...93,787,572

G

protein kinase C, beta

affects expression

EXP

Amphetamine affects the expression of PRKCB mRNA

NCBI chr 1:186,263,397...186,594,743
Ensembl chr 1:186,263,447...186,594,740

G

protein kinase C, delta

increases expression

EXP

Amphetamine results in increased expression of PRKCD mRNA

NCBI chr16:5,775,681...5,806,122
Ensembl chr16:5,775,681...5,805,839

G

protein kinase C, epsilon

decreases expression

EXP

Amphetamine results in decreased expression of PRKCE mRNA

NCBI chr 6:13,718,050...14,204,931
Ensembl chr 6:13,718,050...14,204,288

G

protein kinase C, gamma

increases expression
affects expression

EXP

Amphetamine results in increased expression of PRKCG mRNA
Amphetamine affects the expression of PRKCG mRNA

PMID:16101753 PMID:30779732

NCBI chr 1:74,748,272...74,777,611
Ensembl chr 1:74,748,272...74,774,814

G

protein kinase C, eta

increases expression
decreases expression

EXP

Amphetamine results in increased expression of PRKCH mRNA
Amphetamine results in decreased expression of PRKCH mRNA

PMID:16101753 PMID:30779732

NCBI chr 6:98,027,830...98,226,486
Ensembl chr 6:98,027,646...98,226,477

G

protein kinase C, iota

increases expression

EXP

Amphetamine results in increased expression of PRKCI mRNA

NCBI chr 2:114,250,398...114,310,784
Ensembl chr 2:114,250,398...114,310,784

G

protein kinase C, zeta

affects expression

EXP

Amphetamine affects the expression of PRKCZ mRNA

NCBI chr 5:171,101,774...171,212,694
Ensembl chr 5:171,101,774...171,212,674

G

protein kinase D2

decreases expression

EXP

Amphetamine results in decreased expression of PRKD2 mRNA

NCBI chr 1:86,640,095...86,670,476
Ensembl chr 1:86,642,629...86,670,675

G

protein kinase D3

decreases expression

EXP

Amphetamine results in decreased expression of PRKD3 mRNA

NCBI chr 6:21,784,665...21,860,600
Ensembl chr 6:21,784,673...21,860,600

G

protein kinase, DNA-activated, catalytic subunit

decreases expression

EXP

Amphetamine results in decreased expression of PRKDC mRNA

NCBI chr11:98,544,952...98,762,499
Ensembl chr11:98,544,954...98,762,108

G

parkin RBR E3 ubiquitin protein ligase

increases response to substance
multiple interactions

ISO

PRKN protein results in increased susceptibility to Amphetamine
PRKN protein promotes the reaction [Amphetamine results in increased abundance of Dopamine]

NCBI chr 1:51,236,410...52,430,242
Ensembl chr 1:51,210,330...52,430,304

G

prolactin family 8, subfamily A, member 5

increases expression

EXP

Amphetamine results in increased expression of PRL8A5 mRNA

NCBI chr17:37,674,027...37,680,240
Ensembl chr17:37,674,027...37,680,240

G

protein arginine methyltransferase 6

decreases expression

EXP

Amphetamine results in decreased expression of PRMT6 mRNA

NCBI chr 2:200,615,780...200,620,790
Ensembl chr 2:200,614,979...200,623,308

G

prokineticin 2

increases expression

EXP

Amphetamine results in increased expression of PROK2 mRNA

NCBI chr 4:133,903,210...133,918,126
Ensembl chr 4:133,903,210...133,917,933

G

peripherin

increases expression

EXP

Amphetamine results in increased expression of PRPH mRNA

NCBI chr 7:132,096,888...132,101,070
Ensembl chr 7:132,097,285...132,101,068

G

phosphoribosyl pyrophosphate synthetase 2

decreases expression

EXP

Amphetamine results in decreased expression of PRPS2 mRNA

NCBI chr X:30,592,845...30,630,127
Ensembl chr X:30,593,019...30,630,126

G

proline rich 12

decreases expression

EXP

Amphetamine results in decreased expression of PRR12 mRNA

NCBI chr 1:104,646,492...104,670,454
Ensembl chr 1:104,646,492...104,670,454

G

proline rich 13

increases expression

EXP

Amphetamine results in increased expression of PRR13 mRNA

NCBI chr 7:135,471,040...135,474,344
Ensembl chr 7:135,470,933...135,474,579

G

proline rich 14-like

decreases expression

EXP

Amphetamine results in decreased expression of PRR14L mRNA

NCBI chr14:82,094,360...82,160,985
Ensembl chr14:82,094,358...82,158,323

G

proline rich 15

increases expression

EXP

Amphetamine results in increased expression of PRR15 mRNA

NCBI chr 4:84,762,357...84,765,403
Ensembl chr 4:84,761,523...84,768,442

G

proline rich 7 (synaptic)

increases expression

EXP

Amphetamine results in increased expression of PRR7 mRNA

NCBI chr17:9,170,405...9,178,814
Ensembl chr17:9,170,411...9,179,361

G

proline-rich coiled-coil 2B

decreases expression

EXP

Amphetamine results in decreased expression of PRRC2B mRNA

NCBI chr 3:35,831,017...35,916,854
Ensembl chr 3:35,863,046...35,916,854

G

proline-rich transmembrane protein 2

decreases expression

EXP

Amphetamine results in decreased expression of PRRT2 mRNA

NCBI chr 1:191,054,962...191,059,632
Ensembl chr 1:191,053,050...191,059,414

G

serine protease 3

increases expression

EXP

Amphetamine results in increased expression of TRY4 mRNA

NCBI chr 4:71,169,749...71,173,223
Ensembl chr 4:71,169,749...71,173,223

G

serine protease 36

increases expression

EXP

Amphetamine results in increased expression of PRSS36 mRNA

NCBI chr 1:191,973,556...192,002,231
Ensembl chr 1:191,973,556...191,989,567

G

phosphoribosyl transferase domain containing 1

increases expression

EXP

Amphetamine results in increased expression of PRTFDC1 mRNA

NCBI chr17:88,457,872...88,563,109
Ensembl chr17:88,457,872...88,563,066

G

periaxin

increases expression

EXP

Amphetamine results in increased expression of PRX mRNA

NCBI chr 1:91,912,669...91,934,754
Ensembl chr 1:91,911,999...91,937,235

G

phosphoserine aminotransferase 1

decreases expression

EXP

Amphetamine results in decreased expression of PSAT1 mRNA

NCBI chr 1:222,623,553...222,646,187
Ensembl chr 1:222,623,556...222,655,693

G

pleckstrin and Sec7 domain containing 2

decreases expression

EXP

Amphetamine results in decreased expression of PSD2 mRNA

NCBI chr18:27,838,943...27,890,712
Ensembl chr18:27,839,627...27,890,709

G

proteasome assembly chaperone 3

increases expression

EXP

Amphetamine results in increased expression of PSMG3 mRNA

NCBI chr12:19,923,288...19,926,205
Ensembl chr12:19,923,288...19,926,205

G

proline-serine-threonine phosphatase-interacting protein 1

increases expression

EXP

Amphetamine results in increased expression of PSTPIP1 mRNA

NCBI chr 8:65,395,328...65,434,616
Ensembl chr 8:65,395,358...65,434,627

G

platelet-activating factor receptor

increases expression

EXP

Amphetamine results in increased expression of PTAFR mRNA

NCBI chr 5:150,049,322...150,079,060
Ensembl chr 5:150,049,460...150,079,408

G

patched 1

decreases expression

EXP

Amphetamine results in decreased expression of PTCH1 mRNA

NCBI chr17:1,548,449...1,613,461
Ensembl chr17:1,548,449...1,613,461

G

phosphotriesterase related

increases expression

EXP

Amphetamine results in increased expression of PTER mRNA

NCBI chr17:80,967,463...81,028,707
Ensembl chr17:80,967,477...81,030,099

G

prostaglandin E receptor 2

increases expression

EXP

Amphetamine results in increased expression of PTGER2 mRNA

NCBI chr15:20,694,765...20,708,475
Ensembl chr15:20,696,013...20,708,950

G

prostaglandin E synthase

decreases expression

EXP

Amphetamine results in decreased expression of PTGES mRNA

NCBI chr 3:34,575,643...34,586,987
Ensembl chr 3:34,575,639...34,586,995

G

prostaglandin reductase 1

increases expression

EXP

Amphetamine results in increased expression of PTGR1 mRNA

NCBI chr 5:78,579,060...78,597,671
Ensembl chr 5:78,579,057...78,597,811

G

prostaglandin-endoperoxide synthase 2

increases expression

EXP

Amphetamine results in increased expression of PTGS2 mRNA

NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320

G

pleiotrophin

increases expression
multiple interactions
decreases response to substance

EXP
ISO

Amphetamine results in increased expression of PTN mRNA
[PTN gene mutant form results in decreased susceptibility to Amphetamine] which results in increased expression of and results in increased phosphorylation of ERP29 protein; [PTN gene mutant form results in increased susceptibility to Amphetamine] which results in decreased expression of ANXA7 protein; Amphetamine inhibits the reaction [PTN gene mutant form results in decreased expression of ENO2 protein]; Amphetamine promotes the reaction [PTN gene mutant form results in decreased expression of ATP5F1A protein]; PTN gene mutant form inhibits the reaction [Amphetamine results in decreased expression of ATP5F1D protein]; PTN protein inhibits the reaction [Amphetamine results in decreased expression of TH protein]; PTN protein inhibits the reaction [Amphetamine results in decreased phosphorylation of MAPK3 protein]
Dizocilpine Maleate promotes the reaction [Amphetamine results in increased expression of PTN mRNA]
PTN gene mutant form results in decreased susceptibility to Amphetamine; PTN protein results in decreased susceptibility to Amphetamine

PMID:15862925 PMID:20192945 PMID:20620199 PMID:23459167

NCBI chr 4:66,260,764...66,342,614
Ensembl chr 4:66,260,764...66,342,482

G

protein tyrosine phosphatase 4A1

increases expression

EXP

Amphetamine results in increased expression of PTP4A1 mRNA

NCBI chr 9:40,710,250...40,718,176
Ensembl chr 9:40,710,250...40,718,176

G

protein tyrosine phosphatase 4A3

decreases expression

EXP

Amphetamine results in decreased expression of PTP4A3 mRNA

NCBI chr 7:107,518,220...107,549,949
Ensembl chr 7:107,541,047...107,549,949

G

protein tyrosine phosphatase domain containing 1

decreases expression

EXP

Amphetamine results in decreased expression of PTPDC1 mRNA

NCBI chr17:16,235,311...16,284,160
Ensembl chr17:16,235,263...16,284,158

G

protein tyrosine phosphatase, non-receptor type 4

decreases expression

EXP

Amphetamine results in decreased expression of PTPN4 mRNA

NCBI chr13:33,324,808...33,504,957
Ensembl chr13:33,324,808...33,504,957

G

protein tyrosine phosphatase, non-receptor type 7

decreases expression

EXP

Amphetamine results in decreased expression of PTPN7 mRNA

NCBI chr13:49,122,679...49,136,096
Ensembl chr13:49,122,609...49,136,094

G

protein tyrosine phosphatase, receptor type, K

decreases expression

EXP

Amphetamine results in decreased expression of PTPRK mRNA

NCBI chr 1:18,557,091...19,056,297
Ensembl chr 1:18,558,365...19,056,107

G

protein tyrosine phosphatase, receptor type, N

increases expression

EXP

Amphetamine results in increased expression of PTPRN mRNA

NCBI chr 9:84,189,676...84,205,364
Ensembl chr 9:84,189,676...84,204,850

G

protein tyrosine phosphatase, receptor type, O

increases expression

EXP

Amphetamine results in increased expression of PTPRO mRNA

NCBI chr 4:171,895,104...172,105,911
Ensembl chr 4:171,895,232...172,105,903

G

protein tyrosine phosphatase, receptor type, R

increases expression

EXP

Amphetamine results in increased expression of PTPRR mRNA

NCBI chr 7:53,548,611...53,815,632
Ensembl chr 7:53,548,629...53,815,629

G

protein tyrosine phosphatase, receptor type, S

decreases expression

EXP

Amphetamine results in decreased expression of PTPRS mRNA

NCBI chr 9:1,332,558...1,394,161
Ensembl chr 9:1,332,559...1,394,093

G

pseudouridine synthase 7

decreases expression

EXP

Amphetamine results in decreased expression of PUS7 mRNA

NCBI chr 4:12,252,553...12,293,547
Ensembl chr 4:12,252,545...12,293,539

G

pseudouridine synthase like 1

decreases expression

EXP

Amphetamine results in decreased expression of PUSL1 mRNA

NCBI chr 5:171,773,284...171,782,893
Ensembl chr 5:171,773,331...171,783,339

G

parvalbumin

affects expression

EXP

Amphetamine affects the expression of PVALB protein

PMID:12468030 PMID:15238432

NCBI chr 7:111,653,820...111,668,469
Ensembl chr 7:111,653,111...111,668,446

G

PWP2, small subunit processome component

decreases expression

EXP

Amphetamine results in decreased expression of PWP2 mRNA

NCBI chr20:10,498,998...10,512,631
Ensembl chr20:10,499,013...10,513,309

G

PX domain containing serine/threonine kinase like

increases expression

EXP

Amphetamine results in increased expression of PXK mRNA

NCBI chr15:19,190,085...19,258,711
Ensembl chr15:19,190,085...19,258,671

G

2-phosphoxylose phosphatase 1

decreases expression

EXP

Amphetamine results in decreased expression of PXYLP1 mRNA

NCBI chr 8:106,299,303...106,364,603
Ensembl chr 8:106,299,304...106,364,603

G

pyridine nucleotide-disulphide oxidoreductase domain 2

decreases expression

EXP

Amphetamine results in decreased expression of PYROXD2 mRNA

NCBI chr 1:251,472,609...251,498,316
Ensembl chr 1:251,471,849...251,498,008

G

pyroglutamylated RFamide peptide receptor

decreases expression

EXP

Amphetamine results in decreased expression of QRFPR mRNA

NCBI chr 2:120,981,235...121,025,020
Ensembl chr 2:120,981,235...121,025,020

G

glutamine and serine rich 1

decreases expression

EXP

Amphetamine results in decreased expression of QSER1 mRNA

NCBI chr 3:111,592,377...111,658,825
Ensembl chr 3:111,595,171...111,657,103

G

queuine tRNA-ribosyltransferase accessory subunit 2

decreases expression

EXP

Amphetamine results in decreased expression of QTRT2 mRNA

NCBI chr11:70,312,352...70,343,139
Ensembl chr11:70,312,378...70,343,128

G

RAB11a, member RAS oncogene family

increases expression

EXP

Amphetamine results in increased expression of RAB11A mRNA

NCBI chr 8:74,118,922...74,141,760
Ensembl chr 8:74,118,922...74,141,837

G

RAB11 family interacting protein 2

decreases expression

EXP

Amphetamine results in decreased expression of RAB11FIP2 mRNA

NCBI chr 1:268,908,825...269,080,691
Ensembl chr 1:268,909,413...269,079,661

G

RAB11 family interacting protein 3

decreases expression

EXP

Amphetamine results in decreased expression of RAB11FIP3 mRNA

NCBI chr10:15,507,151...15,591,173
Ensembl chr10:15,507,151...15,591,173

G

RAB11 family interacting protein 4

decreases expression

EXP

Amphetamine results in decreased expression of RAB11FIP4 mRNA

NCBI chr10:65,048,070...65,156,086
Ensembl chr10:65,048,140...65,152,722

G

RAB13, member RAS oncogene family

increases expression

EXP

Amphetamine results in increased expression of RAB13 mRNA

NCBI chr 2:177,972,535...177,977,679
Ensembl chr 2:177,972,372...177,977,684

G

RAB18, member RAS oncogene family

increases expression

EXP

Amphetamine results in increased expression of RAB18 mRNA

NCBI chr17:59,639,264...59,670,653
Ensembl chr17:59,639,203...59,672,806

G

RAB20, member RAS oncogene family

increases expression

EXP

Amphetamine results in increased expression of RAB20 mRNA

NCBI chr16:84,721,427...84,745,610
Ensembl chr16:84,721,427...84,745,610

G

RAB24, member RAS oncogene family

increases expression

EXP

Amphetamine results in increased expression of RAB24 mRNA

NCBI chr17:9,313,593...9,315,675
Ensembl chr17:9,313,593...9,316,575

G

RAB31, member RAS oncogene family

increases expression

EXP

Amphetamine results in increased expression of RAB31 mRNA

NCBI chr 9:112,693,596...112,828,104
Ensembl chr 9:112,693,597...112,828,092

G

RAB38, member RAS oncogene family

increases expression

EXP

Amphetamine results in increased expression of RAB38 mRNA

NCBI chr 1:151,595,153...151,675,492
Ensembl chr 1:151,595,078...151,675,493

G

RAB3A, member RAS oncogene family

decreases expression

EXP

Amphetamine results in decreased expression of RAB3A mRNA

NCBI chr16:18,718,164...18,722,273
Ensembl chr16:18,718,167...18,721,842

G

RAB3A interacting protein

decreases expression

EXP

Amphetamine results in decreased expression of RAB3IP mRNA

NCBI chr 7:54,417,418...54,461,253
Ensembl chr 7:54,418,358...54,447,000

G

RAB44, member RAS oncogene family

increases expression

EXP

Amphetamine results in increased expression of RAB44 mRNA

NCBI chr20:7,166,219...7,200,114
Ensembl chr20:7,166,371...7,200,111

G

RAB, member of RAS oncogene family like 2

increases expression

EXP

Amphetamine results in increased expression of RABL2A mRNA

NCBI chr 7:122,531,787...122,540,500
Ensembl chr 7:122,531,792...122,540,395

G

RAD50 double strand break repair protein

decreases expression

EXP

Amphetamine results in decreased expression of RAD50 mRNA

NCBI chr10:38,310,147...38,362,100
Ensembl chr10:38,310,147...38,362,100

G

RAD54 like 2

decreases expression

EXP

Amphetamine results in decreased expression of RAD54L2 mRNA

NCBI chr 8:116,203,655...116,305,723
Ensembl chr 8:116,203,655...116,305,849

G

recombination activating 1

increases expression

EXP

Amphetamine results in increased expression of RAG1 mRNA

NCBI chr 3:108,372,087...108,383,184
Ensembl chr 3:108,371,978...108,383,261

G

retinoic acid induced 1

decreases expression

EXP

Amphetamine results in decreased expression of RAI1 mRNA

NCBI chr10:45,412,748...45,507,747
Ensembl chr10:45,447,427...45,507,747

G

RAS like proto-oncogene B

increases expression

EXP

Amphetamine results in increased expression of RALB mRNA

NCBI chr13:33,140,834...33,176,997
Ensembl chr13:33,140,835...33,176,998

G

ral guanine nucleotide dissociation stimulator like 1

decreases expression

EXP

Amphetamine results in decreased expression of RGL1 mRNA

NCBI chr13:67,184,402...67,454,019
Ensembl chr13:67,184,402...67,454,019

G

receptor activity modifying protein 1

decreases expression

EXP

Amphetamine results in decreased expression of RAMP1 mRNA

NCBI chr 9:99,213,031...99,263,696

G

receptor activity modifying protein 2

increases expression

EXP

Amphetamine results in increased expression of RAMP2 mRNA

NCBI chr10:86,689,148...86,690,956
Ensembl chr10:86,688,703...86,691,231

G

RAN, member RAS oncogene family

multiple interactions
increases expression

ISO

MDK gene mutant form inhibits the reaction [Amphetamine results in increased expression of RAN protein]

NCBI chr12:33,311,155...33,314,339
Ensembl chr12:33,311,158...33,314,317

G

RAN GTPase activating protein 1

decreases expression

EXP

Amphetamine results in decreased expression of RANGAP1 mRNA

NCBI chr 7:115,104,820...115,130,564
Ensembl chr 7:115,104,823...115,130,564

G

Rap1 GTPase-activating protein

increases expression

EXP

Amphetamine results in increased expression of RAP1GAP mRNA

NCBI chr 5:155,157,511...155,222,622
Ensembl chr 5:155,157,558...155,222,622

G

Rap guanine nucleotide exchange factor 6

decreases expression

EXP

Amphetamine results in decreased expression of RAPGEF6 mRNA

NCBI chr10:39,156,573...39,324,947
Ensembl chr10:39,156,620...39,324,946

G

Ras association (RalGDS/AF-6) and pleckstrin homology domains 1

decreases expression

EXP

Amphetamine results in decreased expression of RAPH1 mRNA

NCBI chr 9:69,397,272...69,484,174
Ensembl chr 9:69,401,517...69,484,019

G

retinoic acid receptor, alpha

increases expression

EXP

Amphetamine results in increased expression of RARA mRNA

NCBI chr10:84,379,780...84,424,371
Ensembl chr10:84,389,622...84,425,160

G

RAS protein activator like 1

decreases expression

EXP

Amphetamine results in decreased expression of RASAL1 mRNA

NCBI chr12:41,541,865...41,574,957
Ensembl chr12:41,541,865...41,574,315

G

ras related dexamethasone induced 1

increases expression

EXP

Amphetamine results in increased expression of RASD1 mRNA

NCBI chr10:45,265,975...45,275,279
Ensembl chr10:45,265,979...45,267,710

G

RAS guanyl releasing protein 1

decreases expression

EXP

Amphetamine results in decreased expression of RASGRP1 mRNA

NCBI chr 3:124,624,039...124,684,079
Ensembl chr 3:124,622,313...124,684,434

G

RAS-like family 11 member B

increases expression

EXP

Amphetamine results in increased expression of RASL11B mRNA

NCBI chr14:34,369,029...34,373,250
Ensembl chr14:34,368,726...34,373,250

G

Ras association domain family member 1

increases expression

EXP

Amphetamine results in increased expression of RASSF1 mRNA

NCBI chr 8:117,103,665...117,114,805
Ensembl chr 8:117,103,362...117,114,805

G

Ras association domain family member 4

increases expression

EXP

Amphetamine results in increased expression of RASSF4 mRNA

NCBI chr 4:151,569,984...151,605,203
Ensembl chr 4:151,569,984...151,604,883

G

defensin rat NP-3 precursor

increases expression

EXP

Amphetamine results in increased expression of RATNP-3B mRNA

NCBI chr16:77,246,811...77,248,977
Ensembl chr16:77,216,342...77,248,966

G

RNA binding fox-1 homolog 3

multiple interactions

ISO

[Amphetamine co-treated with coomassie Brilliant Blue] results in increased expression of RBFOX3 protein

NCBI chr10:104,218,940...104,655,863
Ensembl chr10:104,218,940...104,551,945

G

RB transcriptional corepressor like 1

decreases expression

EXP

Amphetamine results in decreased expression of RBL1 mRNA

NCBI chr 3:166,226,187...166,289,862
Ensembl chr 3:166,226,198...166,289,376

G

RNA binding motif protein 11

increases expression

EXP

Amphetamine results in increased expression of RBM11 mRNA

NCBI chr11:27,721,870...27,731,125
Ensembl chr11:27,721,866...27,731,120

G

RNA binding motif protein 14

decreases expression

EXP

Amphetamine results in decreased expression of RBM14 mRNA

NCBI chr 1:211,476,298...211,535,077
Ensembl chr 1:211,523,972...211,535,065

G

RNA binding motif protein 19

decreases expression

EXP

Amphetamine results in decreased expression of RBM19 mRNA

NCBI chr12:42,026,277...42,111,530
Ensembl chr12:42,026,278...42,111,530

G

RNA binding motif protein 20

increases expression

EXP

Amphetamine results in increased expression of RBM20 mRNA

NCBI chr 1:262,671,311...262,912,551
Ensembl chr 1:262,688,978...262,891,364

G

RNA binding motif protein 26

decreases expression

EXP

Amphetamine results in decreased expression of RBM26 mRNA

NCBI chr15:88,299,378...88,379,365
Ensembl chr15:88,301,436...88,378,686

G

RNA binding motif protein 47

increases expression

EXP

Amphetamine results in increased expression of RBM47 mRNA

NCBI chr14:42,407,226...42,545,304
Ensembl chr14:42,466,335...42,543,163

G

retinol binding protein 7

increases expression

EXP

Amphetamine results in increased expression of RBP7 mRNA

NCBI chr 5:165,169,700...165,177,427
Ensembl chr 5:165,172,785...165,177,399

G

recombination signal binding protein for immunoglobulin kappa J region-like

decreases expression

EXP

Amphetamine results in decreased expression of RBPJL mRNA

NCBI chr 3:173,553,389...173,565,869
Ensembl chr 3:173,553,498...173,565,869

G

RNA binding protein, mRNA processing factor 2

increases expression

EXP

Amphetamine results in increased expression of RBPMS2 mRNA

NCBI chr 8:75,048,159...75,079,393
Ensembl chr 8:75,048,263...75,079,396

G

RCAN family member 3

decreases expression

EXP

Amphetamine results in decreased expression of RCAN3 mRNA

NCBI chr 5:152,934,561...152,955,502
Ensembl chr 5:152,938,711...152,955,589

G

RCC1 and BTB domain containing protein 1

decreases expression

EXP

Amphetamine results in decreased expression of RCBTB1 mRNA

NCBI chr15:37,430,453...37,477,920
Ensembl chr15:37,435,070...37,480,803

G

regulator of chromosome condensation 1

decreases expression

EXP

Amphetamine results in decreased expression of RCC1 mRNA

NCBI chr 5:149,810,037...149,828,475
Ensembl chr 5:149,810,689...149,828,523

G

regulator of chromosome condensation 2

decreases expression

EXP

Amphetamine results in decreased expression of RCC2 mRNA

NCBI chr 5:158,277,476...158,300,294
Ensembl chr 5:158,277,476...158,300,294

G

RCC1 domain containing 1

decreases expression

EXP

Amphetamine results in decreased expression of RCCD1 mRNA

NCBI chr 1:143,681,124...143,690,817
Ensembl chr 1:143,681,035...143,690,362

G

reticulocalbin 2

increases expression

EXP

Amphetamine results in increased expression of RCN2 mRNA

NCBI chr 8:65,345,247...65,362,290
Ensembl chr 8:65,345,273...65,364,632

G

reticulocalbin 3

decreases expression

EXP

Amphetamine results in decreased expression of RCN3 mRNA

NCBI chr 1:104,700,969...104,710,228
Ensembl chr 1:104,700,545...104,710,249

G

retinol dehydrogenase 13

decreases expression

EXP

Amphetamine results in decreased expression of RDH13 mRNA

NCBI chr 1:78,415,765...78,444,116
Ensembl chr 1:78,415,782...78,490,102

G

RecQ like helicase 4

decreases expression

EXP

Amphetamine results in decreased expression of RECQL4 mRNA

NCBI chr 7:110,304,092...110,311,426
Ensembl chr 7:110,304,094...110,311,258

G

RELB proto-oncogene, NF-kB subunit

decreases expression

EXP

Amphetamine results in decreased expression of RELB mRNA

NCBI chr 1:88,385,717...88,413,380
Ensembl chr 1:88,385,717...88,413,420

G

RELT-like 2

decreases expression

EXP

Amphetamine results in decreased expression of RELL2 mRNA

NCBI chr18:30,041,204...30,045,193
Ensembl chr18:30,041,563...30,045,187

G

renin binding protein

increases expression

EXP

Amphetamine results in increased expression of RENBP mRNA

NCBI chr X:156,812,785...156,821,860
Ensembl chr X:156,812,411...156,821,838

G

resistin

increases expression

EXP

Amphetamine results in increased expression of RETN mRNA

NCBI chr12:6,508,653...6,511,115
Ensembl chr12:6,508,801...6,511,116

G

refilin A

decreases expression

EXP

Amphetamine results in decreased expression of RFLNA mRNA

NCBI chr12:37,294,643...37,323,373
Ensembl chr12:37,294,643...37,303,535

G

raftlin lipid raft linker 1

decreases expression

EXP

Amphetamine results in decreased expression of RFTN1 mRNA

NCBI chr 9:18,302,143...18,499,819
Ensembl chr 9:18,285,934...18,499,819

G

regulatory factor X2

increases expression

EXP

Amphetamine results in increased expression of RFX2 mRNA

NCBI chr 9:1,691,762...1,759,159
Ensembl chr 9:1,690,612...1,758,529

G

regulatory factor X5

decreases expression

EXP

Amphetamine results in decreased expression of RFX5 mRNA

NCBI chr 2:185,210,206...185,217,735
Ensembl chr 2:185,210,217...185,217,743

G

RGP1 homolog, RAB6A GEF complex partner 1

decreases expression

EXP

Amphetamine results in decreased expression of RGP1 mRNA

NCBI chr 5:62,630,253...62,638,872
Ensembl chr 5:62,630,133...62,638,864

G

regulator of G-protein signaling 18

increases expression

EXP

Amphetamine results in increased expression of RGS18 mRNA

NCBI chr13:59,043,431...59,066,342
Ensembl chr13:59,043,431...59,066,342

G

regulator of G-protein signaling 2

multiple interactions
increases expression

EXP

Raclopride promotes the reaction [Amphetamine results in increased expression of RGS2 mRNA]; SCH 23390 inhibits the reaction [Amphetamine results in increased expression of RGS2 mRNA]

PMID:10098858 PMID:30779732

NCBI chr13:58,350,063...58,352,666
Ensembl chr13:58,349,163...58,352,697

G

regulator of G-protein signaling 3

increases expression

EXP

Amphetamine results in increased expression of RGS3 mRNA

NCBI chr 5:81,037,588...81,177,446
Ensembl chr 5:81,056,068...81,177,445

G

regulator of G-protein signaling 4

decreases expression

EXP

Amphetamine results in decreased expression of RGS4 mRNA

NCBI chr13:84,469,593...84,475,884
Ensembl chr13:84,469,593...84,475,884

G

regulator of G-protein signaling 5

increases expression

EXP

Amphetamine results in increased expression of RGS5 mRNA

PMID:10098858 PMID:30779732

NCBI chr13:84,381,077...84,417,875
Ensembl chr13:84,380,910...84,421,352

G

regulator of G-protein signaling 9

multiple interactions
decreases expression

EXP

[Amphetamine co-treated with 2,3-bis(4-hydroxyphenyl)-propionitrile] results in decreased expression of RGS9 mRNA; [Amphetamine co-treated with Estradiol] affects the expression of RGS9 mRNA; [Amphetamine co-treated with Estradiol] affects the expression of RGS9 protein
Amphetamine results in decreased expression of RGS9 mRNA

PMID:17318883 PMID:17493623 PMID:30779732

NCBI chr10:94,696,556...94,770,387
Ensembl chr10:94,696,556...94,770,387

G

rhomboid domain containing 2

decreases expression

EXP

Amphetamine results in decreased expression of RHBDD2 mRNA

NCBI chr12:26,680,206...26,690,926
Ensembl chr12:26,680,969...26,691,080

G

RHEB like 1

decreases expression

EXP

Amphetamine results in decreased expression of RHEBL1 mRNA

NCBI chr 7:131,905,207...131,910,088
Ensembl chr 7:131,905,207...131,909,199

G

ras homolog family member B

increases expression

EXP

Amphetamine results in increased expression of RHOB mRNA

NCBI chr 6:37,083,030...37,085,204
Ensembl chr 6:37,075,015...37,112,772

G

ras homolog family member C

increases expression

EXP

Amphetamine results in increased expression of RHOC mRNA

NCBI chr 2:194,975,586...194,981,637
Ensembl chr 2:194,975,242...194,983,745

G

Rhox homeobox family member 5

increases expression

EXP

Amphetamine results in increased expression of RHOX5 mRNA

NCBI chr X:121,401,888...121,407,643

G

RIC8 guanine nucleotide exchange factor B

decreases expression

EXP

Amphetamine results in decreased expression of RIC8B mRNA

NCBI chr 7:20,636,337...20,730,066
Ensembl chr 7:20,636,687...20,730,178

G

replication timing regulatory factor 1

decreases expression

EXP

Amphetamine results in decreased expression of RIF1 mRNA

NCBI chr 3:56,963,840...57,017,106
Ensembl chr 3:56,963,854...57,017,106

G

RNA sensor RIG-1

decreases expression

EXP

Amphetamine results in decreased expression of RIGI mRNA

NCBI chr 5:60,117,398...60,165,995
Ensembl chr 5:60,117,398...60,165,995

G

ring finger protein 1

decreases expression

EXP

Amphetamine results in decreased expression of RING1 mRNA

NCBI chr20:4,832,013...4,835,516
Ensembl chr20:4,831,993...4,835,513

G

receptor-interacting serine-threonine kinase 3

increases expression

EXP

Amphetamine results in increased expression of RIPK3 mRNA

NCBI chr15:33,253,071...33,262,025
Ensembl chr15:33,253,071...33,262,025

G

RLF zinc finger

increases expression

EXP

Amphetamine results in increased expression of RLF mRNA

NCBI chr 5:139,996,782...140,052,419
Ensembl chr 5:139,996,782...140,052,419

G

regulator of microtubule dynamics 1

increases expression

EXP

Amphetamine results in increased expression of RMDN1 mRNA

NCBI chr 5:37,867,172...37,890,826
Ensembl chr 5:37,867,263...38,007,420

G

required for meiotic nuclear division 5 homolog B

increases expression

EXP

Amphetamine results in increased expression of RMND5B mRNA

NCBI chr10:36,382,212...36,394,801
Ensembl chr10:36,382,213...36,393,154

G

ribonuclease A family member 2

increases expression

EXP

Amphetamine results in increased expression of RNASE2 mRNA

NCBI chr15:26,923,125...26,923,934
Ensembl chr15:26,923,134...26,923,955

G

ribonuclease A family member 6

decreases expression

EXP

Amphetamine results in decreased expression of RNASE6 mRNA

NCBI chr15:26,827,896...26,830,807
Ensembl chr15:26,827,009...26,830,825

G

ribonuclease K

increases expression

EXP

Amphetamine results in increased expression of RNASEK mRNA

NCBI chr10:55,453,561...55,455,279
Ensembl chr10:55,453,563...55,455,279

G

Rho family GTPase 3

increases expression

EXP

Amphetamine results in increased expression of RND3 mRNA

NCBI chr 3:55,981,142...55,998,494
Ensembl chr 3:55,980,355...55,998,536

G

ring finger protein 125

decreases expression

EXP

Amphetamine results in decreased expression of RNF125 mRNA

NCBI chr18:12,528,995...12,550,646
Ensembl chr18:12,528,838...12,554,430

G

ring finger protein 141

increases expression

EXP

Amphetamine results in increased expression of RNF141 mRNA

NCBI chr 1:174,365,789...174,391,848

G

ring finger protein 157

decreases expression

EXP

Amphetamine results in decreased expression of RNF157 mRNA

NCBI chr10:102,070,842...102,138,738
Ensembl chr10:102,070,842...102,155,802

G

ring finger protein 183

increases expression

EXP

Amphetamine results in increased expression of RNF183 mRNA

NCBI chr 5:80,892,683...80,914,037
Ensembl chr 5:80,892,190...80,902,196

G

ring finger protein 213

decreases expression

EXP

Amphetamine results in decreased expression of RNF213 mRNA

NCBI chr10:105,154,873...105,254,148
Ensembl chr10:105,157,904...105,254,148

G

ring finger protein 26

decreases expression

EXP

Amphetamine results in decreased expression of RNF26 mRNA

NCBI chr 8:53,351,388...53,353,586
Ensembl chr 8:53,341,487...53,355,777

G

ring finger protein 43

decreases expression

EXP

Amphetamine results in decreased expression of RNF43 mRNA

NCBI chr10:72,958,744...73,034,540
Ensembl chr10:72,961,641...73,034,551

G

ribonuclease/angiogenin inhibitor 1

increases expression

EXP

Amphetamine results in increased expression of RNH1 mRNA

NCBI chr 1:205,698,882...205,711,348
Ensembl chr 1:205,698,882...205,711,582

G

rhophilin associated tail protein 1-like

increases expression

EXP

Amphetamine results in increased expression of ROPN1L mRNA

NCBI chr 2:84,153,529...84,164,216
Ensembl chr 2:84,153,529...84,164,415

G

replication protein A1

decreases expression

EXP

Amphetamine results in decreased expression of RPA1 mRNA

NCBI chr10:60,647,185...60,698,279
Ensembl chr10:60,647,185...60,698,279

G

RPGR interacting protein 1

decreases expression

EXP

Amphetamine results in decreased expression of RPGRIP1 mRNA

NCBI chr15:27,282,997...27,341,021
Ensembl chr15:27,282,998...27,341,021

G

ribosomal protein L38

increases expression

EXP

Amphetamine results in increased expression of RPL38 mRNA

NCBI chr10:100,200,414...100,204,070
Ensembl chr16:10,188,932...10,189,144
Ensembl chr 2:10,188,932...10,189,144
Ensembl chr 3:10,188,932...10,189,144
Ensembl chr14:10,188,932...10,189,144
Ensembl chr10:10,188,932...10,189,144

G

ribonuclease P and MRP subunit p25

increases expression

EXP

Amphetamine results in increased expression of RPP25 mRNA

NCBI chr 8:66,803,262...66,804,642
Ensembl chr 8:66,803,212...66,810,550

G

ribosomal protein S19 binding protein 1

decreases expression

EXP

Amphetamine results in decreased expression of RPS19BP1 mRNA

NCBI chr 7:113,689,636...113,693,116
Ensembl chr 7:113,689,636...113,693,023

G

ribosomal protein S9

increases expression

EXP

Amphetamine results in increased expression of RPS9 mRNA

NCBI chr 1:74,427,084...74,430,513
Ensembl chr 1:74,427,087...74,430,105

G

RNA pseudouridine synthase domain containing 2

decreases expression

EXP

Amphetamine results in decreased expression of RPUSD2 mRNA

NCBI chr 3:126,471,620...126,476,869
Ensembl chr 3:126,471,579...126,477,180

G

RRAD, Ras related glycolysis inhibitor and calcium channel regulator

increases expression

EXP

Amphetamine results in increased expression of RRAD mRNA

NCBI chr19:360,581...363,874
Ensembl chr19:360,973...363,871

G

Ras-related GTP binding B

decreases expression

EXP

Amphetamine results in decreased expression of RRAGB mRNA

NCBI chr X:21,560,313...21,610,550
Ensembl chr X:21,560,361...21,610,346

G

ribosome binding protein 1

increases expression

EXP

Amphetamine results in increased expression of RRBP1 mRNA

NCBI chr 3:151,768,386...151,830,255
Ensembl chr 3:151,768,386...151,830,255

G

ribonucleotide reductase regulatory subunit M2

increases expression

EXP

Amphetamine results in increased expression of RRM2 mRNA

NCBI chr 6:47,044,755...47,075,370
Ensembl chr 6:47,067,690...47,075,370

G

ribosomal RNA processing 12

decreases expression

EXP

Amphetamine results in decreased expression of RRP12 mRNA

NCBI chr 1:250,621,707...250,655,318
Ensembl chr 1:250,621,707...250,655,318

G

ribosomal RNA processing 1B

decreases expression

EXP

Amphetamine results in decreased expression of RRP1B mRNA

NCBI chr20:10,122,825...10,148,404
Ensembl chr20:10,122,812...10,148,404

G

ribosome biogenesis regulator 1 homolog

decreases expression

EXP

Amphetamine results in decreased expression of RRS1 mRNA

NCBI chr 5:14,516,303...14,517,936
Ensembl chr 5:14,515,254...14,517,943

G

radial spoke head component 1

increases expression

EXP

Amphetamine results in increased expression of RSPH1 mRNA

NCBI chr20:9,343,258...9,361,988
Ensembl chr20:9,343,261...9,361,988

G

RT1 class II, locus DOa

decreases expression

EXP

Amphetamine results in decreased expression of RT1-DOA mRNA

NCBI chr20:4,755,287...4,758,491
Ensembl chr20:4,755,499...4,758,478

G

RT1 class II, locus DOb

decreases expression

EXP

Amphetamine results in decreased expression of RT1-DOB mRNA

NCBI chr20:4,621,336...4,627,537
Ensembl chr20:4,619,694...4,627,523

G

RT1 class Ib, locus N2

decreases expression

EXP

Amphetamine results in decreased expression of RT1-N2 mRNA

NCBI chr20:2,645,980...2,650,260
Ensembl chr20:2,645,992...2,650,256

G

RT1 class Ib, locus N3

decreases expression

EXP

Amphetamine results in decreased expression of RT1-N3 mRNA

NCBI chr20:2,666,469...2,670,355
Ensembl chr20:2,666,464...2,670,348

G

RT1 class Ib, locus S2

increases expression

EXP

Amphetamine results in increased expression of RT1-S2 mRNA

NCBI chr20:2,655,054...2,664,895
Ensembl chr20:2,655,054...2,656,475

G

RT1 class Ib, locus T18

increases expression

EXP

Amphetamine results in increased expression of RT1-T18 mRNA

NCBI chr20:2,605,478...2,614,543

G

RT1 class I, locus T24, gene 4

increases expression

EXP

Amphetamine results in increased expression of RT1-T24-4 mRNA

NCBI chr20:2,689,329...2,749,848
Ensembl chr20:2,689,315...2,747,100

G

regulator of telomere elongation helicase 1

decreases expression

EXP

Amphetamine results in decreased expression of RTEL1 mRNA

NCBI chr 3:188,778,329...188,842,877
Ensembl chr 3:188,807,951...188,843,709

G

retrotransposon Gag like 6

decreases expression

EXP

Amphetamine results in decreased expression of RTL6 mRNA

NCBI chr 7:117,564,780...117,569,865
Ensembl chr 7:117,563,239...117,570,129

G

reticulon 3

increases expression

EXP

Amphetamine results in increased expression of RTN3 mRNA

NCBI chr 1:214,041,838...214,098,644
Ensembl chr 1:214,041,838...214,109,638

G

receptor (chemosensory) transporter protein 4

decreases expression

EXP

Amphetamine results in decreased expression of RTP4 mRNA

NCBI chr11:90,741,992...90,840,061
Ensembl chr11:90,741,992...90,753,851

G

RUNX family transcription factor 3

decreases expression

EXP

Amphetamine results in decreased expression of RUNX3 mRNA

NCBI chr 5:152,644,270...152,702,835
Ensembl chr 5:152,644,270...152,702,835

G

S100 calcium binding protein A10

increases expression

EXP

Amphetamine results in increased expression of S100A10 mRNA

NCBI chr 2:181,904,454...181,913,101
Ensembl chr 2:181,904,261...181,913,103

G

S100 calcium binding protein A11

increases expression

EXP

Amphetamine results in increased expression of S100A11 mRNA

NCBI chr 2:181,875,132...181,880,542
Ensembl chr 2:181,875,130...181,880,541

G

S100 calcium binding protein A16

increases expression

EXP

Amphetamine results in increased expression of S100A16 mRNA

NCBI chr 2:178,313,986...178,319,696
Ensembl chr 2:178,313,910...178,319,821

G

S100 calcium binding protein A3

increases expression

EXP

Amphetamine results in increased expression of S100A3 mRNA

NCBI chr 2:178,331,856...178,387,280
Ensembl chr 2:178,384,578...178,387,280

G

S100 calcium-binding protein A4

increases expression

EXP

Amphetamine results in increased expression of S100A4 mRNA

NCBI chr 2:178,388,529...178,390,838
Ensembl chr 2:178,388,526...178,390,837

G

S100 calcium binding protein A6

increases expression

EXP

Amphetamine results in increased expression of S100A6 mRNA

NCBI chr 2:178,398,189...178,399,763
Ensembl chr 2:178,398,481...178,399,762

G

sacsin molecular chaperone

decreases expression

EXP

Amphetamine results in decreased expression of SACS mRNA

NCBI chr15:39,461,853...39,546,419
Ensembl chr15:39,472,905...39,546,419

G

sterile alpha motif domain containing 9 like

decreases expression

EXP

Amphetamine results in decreased expression of SAMD9L mRNA

NCBI chr 4:32,316,748...32,331,112
Ensembl chr 4:32,222,623...32,331,067

G

Sin3A associated protein 130

decreases expression

EXP

Amphetamine results in decreased expression of SAP130 mRNA

NCBI chr18:23,518,773...23,619,840
Ensembl chr18:23,518,680...23,619,840

G

store-operated calcium entry-associated regulatory factor

increases expression

EXP

Amphetamine results in increased expression of SARAF mRNA

NCBI chr16:64,720,404...64,738,653
Ensembl chr16:64,720,418...64,738,653

G

spermidine/spermine N1-acetyl transferase 1

increases expression

EXP

Amphetamine results in increased expression of SAT1 mRNA

NCBI chr X:44,008,089...44,011,376
Ensembl chr X:44,006,781...44,011,374

G

SATB homeobox 1

decreases expression

EXP

Amphetamine results in decreased expression of SATB1 mRNA

NCBI chr 9:4,916,958...5,010,359
Ensembl chr 9:4,917,215...4,989,925

G

SH3 domain binding kinase 1

decreases expression

EXP

Amphetamine results in decreased expression of SBK1 mRNA

NCBI chr 1:190,237,677...190,282,494
Ensembl chr 1:190,273,642...190,282,473

G

secretory carrier membrane protein 1

increases expression

EXP

Amphetamine results in increased expression of SCAMP1 mRNA

NCBI chr 2:27,168,863...27,251,637
Ensembl chr 2:27,168,864...27,251,742

G

SREBF chaperone

decreases expression

EXP

Amphetamine results in decreased expression of SCAP mRNA

NCBI chr 8:119,184,366...119,239,086
Ensembl chr 8:119,184,438...119,239,075

G

S-phase cyclin A-associated protein in the ER

decreases expression

EXP

Amphetamine results in decreased expression of SCAPER mRNA

NCBI chr 8:64,828,789...65,228,240
Ensembl chr 8:64,828,789...65,228,453

G

scavenger receptor class A, member 3

increases expression

EXP

Amphetamine results in increased expression of SCARA3 mRNA

NCBI chr15:44,315,422...44,348,416
Ensembl chr15:44,315,422...44,348,551

G

stearoyl-CoA desaturase

decreases expression

EXP

Amphetamine results in decreased expression of SCD mRNA

NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:253,218,970...253,231,785

G

secretogranin II

multiple interactions
increases expression

EXP

Baclofen inhibits the reaction [Amphetamine results in increased expression of SCG2 mRNA]

PMID:12638131 PMID:15033416 PMID:15592348

NCBI chr 9:88,251,531...88,257,208
Ensembl chr 9:88,251,354...88,269,598

G

schwannomin interacting protein 1

increases expression

EXP

Amphetamine results in increased expression of SCHIP1 mRNA

NCBI chr 2:154,437,217...155,198,560
Ensembl chr 2:155,060,798...155,198,557

G

SLP adaptor and CSK interacting membrane protein

increases expression

EXP

Amphetamine results in increased expression of SCIMP mRNA

NCBI chr10:56,006,243...56,026,357
Ensembl chr10:56,006,243...56,026,357

G

Scm polycomb group protein homolog 1

decreases expression

EXP

Amphetamine results in decreased expression of SCMH1 mRNA

NCBI chr 5:139,276,352...139,401,118
Ensembl chr 5:139,314,447...139,403,081

G

Scm polycomb group protein like 4

decreases expression

EXP

Amphetamine results in decreased expression of SCML4 mRNA

NCBI chr20:47,929,539...48,023,419
Ensembl chr20:47,929,539...48,023,419

G

sodium voltage-gated channel alpha subunit 4

decreases expression

EXP

Amphetamine results in decreased expression of SCN4A mRNA

NCBI chr10:91,745,459...91,796,452
Ensembl chr10:91,746,715...91,796,324

G

syndecan binding protein

increases expression

EXP

Amphetamine results in increased expression of SDCBP mRNA

NCBI chr 5:24,245,279...24,314,712
Ensembl chr 5:24,245,033...24,326,197

G

short chain dehydrogenase/reductase family 39U, member 1

decreases expression

EXP

Amphetamine results in decreased expression of SDR39U1 mRNA

NCBI chr15:33,348,057...33,350,892
Ensembl chr15:33,348,059...33,354,600

G

SEC11 homolog C, signal peptidase complex subunit

increases expression

EXP

Amphetamine results in increased expression of SEC11C mRNA

NCBI chr18:61,590,905...61,607,247
Ensembl chr18:61,590,885...61,607,348

G

SEC24 homolog D, COPII coat complex component

increases expression

EXP

Amphetamine results in increased expression of SEC24D mRNA

NCBI chr 2:214,103,138...214,211,155
Ensembl chr 2:214,103,190...214,211,144

G

SEC31 homolog A, COPII coat complex component

decreases expression

EXP

Amphetamine results in decreased expression of SEC31A mRNA

NCBI chr14:9,518,655...9,573,579
Ensembl chr14:9,518,648...9,573,585

G

SEC31 homolog B, COPII coat complex component

decreases expression

EXP

Amphetamine results in decreased expression of SEC31B mRNA

NCBI chr 1:253,324,081...253,353,779
Ensembl chr 1:253,327,232...253,353,779

G

SEC61 translocon subunit beta

increases expression

EXP

Amphetamine results in increased expression of SEC61B mRNA

NCBI chr 5:66,569,184...66,577,394
Ensembl chr 5:66,569,196...66,580,028

G

selenium binding protein 1

increases expression

EXP

Amphetamine results in increased expression of SELENBP1 mRNA

NCBI chr 2:185,183,022...185,193,612
Ensembl chr 2:185,183,004...185,194,295

G

semaphorin 3D

increases expression

EXP

Amphetamine results in increased expression of SEMA3D mRNA

NCBI chr 4:23,271,815...23,460,971
Ensembl chr 4:23,271,825...23,460,971

G

semaphorin 6B

increases expression

EXP

Amphetamine results in increased expression of SEMA6B mRNA

NCBI chr 9:1,038,103...1,055,063
Ensembl chr 9:1,038,103...1,048,868

G

semenogelin 1

increases expression

EXP

Amphetamine results in increased expression of SEMG1 mRNA

NCBI chr 3:173,329,413...173,332,261
Ensembl chr 3:173,329,414...173,332,261

G

small EDRK-rich factor 1

increases expression

EXP

Amphetamine results in increased expression of SERF1 mRNA

NCBI chr 2:33,210,001...33,216,129
Ensembl chr 2:33,209,851...33,216,127

G

serine incorporator 2

increases expression

EXP

Amphetamine results in increased expression of SERINC2 mRNA

NCBI chr 5:147,876,477...147,898,797
Ensembl chr 5:147,876,477...147,902,765

G

serpin family B member 10

increases expression

EXP

Amphetamine results in increased expression of SERPINB10 mRNA

NCBI chr13:24,067,971...24,085,814
Ensembl chr13:24,068,040...24,085,802

G

serpin family B member 2

increases expression

EXP

Amphetamine results in increased expression of SERPINB2 mRNA

NCBI chr13:24,051,933...24,065,032
Ensembl chr13:24,056,021...24,065,031

G

serpin family B member 8

increases expression

EXP

Amphetamine results in increased expression of SERPINB8 mRNA

NCBI chr13:24,141,557...24,164,894
Ensembl chr13:24,129,855...24,166,076

G

serpin family I member 1

increases expression

EXP

Amphetamine results in increased expression of SERPINI1 mRNA

NCBI chr 2:162,645,209...162,731,737
Ensembl chr 2:162,645,350...162,731,740

G

SERTA domain containing 1

increases expression

EXP

Amphetamine results in increased expression of SERTAD1 mRNA

NCBI chr 1:91,903,297...91,906,565
Ensembl chr 1:91,891,814...91,907,001

G

SERTA domain containing 3

increases expression

EXP

Amphetamine results in increased expression of SERTAD3 mRNA

NCBI chr 1:91,891,141...91,894,861
Ensembl chr 1:91,893,616...91,897,110

G

sestrin 1

decreases expression

EXP

Amphetamine results in decreased expression of SESN1 mRNA

NCBI chr20:46,876,918...46,970,010
Ensembl chr20:46,876,895...46,970,010

G

sestrin 3

decreases expression

EXP

Amphetamine results in decreased expression of SESN3 mRNA

NCBI chr 8:19,415,307...19,470,943
Ensembl chr 8:19,415,347...19,466,904

G

SEC14 and spectrin domain containing 1

increases expression

EXP

Amphetamine results in increased expression of SESTD1 mRNA

NCBI chr 3:82,530,796...82,627,960
Ensembl chr 3:82,537,092...82,588,078

G

senataxin

decreases expression

EXP

Amphetamine results in decreased expression of SETX mRNA

NCBI chr 3:32,825,771...32,878,740
Ensembl chr 3:32,828,412...32,878,740

G

Scm-like with four mbt domains 1

decreases expression

EXP

Amphetamine results in decreased expression of SFMBT1 mRNA

NCBI chr16:5,896,686...6,016,311
Ensembl chr16:5,897,187...6,011,934

G

sarcoglycan, epsilon

increases expression

EXP

Amphetamine results in increased expression of SGCE mRNA

NCBI chr 4:33,738,066...33,808,907
Ensembl chr 4:33,737,814...33,808,908

G

serum/glucocorticoid regulated kinase 1

increases expression

EXP

Amphetamine results in increased expression of SGK1 mRNA

NCBI chr 1:24,799,391...24,916,886
Ensembl chr 1:24,799,396...24,807,231

G

sphingosine-1-phosphate phosphatase 2

increases expression

EXP

Amphetamine results in increased expression of SGPP2 mRNA

NCBI chr 9:87,211,155...87,331,787
Ensembl chr 9:87,211,717...87,333,132

G

small G protein signaling modulator 3

increases expression

EXP

Amphetamine results in increased expression of SGSM3 mRNA

NCBI chr 7:114,394,724...114,424,285
Ensembl chr 7:114,394,813...114,424,489

G

SH3 domain containing GRB2 like 2, endophilin A1

increases expression

EXP

Amphetamine results in increased expression of SH3GL2 mRNA

NCBI chr 5:104,699,270...104,874,724
Ensembl chr 5:104,698,929...105,159,896

G

SH3 and PX domains 2A

decreases expression

EXP

Amphetamine results in decreased expression of SH3PXD2A mRNA

NCBI chr 1:256,094,991...256,301,120
Ensembl chr 1:256,094,991...256,300,967

G

src homology 2 domain-containing transforming protein D

decreases expression

EXP

Amphetamine results in decreased expression of SHD mRNA

NCBI chr 9:888,865...895,557
Ensembl chr 9:889,704...895,557

G

Src homology 2 domain containing E

decreases expression

EXP

Amphetamine results in decreased expression of SHE mRNA

NCBI chr 2:177,559,636...177,585,485
Ensembl chr 2:177,560,207...177,588,016

G

shisa family member 7

decreases expression

EXP

Amphetamine results in decreased expression of SHISA7 mRNA

NCBI chr 1:78,022,680...78,041,748
Ensembl chr 1:78,022,831...78,041,748

G

serine hydroxymethyltransferase 2

decreases expression

EXP

Amphetamine results in decreased expression of SHMT2 mRNA

NCBI chr 7:65,244,247...65,249,580
Ensembl chr 7:65,244,247...65,249,567

G

sedoheptulokinase

increases expression

EXP

Amphetamine results in increased expression of SHPK mRNA

NCBI chr10:58,316,065...58,340,489
Ensembl chr10:58,316,111...58,340,490

G

SNF2 histone linker PHD RING helicase

decreases expression

EXP

Amphetamine results in decreased expression of SHPRH mRNA

NCBI chr 1:7,349,073...7,422,804
Ensembl chr 1:7,320,395...7,422,794

G

SID1 transmembrane family, member 1

decreases expression

EXP

Amphetamine results in decreased expression of SIDT1 mRNA

NCBI chr11:69,867,758...69,965,377
Ensembl chr11:69,868,795...69,965,519

G

single Ig and TIR domain containing

decreases expression

EXP

Amphetamine results in decreased expression of SIGIRR mRNA

NCBI chr 1:205,625,742...205,637,883
Ensembl chr 1:205,627,708...205,637,802

G

SIL1 nucleotide exchange factor

decreases expression

EXP

Amphetamine results in decreased expression of SIL1 mRNA

NCBI chr18:27,146,526...27,378,459
Ensembl chr18:27,146,527...27,307,693

G

signal-induced proliferation-associated 1 like 1

decreases expression

EXP

Amphetamine results in decreased expression of SIPA1L1 mRNA

NCBI chr 6:107,570,569...107,849,613
Ensembl chr 6:107,737,392...107,848,160

G

signal-induced proliferation-associated 1 like 2

increases expression

EXP

Amphetamine results in increased expression of SIPA1L2 mRNA

NCBI chr19:70,287,134...70,437,810
Ensembl chr19:70,287,147...70,437,773

G

src kinase associated phosphoprotein 1

decreases expression

EXP

Amphetamine results in decreased expression of SKAP1 mRNA

NCBI chr10:81,921,961...82,229,106
Ensembl chr10:81,921,980...82,229,105

G

Src-like-adaptor 2

decreases expression

EXP

Amphetamine results in decreased expression of SLA2 mRNA

NCBI chr 3:165,821,164...165,848,087
Ensembl chr 3:165,828,657...165,847,062

G

SLAIN motif family, member 1

decreases expression

EXP

Amphetamine results in decreased expression of SLAIN1 mRNA

NCBI chr15:86,897,476...86,957,113
Ensembl chr15:86,897,476...86,957,113

G

signaling lymphocytic activation molecule family member 1

decreases expression

EXP

Amphetamine results in decreased expression of SLAMF1 mRNA

NCBI chr13:86,802,708...86,837,890
Ensembl chr13:86,802,708...86,837,890

G

SLAM family member 7

decreases expression

EXP

Amphetamine results in decreased expression of SLAMF7 mRNA

NCBI chr13:86,668,060...86,688,222
Ensembl chr13:86,668,060...86,686,341

G

SLAM family member 9

increases expression

EXP

Amphetamine results in increased expression of SLAMF9 mRNA

NCBI chr13:87,474,290...87,477,108
Ensembl chr13:87,474,290...87,477,107

G

stem-loop histone mRNA binding protein

increases expression

EXP

Amphetamine results in increased expression of SLBP mRNA

NCBI chr14:81,295,479...81,306,446
Ensembl chr14:81,296,223...81,306,447

G

solute carrier family 10 member 6

increases expression

EXP

Amphetamine results in increased expression of SLC10A6 mRNA

NCBI chr14:6,385,348...6,407,532
Ensembl chr14:6,385,537...6,408,894

G

solute carrier family 12 member 3

decreases expression

EXP

Amphetamine results in decreased expression of SLC12A3 mRNA

NCBI chr19:10,636,594...10,690,008
Ensembl chr19:10,636,596...10,675,050

G

solute carrier family 12 member 5

decreases expression

EXP

Amphetamine results in decreased expression of SLC12A5 mRNA

NCBI chr 3:174,115,833...174,155,112
Ensembl chr 3:174,115,833...174,155,112

G

solute carrier family 12 member 7

decreases expression

EXP

Amphetamine results in decreased expression of SLC12A7 mRNA

NCBI chr 1:31,301,243...31,382,825
Ensembl chr 1:31,301,243...31,382,957

G

solute carrier family 14 member 1 (Kidd blood group)

decreases expression

EXP

Amphetamine results in decreased expression of SLC14A1 mRNA

NCBI chr18:73,840,568...73,883,925
Ensembl chr18:73,840,569...73,870,489

G

solute carrier family 16 member 3

increases expression

EXP

Amphetamine results in increased expression of SLC16A3 mRNA

NCBI chr10:106,712,328...106,756,168
Ensembl chr10:106,714,466...106,720,903

G

solute carrier family 18 member A2

decreases expression
multiple interactions

ISO

Amphetamine results in decreased expression of SLC18A2 protein
SOD1 protein inhibits the reaction [Amphetamine results in decreased expression of SLC18A2 protein]

NCBI chr 1:268,399,815...268,435,229
Ensembl chr 1:268,400,016...268,435,231

G

solute carrier family 22, member 15

increases expression

EXP

Amphetamine results in increased expression of SLC22A15 mRNA

NCBI chr 2:191,987,409...192,049,859
Ensembl chr 2:191,987,409...192,047,362

G

solute carrier family 22 member 3

multiple interactions

EXP

Amphetamine inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]

NCBI chr 1:50,783,218...50,872,358
Ensembl chr 1:50,783,218...50,872,353

G

solute carrier family 24 member 5

increases expression

EXP

Amphetamine results in increased expression of SLC24A5 mRNA

NCBI chr 3:132,772,804...132,792,342
Ensembl chr 3:132,772,804...132,792,342

G

solute carrier family 25 member 10

decreases expression

EXP

Amphetamine results in decreased expression of SLC25A10 mRNA

NCBI chr10:106,264,396...106,271,895
Ensembl chr10:106,264,344...106,273,498

G

solute carrier family 25 member 16

increases expression

EXP

Amphetamine results in increased expression of SLC25A16 mRNA

NCBI chr20:25,659,847...25,717,080
Ensembl chr20:25,660,339...25,689,285
Ensembl chr20:25,660,339...25,689,285

G

solute carrier family 25 (pyrimidine nucleotide carrier ), member 36-like 1

decreases expression

EXP

Amphetamine results in decreased expression of SLC25A36L1 mRNA

NCBI chr19:49,851,197...49,853,288
Ensembl chr19:49,852,049...49,853,144

G

solute carrier family 26 member 2

decreases expression

EXP

Amphetamine results in decreased expression of SLC26A2 mRNA

NCBI chr18:56,918,662...56,937,032
Ensembl chr18:56,923,337...56,937,012

G

solute carrier family 26 member 3

increases expression

EXP

Amphetamine results in increased expression of SLC26A3 mRNA

NCBI chr 6:53,751,415...53,792,300
Ensembl chr 6:53,751,415...53,792,294

G

solute carrier family 26 member 6

decreases expression

EXP

Amphetamine results in decreased expression of SLC26A6 mRNA

NCBI chr 8:118,438,110...118,448,271
Ensembl chr 8:118,438,180...118,448,270

G

solute carrier family 2 member 1

increases expression

EXP

Amphetamine results in increased expression of SLC2A1 mRNA

NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:138,002,522...138,030,742

G

solute carrier family 35, member E4

increases expression

EXP

Amphetamine results in increased expression of SLC35E4 mRNA

NCBI chr14:83,026,914...83,033,778
Ensembl chr14:83,026,915...83,033,778

G

solute carrier family 35, member F5

increases expression

EXP

Amphetamine results in increased expression of SLC35F5 mRNA

NCBI chr13:39,544,253...39,581,210
Ensembl chr13:39,544,757...39,581,223

G

solute carrier family 35, member G2

increases expression

EXP

Amphetamine results in increased expression of SLC35G2 mRNA

NCBI chr 8:109,964,589...109,992,347
Ensembl chr 8:109,964,378...109,992,412

G

solute carrier family 36 member 4

decreases expression

EXP

Amphetamine results in decreased expression of SLC36A4 mRNA

NCBI chr 8:20,801,256...20,834,046
Ensembl chr 8:20,801,289...20,834,044

G

solute carrier family 37, member 3

increases expression

EXP

Amphetamine results in increased expression of SLC37A3 mRNA

NCBI chr 4:69,076,124...69,120,392
Ensembl chr 4:69,076,149...69,120,371

G

solute carrier family 38, member 1

decreases expression

EXP

Amphetamine results in decreased expression of SLC38A1 mRNA

NCBI chr 7:129,612,414...129,681,727
Ensembl chr 7:129,617,387...129,681,778

G

solute carrier family 38, member 2

increases expression

EXP

Amphetamine results in increased expression of SLC38A2 mRNA

NCBI chr 7:129,730,450...129,742,619
Ensembl chr 7:129,730,450...129,742,619

G

solute carrier family 39 member 8

increases expression

EXP

Amphetamine results in increased expression of SLC39A8 mRNA

NCBI chr 2:226,845,686...226,992,668
Ensembl chr 2:226,929,644...226,992,667

G

solute carrier family 43, member 3

increases expression

EXP

Amphetamine results in increased expression of SLC43A3 mRNA

NCBI chr 3:90,414,822...90,450,654
Ensembl chr 3:90,415,977...90,436,976

G

solute carrier family 45, member 3

decreases expression

EXP

Amphetamine results in decreased expression of SLC45A3 mRNA

NCBI chr13:45,959,467...45,979,763
Ensembl chr13:45,959,467...45,979,763

G

solute carrier family 4 member 11

decreases expression

EXP

Amphetamine results in decreased expression of SLC4A11 mRNA

NCBI chr 3:138,353,305...138,365,983
Ensembl chr 3:138,353,305...138,365,754

G

solute carrier family 4 member 4

decreases expression

EXP

Amphetamine results in decreased expression of SLC4A4 mRNA

NCBI chr14:19,125,394...19,577,379
Ensembl chr14:19,129,264...19,577,435

G

solute carrier family 5 member 6

decreases expression

EXP

Amphetamine results in decreased expression of SLC5A6 mRNA

NCBI chr 6:31,039,865...31,051,671
Ensembl chr 6:31,040,017...31,051,670

G

solute carrier family 66 member 2

increases expression

EXP

Amphetamine results in increased expression of SLC66A2 mRNA

NCBI chr18:75,976,000...76,014,651
Ensembl chr18:75,977,458...76,014,651

G

solute carrier family 6 member 2

multiple interactions
affects response to substance
decreases expression
decreases activity

ISO

Amphetamine inhibits the reaction [nisoxetine binds to SLC6A2 protein]; Amphetamine inhibits the reaction [SLC6A2 protein results in increased import of Biogenic Monoamines analog]; Amphetamine inhibits the reaction [SLC6A2 protein results in increased import of Fluorescent Dyes]
SLC6A2 SNP affects the susceptibility to Amphetamine
Amphetamine results in decreased expression of SLC6A2 protein
Amphetamine results in decreased activity of SLC6A2 protein

PMID:11082428 PMID:19727679 PMID:28506818

NCBI chr19:30,183,289...30,228,292
Ensembl chr19:30,183,383...30,223,348

G

solute carrier family 6 member 3

increases expression
decreases response to substance
decreases expression
multiple interactions
increases response to substance
affects localization
affects response to substance

EXP
ISO

Amphetamine results in increased expression of SLC6A3 mRNA
SLC6A3 3' UTR polymorphism results in decreased susceptibility to Amphetamine
Amphetamine results in decreased expression of DAT mRNA
[Amphetamine co-treated with SLC6A3 protein] results in increased expression of FOS mRNA; [Amphetamine co-treated with SLC6A3 protein] results in increased expression of FOS protein; [Amphetamine co-treated with Zinc] results in decreased localization of SLC6A3 protein; Amphetamine inhibits the reaction [SLC6A3 protein mutant form results in increased export of Dopamine]; Amphetamine inhibits the reaction [SLC6A3 protein results in increased import of Biogenic Monoamines analog]; Amphetamine inhibits the reaction [SLC6A3 protein results in increased import of Fluorescent Dyes]; Amphetamine inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine]; SOD1 protein inhibits the reaction [Amphetamine results in decreased expression of SLC6A3 protein]
SLC6A3 protein results in increased susceptibility to Amphetamine
SLC6A3 protein affects the reaction [Amphetamine results in increased expression of FOS protein]
Amphetamine affects the localization of SLC6A3 protein
SLC6A3 3' UTR polymorphism affects the susceptibility to Amphetamine

PMID:11731100 PMID:12112414 PMID:12699766 PMID:15183010 PMID:15602501 More...

NCBI chr 1:31,537,990...31,578,962
Ensembl chr 1:31,537,990...31,578,962

G

solute carrier family 6 member 4

multiple interactions

ISO

Amphetamine inhibits the reaction [SLC6A4 protein results in increased import of Biogenic Monoamines analog]; Amphetamine inhibits the reaction [SLC6A4 protein results in increased import of Fluorescent Dyes]

NCBI chr10:62,322,688...62,357,060
Ensembl chr10:62,324,254...62,357,056

G

solute carrier family 6 member 9

affects response to substance

ISO

SLC6A9 protein affects the susceptibility to Amphetamine

NCBI chr 5:136,660,022...136,694,173
Ensembl chr 5:136,659,948...136,694,172

G

solute carrier family 7 member 1

decreases expression

EXP

Amphetamine results in decreased expression of SLC7A1 mRNA

NCBI chr12:11,664,488...11,740,030
Ensembl chr12:11,664,399...11,740,030

G

solute carrier family 7 member 11

increases expression

EXP

Amphetamine results in increased expression of SLC7A11 mRNA

NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695

G

solute carrier family 7 member 2

decreases expression

EXP

Amphetamine results in decreased expression of SLC7A2 mRNA

NCBI chr16:58,115,991...58,174,256
Ensembl chr16:58,120,968...58,174,256

G

solute carrier family 8 member B1

increases expression

EXP

Amphetamine results in increased expression of SLC8B1 mRNA

NCBI chr12:41,690,333...41,713,657
Ensembl chr12:41,690,334...41,713,601

G

solute carrier family 9 member A7

decreases expression

EXP

Amphetamine results in decreased expression of SLC9A7 mRNA

NCBI chr X:4,767,578...4,948,602
Ensembl chr X:4,767,915...4,948,602

G

solute carrier family 9 member A9

decreases expression

EXP

Amphetamine results in decreased expression of SLC9A9 mRNA

NCBI chr 8:104,112,279...104,675,944
Ensembl chr 8:104,112,559...104,676,891

G

solute carrier organic anion transporter family, member 4C1

decreases expression

EXP

Amphetamine results in decreased expression of SLCO4C1 mRNA

NCBI chr 9:104,624,802...104,676,462
Ensembl chr 9:104,624,802...104,676,462

G

solute carrier organic anion transporter family, member 5A1

decreases expression

EXP

Amphetamine results in decreased expression of SLCO5A1 mRNA

NCBI chr 5:11,012,001...11,141,180
Ensembl chr 5:11,012,075...11,141,177

G

schlafen 3

increases expression

EXP

Amphetamine results in increased expression of SLFN3 mRNA

NCBI chr10:68,515,815...68,557,674

G

schlafen family member 5

decreases expression

EXP

Amphetamine results in decreased expression of SLFN5 mRNA

NCBI chr10:68,378,440...68,392,515
Ensembl chr10:68,378,449...68,392,544

G

secretory leukocyte peptidase inhibitor

increases expression

EXP

Amphetamine results in increased expression of SLPI mRNA

NCBI chr 3:173,501,573...173,503,822
Ensembl chr 3:173,501,573...173,503,822

G

secretory leukocyte peptidase inhibitor, pseudogene 1

increases expression

EXP

Amphetamine results in increased expression of SLPI-PS1 mRNA

NCBI chr 3:173,438,485...173,440,746
Ensembl chr 3:173,438,487...173,478,848
Ensembl chr 3:173,438,487...173,478,848

G

SLX4 structure-specific endonuclease subunit

decreases expression

EXP

Amphetamine results in decreased expression of SLX4 mRNA

NCBI chr10:12,032,131...12,055,685
Ensembl chr10:12,033,048...12,055,650

G

SMAD family member 3

decreases expression

EXP

Amphetamine results in decreased expression of SMAD3 mRNA

NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:73,024,760...73,132,324

G

SMAD family member 5

decreases expression

EXP

Amphetamine results in decreased expression of SMAD5 mRNA

NCBI chr17:7,867,640...7,896,983
Ensembl chr17:7,871,984...7,890,992

G

SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4

decreases expression

EXP

Amphetamine results in decreased expression of SMARCA4 mRNA

NCBI chr 8:28,438,370...28,535,071
Ensembl chr 8:28,443,810...28,535,070

G

SWI/SNF related BAF chromatin remodeling complex subunit C1

decreases expression

EXP

Amphetamine results in decreased expression of SMARCC1 mRNA

NCBI chr 8:118,986,917...119,093,161
Ensembl chr 8:118,989,516...119,093,152

G

SMG1, nonsense mediated mRNA decay associated PI3K related kinase

decreases expression

EXP

Amphetamine results in decreased expression of SMG1 mRNA

NCBI chr 1:181,876,134...181,977,894
Ensembl chr 1:181,876,134...181,977,894

G

small integral membrane protein 3

increases expression

EXP

Amphetamine results in increased expression of SMIM3 mRNA

NCBI chr18:56,200,458...56,252,778
Ensembl chr18:56,200,459...56,227,379

G

sphingomyelin phosphodiesterase, acid-like 3A

increases expression

EXP

Amphetamine results in increased expression of SMPDL3A mRNA

NCBI chr20:37,679,004...37,701,979
Ensembl chr20:37,678,964...37,704,260

G

small muscle protein, X-linked

increases expression

EXP

Amphetamine results in increased expression of SMPX mRNA

NCBI chr X:41,049,354...41,107,323
Ensembl chr X:41,049,356...41,107,137

G

single-strand-selective monofunctional uracil-DNA glycosylase 1

decreases expression

EXP

Amphetamine results in decreased expression of SMUG1 mRNA

NCBI chr 7:136,166,157...136,177,673
Ensembl chr 7:136,167,532...136,170,658

G

SET and MYND domain containing 4

decreases expression

EXP

Amphetamine results in decreased expression of SMYD4 mRNA

NCBI chr10:60,698,376...60,744,693
Ensembl chr10:60,698,388...60,744,711

G

SMYD family member 5

decreases expression

EXP

Amphetamine results in decreased expression of SMYD5 mRNA

NCBI chr 4:119,527,115...119,541,580
Ensembl chr 4:119,527,113...119,541,838

G

small nuclear RNA activating complex, polypeptide 4

decreases expression

EXP

Amphetamine results in decreased expression of SNAPC4 mRNA

NCBI chr 3:29,580,157...29,598,440
Ensembl chr 3:29,580,159...29,597,610

G

stannin

decreases expression

EXP

Amphetamine results in decreased expression of SNN mRNA

NCBI chr10:5,079,885...5,088,565
Ensembl chr 1:82,440,586...82,441,390
Ensembl chr10:82,440,586...82,441,390

G

syntrophin, beta 1

decreases expression

EXP

Amphetamine results in decreased expression of SNTB1 mRNA

NCBI chr 7:88,950,642...89,219,017
Ensembl chr 7:88,950,642...89,219,017

G

syntrophin, gamma 2

increases expression

EXP

Amphetamine results in increased expression of SNTG2 mRNA

NCBI chr 6:52,529,481...52,730,972
Ensembl chr 6:52,529,481...52,730,972

G

sorting nexin 18

increases expression

EXP

Amphetamine results in increased expression of SNX18 mRNA

NCBI chr 2:46,965,498...46,991,516
Ensembl chr 2:46,965,498...46,991,516

G

sorting nexin 29

decreases expression

EXP

Amphetamine results in decreased expression of SNX29 mRNA

NCBI chr10:4,391,866...4,805,682
Ensembl chr10:4,394,544...4,813,772

G

sorting nexin family member 30

decreases expression

EXP

Amphetamine results in decreased expression of SNX30 mRNA

NCBI chr 5:79,478,804...79,608,118
Ensembl chr 5:79,478,912...79,607,052

G

sorting nexin 8

decreases expression

EXP

Amphetamine results in decreased expression of SNX8 mRNA

NCBI chr12:19,365,746...19,414,333
Ensembl chr12:19,365,755...19,414,332

G

sterol O-acyltransferase 1

increases expression

EXP

Amphetamine results in increased expression of SOAT1 mRNA

NCBI chr13:71,105,178...71,147,776
Ensembl chr13:71,105,178...71,147,672

G

sterol O-acyltransferase 2

decreases expression

EXP

Amphetamine results in decreased expression of SOAT2 mRNA

NCBI chr 7:135,160,424...135,173,521
Ensembl chr 7:135,160,402...135,173,513

G

suppressor of cytokine signaling 7

decreases expression

EXP

Amphetamine results in decreased expression of SOCS7 mRNA

NCBI chr10:82,848,525...82,885,201
Ensembl chr10:82,848,612...82,885,201

G

superoxide dismutase 1

decreases response to substance
multiple interactions
increases expression

ISO
EXP

SOD1 protein results in decreased susceptibility to Amphetamine
FOS protein promotes the reaction [Amphetamine results in increased expression of SOD1 mRNA]; JUN protein promotes the reaction [Amphetamine results in increased expression of SOD1 mRNA]
SOD1 protein inhibits the reaction [Amphetamine results in decreased expression of SLC6A3 protein]
SOD1 protein inhibits the reaction [Amphetamine results in decreased expression of SLC18A2 protein]

PMID:11731100 PMID:16084549 PMID:30779732

NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399

G

superoxide dismutase 2

increases expression

EXP

Amphetamine results in increased expression of SOD2 mRNA

NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168

G

sortilin 1

increases expression

EXP

Amphetamine results in increased expression of SORT1 mRNA

NCBI chr 2:198,609,466...198,690,481
Ensembl chr 2:198,612,148...198,690,481

G

sosondowah ankyrin repeat domain family member C

increases expression

EXP

Amphetamine results in increased expression of SOWAHC mRNA

NCBI chr20:27,738,247...27,742,713
Ensembl chr20:27,736,326...27,752,912

G

SRY-box transcription factor 13

increases expression

EXP

Amphetamine results in increased expression of SOX13 mRNA

NCBI chr13:47,383,145...47,427,572
Ensembl chr13:47,383,145...47,435,663

G

sperm associated antigen 6

increases expression

EXP

Amphetamine results in increased expression of SPAG6 mRNA

NCBI chr17:86,258,418...86,309,922
Ensembl chr17:86,262,000...86,309,909

G

secreted protein acidic and cysteine rich

increases expression

EXP

Amphetamine results in increased expression of SPARC mRNA

NCBI chr10:40,017,065...40,038,816
Ensembl chr10:40,017,075...40,039,268

G

SPARC like 1

increases expression

EXP

Amphetamine results in increased expression of SPARCL1 mRNA

NCBI chr14:5,937,484...5,968,532
Ensembl chr14:5,914,535...5,969,120

G

spermatogenesis associated 13

decreases expression

EXP

Amphetamine results in decreased expression of SPATA13 mRNA

NCBI chr15:38,954,585...39,083,752
Ensembl chr15:38,810,386...39,083,755

G

spermatogenesis associated 22

decreases expression

EXP

Amphetamine results in decreased expression of SPATA22 mRNA

NCBI chr10:58,443,736...58,461,578
Ensembl chr10:58,417,415...58,461,908

G

Spi-B transcription factor

decreases expression

EXP

Amphetamine results in decreased expression of SPIB mRNA

NCBI chr 1:104,155,456...104,161,311
Ensembl chr 1:104,155,464...104,161,517

G

spindle and centriole associated protein 1

decreases expression

EXP

Amphetamine results in decreased expression of SPICE1 mRNA

NCBI chr11:69,796,490...69,838,304
Ensembl chr11:69,795,884...69,838,266

G

serine peptidase inhibitor, Kazal type 2

decreases expression

EXP

Amphetamine results in decreased expression of SPINK2 mRNA

NCBI chr14:31,321,976...31,328,622
Ensembl chr14:31,322,010...31,328,622

G

sialophorin

decreases expression

EXP

Amphetamine results in decreased expression of SPN mRNA

NCBI chr 1:191,177,449...191,190,115
Ensembl chr 1:191,178,096...191,187,852

G

SPNS lysolipid transporter 3, sphingosine-1-phosphate

decreases expression

EXP

Amphetamine results in decreased expression of SPNS3 mRNA

NCBI chr10:57,612,796...57,667,601
Ensembl chr10:57,612,819...57,667,414

G

SPO11 initiator of meiotic double strand breaks

decreases expression

EXP

Amphetamine results in decreased expression of SPO11 mRNA

NCBI chr 3:182,173,615...182,189,273
Ensembl chr 3:182,175,861...182,189,276

G

speckle type BTB/POZ protein like

decreases expression

EXP

Amphetamine results in decreased expression of SPOPL mRNA

NCBI chr 3:26,478,535...26,552,344
Ensembl chr 3:26,482,163...26,512,634

G

sprouty-related, EVH1 domain containing 3

increases expression

EXP

Amphetamine results in increased expression of SPRED3 mRNA

NCBI chr 1:93,586,259...93,597,692
Ensembl chr 1:93,586,259...93,598,254

G

SPRY domain containing 7

increases expression

EXP

Amphetamine results in increased expression of SPRYD7 mRNA

NCBI chr15:39,883,237...39,903,770
Ensembl chr15:39,883,238...39,903,674

G

splA/ryanodine receptor domain and SOCS box containing 2

increases expression

EXP

Amphetamine results in increased expression of SPSB2 mRNA

NCBI chr 4:159,298,362...159,301,568
Ensembl chr 4:159,299,159...159,309,021

G

serine palmitoyltransferase, long chain base subunit 2

increases expression

EXP

Amphetamine results in increased expression of SPTLC2 mRNA

NCBI chr 6:112,679,623...112,762,470
Ensembl chr 6:112,679,623...112,762,640

G

sulfide quinone oxidoreductase

increases expression

EXP

Amphetamine results in increased expression of SQOR mRNA

NCBI chr 3:130,294,783...130,341,655
Ensembl chr 3:130,292,814...130,340,799

G

Snf2-related CREBBP activator protein

decreases expression

EXP

Amphetamine results in decreased expression of SRCAP mRNA

NCBI chr 1:191,554,043...191,607,096
Ensembl chr 1:191,554,043...191,604,265

G

SRC kinase signaling inhibitor 1

decreases expression

EXP

Amphetamine results in decreased expression of SRCIN1 mRNA

NCBI chr10:82,999,295...83,066,359
Ensembl chr10:82,991,033...83,067,419

G

serglycin

increases expression

EXP

Amphetamine results in increased expression of SRGN mRNA

NCBI chr20:30,985,508...31,022,296
Ensembl chr20:30,985,508...31,000,327

G

spermidine synthase

decreases expression

EXP

Amphetamine results in decreased expression of SRM mRNA

NCBI chr 5:164,309,002...164,312,203
Ensembl chr 5:164,308,991...164,332,705

G

src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites

decreases expression

EXP

Amphetamine results in decreased expression of SRMS mRNA

NCBI chr 3:188,696,070...188,702,474
Ensembl chr 3:188,696,071...188,702,474

G

SRSF protein kinase 3

decreases expression

EXP

Amphetamine results in decreased expression of SRPK3 mRNA

NCBI chr X:156,661,888...156,666,537
Ensembl chr X:156,661,875...156,666,531

G

serine and arginine rich splicing factor 12

decreases expression

EXP

Amphetamine results in decreased expression of SRSF12 mRNA

NCBI chr 5:52,402,033...52,427,839
Ensembl chr 5:52,402,618...52,427,846

G

SCO-spondin

decreases expression

EXP

Amphetamine results in decreased expression of SSPO mRNA

NCBI chr 4:78,725,829...78,781,330
Ensembl chr 4:78,727,275...78,781,315

G

somatostatin receptor 4

increases expression

EXP

Amphetamine results in increased expression of SSTR4 mRNA

NCBI chr 3:156,307,992...156,309,855
Ensembl chr 3:156,307,093...156,550,348

G

ST14 transmembrane serine protease matriptase

increases expression

EXP

Amphetamine results in increased expression of ST14 mRNA

NCBI chr 8:37,798,994...37,839,881
Ensembl chr 8:37,798,995...37,855,652

G

ST3 beta-galactoside alpha-2,3-sialyltransferase 4

increases expression

EXP

Amphetamine results in increased expression of ST3GAL4 mRNA

NCBI chr 8:41,673,510...41,723,158
Ensembl chr 8:41,673,510...41,712,551

G

ST6 beta-galactoside alpha-2,6-sialyltransferase 1

decreases expression

EXP

Amphetamine results in decreased expression of ST6GAL1 mRNA

NCBI chr11:91,031,481...91,158,111
Ensembl chr11:91,032,450...91,040,415

G

ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3

increases expression

EXP

Amphetamine results in increased expression of ST6GALNAC3 mRNA

NCBI chr 2:244,789,627...245,304,975
Ensembl chr 2:244,789,627...245,304,977

G

suppression of tumorigenicity 7

increases expression

EXP

Amphetamine results in increased expression of ST7 mRNA

NCBI chr 4:47,007,568...47,255,639
Ensembl chr 4:47,008,095...47,255,637

G

suppression of tumorigenicity 7-like

increases expression

EXP

Amphetamine results in increased expression of ST7L mRNA

NCBI chr 2:195,052,939...195,122,755
Ensembl chr 2:195,052,922...195,175,857

G

ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1

decreases expression

EXP

Amphetamine results in decreased expression of ST8SIA1 mRNA

NCBI chr 4:177,513,966...177,651,553
Ensembl chr 4:177,520,926...177,651,553

G

ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6

decreases expression

EXP

Amphetamine results in decreased expression of ST8SIA6 mRNA

NCBI chr17:81,649,866...81,847,970
Ensembl chr17:81,653,687...81,792,732

G

stabilin 1

increases expression

EXP

Amphetamine results in increased expression of STAB1 mRNA

NCBI chr16:6,336,871...6,367,374
Ensembl chr16:6,336,871...6,364,579

G

StAR-related lipid transfer domain containing 7

increases expression

EXP

Amphetamine results in increased expression of STARD7 mRNA

NCBI chr 3:134,935,602...134,969,140
Ensembl chr 3:134,940,471...134,969,168

G

StAR-related lipid transfer domain containing 8

increases expression

EXP

Amphetamine results in increased expression of STARD8 mRNA

NCBI chr X:68,119,276...68,236,247
Ensembl chr X:68,119,644...68,236,246

G

signal transducer and activator of transcription 5A

decreases expression

EXP

Amphetamine results in decreased expression of STAT5A mRNA

NCBI chr10:86,285,859...86,310,187
Ensembl chr10:86,285,547...86,310,184

G

stefin A3-like 1

increases expression

EXP

Amphetamine results in increased expression of STFA3L1 mRNA

NCBI chr11:78,114,013...78,121,232
Ensembl chr11:78,114,013...78,121,232

G

serine/threonine kinase 3

increases expression

EXP

Amphetamine results in increased expression of STK3 mRNA

NCBI chr 7:67,938,341...68,208,472
Ensembl chr 7:67,938,378...68,208,508

G

serine threonine kinase 39

decreases expression

EXP

Amphetamine results in decreased expression of STK39 mRNA

NCBI chr 3:73,321,522...73,588,397
Ensembl chr 3:73,321,522...73,586,740

G

STN1 subunit of CST complex

increases expression

EXP

Amphetamine results in increased expression of STN1 mRNA

NCBI chr 1:256,336,916...256,371,143
Ensembl chr 1:256,315,367...256,370,736

G

striatin interacting protein 2

increases expression

EXP

Amphetamine results in increased expression of STRIP2 mRNA

NCBI chr 4:59,503,478...59,545,745
Ensembl chr 4:59,503,481...59,545,739

G

steroid sulfatase

increases expression

EXP

Amphetamine results in increased expression of STS mRNA

NCBI chr X:46,102,524...46,110,868
Ensembl chr X:46,102,548...46,111,104

G

syntaxin 12

increases expression

EXP

Amphetamine results in increased expression of STX12 mRNA

NCBI chr 5:150,347,554...150,376,426
Ensembl chr 5:150,334,836...150,376,346

G

syntaxin 16

decreases expression

EXP

Amphetamine results in decreased expression of STX16 mRNA

NCBI chr 3:183,271,417...183,300,746
Ensembl chr 3:183,272,031...183,300,745

G

syntaxin 17

decreases expression

EXP

Amphetamine results in decreased expression of STX17 mRNA

NCBI chr 5:67,241,673...67,302,228
Ensembl chr 5:67,241,727...67,302,218

G

syntaxin 1A

decreases expression

EXP

Amphetamine results in decreased expression of STX1A mRNA

NCBI chr12:27,278,517...27,306,547
Ensembl chr12:27,278,517...27,306,471

G

serine/threonine/tyrosine interacting protein

decreases expression

EXP

Amphetamine results in decreased expression of STYX mRNA

NCBI chr15:21,043,738...21,075,515

G

SUFU negative regulator of hedgehog signaling

decreases expression

EXP

Amphetamine results in decreased expression of SUFU mRNA

NCBI chr 1:255,199,108...255,296,983
Ensembl chr 1:255,199,164...255,296,981

G

sulfatase 2

increases expression

EXP

Amphetamine results in increased expression of SULF2 mRNA

NCBI chr 3:175,241,322...175,323,808
Ensembl chr 3:175,241,322...175,323,651

G

sulfatase modifying factor 2

decreases expression

EXP

Amphetamine results in decreased expression of SUMF2 mRNA

NCBI chr12:32,489,671...32,507,941
Ensembl chr12:32,489,671...32,507,928

G

Sad1 and UNC84 domain containing 2

decreases expression

EXP

Amphetamine results in decreased expression of SUN2 mRNA

NCBI chr 7:113,155,766...113,172,950
Ensembl chr 7:113,155,766...113,172,940

G

SPT4 homolog, DSIF elongation factor subunit

increases expression

EXP

Amphetamine results in increased expression of SUPT4H1 mRNA

NCBI chr10:73,036,560...73,042,821
Ensembl chr10:73,036,343...73,043,088

G

sushi domain containing 3

increases expression

EXP

Amphetamine results in increased expression of SUSD3 mRNA

NCBI chr17:15,607,259...15,623,322
Ensembl chr17:15,606,906...15,624,262

G

SUV39H1 histone lysine methyltransferase

increases expression

EXP

Amphetamine results in increased expression of SUV39H1 mRNA

NCBI chr X:17,093,059...17,105,942
Ensembl chr X:17,092,986...17,105,942

G

switching B-cell complex subunit SWAP70

decreases expression

EXP

Amphetamine results in decreased expression of SWAP70 mRNA

NCBI chr 1:173,702,338...173,763,540
Ensembl chr 1:173,702,347...173,763,947

G

synaptonemal complex protein 2

increases expression

EXP

Amphetamine results in increased expression of SYCP2 mRNA

NCBI chr 3:185,814,033...185,876,516
Ensembl chr 3:185,814,035...185,876,492

G

synaptojanin 2

increases expression

EXP

Amphetamine results in increased expression of SYNJ2 mRNA

NCBI chr 1:48,923,742...49,027,153
Ensembl chr 1:48,923,737...49,038,650

G

synaptopodin

decreases expression

EXP

Amphetamine results in decreased expression of SYNPO mRNA

NCBI chr18:56,326,369...56,347,359
Ensembl chr18:56,319,571...56,353,306

G

synergin, gamma

decreases expression

EXP

Amphetamine results in decreased expression of SYNRG mRNA

NCBI chr10:69,346,154...69,428,714
Ensembl chr10:69,322,114...69,428,714

G

synaptophysin-like 1

increases expression

EXP

Amphetamine results in increased expression of SYPL1 mRNA

NCBI chr 6:55,292,555...55,311,519
Ensembl chr 6:55,292,567...55,314,714

G

synaptotagmin 3

increases expression

EXP

Amphetamine results in increased expression of SYT3 mRNA

NCBI chr 1:104,017,341...104,032,046
Ensembl chr 1:104,017,379...104,032,045

G

synaptotagmin-like 1

decreases expression

EXP

Amphetamine results in decreased expression of SYTL1 mRNA

NCBI chr 5:150,736,425...150,746,840
Ensembl chr 5:150,736,425...150,746,840

G

SZT2 subunit of KICSTOR complex

decreases expression

EXP

Amphetamine results in decreased expression of SZT2 mRNA

NCBI chr 5:137,182,648...137,229,349
Ensembl chr 5:137,182,648...137,229,419

G

tachykinin, precursor 1

increases expression
multiple interactions

EXP

Amphetamine results in increased expression of TAC1 mRNA
Baclofen inhibits the reaction [Amphetamine results in increased expression of TAC1 mRNA]

NCBI chr 4:36,645,344...36,653,548
Ensembl chr 4:36,645,571...36,653,546

G

TATA-box binding protein associated factor 4b

decreases expression

EXP

Amphetamine results in decreased expression of TAF4B mRNA

NCBI chr18:6,227,299...6,360,970
Ensembl chr18:6,227,345...6,356,275

G

TAFA chemokine like family member 3

decreases expression

EXP

Amphetamine results in decreased expression of TAFA3 mRNA

NCBI chr 2:194,952,499...194,968,776
Ensembl chr 2:194,954,998...194,962,061

G

transgelin

increases expression

EXP

Amphetamine results in increased expression of TAGLN mRNA

NCBI chr 8:55,121,647...55,127,121
Ensembl chr 8:55,121,301...55,127,563

G

transgelin 2

increases expression

EXP

Amphetamine results in increased expression of TAGLN2 mRNA

NCBI chr13:87,499,350...87,506,328
Ensembl chr13:87,499,394...87,506,330

G

transaldolase 1

increases expression

EXP

Amphetamine results in increased expression of TALDO1 mRNA

NCBI chr 1:205,923,196...205,933,526
Ensembl chr 1:205,923,165...205,933,535

G

trafficking regulator and scaffold protein tamalin

decreases expression

EXP

Amphetamine results in decreased expression of TAMALIN mRNA

NCBI chr 7:134,217,612...134,225,378
Ensembl chr 7:134,217,065...134,225,378

G

tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2

decreases expression

EXP

Amphetamine results in decreased expression of TANC2 mRNA

NCBI chr10:91,052,860...91,373,291
Ensembl chr10:91,053,067...91,368,570

G

TAO kinase 3

decreases expression

EXP

Amphetamine results in decreased expression of TAOK3 mRNA

NCBI chr12:44,973,180...45,134,439
Ensembl chr12:44,973,180...45,134,439

G

taste 1 receptor member 2

decreases expression

EXP

Amphetamine results in decreased expression of TAS1R2 mRNA

NCBI chr 5:157,192,799...157,208,937
Ensembl chr 5:157,192,799...157,208,937

G

taste receptor, type 2, member 143

increases expression

EXP

Amphetamine results in increased expression of TAS2R143 mRNA

NCBI chr 4:72,254,484...72,255,368
Ensembl chr 4:72,251,300...72,256,376

G

transcription activation suppressor

decreases expression

EXP

Amphetamine results in decreased expression of TASOR mRNA

NCBI chr16:2,612,942...2,669,870
Ensembl chr16:2,613,505...2,669,867

G

transcription activation suppressor family member 2

decreases expression

EXP

Amphetamine results in decreased expression of TASOR2 mRNA

NCBI chr17:71,504,656...71,559,878
Ensembl chr17:71,504,822...71,559,035

G

TBC1 domain family, member 15

increases expression

EXP

Amphetamine results in increased expression of TBC1D15 mRNA

NCBI chr 7:52,690,770...52,746,309
Ensembl chr 7:52,690,770...52,746,303

G

TBC1 domain family, member 16

decreases expression

EXP

Amphetamine results in decreased expression of TBC1D16 mRNA

NCBI chr10:104,899,507...104,985,233
Ensembl chr10:104,899,507...104,985,216

G

TBC1 domain family, member 22B

decreases expression

EXP

Amphetamine results in decreased expression of TBC1D22B mRNA

NCBI chr20:7,620,716...7,676,809
Ensembl chr20:7,620,713...7,676,807

G

TBC1 domain family, member 30

decreases expression

EXP

Amphetamine results in decreased expression of TBC1D30 mRNA

NCBI chr 7:58,665,054...58,754,427
Ensembl chr 7:58,665,054...58,754,614

G

TBC1 domain family, member 5

decreases expression

EXP

Amphetamine results in decreased expression of TBC1D5 mRNA

NCBI chr 9:3,740,032...4,256,971
Ensembl chr 9:3,750,325...4,253,581

G

TBC1 domain family, member 8

decreases expression

EXP

Amphetamine results in decreased expression of TBC1D8 mRNA

NCBI chr 9:49,147,109...49,257,140
Ensembl chr 9:49,147,109...49,257,118

G

tubulin folding cofactor C

increases expression

EXP

Amphetamine results in increased expression of TBCC mRNA

NCBI chr 9:21,596,472...21,597,660
Ensembl chr 9:21,595,615...21,597,842

G

transducin (beta)-like 1 X-linked

decreases expression

EXP

Amphetamine results in decreased expression of TBL1X mRNA

NCBI chr X:45,452,983...45,609,532
Ensembl chr X:45,454,482...45,609,525

G

TATA-box binding protein like 1

increases expression

EXP

Amphetamine results in increased expression of TBPL1 mRNA

NCBI chr 1:24,597,028...24,622,445
Ensembl chr 1:24,597,074...24,622,439

G

T-box transcription factor 21

decreases expression

EXP

Amphetamine results in decreased expression of TBX21 mRNA

NCBI chr10:82,578,751...82,595,253
Ensembl chr10:82,578,751...82,595,253

G

T-box transcription factor 4

increases expression

EXP

Amphetamine results in increased expression of TBX4 mRNA

NCBI chr10:71,228,145...71,258,222
Ensembl chr10:71,197,727...71,258,218

G

thromboxane A2 receptor

decreases expression

EXP

Amphetamine results in decreased expression of TBXA2R mRNA

NCBI chr 7:9,034,077...9,041,489
Ensembl chr 7:9,034,108...9,038,905

G

thromboxane A synthase 1

increases expression

EXP

Amphetamine results in increased expression of TBXAS1 mRNA

NCBI chr 4:68,631,841...68,803,959
Ensembl chr 4:68,631,838...68,803,969

G

transcription elongation factor A like 8

increases expression

EXP

Amphetamine results in increased expression of TCEAL8 mRNA

NCBI chr X:103,962,930...103,965,000
Ensembl chr X:103,961,187...103,965,394

G

transcription factor 12

decreases expression

EXP

Amphetamine results in decreased expression of TCF12 mRNA

NCBI chr 8:81,371,201...81,682,337
Ensembl chr 8:81,373,321...81,679,922

G

transcription factor 21

increases expression

EXP

Amphetamine results in increased expression of TCF21 mRNA

NCBI chr 1:24,520,499...24,523,358
Ensembl chr 1:24,520,481...24,523,348

G

transcription factor 3

decreases expression

EXP

Amphetamine results in decreased expression of TCF3 mRNA

NCBI chr 7:9,931,251...9,952,994
Ensembl chr 7:9,928,685...9,953,044

G

transcription factor 7

decreases expression

EXP

Amphetamine results in decreased expression of TCF7 mRNA

NCBI chr10:36,924,363...36,954,279
Ensembl chr10:36,924,363...36,954,279

G

trichoplein, keratin filament binding

decreases expression

EXP

Amphetamine results in decreased expression of TCHP mRNA

NCBI chr12:47,538,520...47,553,895
Ensembl chr12:47,538,520...47,553,836

G

transcobalamin 2

increases expression

EXP

Amphetamine results in increased expression of TCN2 mRNA

NCBI chr14:83,036,935...83,052,187
Ensembl chr14:83,036,935...83,051,552

G

treacle ribosome biogenesis factor 1

decreases expression

EXP

Amphetamine results in decreased expression of TCOF1 mRNA

NCBI chr18:56,537,437...56,570,727
Ensembl chr18:56,537,437...56,570,727

G

tectonic family member 3

increases expression

EXP

Amphetamine results in increased expression of TCTN3 mRNA

NCBI chr 1:249,363,428...249,374,698
Ensembl chr 1:249,363,428...249,374,841

G

tyrosyl-DNA phosphodiesterase 1

decreases expression

EXP

Amphetamine results in decreased expression of TDP1 mRNA

NCBI chr 6:124,892,821...124,960,646
Ensembl chr 6:124,881,574...124,960,642

G

tectonin beta-propeller repeat containing 1

decreases expression

EXP

Amphetamine results in decreased expression of TECPR1 mRNA

NCBI chr12:15,504,456...15,534,541
Ensembl chr12:15,505,343...15,534,116

G

telomere maintenance 2

decreases expression

EXP

Amphetamine results in decreased expression of TELO2 mRNA

NCBI chr10:14,624,998...14,640,235
Ensembl chr10:14,624,998...14,640,211

G

testin LIM domain protein

increases expression

EXP

Amphetamine results in increased expression of TES mRNA

NCBI chr 4:46,331,257...46,369,782
Ensembl chr 4:46,331,257...46,369,780

G

tet methylcytosine dioxygenase 1

decreases expression

EXP

Amphetamine results in decreased expression of TET1 mRNA

NCBI chr20:25,766,806...25,839,598
Ensembl chr20:25,760,057...25,832,730

G

tet methylcytosine dioxygenase 3

decreases expression

EXP

Amphetamine results in decreased expression of TET3 mRNA

NCBI chr 4:117,425,106...117,525,495
Ensembl chr 4:117,429,857...117,520,486

G

transferrin

increases expression

EXP

Amphetamine results in increased expression of TF mRNA

NCBI chr 8:112,668,667...112,695,376
Ensembl chr 8:112,647,642...112,695,400

G

transcription factor AP-4

decreases expression

EXP

Amphetamine results in decreased expression of TFAP4 mRNA

NCBI chr10:11,507,242...11,525,794
Ensembl chr10:11,485,565...11,525,794

G

transcription factor EC

increases expression

EXP

Amphetamine results in increased expression of TFEC mRNA

NCBI chr 4:46,072,093...46,146,200
Ensembl chr 4:46,073,605...46,146,200

G

tissue factor pathway inhibitor

decreases expression

ISO

Amphetamine results in decreased expression of TFPI protein

NCBI chr 3:89,939,862...89,989,253
Ensembl chr 3:89,939,868...89,980,742

G

TCF3 fusion partner

increases expression

EXP

Amphetamine results in increased expression of TFPT mRNA

NCBI chr 1:74,502,994...74,512,766
Ensembl chr 1:74,502,994...74,513,370

G

transforming growth factor, beta induced

increases expression

EXP

Amphetamine results in increased expression of TGFBI mRNA

NCBI chr17:7,960,885...7,990,234
Ensembl chr17:7,960,516...7,990,471

G

tyrosine hydroxylase

increases expression
multiple interactions
decreases expression

ISO
EXP

Amphetamine results in increased expression of TH mRNA; Amphetamine results in increased expression of TH protein
PTN protein inhibits the reaction [Amphetamine results in decreased expression of TH protein]

PMID:12468030 PMID:15836913 PMID:16126238 PMID:16916582 PMID:19059431 More...

NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:207,500,962...207,557,227

G

THADA, armadillo repeat containing

decreases expression

EXP

Amphetamine results in decreased expression of THADA mRNA

NCBI chr 6:15,936,593...16,240,523
Ensembl chr 6:15,936,632...16,239,749

G

THAP domain containing 2

decreases expression

EXP

Amphetamine results in decreased expression of THAP2 mRNA

NCBI chr 7:52,879,011...52,893,680
Ensembl chr 7:52,879,011...52,891,932

G

thrombomodulin

increases expression

EXP

Amphetamine results in increased expression of THBD mRNA

NCBI chr 3:156,316,526...156,320,178
Ensembl chr 3:156,306,632...156,320,582

G

thrombospondin 1

increases expression

EXP

Amphetamine results in increased expression of THBS1 mRNA

NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:125,510,250...125,525,402

G

thymocyte selection associated family member 2

increases expression

EXP

Amphetamine results in increased expression of THEMIS2 mRNA

NCBI chr 5:150,275,094...150,290,343
Ensembl chr 5:150,275,094...150,290,343

G

threonine synthase-like 1

increases expression

EXP

Amphetamine results in increased expression of THNSL1 mRNA

NCBI chr17:88,623,054...88,630,681
Ensembl chr17:88,614,606...88,641,871

G

thyroid hormone receptor beta

decreases expression

EXP

Amphetamine results in decreased expression of THRB mRNA

NCBI chr15:10,115,954...10,465,231
Ensembl chr15:10,115,954...10,313,680

G

THUMP domain containing 1

decreases expression

EXP

Amphetamine results in decreased expression of THUMPD1 mRNA

NCBI chr 1:183,510,242...183,516,282
Ensembl chr 1:183,431,657...183,516,282

G

THUMP domain containing 2

decreases expression

EXP

Amphetamine results in decreased expression of THUMPD2 mRNA

NCBI chr 6:19,677,039...19,728,947
Ensembl chr 6:19,677,025...19,739,317

G

timeless circadian regulator

decreases expression

EXP

Amphetamine results in decreased expression of TIMELESS mRNA

NCBI chr 7:1,239,388...1,263,344
Ensembl chr 7:1,239,450...1,263,337

G

TIMP metallopeptidase inhibitor 2

increases expression

EXP

Amphetamine results in increased expression of TIMP2 mRNA

NCBI chr10:104,041,604...104,089,214
Ensembl chr10:104,041,604...104,089,214

G

TLC domain containing 1

increases expression

EXP

Amphetamine results in increased expression of TLCD1 mRNA

NCBI chr10:63,572,541...63,574,574
Ensembl chr10:63,572,518...63,574,567

G

TLC domain containing 3B

increases expression

EXP

Amphetamine results in increased expression of TLCD3B mRNA

NCBI chr 1:190,851,582...190,870,278
Ensembl chr 1:190,835,208...190,870,277

G

TLE family member 3, transcriptional corepressor

increases expression

EXP

Amphetamine results in increased expression of TLE3 mRNA

NCBI chr 8:70,753,182...70,799,080
Ensembl chr 8:70,753,383...70,799,074

G

toll-like receptor 10

increases expression

EXP

Amphetamine results in increased expression of TLR10 mRNA

NCBI chr14:43,758,940...43,768,352
Ensembl chr14:43,759,827...43,768,351

G

toll-like receptor 2

increases expression

EXP

Amphetamine results in increased expression of TLR2 mRNA

NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:171,497,060...171,520,194

G

toll-like receptor 6

increases expression

EXP

Amphetamine results in increased expression of TLR6 mRNA

NCBI chr14:43,715,809...43,727,019
Ensembl chr14:43,698,751...43,740,462

G

toll-like receptor 7

increases expression

EXP

Amphetamine results in increased expression of TLR7 mRNA

NCBI chr X:30,644,324...30,670,796
Ensembl chr X:30,644,355...30,672,151

G

toll-like receptor 9

decreases expression

EXP

Amphetamine results in decreased expression of TLR9 mRNA

NCBI chr 8:115,743,407...115,747,523
Ensembl chr 8:115,742,889...115,750,148

G

TM2 domain containing 2

increases expression

EXP

Amphetamine results in increased expression of TM2D2 mRNA

NCBI chr16:73,719,331...73,724,853
Ensembl chr16:73,719,332...73,724,981

G

transmembrane 6 superfamily member 1

increases expression

EXP

Amphetamine results in increased expression of TM6SF1 mRNA

NCBI chr 1:145,209,052...145,237,725
Ensembl chr 1:145,209,585...145,237,715

G

transmembrane BAX inhibitor motif containing 1

decreases expression

EXP

Amphetamine results in decreased expression of TMBIM1 mRNA

NCBI chr 9:83,320,972...83,338,469
Ensembl chr 9:83,320,979...83,338,657

G

transmembrane channel-like 4

increases expression

EXP

Amphetamine results in increased expression of TMC4 mRNA

NCBI chr 1:74,455,135...74,467,043
Ensembl chr 1:74,454,909...74,467,043

G

transmembrane p24 trafficking protein family member 8

decreases expression

EXP

Amphetamine results in decreased expression of TMED8 mRNA

NCBI chr 6:112,537,921...112,572,199
Ensembl chr 6:112,542,932...112,572,383

G

transmembrane protein 100

increases expression

EXP

Amphetamine results in increased expression of TMEM100 mRNA

NCBI chr10:75,351,891...75,357,748
Ensembl chr10:75,351,271...75,360,364

G

transmembrane protein 104

decreases expression

EXP

Amphetamine results in decreased expression of TMEM104 mRNA

NCBI chr10:100,926,219...100,984,870
Ensembl chr10:100,926,270...100,984,869

G

transmembrane protein 156

increases expression

EXP

Amphetamine results in increased expression of TMEM156 mRNA

NCBI chr14:43,568,131...43,606,109
Ensembl chr14:43,577,023...43,606,109

G

transmembrane protein 163

decreases expression

EXP

Amphetamine results in decreased expression of TMEM163 mRNA

NCBI chr13:41,520,595...41,693,938
Ensembl chr13:41,520,359...41,693,938

G

transmembrane protein 182

increases expression

EXP

Amphetamine results in increased expression of TMEM182 mRNA

NCBI chr 9:50,555,029...50,606,908
Ensembl chr 9:50,550,462...50,606,907

G

transmembrane protein 184B

increases expression

EXP

Amphetamine results in increased expression of TMEM184B mRNA

NCBI chr 7:112,805,512...112,848,398
Ensembl chr 7:112,805,512...112,848,351

G

transmembrane protein 201

decreases expression

EXP

Amphetamine results in decreased expression of TMEM201 mRNA

NCBI chr 5:165,449,270...165,471,901
Ensembl chr 5:165,449,858...165,471,922

G

transmembrane protein 203

increases expression

EXP

Amphetamine results in increased expression of TMEM203 mRNA

NCBI chr 3:28,469,062...28,469,890
Ensembl chr 3:28,465,345...28,472,140

G

transmembrane protein 204

decreases expression

EXP

Amphetamine results in decreased expression of TMEM204 mRNA

NCBI chr10:14,581,025...14,608,878
Ensembl chr10:14,581,026...14,606,427

G

transmembrane protein 205

increases expression

EXP

Amphetamine results in increased expression of TMEM205 mRNA

NCBI chr 8:28,728,172...28,733,908
Ensembl chr 8:28,728,172...28,733,908

G

transmembrane protein 209

decreases expression

EXP

Amphetamine results in decreased expression of TMEM209 mRNA

NCBI chr 4:60,070,346...60,096,039
Ensembl chr 4:60,069,060...60,105,946

G

transmembrane protein 229B

decreases expression

EXP

Amphetamine results in decreased expression of TMEM229B mRNA

NCBI chr 6:103,509,457...103,552,600
Ensembl chr 6:103,508,342...103,552,647

G

transmembrane protein 43

increases expression

EXP

Amphetamine results in increased expression of TMEM43 mRNA

NCBI chr 4:125,534,844...125,549,986
Ensembl chr 4:125,534,813...125,549,988

G

transmembrane protein 88

increases expression

EXP

Amphetamine results in increased expression of TMEM88 mRNA

NCBI chr10:54,617,554...54,619,309
Ensembl chr10:54,617,630...54,619,438

G

transmembrane protein 91

increases expression

EXP

Amphetamine results in increased expression of TMEM91 mRNA

NCBI chr 1:90,307,264...90,314,796
Ensembl chr 1:90,306,289...90,313,320

G

TMEM9 domain family, member B

increases expression

EXP

Amphetamine results in increased expression of TMEM9B mRNA

NCBI chr 1:173,199,225...173,218,674
Ensembl chr 1:173,200,869...173,218,053

G

thiol methyltransferase 1A

decreases expression

EXP

Amphetamine results in decreased expression of TMT1A mRNA

NCBI chr 7:133,330,141...133,377,172
Ensembl chr 7:133,330,447...133,338,959

G

transmembrane O-mannosyltransferase targeting cadherins 2

increases expression

EXP

Amphetamine results in increased expression of TMTC2 mRNA

NCBI chr 7:42,280,746...42,695,651
Ensembl chr 7:42,280,746...42,693,350

G

transmembrane O-mannosyltransferase targeting cadherins 4

decreases expression

EXP

Amphetamine results in decreased expression of TMTC4 mRNA

NCBI chr15:106,406,795...106,463,226
Ensembl chr15:106,407,597...106,463,210

G

transmembrane and ubiquitin-like domain containing 2

increases expression

EXP

Amphetamine results in increased expression of TMUB2 mRNA

NCBI chr10:87,738,662...87,743,118
Ensembl chr10:87,738,698...87,742,933

G

thioredoxin-related transmembrane protein 4

increases expression

EXP

Amphetamine results in increased expression of TMX4 mRNA

NCBI chr 3:142,309,026...142,352,415
Ensembl chr 3:142,309,033...142,352,415

G

tumor necrosis factor

decreases expression
increases expression
multiple interactions

EXP
ISO

Amphetamine results in decreased expression of TNF mRNA
Amphetamine results in increased expression of TNF mRNA
3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine inhibits the reaction [Amphetamine promotes the reaction [TNF protein results in increased expression of F3 protein]]; Amphetamine promotes the reaction [TNF protein results in increased activity of F3 protein]; Amphetamine promotes the reaction [TNF protein results in increased expression of F3 mRNA]; Amphetamine promotes the reaction [TNF protein results in increased expression of F3 protein]; L 750667 inhibits the reaction [Amphetamine promotes the reaction [TNF protein results in increased expression of F3 protein]]

PMID:20118172 PMID:20223277 PMID:30779732

NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303

G

TNF alpha induced protein 3

decreases expression

EXP

Amphetamine results in decreased expression of TNFAIP3 mRNA

NCBI chr 1:15,528,921...15,543,993
Ensembl chr 1:15,528,921...15,543,979

G

TNF receptor superfamily member 13B

decreases expression

EXP

Amphetamine results in decreased expression of TNFRSF13B mRNA

NCBI chr10:46,301,336...46,322,460
Ensembl chr10:46,301,316...46,324,408

G

TNF receptor superfamily member 14

decreases expression

EXP

Amphetamine results in decreased expression of TNFRSF14 mRNA

NCBI chr 5:170,768,413...170,776,749
Ensembl chr 5:170,768,416...170,776,046

G

TNF receptor superfamily member 1A

increases expression

EXP

Amphetamine results in increased expression of TNFRSF1A mRNA

NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:159,837,032...159,849,816

G

TNF receptor superfamily member 25

decreases expression

EXP

Amphetamine results in decreased expression of TNFRSF25 mRNA

NCBI chr 5:167,904,377...167,909,052
Ensembl chr 5:167,904,786...167,909,052

G

TNF superfamily member 10

decreases expression

EXP

Amphetamine results in decreased expression of TNFSF10 mRNA

NCBI chr 2:112,136,550...112,155,903

G

TNF superfamily member 14

increases expression

EXP

Amphetamine results in increased expression of TNFSF14 mRNA

NCBI chr 9:2,155,270...2,160,100
Ensembl chr 9:2,155,270...2,160,191

G

TNF superfamily member 8

decreases expression

EXP

Amphetamine results in decreased expression of TNFSF8 mRNA

NCBI chr 5:82,266,436...82,292,858
Ensembl chr 5:82,266,436...82,292,858

G

TNF superfamily member 9

increases expression

EXP

Amphetamine results in increased expression of TNFSF9 mRNA

NCBI chr 9:2,031,011...2,033,345
Ensembl chr 9:2,030,953...2,033,339

G

TRAF2 and NCK interacting kinase

decreases expression

EXP

Amphetamine results in decreased expression of TNIK mRNA

NCBI chr 2:113,112,937...113,511,341
Ensembl chr 2:113,112,938...113,511,339

G

TNFAIP3 interacting protein 2

increases expression

EXP

Amphetamine results in increased expression of TNIP2 mRNA

NCBI chr14:80,452,936...80,470,141
Ensembl chr14:80,452,845...80,470,992

G

tankyrase 1 binding protein 1

decreases expression

EXP

Amphetamine results in decreased expression of TNKS1BP1 mRNA

NCBI chr 3:90,542,006...90,566,720
Ensembl chr 3:90,542,033...90,566,713

G

tenascin N

decreases expression

EXP

Amphetamine results in decreased expression of TNN mRNA

NCBI chr13:74,852,586...74,919,789
Ensembl chr13:74,852,586...74,919,789

G

troponin C1, slow skeletal and cardiac type

increases expression

EXP

Amphetamine results in increased expression of TNNC1 mRNA

NCBI chr16:6,408,607...6,412,070
Ensembl chr16:6,408,607...6,412,070

G

troponin I3, cardiac type

increases expression

EXP

Amphetamine results in increased expression of TNNI3 mRNA

NCBI chr 1:78,342,571...78,346,255
Ensembl chr 1:78,342,592...78,346,253

G

troponin T2, cardiac type

increases expression

EXP

Amphetamine results in increased expression of TNNT2 mRNA

NCBI chr13:49,819,123...49,837,125
Ensembl chr13:49,822,304...49,837,125

G

trinucleotide repeat containing adaptor 6C

decreases expression

EXP

Amphetamine results in decreased expression of TNRC6C mRNA

NCBI chr10:103,367,498...103,478,246
Ensembl chr10:103,367,647...103,478,246

G

transducer of ErbB-2.1

increases expression

EXP

Amphetamine results in increased expression of TOB1 mRNA

NCBI chr10:79,659,993...79,662,031
Ensembl chr10:79,656,433...79,666,601

G

DNA topoisomerase II beta

decreases expression

EXP

Amphetamine results in decreased expression of TOP2B mRNA

NCBI chr15:11,482,089...11,542,464
Ensembl chr15:11,482,089...11,542,464

G

thymocyte selection-associated high mobility group box

decreases expression

EXP

Amphetamine results in decreased expression of TOX mRNA

NCBI chr 5:24,672,487...24,968,754
Ensembl chr 5:24,672,487...24,968,754

G

tumor protein p53

increases expression
decreases expression

ISO
EXP

Amphetamine results in increased expression of TRP53 mRNA; Amphetamine results in increased expression of TRP53 protein
Amphetamine results in decreased expression of TP53 mRNA

PMID:15731293 PMID:30779732

NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299

G

tumor protein p53 binding protein, 2

decreases expression

EXP

Amphetamine results in decreased expression of TP53BP2 mRNA

NCBI chr13:96,620,429...96,677,090
Ensembl chr13:96,620,428...96,677,616

G

tumor protein p53 inducible protein 11

decreases expression

EXP

Amphetamine results in decreased expression of TP53I11 mRNA

NCBI chr 3:99,600,213...99,615,462
Ensembl chr 3:99,600,159...99,615,432

G

TPD52 like 3

decreases expression

EXP

Amphetamine results in decreased expression of TPD52L3 mRNA

NCBI chr 1:237,195,695...237,197,988
Ensembl chr 1:237,187,252...237,201,603

G

triosephosphate isomerase 1

increases expression

EXP

Amphetamine results in increased expression of TPI1 mRNA

NCBI chr 4:159,301,558...159,305,088
Ensembl chr 4:159,301,562...159,305,413

G

tubulin polymerization-promoting protein family member 3

increases expression

EXP

Amphetamine results in increased expression of TPPP3 mRNA

NCBI chr19:50,255,809...50,259,655
Ensembl chr19:50,255,810...50,259,489

G

Tnf receptor-associated factor 3

decreases expression

EXP

Amphetamine results in decreased expression of TRAF3 mRNA

NCBI chr 6:136,025,097...136,128,363
Ensembl chr 6:136,027,157...136,128,363

G

Traf3 interacting protein 2

decreases expression

EXP

Amphetamine results in decreased expression of TRAF3IP2 mRNA

NCBI chr20:44,565,992...44,609,240
Ensembl chr20:44,517,242...44,609,618

G

TRAF3 interacting protein 3

decreases expression

EXP

Amphetamine results in decreased expression of TRAF3IP3 mRNA

NCBI chr13:107,223,499...107,248,358
Ensembl chr13:107,223,502...107,248,155

G

TNF receptor-associated factor 5

decreases expression

EXP

Amphetamine results in decreased expression of TRAF5 mRNA

NCBI chr13:106,100,921...106,149,724
Ensembl chr13:106,103,291...106,149,707

G

trafficking kinesin protein 1

increases expression

EXP

Amphetamine results in increased expression of TRAK1 mRNA

NCBI chr 8:129,861,967...130,016,870
Ensembl chr 8:129,861,977...130,016,870

G

trafficking protein particle complex subunit 2L

increases expression

EXP

Amphetamine results in increased expression of TRAPPC2L mRNA

NCBI chr19:67,570,954...67,574,722

G

triggering receptor expressed on myeloid cells 1

increases expression

EXP

Amphetamine results in increased expression of TREM1 mRNA

NCBI chr 9:20,259,227...20,276,879
Ensembl chr 9:20,261,408...20,276,892

G

triggering receptor expressed on myeloid cells 2

increases expression

EXP

Amphetamine results in increased expression of TREM2 mRNA

NCBI chr 9:20,145,215...20,151,797
Ensembl chr 9:20,144,334...20,151,779

G

triggering receptor expressed on myeloid cells 3

increases expression

EXP

Amphetamine results in increased expression of TREM3 mRNA

NCBI chr 9:20,247,453...20,259,071
Ensembl chr 9:20,247,453...20,257,918

G

triggering receptor expressed on myeloid cells-like 4

decreases expression

EXP

Amphetamine results in decreased expression of TREML4 mRNA

NCBI chr 9:20,216,569...20,241,476
Ensembl chr 9:20,219,416...20,240,486

G

transcriptional regulating factor 1

decreases expression

EXP

Amphetamine results in decreased expression of TRERF1 mRNA

NCBI chr 9:21,131,772...21,355,830
Ensembl chr 9:21,131,777...21,176,016

G

three prime repair exonuclease 1

increases expression
multiple interactions

EXP

Amphetamine results in increased expression of TREX1 mRNA; Amphetamine results in increased expression of TREX1 protein
eticlopride inhibits the reaction [Amphetamine results in increased expression of TREX1 mRNA]; eticlopride inhibits the reaction [Amphetamine results in increased expression of TREX1 protein]; Mifepristone inhibits the reaction [Amphetamine results in increased expression of TREX1 mRNA]

NCBI chr 8:118,585,082...118,586,382
Ensembl chr 8:118,585,081...118,586,083

G

tribbles pseudokinase 2

decreases expression

EXP

Amphetamine results in decreased expression of TRIB2 mRNA

NCBI chr 6:44,274,762...44,299,139
Ensembl chr 6:44,274,762...44,299,094

G

tripartite motif-containing 14

decreases expression

EXP

Amphetamine results in decreased expression of TRIM14 mRNA

NCBI chr 5:65,596,149...65,620,434
Ensembl chr 5:65,596,149...65,620,434

G

tripartite motif-containing 25

decreases expression

EXP

Amphetamine results in decreased expression of TRIM25 mRNA

NCBI chr10:74,310,024...74,328,473
Ensembl chr10:74,310,022...74,331,716

G

tripartite motif-containing 32

decreases expression

EXP

Amphetamine results in decreased expression of TRIM32 mRNA

NCBI chr 5:84,020,604...84,031,483
Ensembl chr 5:84,014,803...84,042,748

G

tripartite motif-containing 37

decreases expression

EXP

Amphetamine results in decreased expression of TRIM37 mRNA

NCBI chr10:72,440,672...72,572,831
Ensembl chr10:72,440,644...72,572,828

G

tripartite motif-containing 44

decreases expression

EXP

Amphetamine results in decreased expression of TRIM44 mRNA

NCBI chr 3:109,048,643...109,183,821
Ensembl chr 3:109,048,643...109,183,821

G

tripartite motif-containing 45

decreases expression

EXP

Amphetamine results in decreased expression of TRIM45 mRNA

NCBI chr 2:191,038,355...191,047,826
Ensembl chr 2:191,038,356...191,047,825

G

tripartite motif-containing 54

increases expression

EXP

Amphetamine results in increased expression of TRIM54 mRNA

NCBI chr 6:30,959,306...30,978,475
Ensembl chr 6:30,959,306...30,978,475

G

tripartite motif-containing 55

increases expression

EXP

Amphetamine results in increased expression of TRIM55 mRNA

NCBI chr 2:104,016,361...104,058,302
Ensembl chr 2:104,016,368...104,058,301

G

tripartite motif containing 68

decreases expression

EXP

Amphetamine results in decreased expression of TRIM68 mRNA

NCBI chr 1:166,525,981...166,539,407
Ensembl chr 1:166,525,981...166,539,407

G

tripartite motif containing 72

increases expression

EXP

Amphetamine results in increased expression of TRIM72 mRNA

NCBI chr 1:192,044,220...192,052,080
Ensembl chr 1:192,044,179...192,052,073

G

trio Rho guanine nucleotide exchange factor

decreases expression

EXP

Amphetamine results in decreased expression of TRIO mRNA

NCBI chr 2:80,235,485...80,531,824
Ensembl chr 2:80,235,485...80,531,612

G

tRNA methyltransferase 61A

decreases expression

EXP

Amphetamine results in decreased expression of TRMT61A mRNA

NCBI chr 6:136,558,417...136,564,411
Ensembl chr 6:136,558,391...136,564,410

G

tRNA mitochondrial 2-thiouridylase

decreases expression

EXP

Amphetamine results in decreased expression of TRMU mRNA

NCBI chr 7:118,849,586...118,866,190
Ensembl chr 7:118,849,600...118,867,539

G

transient receptor potential cation channel subfamily C member 2

decreases expression

EXP

Amphetamine results in decreased expression of TRPC2 mRNA

NCBI chr 1:165,871,991...165,885,339
Ensembl chr 1:165,857,557...165,885,055

G

transient receptor potential cation channel, subfamily C, member 6

increases expression

EXP

Amphetamine results in increased expression of TRPC6 mRNA

NCBI chr 8:14,044,216...14,148,808
Ensembl chr 8:14,043,877...14,149,304

G

transient receptor potential cation channel, subfamily M, member 1

increases expression

EXP

Amphetamine results in increased expression of TRPM1 mRNA

NCBI chr 1:127,130,686...127,247,219
Ensembl chr 1:127,130,686...127,247,391

G

transient receptor potential cation channel, subfamily M, member 6

decreases expression

EXP

Amphetamine results in decreased expression of TRPM6 mRNA

NCBI chr 1:225,559,528...225,747,106
Ensembl chr 1:225,576,872...225,747,108

G

transient receptor potential cation channel, subfamily V, member 3

decreases expression

EXP

Amphetamine results in decreased expression of TRPV3 mRNA

NCBI chr10:58,382,054...58,413,657
Ensembl chr10:58,382,054...58,411,800

G

transformation/transcription domain-associated protein

decreases expression

EXP

Amphetamine results in decreased expression of TRRAP mRNA

NCBI chr12:14,851,758...14,941,444
Ensembl chr12:14,851,758...14,941,407

G

TSC22 domain family, member 1

increases expression

EXP

Amphetamine results in increased expression of TSC22D1 mRNA

NCBI chr15:58,159,612...58,260,244
Ensembl chr15:58,159,952...58,183,322

G

TSC22 domain family, member 3

increases expression

EXP

Amphetamine results in increased expression of TSC22D3 mRNA

NCBI chr X:109,006,410...109,066,389
Ensembl chr X:109,006,420...109,015,519

G

thyroid stimulating hormone receptor

decreases expression

EXP

Amphetamine results in decreased expression of TSHR mRNA

NCBI chr 6:116,072,321...116,206,009
Ensembl chr 6:116,072,281...116,206,010

G

teashirt zinc finger homeobox 1

decreases expression

EXP

Amphetamine results in decreased expression of TSHZ1 mRNA

NCBI chr18:79,651,256...79,727,662
Ensembl chr18:79,651,256...79,727,662

G

tetraspanin 31

increases expression

EXP

Amphetamine results in increased expression of TSPAN31 mRNA

NCBI chr 7:64,774,881...64,783,534
Ensembl chr 7:64,774,910...64,777,726

G

tetraspanin 8

increases expression

EXP

Amphetamine results in increased expression of TSPAN8 mRNA

NCBI chr 7:53,331,019...53,365,402
Ensembl chr 7:53,330,963...53,365,401

G

translocator protein

increases expression

EXP

Amphetamine results in increased expression of TSPO mRNA

NCBI chr 7:116,600,214...116,610,461
Ensembl chr 7:116,600,210...116,610,460

G

TSPO associated protein 1

decreases expression

EXP

Amphetamine results in decreased expression of TSPOAP1 mRNA

NCBI chr10:73,053,414...73,083,640
Ensembl chr10:73,058,354...73,083,640

G

testis specific protein, Y-linked 26

decreases expression

EXP

Amphetamine results in decreased expression of TSPYL3 mRNA

NCBI chr 3:162,150,885...162,152,961
Ensembl chr 3:162,149,203...162,153,204

G

TSR2, ribosome maturation factor

decreases expression

EXP

Amphetamine results in decreased expression of TSR2 mRNA

NCBI chr X:23,507,141...23,515,711
Ensembl chr X:23,507,142...23,515,659

G

thiosulfate sulfurtransferase like domain containing 3

increases expression

EXP

Amphetamine results in increased expression of TSTD3 mRNA

NCBI chr 5:40,091,438...40,101,509
Ensembl chr 5:40,065,807...40,100,878

G

tau tubulin kinase 1

decreases expression

EXP

Amphetamine results in decreased expression of TTBK1 mRNA

NCBI chr 9:21,990,973...22,035,961
Ensembl chr 9:21,990,973...22,035,961

G

tetratricopeptide repeat domain 23

increases expression

EXP

Amphetamine results in increased expression of TTC23 mRNA

NCBI chr 1:130,656,040...130,739,670
Ensembl chr 1:130,656,110...130,739,673

G

tetratricopeptide repeat domain 28

decreases expression

EXP

Amphetamine results in decreased expression of TTC28 mRNA

NCBI chr12:51,002,816...51,443,461
Ensembl chr12:51,005,089...51,443,531

G

transcription termination factor 2

decreases expression

EXP

Amphetamine results in decreased expression of TTF2 mRNA

NCBI chr 2:191,054,942...191,086,331
Ensembl chr 2:191,054,966...191,086,386

G

tubulin tyrosine ligase like 4

decreases expression

EXP

Amphetamine results in decreased expression of TTLL4 mRNA

NCBI chr 9:83,670,788...83,706,891
Ensembl chr 9:83,681,025...83,700,404

G

tubulin tyrosine ligase like 7

decreases expression

EXP

Amphetamine results in decreased expression of TTLL7 mRNA

NCBI chr 2:238,425,786...238,549,296
Ensembl chr 2:238,426,076...238,545,960

G

alpha tocopherol transfer protein like

decreases expression

EXP

Amphetamine results in decreased expression of TTPAL mRNA

NCBI chr 3:172,697,683...172,715,973
Ensembl chr 3:172,697,729...172,715,983

G

tubulin, alpha 1A

decreases expression

EXP

Amphetamine results in decreased expression of TUBA1A mRNA

NCBI chr 7:131,992,151...131,996,850
Ensembl chr 7:131,968,770...131,996,035

G

tubulin, alpha 4A

increases expression

EXP

Amphetamine results in increased expression of TUBA4A mRNA

NCBI chr 9:84,158,871...84,174,041
Ensembl chr 9:84,158,280...84,162,584

G

tubulin, beta 2B class IIb

increases expression

EXP

Amphetamine results in increased expression of TUBB2B mRNA

NCBI chr17:30,953,086...30,956,133
Ensembl chr17:30,952,923...30,955,990

G

tubulin, beta 3 class III

increases expression

EXP

Amphetamine results in increased expression of TUBB3 mRNA

NCBI chr19:68,365,687...68,374,741
Ensembl chr19:68,365,587...68,374,740

G

tubulin, delta 1

decreases expression

EXP

Amphetamine results in decreased expression of TUBD1 mRNA

NCBI chr10:71,865,446...71,888,731
Ensembl chr10:71,864,904...71,888,730

G

tubulin, epsilon 1

decreases expression

EXP

Amphetamine results in decreased expression of TUBE1 mRNA

NCBI chr20:44,105,405...44,124,947
Ensembl chr20:44,107,022...44,125,271

G

tubulin gamma complex component 6

decreases expression

EXP

Amphetamine results in decreased expression of TUBGCP6 mRNA

NCBI chr 7:122,057,328...122,078,639
Ensembl chr 7:122,057,328...122,078,490

G

TUB like protein 4

decreases expression

EXP

Amphetamine results in decreased expression of TULP4 mRNA

NCBI chr 1:49,082,492...49,218,262
Ensembl chr 1:49,087,886...49,218,250

G

tumor suppressor candidate 3

increases expression

EXP

Amphetamine results in increased expression of TUSC3 mRNA

NCBI chr16:59,899,642...60,048,813
Ensembl chr16:59,899,091...60,048,215

G

twinfilin actin-binding protein 1

increases expression

EXP

Amphetamine results in increased expression of TWF1 mRNA

NCBI chr 7:127,595,210...127,607,821
Ensembl chr 7:127,595,210...127,607,105

G

taxilin alpha

decreases expression

EXP

Amphetamine results in decreased expression of TXLNA mRNA

NCBI chr 5:147,253,694...147,269,410
Ensembl chr 5:147,255,649...147,269,273

G

taxilin beta

increases expression

EXP

Amphetamine results in increased expression of TXLNB mRNA

NCBI chr 1:14,224,647...14,269,837
Ensembl chr 1:14,195,329...14,269,835

G

thioredoxin domain containing 16

decreases expression

EXP

Amphetamine results in decreased expression of TXNDC16 mRNA

NCBI chr15:20,831,541...20,905,661
Ensembl chr15:20,831,391...20,905,452

G

transmembrane immune signaling adaptor Tyrobp

increases expression

EXP

Amphetamine results in increased expression of TYROBP mRNA

NCBI chr 1:94,800,372...94,804,307
Ensembl chr 1:94,800,117...94,804,299

G

trypsin like peroxisomal matrix peptidase 1

decreases expression

EXP

Amphetamine results in decreased expression of TYSND1 mRNA

NCBI chr20:30,180,878...30,188,239
Ensembl chr20:30,181,090...30,188,236

G

tRNA-yW synthesizing protein 1 homolog

decreases expression

EXP

Amphetamine results in decreased expression of TYW1 mRNA

NCBI chr12:31,968,198...32,054,454
Ensembl chr12:31,968,198...32,054,647

G

uveal autoantigen with coiled-coil domains and ankyrin repeats

increases expression

EXP

Amphetamine results in increased expression of UACA mRNA

NCBI chr 8:70,155,059...70,243,416
Ensembl chr 8:70,155,047...70,243,415

G

ubiquitin associated protein 1-like

increases expression

EXP

Amphetamine results in increased expression of UBAP1L mRNA

NCBI chr 8:74,772,794...74,792,753
Ensembl chr 8:74,781,395...74,792,716

G

ubiquitin-associated protein 2

decreases expression

EXP

Amphetamine results in decreased expression of UBAP2 mRNA

NCBI chr 5:61,144,182...61,233,355
Ensembl chr 5:61,144,182...61,232,828

G

ubiquitin associated and SH3 domain containing, A

decreases expression

EXP

Amphetamine results in decreased expression of UBASH3A mRNA

NCBI chr20:9,292,819...9,336,036
Ensembl chr20:9,287,590...9,344,772

G

ubiquitin D

decreases expression

EXP

Amphetamine results in decreased expression of UBD mRNA

NCBI chr20:1,390,734...1,392,685
Ensembl chr20:1,390,600...1,413,965

G

ubiquitin protein ligase E3A

decreases expression

EXP

Amphetamine results in decreased expression of UBE3A mRNA

NCBI chr 1:119,204,244...119,297,097
Ensembl chr 1:119,206,148...119,297,097

G

ubiquitin-like 3

increases expression

EXP

Amphetamine results in increased expression of UBL3 mRNA

NCBI chr12:11,509,912...11,554,548
Ensembl chr12:11,509,848...11,554,547

G

ubiquitin protein ligase E3 component n-recognin 5

increases expression

EXP

Amphetamine results in increased expression of UBR5 mRNA

NCBI chr 7:71,000,197...71,109,841
Ensembl chr 7:71,000,197...71,109,813

G

ubiquitin domain containing 1

increases expression

EXP

Amphetamine results in increased expression of UBTD1 mRNA

NCBI chr 1:250,743,883...250,795,103
Ensembl chr 1:250,743,883...250,795,096

G

uncoupling protein 3

increases expression

EXP

Amphetamine results in increased expression of UCP3 mRNA

NCBI chr 1:164,227,910...164,240,893
Ensembl chr 1:164,227,882...164,241,210

G

UFM1-specific peptidase 2

increases expression

EXP

Amphetamine results in increased expression of UFSP2 mRNA

NCBI chr16:53,004,590...53,023,640
Ensembl chr16:53,004,598...53,023,592

G

UDP glucuronosyltransferase 1 family, polypeptide A7C

increases expression

EXP

Amphetamine results in increased expression of UGT1A8 mRNA

NCBI chr 9:96,187,382...96,256,264
Ensembl chr 9:96,144,786...96,256,264

G

unc-51 like autophagy activating kinase 1

increases expression

EXP

Amphetamine results in increased expression of ULK1 mRNA

NCBI chr12:51,511,492...51,537,746
Ensembl chr12:51,511,492...51,537,746

G

unc-51 like kinase 4

increases expression

EXP

Amphetamine results in increased expression of ULK4 mRNA

NCBI chr 8:129,548,431...129,843,555
Ensembl chr 8:129,548,431...129,843,501

G

unc-13 homolog A

decreases expression

EXP

Amphetamine results in decreased expression of UNC13A mRNA

NCBI chr16:18,367,891...18,415,808
Ensembl chr16:18,367,919...18,415,899

G

unc-5 netrin receptor B

decreases expression

EXP

Amphetamine results in decreased expression of UNC5B mRNA

NCBI chr20:29,240,639...29,307,270
Ensembl chr20:29,240,650...29,307,270

G

unc-79 homolog, NALCN channel complex subunit

decreases expression

EXP

Amphetamine results in decreased expression of UNC79 mRNA

NCBI chr 6:127,841,671...128,092,380
Ensembl chr 6:127,848,074...128,092,995

G

uracil-DNA glycosylase

decreases expression

EXP

Amphetamine results in decreased expression of UNG mRNA

NCBI chr12:48,145,838...48,154,789
Ensembl chr12:48,145,838...48,155,257

G

unk zinc finger

decreases expression

EXP

Amphetamine results in decreased expression of UNK mRNA

NCBI chr10:101,764,732...101,794,847
Ensembl chr10:101,757,648...101,794,845

G

uroplakin 1B

increases expression

EXP

Amphetamine results in increased expression of UPK1B mRNA

NCBI chr11:75,459,244...75,496,579
Ensembl chr11:75,459,200...75,496,579

G

uridine phosphorylase 1

increases expression

EXP

Amphetamine results in increased expression of UPP1 mRNA

NCBI chr14:88,023,155...88,043,036
Ensembl chr14:88,023,351...88,043,034

G

uridine phosphorylase 2

increases expression

EXP

Amphetamine results in increased expression of UPP2 mRNA

NCBI chr 3:63,681,671...63,726,194
Ensembl chr 3:63,681,826...63,726,191

G

uracil phosphoribosyltransferase homolog

decreases expression

EXP

Amphetamine results in decreased expression of UPRT mRNA

NCBI chr X:73,582,267...73,612,488
Ensembl chr X:73,582,361...73,612,496

G

URB1 ribosome biogenesis homolog

decreases expression

EXP

Amphetamine results in decreased expression of URB1 mRNA

NCBI chr11:43,490,633...43,551,398
Ensembl chr11:43,490,633...43,551,767

G

ubiquitin specific peptidase 24

decreases expression

EXP

Amphetamine results in decreased expression of USP24 mRNA

NCBI chr 5:126,309,396...126,439,147
Ensembl chr 5:126,309,597...126,439,135

G

ubiquitin specific peptidase 3

increases expression

EXP

Amphetamine results in increased expression of USP3 mRNA

NCBI chr 8:75,973,278...76,049,151
Ensembl chr 8:75,974,615...76,049,153

G

ubiquitin specific peptidase 31

decreases expression

EXP

Amphetamine results in decreased expression of USP31 mRNA

NCBI chr 1:185,642,631...185,709,499
Ensembl chr 1:185,581,444...185,709,464

G

ubiquitin specific peptidase 36

decreases expression

EXP

Amphetamine results in decreased expression of USP36 mRNA

NCBI chr10:103,995,970...104,027,492
Ensembl chr10:103,995,970...104,023,450

G

ubiquitin specific peptidase 40

decreases expression

EXP

Amphetamine results in decreased expression of USP40 mRNA

NCBI chr 9:96,055,741...96,126,766
Ensembl chr 9:96,055,741...96,126,721

G

ubiquitin specific peptidase 44

decreases expression

EXP

Amphetamine results in decreased expression of USP44 mRNA

NCBI chr 7:30,251,142...30,301,185
Ensembl chr 7:30,251,205...30,297,906

G

USP6 N-terminal like

decreases expression

EXP

Amphetamine results in decreased expression of USP6NL mRNA

NCBI chr17:76,737,870...76,865,953
Ensembl chr17:76,739,906...76,865,373

G

uronyl-2-sulfotransferase

decreases expression

EXP

Amphetamine results in decreased expression of UST mRNA

NCBI chr 1:4,487,316...4,782,579
Ensembl chr 1:4,489,925...4,782,356

G

UTP20 small subunit processome component

decreases expression

EXP

Amphetamine results in decreased expression of UTP20 mRNA

NCBI chr 7:25,022,029...25,103,024
Ensembl chr 7:25,022,036...25,103,041

G

UTP25 small subunit processome component

decreases expression

EXP

Amphetamine results in decreased expression of UTP25 mRNA

NCBI chr13:107,159,092...107,180,361
Ensembl chr13:107,149,183...107,180,361

G

UV radiation resistance associated

decreases expression

EXP

Amphetamine results in decreased expression of UVRAG mRNA

NCBI chr 1:162,596,514...162,854,348
Ensembl chr 1:162,596,515...162,854,348

G

vesicle-associated membrane protein 1

decreases expression

EXP

Amphetamine results in decreased expression of VAMP1 mRNA

NCBI chr 4:159,698,894...159,705,582
Ensembl chr 4:159,698,629...159,713,608

G

vesicle-associated membrane protein 8

increases expression

EXP

Amphetamine results in increased expression of VAMP8 mRNA

NCBI chr 4:106,000,570...106,011,081
Ensembl chr 4:106,000,570...106,011,073

G

VAMP associated protein A

increases expression

EXP

Amphetamine results in increased expression of VAPA mRNA

NCBI chr 9:112,624,791...112,654,731
Ensembl chr 9:112,624,794...112,654,731

G

valyl-tRNA synthetase 1

decreases expression

EXP

Amphetamine results in decreased expression of VARS1 mRNA

NCBI chr20:3,810,427...3,825,193
Ensembl chr20:3,810,429...3,824,951

G

valyl-tRNA synthetase 2, mitochondrial

decreases expression

EXP

Amphetamine results in decreased expression of VARS2 mRNA

NCBI chr20:3,081,869...3,092,907
Ensembl chr20:3,081,893...3,092,901

G

vav guanine nucleotide exchange factor 2

decreases expression

EXP

Amphetamine results in decreased expression of VAV2 mRNA

NCBI chr 3:30,982,754...31,152,116
Ensembl chr 3:30,982,754...31,152,116

G

versican

increases expression

EXP

Amphetamine results in increased expression of VCAN mRNA

NCBI chr 2:22,497,035...22,595,955
Ensembl chr 2:22,497,035...22,595,955

G

vascular endothelial growth factor A

increases expression

EXP

Amphetamine results in increased expression of VEGFA mRNA

NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194

G

vestigial-like family member 4

decreases expression

EXP

Amphetamine results in decreased expression of VGLL4 mRNA

NCBI chr 4:149,598,151...149,711,186
Ensembl chr 4:149,598,891...149,660,594

G

vimentin

increases expression

EXP

Amphetamine results in increased expression of VIM mRNA

NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746

G

vasoactive intestinal peptide receptor 1

decreases expression

EXP

Amphetamine results in decreased expression of VIPR1 mRNA

NCBI chr 8:130,181,219...130,217,098
Ensembl chr 8:130,187,731...130,217,096

G

vacuole membrane protein 1

increases expression

EXP

Amphetamine results in increased expression of VMP1 mRNA

NCBI chr10:71,903,223...72,002,337
Ensembl chr10:71,903,227...72,002,319

G

vomeronasal 2 receptor, 48

increases expression

EXP

Amphetamine results in increased expression of VOM2R48 mRNA

NCBI chr 4:158,347,664...158,388,644
Ensembl chr 4:158,347,664...158,388,644

G

VPS29 retromer complex component

increases expression

EXP

Amphetamine results in increased expression of VPS29 mRNA

NCBI chr12:39,869,688...39,878,732
Ensembl chr12:39,869,688...39,878,848

G

VPS54 subunit of GARP complex

increases expression

EXP

Amphetamine results in increased expression of VPS54 mRNA

NCBI chr14:99,580,120...99,657,178
Ensembl chr14:99,580,148...99,657,164

G

VPS9 domain containing 1

increases expression

EXP

Amphetamine results in increased expression of VPS9D1 mRNA

NCBI chr19:68,185,517...68,199,469
Ensembl chr19:68,185,517...68,199,244

G

V-set and immunoglobulin domain containing 10 like

increases expression

EXP

Amphetamine results in increased expression of VSIG10L mRNA

NCBI chr 1:103,007,933...103,016,161
Ensembl chr 1:103,008,095...103,016,790

G

von Willebrand factor A domain containing 5B2

decreases expression

EXP

Amphetamine results in decreased expression of VWA5B2 mRNA

NCBI chr11:93,810,456...93,827,609
Ensembl chr11:93,810,739...93,826,205

G

WD repeat domain 19

increases expression

EXP

Amphetamine results in increased expression of WDR19 mRNA

NCBI chr14:43,396,130...43,460,012
Ensembl chr14:43,397,835...43,459,939

G

WD repeat domain 25

decreases expression

EXP

Amphetamine results in decreased expression of WDR25 mRNA

NCBI chr 6:133,571,790...133,704,154
Ensembl chr 6:133,571,804...133,704,145

G

WD repeat domain 38

increases expression

EXP

Amphetamine results in increased expression of WDR38 mRNA

NCBI chr 3:43,158,737...43,169,466
Ensembl chr 3:43,158,785...43,166,856

G

WD repeat domain 4

decreases expression

EXP

Amphetamine results in decreased expression of WDR4 mRNA

NCBI chr20:9,588,532...9,604,718
Ensembl chr20:9,588,532...9,605,007

G

WD repeat domain 54

increases expression

EXP

Amphetamine results in increased expression of WDR54 mRNA

NCBI chr 4:117,212,677...117,236,456
Ensembl chr 4:117,212,677...117,219,270

G

WD repeat domain 6

decreases expression

EXP

Amphetamine results in decreased expression of WDR6 mRNA

NCBI chr 8:118,146,608...118,153,024
Ensembl chr 8:118,146,608...118,153,092

G

WD repeat domain 76

decreases expression

EXP

Amphetamine results in decreased expression of WDR76 mRNA

NCBI chr 3:128,910,500...128,945,241
Ensembl chr 3:128,910,503...128,945,239

G

WAP four-disulfide core domain 15B

increases expression

EXP

Amphetamine results in increased expression of WFDC15B mRNA

NCBI chr 3:173,308,835...173,318,772
Ensembl chr 3:173,309,503...173,318,772

G

whirlin

increases expression

EXP

Amphetamine results in increased expression of WHRN mRNA

NCBI chr 5:81,843,820...81,933,400
Ensembl chr 5:81,843,820...81,927,381

G

WAS/WASL interacting protein family, member 3

decreases expression

EXP

Amphetamine results in decreased expression of WIPF3 mRNA

NCBI chr 4:84,880,403...84,960,250
Ensembl chr 4:84,880,740...84,961,524

G

Wnt family member 11

increases expression

EXP

Amphetamine results in increased expression of WNT11 mRNA

NCBI chr 1:162,545,660...162,565,456
Ensembl chr 1:162,545,680...162,564,660

G

X-C motif chemokine receptor 1

increases expression

EXP

Amphetamine results in increased expression of XCR1 mRNA

NCBI chr 8:132,357,020...132,393,596
Ensembl chr 8:132,357,020...132,385,862

G

XK related, X-linked

decreases expression

EXP

Amphetamine results in decreased expression of XKRX mRNA

NCBI chr X:101,634,438...101,733,814
Ensembl chr X:101,635,283...101,646,461

G

XPC complex subunit, DNA damage recognition and repair factor

increases expression

EXP

Amphetamine results in increased expression of XPC mRNA

NCBI chr 4:125,550,833...125,578,084
Ensembl chr 4:125,550,833...125,578,305

G

X-ray repair cross complementing 3

decreases expression

EXP

Amphetamine results in decreased expression of XRCC3 mRNA

NCBI chr 6:136,684,558...136,694,822
Ensembl chr 6:136,684,558...136,694,822

G

xylosyltransferase 2

decreases expression

EXP

Amphetamine results in decreased expression of XYLT2 mRNA

NCBI chr10:80,102,776...80,116,346
Ensembl chr10:80,102,873...80,116,257

G

YEATS domain containing 2

decreases expression

EXP

Amphetamine results in decreased expression of YEATS2 mRNA

NCBI chr11:94,247,538...94,333,652
Ensembl chr11:94,247,538...94,333,292

G

YLP motif containing 1

decreases expression

EXP

Amphetamine results in decreased expression of YLPM1 mRNA

NCBI chr 6:110,373,371...110,449,578
Ensembl chr 6:110,373,686...110,449,578

G

yippee-like 4

increases expression

EXP

Amphetamine results in increased expression of YPEL4 mRNA

NCBI chr 3:90,222,060...90,227,395
Ensembl chr 3:90,222,803...90,227,381

G

zeta chain of T cell receptor associated protein kinase 70

decreases expression

EXP

Amphetamine results in decreased expression of ZAP70 mRNA

NCBI chr 9:46,485,605...46,507,552
Ensembl chr 9:46,485,598...46,509,062

G

zinc finger BED-type containing 5

increases expression

EXP

Amphetamine results in increased expression of ZBED5 mRNA

NCBI chr12:32,443,687...32,449,817
Ensembl chr12:32,443,763...32,449,817

G

Z-DNA binding protein 1

decreases expression

EXP

Amphetamine results in decreased expression of ZBP1 mRNA

NCBI chr 3:182,411,665...182,427,604
Ensembl chr 3:182,411,665...182,422,839

G

zinc finger and BTB domain containing 1

decreases expression

EXP

Amphetamine results in decreased expression of ZBTB1 mRNA

NCBI chr 6:100,832,506...100,864,019
Ensembl chr 6:100,838,714...100,852,643

G

zinc finger and BTB domain containing 12

decreases expression

EXP

Amphetamine results in decreased expression of ZBTB12 mRNA

NCBI chr20:3,942,302...3,945,148
Ensembl chr20:3,941,411...3,945,020

G

zinc finger and BTB domain containing 18

decreases expression

EXP

Amphetamine results in decreased expression of ZBTB18 mRNA

NCBI chr13:91,971,602...91,980,058
Ensembl chr13:91,969,755...91,980,386

G

zinc finger and BTB domain containing 25

decreases expression

EXP

Amphetamine results in decreased expression of ZBTB25 mRNA

NCBI chr 6:100,807,083...100,831,555
Ensembl chr 6:100,810,961...100,830,135

G

zinc finger and BTB domain containing 3

decreases expression

EXP

Amphetamine results in decreased expression of ZBTB3 mRNA

NCBI chr 1:215,125,200...215,127,517
Ensembl chr 1:215,112,991...215,139,026

G

zinc finger and BTB domain containing 32

decreases expression

EXP

Amphetamine results in decreased expression of ZBTB32 mRNA

NCBI chr 1:94,969,374...94,978,553
Ensembl chr 1:94,969,374...94,971,679

G

zinc finger and BTB domain containing 38

decreases expression

EXP

Amphetamine results in decreased expression of ZBTB38 mRNA

NCBI chr 8:106,124,181...106,231,215
Ensembl chr 8:106,157,084...106,230,951

G

zinc finger and BTB domain containing 39

decreases expression

EXP

Amphetamine results in decreased expression of ZBTB39 mRNA

NCBI chr 7:65,462,255...65,469,806
Ensembl chr 7:65,462,018...65,485,601

G

zinc finger and BTB domain containing 4

decreases expression

EXP

Amphetamine results in decreased expression of ZBTB4 mRNA

NCBI chr10:54,979,421...55,000,215
Ensembl chr10:54,979,648...55,000,215

G

zinc finger and BTB domain containing 40

decreases expression

EXP

Amphetamine results in decreased expression of ZBTB40 mRNA

NCBI chr 5:154,499,952...154,569,390
Ensembl chr 5:154,503,128...154,537,863

G

zinc finger and BTB domain containing 9

decreases expression

EXP

Amphetamine results in decreased expression of ZBTB9 mRNA

NCBI chr20:5,059,296...5,069,422
Ensembl chr20:5,059,297...5,067,144

G

zinc finger CCCH type containing 6

decreases expression

EXP

Amphetamine results in decreased expression of ZC3H6 mRNA

NCBI chr 3:136,656,116...136,717,560
Ensembl chr 3:136,657,414...136,706,504

G

zinc finger CCCH-type containing 7B

decreases expression

EXP

Amphetamine results in decreased expression of ZC3H7B mRNA

NCBI chr 7:115,142,245...115,190,513
Ensembl chr 7:115,142,420...115,190,513

G

ZC3HAV1 like

decreases expression

EXP

Amphetamine results in decreased expression of ZC3HAV1L mRNA

NCBI chr 4:67,957,250...67,972,540
Ensembl chr 4:67,961,862...67,968,837

G

zinc finger CCHC-type containing 12

increases expression

EXP

Amphetamine results in increased expression of ZCCHC12 mRNA

NCBI chr X:120,299,138...120,302,465
Ensembl chr X:120,298,652...120,302,614

G

zinc finger, DHHC-type containing 1

increases expression

EXP

Amphetamine results in increased expression of ZDHHC1 mRNA

NCBI chr19:50,260,445...50,285,634
Ensembl chr19:50,260,445...50,271,957

G

zinc finger DHHC-type palmitoyltransferase 21

decreases expression

EXP

Amphetamine results in decreased expression of ZDHHC21 mRNA

NCBI chr 5:102,273,561...102,333,174
Ensembl chr 5:102,278,710...102,327,247

G

zinc finger DHHC-type palmitoyltransferase 8

decreases expression

EXP

Amphetamine results in decreased expression of ZDHHC8 mRNA

NCBI chr11:96,259,383...96,273,588
Ensembl chr11:96,259,449...96,284,003

G

zinc finger protein 112

decreases expression

EXP

Amphetamine results in decreased expression of ZFP112 mRNA

NCBI chr 1:88,804,833...88,819,889
Ensembl chr 1:88,813,821...88,819,761

G

ZFP14 zinc finger protein

decreases expression

EXP

Amphetamine results in decreased expression of ZFP968 mRNA

NCBI chr 1:94,396,055...94,413,338
Ensembl chr 1:94,396,057...94,413,534

G

zinc finger protein 169

decreases expression

EXP

Amphetamine results in decreased expression of ZFP169 mRNA

NCBI chr17:16,345,569...16,379,079
Ensembl chr17:16,345,647...16,373,928

G

zinc finger protein 202

decreases expression

EXP

Amphetamine results in decreased expression of ZFP202 mRNA

NCBI chr 8:49,439,849...49,460,117
Ensembl chr 8:49,447,840...49,459,900

G

zinc finger protein 213

decreases expression

EXP

Amphetamine results in decreased expression of ZFP213 mRNA

NCBI chr10:13,096,995...13,103,918
Ensembl chr10:13,096,840...13,103,908

G

zinc finger protein 248

decreases expression

EXP

Amphetamine results in decreased expression of ZNF248 mRNA

NCBI chr 4:153,277,735...153,302,545
Ensembl chr 4:153,277,736...153,301,941

G

zinc finger protein 251

decreases expression

EXP

Amphetamine results in decreased expression of ZFP251 mRNA

NCBI chr 7:110,449,194...110,479,218
Ensembl chr 7:110,449,194...110,479,218

G

zinc finger protein 275

decreases expression

EXP

Amphetamine results in decreased expression of ZFP275 mRNA

NCBI chr X:156,208,873...156,225,732
Ensembl chr X:156,208,914...156,225,617

G

zinc finger protein (C2H2 type) 276

increases expression

EXP

Amphetamine results in increased expression of ZFP276 mRNA

NCBI chr19:68,199,709...68,212,757
Ensembl chr19:68,199,265...68,212,757

G

zinc finger protein 280B

decreases expression

EXP

Amphetamine results in decreased expression of ZFP280B mRNA

NCBI chr20:12,626,550...12,641,383
Ensembl chr20:12,626,259...12,646,139

G

zinc finger protein 286A

decreases expression

EXP

Amphetamine results in decreased expression of ZFP286A mRNA

NCBI chr10:47,949,698...47,960,496
Ensembl chr10:47,949,699...47,960,606

G

zinc finger protein 287

decreases expression

EXP

Amphetamine results in decreased expression of ZFP287 mRNA

NCBI chr10:47,896,517...47,914,860
Ensembl chr10:47,896,517...47,914,950

G

zinc finger protein 3

decreases expression

EXP

Amphetamine results in decreased expression of ZFP3 mRNA

NCBI chr10:55,977,027...55,985,284
Ensembl chr10:55,976,318...55,988,741

G

zinc finger protein 318

decreases expression

EXP

Amphetamine results in decreased expression of ZFP318 mRNA

NCBI chr 9:22,060,899...22,100,174
Ensembl chr 9:22,060,916...22,099,551

G

zinc finger protein 319

decreases expression

EXP

Amphetamine results in decreased expression of ZFP319 mRNA

NCBI chr19:9,708,881...9,712,860
Ensembl chr19:9,707,983...9,728,711

G

zinc finger protein 362

decreases expression

EXP

Amphetamine results in decreased expression of ZFP362 mRNA

NCBI chr 5:146,403,469...146,437,707
Ensembl chr 5:146,404,294...146,437,163

G

zinc finger protein 365

decreases expression

EXP

Amphetamine results in decreased expression of ZFP365 mRNA

NCBI chr20:20,665,122...20,688,607
Ensembl chr20:20,665,046...20,690,114

G

zinc finger protein 382

decreases expression

EXP

Amphetamine results in decreased expression of ZFP382 mRNA

NCBI chr 1:94,504,344...94,528,316
Ensembl chr 1:94,505,067...94,528,334

G

zinc finger protein 385C

decreases expression

EXP

Amphetamine results in decreased expression of ZFP385C mRNA

NCBI chr10:86,062,329...86,118,454
Ensembl chr10:86,062,512...86,106,063

G

zinc finger protein 395

decreases expression

EXP

Amphetamine results in decreased expression of ZFP395 mRNA

NCBI chr15:43,757,350...43,797,513
Ensembl chr15:43,757,473...43,797,512

G

zinc finger protein 398

decreases expression

EXP

Amphetamine results in decreased expression of ZFP398 mRNA

NCBI chr 4:78,180,620...78,214,367
Ensembl chr 4:78,180,561...78,207,187

G

zinc finger protein 41

decreases expression

EXP

Amphetamine results in decreased expression of ZFP41 mRNA

NCBI chr 7:109,188,010...109,198,546
Ensembl chr 7:109,187,608...109,214,127

G

zinc finger protein 446

decreases expression

EXP

Amphetamine results in decreased expression of ZFP446 mRNA

NCBI chr 1:82,673,920...82,680,414
Ensembl chr 1:82,673,918...82,685,430

G

zinc finger protein 496

decreases expression

EXP

Amphetamine results in decreased expression of ZFP496 mRNA

NCBI chr10:44,768,463...44,787,386
Ensembl chr10:44,768,468...44,787,190

G

zinc finger protein 507

decreases expression

EXP

Amphetamine results in decreased expression of ZFP507 mRNA

NCBI chr 1:97,572,675...97,605,449
Ensembl chr 1:97,575,133...97,605,405

G

zinc finger protein 512

decreases expression

EXP

Amphetamine results in decreased expression of ZFP512 mRNA

NCBI chr 6:30,696,889...30,727,895
Ensembl chr 6:30,697,426...30,727,966

G

zinc finger protein 512B

decreases expression

EXP

Amphetamine results in decreased expression of ZFP512B mRNA

NCBI chr 3:189,065,036...189,075,587
Ensembl chr 3:189,065,037...189,075,761

G

zinc finger protein 526

decreases expression

EXP

Amphetamine results in decreased expression of ZFP526 mRNA

NCBI chr 1:89,935,604...89,945,669
Ensembl chr 1:89,933,478...89,956,958

G

zinc finger protein 579

decreases expression

EXP

Amphetamine results in decreased expression of ZFP579 mRNA

NCBI chr 1:77,876,367...77,879,591
Ensembl chr 1:77,875,814...77,879,783

G

zinc finger protein 605

decreases expression

EXP

Amphetamine results in decreased expression of ZFP605 mRNA

NCBI chr12:52,202,487...52,234,782
Ensembl chr12:52,205,132...52,234,512

G

zinc finger protein 606

decreases expression

EXP

Amphetamine results in decreased expression of ZFP606 mRNA

NCBI chr 1:82,054,118...82,097,574

G

zinc finger protein 612

decreases expression

EXP

Amphetamine results in decreased expression of ZFP612 mRNA

NCBI chr19:54,963,400...54,976,888
Ensembl chr19:54,963,379...54,977,075

G

zinc finger protein 64

increases expression

EXP

Amphetamine results in increased expression of ZFP64 mRNA

NCBI chr 3:178,085,604...178,114,557
Ensembl chr 3:178,085,605...178,114,557

G

zinc finger protein 641

decreases expression

EXP

Amphetamine results in decreased expression of ZFP641 mRNA

NCBI chr 7:131,313,620...131,324,149
Ensembl chr 7:131,313,624...131,323,691

G

zinc finger protein 683

decreases expression

EXP

Amphetamine results in decreased expression of ZFP683 mRNA

NCBI chr 5:151,558,880...151,569,937
Ensembl chr 5:151,561,480...151,569,764

G

zinc finger protein 703

increases expression

EXP

Amphetamine results in increased expression of ZFP703 mRNA

NCBI chr16:71,779,340...71,783,510
Ensembl chr16:71,779,340...71,783,510

G

zinc finger protein 708

decreases expression

EXP

Amphetamine results in decreased expression of ZFP708 mRNA

NCBI chr 2:86,181,796...86,233,420
Ensembl chr 2:86,182,225...86,190,171

G

zinc finger protein 709

decreases expression

EXP

Amphetamine results in decreased expression of ZFP709 mRNA

NCBI chr16:17,942,986...17,953,720
Ensembl chr16:17,944,162...17,953,463

G

zinc finger protein 710

decreases expression

EXP

Amphetamine results in decreased expression of ZFP710 mRNA

NCBI chr 1:143,375,524...143,445,874
Ensembl chr 1:143,375,271...143,445,874

G

zinc finger protein 768

increases expression

EXP

Amphetamine results in increased expression of ZFP768 mRNA

NCBI chr 1:191,396,807...191,401,880
Ensembl chr 1:191,396,809...191,399,640

G

zinc finger protein 420-like

decreases expression

EXP

Amphetamine results in decreased expression of ZFP790 mRNA

NCBI chr 1:94,166,366...94,180,766
Ensembl chr 1:94,166,320...94,180,765

G

zinc finger protein 799

decreases expression

EXP

Amphetamine results in decreased expression of ZFP799 mRNA

NCBI chr 7:12,548,586...12,561,317
Ensembl chr 7:12,550,400...12,561,507

G

zinc finger protein 81

decreases expression

EXP

Amphetamine results in decreased expression of ZFP81 mRNA

NCBI chr 7:13,294,967...13,327,636
Ensembl chr 7:13,297,651...13,318,759

G

zinc finger protein 827

decreases expression

EXP

Amphetamine results in decreased expression of ZFP827 mRNA

NCBI chr19:45,624,849...45,791,739
Ensembl chr19:45,614,604...45,844,430

G

zinc finger protein 862

decreases expression

EXP

Amphetamine results in decreased expression of ZFP862 mRNA

NCBI chr 4:78,783,833...78,812,884

G

zinc finger protein 866

decreases expression

EXP

Amphetamine results in decreased expression of ZFP866 mRNA

NCBI chr16:19,687,869...19,710,407
Ensembl chr16:19,702,297...19,709,330

G

zinc finger protein 873

decreases expression

EXP

Amphetamine results in decreased expression of ZFP873 mRNA

NCBI chr 7:8,577,725...8,602,577
Ensembl chr 7:8,577,999...8,602,710

G

zinc finger protein 879

decreases expression

EXP

Amphetamine results in decreased expression of ZFP980 mRNA

NCBI chr10:35,649,693...35,659,692
Ensembl chr10:35,649,697...35,659,732

G

zinc finger protein 93

increases expression

EXP

Amphetamine results in increased expression of ZFP93 mRNA

NCBI chr 3:178,052,001...178,073,023
Ensembl chr 3:178,052,001...178,073,023

G

zinc finger protein 939

decreases expression

EXP

Amphetamine results in decreased expression of ZFP939 mRNA

NCBI chr 1:100,254,027...100,278,418
Ensembl chr 1:100,264,978...100,278,415

G

zinc finger protein 952

decreases expression

EXP

Amphetamine results in decreased expression of ZFP952 mRNA

NCBI chr 7:12,752,698...12,765,724
Ensembl chr 7:12,754,311...12,765,729

G

zinc finger protein 955A

decreases expression

EXP

Amphetamine results in decreased expression of ZFP967 mRNA

NCBI chr 7:13,406,328...13,420,160
Ensembl chr 7:13,406,540...13,420,371

G

zinc finger FYVE-type containing 21

increases expression

EXP

Amphetamine results in increased expression of ZFYVE21 mRNA

NCBI chr 6:136,695,132...136,715,601
Ensembl chr 6:136,694,908...136,715,601

G

zinc finger FYVE-type containing 27

increases expression

EXP

Amphetamine results in increased expression of ZFYVE27 mRNA

NCBI chr 1:250,929,110...250,952,481
Ensembl chr 1:250,928,012...250,952,481

G

zinc fingers and homeoboxes 2

decreases expression

EXP

Amphetamine results in decreased expression of ZHX2 mRNA

NCBI chr 7:91,115,894...91,263,823
Ensembl chr 7:91,087,186...91,265,181

G

zinc fingers and homeoboxes 3

decreases expression

EXP

Amphetamine results in decreased expression of ZHX3 mRNA

NCBI chr 3:169,837,497...169,968,371
Ensembl chr 3:169,837,516...169,935,530

G

zinc finger with KRAB and SCAN domains 8

decreases expression

EXP

Amphetamine results in decreased expression of ZKSCAN8 mRNA

NCBI chr17:47,735,120...47,753,126
Ensembl chr17:47,735,120...47,753,126

G

zinc finger, matrin type 3

decreases expression

EXP

Amphetamine results in decreased expression of ZMAT3 mRNA

NCBI chr 2:117,034,517...117,066,141
Ensembl chr 2:117,034,517...117,065,294

G

zinc finger, MIZ-type containing 2

decreases expression

EXP

Amphetamine results in decreased expression of ZMIZ2 mRNA

NCBI chr14:85,465,323...85,481,860
Ensembl chr14:85,465,373...85,481,860

G

zinc finger, MYND-type containing 15

decreases expression

EXP

Amphetamine results in decreased expression of ZMYND15 mRNA

NCBI chr10:55,669,832...55,676,446
Ensembl chr10:55,669,752...55,676,434

G

zinc finger protein 48

decreases expression

EXP

Amphetamine results in decreased expression of ZFP553 mRNA

NCBI chr 1:191,284,976...191,289,482
Ensembl chr 1:191,263,224...191,291,307

G

zinc and ring finger 3

decreases expression

EXP

Amphetamine results in decreased expression of ZNRF3 mRNA

NCBI chr14:84,375,668...84,527,465
Ensembl chr14:84,374,412...84,527,448

G

zona pellucida glycoprotein 1

increases expression

EXP

Amphetamine results in increased expression of ZP1 mRNA

NCBI chr 1:216,984,343...216,993,882
Ensembl chr 1:216,985,768...216,992,148

G

zona pellucida binding protein 2

decreases expression

EXP

Amphetamine results in decreased expression of ZPBP2 mRNA

NCBI chr10:84,055,184...84,063,776
Ensembl chr10:84,055,244...84,063,774

G

zinc finger (CCCH type), RNA binding motif and serine/arginine rich 2

decreases expression

EXP

Amphetamine results in decreased expression of ZRSR2 mRNA

NCBI chr X:34,179,279...34,201,989
Ensembl chr X:34,179,311...34,201,986

G

zinc finger and SCAN domain containing 2

decreases expression

EXP

Amphetamine results in decreased expression of ZSCAN2 mRNA

NCBI chr 1:144,243,082...144,258,192
Ensembl chr 1:144,242,595...144,258,188

G

zinc finger and SCAN domain containing 20

decreases expression

EXP

Amphetamine results in decreased expression of ZSCAN20 mRNA

NCBI chr 5:146,214,023...146,240,678
Ensembl chr 5:146,215,082...146,240,777

G

zinc finger and SCAN domain containing 25

decreases expression

EXP

Amphetamine results in decreased expression of ZSCAN25 mRNA

NCBI chr12:14,441,458...14,451,919
Ensembl chr12:14,441,458...14,451,985

G

zinc finger and SCAN domain containing 26

decreases expression

EXP

Amphetamine results in decreased expression of ZSCAN26 mRNA

NCBI chr17:47,843,822...47,863,799
Ensembl chr17:47,807,150...47,863,790

G

zinc finger, SWIM-type containing 5

decreases expression

EXP

Amphetamine results in decreased expression of ZSWIM5 mRNA

NCBI chr 5:135,583,356...135,700,390
Ensembl chr 5:135,582,724...135,700,390

Term paths to the root

Path 1
Term	Annotations
CHEBI ontology	20874
role	20844
biological role	20831
xenobiotic	19528
amphetamine	2238
amphetamine sulfate +	0
Path 2
Term	Annotations
CHEBI ontology	20874
subatomic particle	20883
composite particle	20883
hadron	20872
baryon	20883
nucleon	20872
atomic nucleus	20883
atom	20872
main group element atom	20796
p-block element atom	20796
carbon group element atom	20712
carbon atom	20706
organic molecular entity	20706
heteroorganic entity	20201
organonitrogen compound	19311
organic amino compound	17164
amine	6497
primary amine	2768
1-phenylpropan-2-amine	2364
(R)-amphetamine	2238
amphetamine	2238
amphetamine sulfate +	0

paths to the root